<SEC-DOCUMENT>0001387131-23-004393.txt : 20230403
<SEC-HEADER>0001387131-23-004393.hdr.sgml : 20230403
<ACCEPTANCE-DATETIME>20230403153736
ACCESSION NUMBER:		0001387131-23-004393
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		22
FILED AS OF DATE:		20230403
DATE AS OF CHANGE:		20230403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARTIVION, INC.
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		23792401

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOLIFE INC
		DATE OF NAME CHANGE:	19940526
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>aort-def14a_051623.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:aort="http://cryolife.com/20221231">
<!-- Document Created by Quality EDGAR Solutions Single Source System -->
<!-- Ver. 7h3d0c70r.1.0 (tvnabbpndsdnf) [1680223052866-6106] -->
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_ECD%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_aort_cryolife.com_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000784199 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_071_XDX_aort%2Ddef14a__051623.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCentralIndexKey">0000784199</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  <ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0126" decimals="0" unitRef="USD">454525</ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aort-20221231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_StantonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:StantonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_StantonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:StantonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_SimpsonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:SimpsonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_2">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_3">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000047" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000049" toRefs="Footnote000062"></ix:relationship>
  <ix:relationship fromRefs="Fact000091" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000092" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000093" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000094" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000095" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000096" toRefs="Footnote000127"></ix:relationship>
  <ix:relationship fromRefs="Fact000097" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000098" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000099" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000100" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000101" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000102" toRefs="Footnote000128"></ix:relationship>
  <ix:relationship fromRefs="Fact000103" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000104" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000105" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000106" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000107" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000108" toRefs="Footnote000129"></ix:relationship>
  <ix:relationship fromRefs="Fact000109" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000110" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000111" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000112" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000113" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000114" toRefs="Footnote000130"></ix:relationship>
  <ix:relationship fromRefs="Fact000121" toRefs="Footnote000131"></ix:relationship>
  <ix:relationship fromRefs="Fact000122" toRefs="Footnote000131"></ix:relationship>
  <ix:relationship fromRefs="Fact000123" toRefs="Footnote000131"></ix:relationship>
  <ix:relationship fromRefs="Fact000124" toRefs="Footnote000131"></ix:relationship>
  <ix:relationship fromRefs="Fact000125" toRefs="Footnote000131"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0126" toRefs="Footnote000131"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: uppercase; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: uppercase; font-size: 14pt; font-family: Times New Roman, Times, serif"><b>UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</b><br /></span><span style="text-transform: uppercase; font-family: Times New Roman, Times, serif"><b>WASHINGTON, D.C. 20549</b></span><span id="aort-def14a_051623a285"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: uppercase; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: uppercase; font-size: 14pt; font-family: Times New Roman, Times, serif"><b><span id="xdx_903_edei--DocumentType_dxL_c20220101__20221231_z8lU6iskgdl2" title="::XDX::DEF 14A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE 14A</span></span> INFORMATION</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>Proxy Statement Pursuant to Section 14(a) of the<br />Securities Exchange Act of 1934<br />(Amendment </b></span><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>No. )</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Times New Roman, Times, serif">Filed by the </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">Registrant </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9746;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Times New Roman, Times, serif">Filed by a Party other than the </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">Registrant </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Times New Roman, Times, serif">Check the </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">appropriate box:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif">Preliminary </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">Proxy Statement</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif"></span><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>Confidential, for Use of the Commission Only (as permitted by </b></span><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>Rule 14a-6(e)(2))</b></span></p>
				<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 8pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 10pt; font-family: Times New Roman, Times, serif">&#9746;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 10pt; font-family: Times New Roman, Times, serif; line-height: 12pt">Definitive Proxy Statement</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif">Definitive </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">Additional Materials</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif">Soliciting Material </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">under &#167;240.14a-12</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 20.7pt; border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><span style="text-transform: none; font-size: 16pt; font-family: Times New Roman, Times, serif"><b><span id="xdx_901_edei--EntityRegistrantName_c20220101__20221231_zsCQPlVSEbs6"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityRegistrantName">ARTIVION, INC.</ix:nonNumeric></span></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 16pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: center"><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>(Name of Registrant as Specified In </b></span><span style="text-transform: none; font-family: Times New Roman, Times, serif"><b>Its Charter)</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Times New Roman, Times, serif">Payment of Filing Fee (Check all boxes </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">that apply):</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9746;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif"></span><span style="text-transform: none; font-family: Times New Roman, Times, serif">No </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">fee required.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif">Fee paid previously with </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">preliminary materials.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -41.4pt; text-align: justify"><!--[if IE]><FONT style=" width: 41.4pt; text-indent: -36.0pt; display: inline-block;"><![endif]--><span style="width: 41.4pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#9744;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Times New Roman, Times, serif">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) </span><span style="text-transform: none; font-family: Times New Roman, Times, serif">and 0-11.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 313.52pt; height: 45.85pt; text-align: left">
						<img src="aort-def14a_051623img001.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 313.95pt; margin-top: 0pt; height: 46pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>1655 ROBERTS BOULEVARD, NW<br />KENNESAW, </b></span><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>GEORGIA 30144</b></span></p>
				<p style="border-bottom: #024a76 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0pt 227.7pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #17365d; font-family: Arial, sans-serif"><b>&#160;</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>NOTICE OF ANNUAL </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>MEETING<br />AND<br />PROXY STATEMENT</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">April </span><span style="text-transform: none">3, 2023</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">To </span><span style="text-transform: none">Our Stockholders:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">On behalf of the Board of Directors, we invite you to attend the Annual Meeting of Stockholders of Artivion, Inc. on May 16, 2023 at 9:00 a.m., </span><span style="text-transform: none">EDT</span><span style="text-transform: none">. Given our successful use of the virtual-only format at our last two annual meetings, we have again adopted a virtual-only format for our Annual Meeting this year. The Annual Meeting will be accessible at the following website address: </span><span style="text-decoration: underline; text-transform: none; color: #000000"><span style="text-decoration: underline">https://web.lumiagm.com/295739807</span></span><span style="text-transform: none">. After this year&#8217;s Annual Meeting, we intend to again evaluate the best method for holding our annual stockholder meetings </span><span style="text-transform: none">going forward. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Please review this Notice of Annual Meeting and Proxy Statement, which describes the formal business to be transacted and procedures for voting on matters to be considered during the <span style="text-transform: none">Annual Meeting.</span></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">YOUR VOTE IS IMPORTANT. Regardless of whether you plan to attend the virtual Annual Meeting, we request that you please take a few minutes and follow the instructions provided on the Notice or Proxy Card you received by mail, and further described herein, to review the Proxy Statement and vote your shares via internet, telephone, or mail. You may, of course, choose to attend the Annual Meeting virtually and vote your shares online during the meeting. If you wish to participate in the meeting, you will need your control number </span><span style="text-transform: none">to join. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">However you choose to participate, we encourage you to review this Proxy Statement and vote </span><span style="text-transform: none">your shares. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Sincerely,</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 121.99pt; height: 41.4pt; text-align: left">
						<img src="aort-def14a_051623img002.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 121.89pt; margin-top: 0pt; height: 41.4pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. PATRICK MACKIN<br />Chairman, President, and Chief </span><span style="text-transform: none">Executive Officer</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 313.52pt; height: 45.85pt; text-align: left">
						<img src="aort-def14a_051623img001.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 313.95pt; margin-top: 0pt; height: 46pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>1655 ROBERTS BOULEVARD, NW<br />KENNESAW, </b></span><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>GEORGIA 30144</b></span></p>
				<p style="border-bottom: #024a76 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0pt 227.7pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #17365d; font-family: Arial, sans-serif"><b>&#160;</b></span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></span><span id="aort-def14a_051623a345"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>TO THE STOCKHOLDERS </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>OF ARTIVION,&#160;INC.:</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of ARTIVION,&#160;INC. (the &#8220;Annual Meeting&#8221;) will be held on May 16, 2023 at 9:00 a.m., </span><span style="text-transform: none">EDT</span><span style="text-transform: none">. Like last year, the Annual Meeting will be held as a virtual-only meeting. The Annual Meeting will be accessible at the following website address: https://web.lumiagm.com/295739807, for the </span><span style="text-transform: none">following purposes:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">1.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To elect as directors the nine nominees named in the attached Proxy Statement to serve until the next Annual Meeting of Stockholders or until their successors are duly qualified or until their earlier death, resignation, </span><span style="text-transform: none">or removal.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve, by non-binding vote, the compensation paid to Artivion&#8217;s Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and </span><span style="text-transform: none">narrative discussion.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">3.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve, by non-binding vote, the frequency of stockholder advisory votes on the compensation of our named </span><span style="text-transform: none">executive officers.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">4.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To ratify the preliminary approval of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December </span><span style="text-transform: none">31, 2023.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">5.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash </span><span style="text-transform: none">Incentive Plan. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To transact such other business as may be properly brought before the Annual Meeting or any </span><span style="text-transform: none">adjournments thereof.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Only record holders of Artivion&#8217;s common stock at the close of business on March 22, 2023 will be eligible to vote during the Annual Meeting. Artivion would like for you to attend the Annual Meeting. However, if there is any chance you may not be able to attend the Annual Meeting, please follow the instructions on the Notice or Proxy Card you received by mail to vote via internet, telephone, </span><span style="text-transform: none">or mail.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Important notice regarding the availability of proxy materials for the Annual Meeting of Stockholders to be held on May 16, 2023.</b></span><span style="text-transform: none"> Pursuant to the rules promulgated by the Securities and Exchange Commission, we have elected to provide access to our proxy materials by notifying you of the availability of our proxy materials, including the Annual Meeting notice, Proxy Statement, and our 2022 Annual Report to Stockholders, both via internet at </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">ht</span></span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">tp://www.astproxyportal.com/ast/01609</span></span><span style="text-transform: none"> and providing the means whereby you can request a paper copy of proxy materials be sent via </span><span style="text-transform: none">U.S. mail.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">By Order of the Board </span><span style="text-transform: none">of Directors:</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 116.47pt; height: 56.58pt; text-align: left">
						<img src="aort-def14a_051623img003.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 116.14pt; margin-top: 0pt; height: 56.34pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">JEAN F. </span><span style="text-transform: none">HOLLOWAY<br />Corporate Secretary</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Date:  April </span><span style="text-transform: none">3, 2023</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">An electronic copy of Artivion&#8217;s 2022 Annual Report to Stockholders, which includes Artivion&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022, and which contains financial statements, is available via the proxy information website provided on your proxy Notice or </span><span style="text-transform: none">Proxy Card.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">1</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>TABLE OF CONTENTS</b></span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621.68pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 590.64pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 31.04pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Page</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a343"><span style="text-transform: uppercase">QUESTIONS AND ANSWERS REGARDING THIS SOLICITATION AND VOTING DURING THE ANN</span><span style="text-transform: uppercase">UAL MEETIN</span><span style="text-transform: uppercase">G</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a347"><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>PROPOSAL ONE &#8211; ELECTION OF DIRECTORS</b></span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a348"><span style="text-transform: uppercase">CORPORATE GOVERNANCE AND BOARD OF DIRECTORS MATTERS</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">12</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a349"><span style="text-transform: uppercase">PROCEDURES FOR STOCKHOLDERS WHO WISH TO SUBMIT RECOMMENDATIONS TO THE BO</span><span style="text-transform: uppercase">ARD OF DIRECTORS</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">16</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a350"><span style="text-transform: uppercase">ARTIVION, INC.&#8217;S CODE OF CONDUCT</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">17</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a351"><span style="text-transform: uppercase">CORPORATE RESPONSIBILITY</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">17</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a352"><span style="text-transform: uppercase">POLICIES AND PROCEDURES FOR REVIEW, APPROVAL, OR RATIFICATION OF TRANSACTIONS WITH RELATED PARTIES</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">17</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a353"><span style="text-transform: uppercase">COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">18</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a354"><span style="text-transform: uppercase">COMMUNICATION WITH THE BOARD OF DIRECTORS AND ITS COMMITTEES</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">18</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a355"><span style="text-transform: uppercase">AVAILABILITY OF CORPORATE GOVERNANCE DOCUMENTS</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">18</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a344"><span style="text-transform: uppercase">DIRECTOR COMPENSATION</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">19</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a359"><span style="text-transform: uppercase">REPORT OF THE AUDIT COMMITTEE</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">21</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a360"><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>PROPOSAL TWO &#8211; ADVISORY VOTE ON EXECUTIVE OFFICER COMPENSATION&#160;</b></span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">23</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a361"><span style="text-transform: uppercase">COMPENSATION DISCUSSION AND ANALYSIS</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">24</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a372"><span style="text-transform: uppercase">REPORT OF THE COMPENSATION COMMITTEE</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">43</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a390"><span style="text-transform: uppercase">EXECUTIVE OFFICER COMPENSATION</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">44</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a381"><span style="text-transform: uppercase">CERTAIN BENEFICIAL OWNERSHIP</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">68</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a382"><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>PROPOSAL THREE &#8211; &#8220;SAY WHEN ON PAY&#8221; ADVISORY VOTE ON THE FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</b></span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">70</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a383"><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>PROPOSAL FOUR &#8211; RATIFICATION OF THE PRELIMINARY APPROVAL OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#160;</b></span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">71</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a384"><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>PROPOSAL FIVE &#8211; APPROVAL OF ADDITIONAL FUNDING OF 3,040,000 SHARES FOR THE ARTIVION, INC. 2020 EQUITY AND CASH INCENTIVE PLAN&#160;</b></span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">73</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a385"><span style="text-transform: uppercase">HOUSEHOLDING</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">76</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a386"><span style="text-transform: uppercase">TRANSACTION OF OTHER BUSINESS</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">76</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a387"><span style="text-transform: uppercase">WHERE YOU CAN FIND ADDITIONAL INFORMATION</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">76</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a389"><span style="text-transform: uppercase"> APPENDIX A &#8211; ARTIVION&#8217;S 2022 ANNUAL REPORT AND NON-GAAP FINANCIAL MEASURE INFORMATION</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 6pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">A-1</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><a href="#aort-def14a_051623a388"><span style="text-transform: uppercase"> APPENDIX B &#8211; ARTIVION, INC. 2020 EQUITY AND CASH INCENTIVE PLAN</span></a></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">B-1</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">2</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 313.52pt; height: 45.85pt; text-align: left">
						<img src="aort-def14a_051623img001.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 313.95pt; margin-top: 0pt; height: 46pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>1655 ROBERTS BOULEVARD, NW<br />KENNESAW, </b></span><span style="text-transform: none; color: #024a76; font-family: Arial, sans-serif"><b>GEORGIA 30144</b></span></p>
				<p style="border-bottom: #024a76 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0pt 227.7pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #17365d; font-family: Arial, sans-serif"><b>&#160;</b></span></p>
				<p style="font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>PROXY STATEMENT<br />FOR ANNUAL MEETING OF STOCKHOLDERS</b></span><span id="aort-def14a_051623a346"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">This Proxy Statement is furnished to our stockholders as of the close of business on March 22, 2023, the record date, for the solicitation of proxies by the Board of Directors of Artivion, Inc. (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) for the Annual Meeting of Stockholders of Artivion (the &#8220;Annual Meeting&#8221;) to be held on May 16, 2023 at 9:00&#160;a.m., EDT. The Annual Meeting will only be held virtually at the following web address: </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://web.lumiagm.com/295739807</span></span><span style="text-transform: none">. The voting of shares will not affect a stockholder&#8217;s right to attend the Annual Meeting. A signed paper proxy may be changed by sending in a timely, but later dated, signed paper proxy. Any stockholder sending in or completing a proxy may also revoke it at any time before it is exercised by giving timely notice to Jean F. Holloway, General Counsel and Corporate Secretary, Artivion, Inc., 1655 Roberts Boulevard, NW, Kennesaw, Georgia 30144, (770) 419-3355. Artivion is providing notice of the Annual Meeting and access to the Proxy Statement and Annual Report via the &#8220;Notice and </span><span style="text-transform: none">Access&#8221; method.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 5pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span id="aort-def14a_051623a343"></span><span style="text-transform: none"><b>QUESTIONS AND ANSWERS REGARDING THIS SOLICITATION<br />AND VOTING DURING THE ANNUAL MEETING</b></span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Why am I receiving this </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Proxy Statement?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">You are receiving this Proxy Statement because you were a stockholder of record at the close of business on the record date of March 22, 2023. As a stockholder of record, you are invited to attend our Annual Meeting and are entitled to vote on the items of business described in this Proxy Statement. This Proxy Statement contains important information about the Annual Meeting and the items of business to be transacted at the Annual Meeting. You are strongly encouraged to read this Proxy Statement, which includes information that you may find useful in determining how </span><span style="text-transform: none">to vote.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">At the close of business on the record date, we had a total of 40,875,444 shares of common stock outstanding, excluding a total of 1,486,803 shares of treasury stock held by Artivion, which are not entitled to vote. Each outstanding share of common stock will be entitled to one vote, non-cumulative, at the </span><span style="text-transform: none">Annual Meeting.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What does it mean if I receive more than one Notice of Internet Availability of Proxy Materials or more than one set of </i></b></span><span style="text-transform: none; font-style: italic"><b><i>proxy materials?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">It means that your shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your shares. To ensure that all of your shares are voted, for each Notice or set of proxy materials, please submit your proxy by phone, via the internet, or, if you received printed copies of the proxy materials, by signing, dating, and returning the enclosed Proxy Card in the </span><span style="text-transform: none">enclosed envelope.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Who is entitled to attend and vote during the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Only holders of record of shares of our common stock at the close of business on March 22, 2023 are entitled to notice of, to attend, and to vote during the Annual Meeting and to notice of any adjournments or postponements of such </span><span style="text-transform: none">Annual Meeting.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">3</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>How many shares must be present or represented to conduct business during the Annual Meeting (that is, what constitutes </i></b></span><span style="text-transform: none; font-style: italic"><b><i>a quorum)?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The presence during the Annual Meeting, attendance through the virtual meeting, or represented by proxy, of at least a majority of the shares outstanding and entitled to vote during the Annual Meeting, will constitute a quorum for the transaction of business. Shares represented during the Annual Meeting or by proxy are counted for quorum purposes, even if they are not voted on one or more matters. Abstentions from voting and broker non-votes, as defined below, will be counted for the purpose of determining the presence or absence of a quorum for the transaction of business. The Corporate Secretary or Assistant Secretary of Artivion, in consultation with the inspector of election, who will be an agent of American Stock Transfer &amp; Trust Company, LLC, shall determine the eligibility of persons present during the Annual Meeting to vote and whether the name signed on each Proxy Card corresponds to the name of a stockholder of Artivion. The Corporate Secretary or Assistant Secretary, based on such consultation, shall also determine whether or not a quorum exists during the Annual Meeting.  </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What items of business will be voted on during the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The items of business to be voted on during the Annual Meeting are </span><span style="text-transform: none">as follows:</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">1.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To elect as directors the nine nominees named in the enclosed Proxy Statement to serve until the next Annual Meeting of Stockholders or until their successors are duly qualified or until their earlier death, resignation, </span><span style="text-transform: none">or removal.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve, by non-binding vote, the compensation paid to Artivion&#8217;s Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and </span><span style="text-transform: none">narrative discussion.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">3.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve, by non-binding vote, the frequency of stockholder advisory votes on the compensation of our named </span><span style="text-transform: none">executive officers.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">4.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To ratify the preliminary approval of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December </span><span style="text-transform: none">31, 2023.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">5.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To approve additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash </span><span style="text-transform: none">Incentive Plan.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To transact such other business as may be properly brought before the Annual Meeting or any </span><span style="text-transform: none">adjournments thereof.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What happens if additional matters are presented during the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Other than the matters set forth in items 1-5 above, management is not aware of any matters that may come before the Annual Meeting. If any other matter or matters are properly brought before the Annual Meeting, the person(s) named as proxyholder(s) on your Notice or Proxy Card will have discretionary authority to vote the shares represented by the effective proxies as they </span><span style="text-transform: none">deem advisable.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>How does the Board of Directors recommend tha</i></b></span><span style="text-transform: none; font-style: italic"><b><i>t </i></b></span><span style="text-transform: none; font-style: italic"><b><i>I vot</i></b></span><span style="text-transform: none; font-style: italic"><b><i>e?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Our Board of Directors recommends that you vote </span><span style="text-transform: none">your shares:</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the election of each of the director nominees identified in this </span><span style="text-transform: none">Proxy Statement;</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the approval, on an advisory basis, of the compensation of our Named </span><span style="text-transform: none">Executive Officers; </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> one-year frequency, on an advisory basis, of the compensation of our named </span><span style="text-transform: none">executive offers;</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the ratification of the preliminary approval of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, </span><span style="text-transform: none">2023; and </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the approval of additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash </span><span style="text-transform: none">Incentive Plan.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">4</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What shares can I vote during the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">You may vote shares you owned as of March 22, 2023, the record date, including shares held directly in your name as the </span><span style="text-transform: none; font-style: italic"><i>stockholder of record</i></span><span style="text-transform: none"> and all shares held for you as the </span><span style="text-transform: none; font-style: italic"><i>beneficial owner</i></span><span style="text-transform: none"> through a broker, trustee, or other nominee such as </span><span style="text-transform: none">a bank.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What is the difference between holding shares as a stockholder of record and as a </i></b></span><span style="text-transform: none; font-style: italic"><b><i>beneficial owner?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Some of our stockholders hold their shares through a broker or other nominee rather than directly in their own name. As summarized below, there are some distinctions between common stock held of record and those </span><span style="text-transform: none">owned beneficially.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Stockholders of Record.</i></span><span style="text-transform: none"> If your shares are registered directly in your name with our transfer agent, you are considered the </span><span style="text-transform: none; font-style: italic"><i>stockholder of record</i></span><span style="text-transform: none"> with respect to those shares, and these proxy materials are being sent directly to you by the Company. As the </span><span style="text-transform: none; font-style: italic"><i>stockholder of record</i></span><span style="text-transform: none">, you have the right to vote your shares during the Annual Meeting or direct the proxyholder how to vote your shares on your behalf at the </span><span style="text-transform: none">Annual Meeting.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Beneficial Owner.</i></span><span style="text-transform: none"> If your shares are held in a brokerage account or by another nominee, you are considered the </span><span style="text-transform: none; font-style: italic"><i>beneficial owner</i></span><span style="text-transform: none"> of shares held in </span><span style="text-transform: none; font-style: italic"><i>street name</i></span><span style="text-transform: none">. As the beneficial owner, you have the right to direct your broker, trustee, or nominee to vote your shares as you instruct. The broker, trustee, or other nominee may either vote during the Annual Meeting or grant a proxy and direct the proxyholder to vote your shares during the Annual Meeting as you have instructed. If you hold shares through a broker, trustee, or nominee, you may also vote your shares during the Annual Meeting, but only after you obtain a &#8220;legal proxy&#8221; from the broker, trustee, or nominee that holds your shares in advance of the Annual Meeting, giving you the right to vote your shares during the </span><span style="text-transform: none">Annual Meeting. </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>How can I vote my shares without attending the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Whether you hold shares directly as the stockholder of record or as a beneficial owner, you may vote in advance of the Annual </span><span style="text-transform: none">Meeting by:</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Voting by Mail</i></span><span style="text-transform: none">. You may vote by filling out and returning your Proxy Card (if you are a stockholder of record), or by filling out and returning to your broker, trustee, or other nominee your voting instruction card (if you are a </span><span style="text-transform: none">beneficial owner).</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Voting by Internet</i></span><span style="text-transform: none">. If you are a stockholder of record, you may vote in advance of the Annual Meeting by following the instructions provided on your Proxy Card. Most brokers, trustees, and similar nominees also provide beneficial owners with the option to vote by internet, although practices may vary. If you are a beneficial owner, you must follow the instructions provided to you by your broker, trustee, or other nominee on your voting </span><span style="text-transform: none">instruction card.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Voting by Telephone. </i></span><span style="text-transform: none">If you are a stockholder of record, you may vote in advance of the Annual Meeting by telephone by following the instructions provided on your Proxy Card. Most brokers, trustees, and similar nominees also provide beneficial owners with the option to vote by telephone, although practices may vary. If you are a beneficial owner, you must follow the instructions provided to you by your broker, trustee, or other nominee on your voting </span><span style="text-transform: none">instruction card.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Whether you hold shares directly as the stockholder of record or as a beneficial owner, you may direct how your shares are voted without attending the Annual Meeting. If you provide specific instructions with regard to items of business to be voted on during the Annual Meeting, your shares will be voted as you instruct on those items. Proxies properly submitted to us that are signed but do not contain voting instructions and are not revoked prior to the Annual Meeting will be voted </span><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the election of each of the director nominees identified in this Proxy Statement, </span><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the approval, on an advisory basis, of the compensation of our Named Executive Officers, </span><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> one-year frequency, on an advisory basis, of the compensation of our named executive offers, </span><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the ratification of the preliminary approval of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023, and </span><span style="text-transform: none; font-family: Arial, sans-serif"><b>FOR</b></span><span style="text-transform: none"> the approval of additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash </span><span style="text-transform: none">Incentive Plan.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">5</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>How can I vote my shares during the virtual </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Shares held in your name as the stockholder of record may be voted during the Annual Meeting. You will need your control number and the meeting password, artivion2023, to vote your shares at the Annual Meeting.  </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">You may vote shares held beneficially in street name during the Annual Meeting only if you obtain a &#8220;legal proxy&#8221; from the broker, trustee, or nominee holding your shares that gives you the right to vote the shares during the Annual Meeting. After obtaining a valid legal proxy reflecting the number of shares of the Company that you held as of the record date of Ma</span><span style="text-transform: none">rch 22, 20</span><span style="text-transform: none">23, you may then register to attend the Annual Meeting by submitting proof of your legal proxy reflecting the number of your shares, along with your name and email address to American Stock Transfer &amp; Trust Company, LLC. Requests for registration should be directed to </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">proxy@astfinancial.com</span></span><span style="text-transform: none"> or to facsimile number (718) 765-8730. Written requests can be mailed to: American Stock Transfer &amp; Trust Company, LLC, Attn: Proxy Tabulation Department, 6201 15</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> Avenue, Brooklyn, NY 11219. Requests for registration must be labeled as &#8220;Legal Proxy&#8221; and be received no later than 5:00 p.m., EDT, on May 11, 2023. Upon completion of registration, meeting access information will be issued to beneficial stockholders by American Stock Transfer &amp; Trust </span><span style="text-transform: none">Company, LLC.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Online access to the meeting will begin at 8:00 a.m., EDT, and stockholders are encouraged to log in to the meeting early. The Annual Meeting will begin promptly at 9:00 a.m., EDT.</span><span style="text-transform: none; font-style: italic"><b><i> Even if you plan to attend the Annual Meeting, we recommend that you also vote via internet or telephone in advance to ensure that your vote will be counted if you later decide not to attend the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting.</i></b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Can I change my vote or revoke </i></b></span><span style="text-transform: none; font-style: italic"><b><i>my proxy?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">If you are the stockholder of record, and you have submitted a vote via the internet, telephone, or by mail, you may revoke your vote by submitting a timely later-dated vote via the same process you used to cast your original vote. Note, internet voting through </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">www.voteproxy.com</span></span><span style="text-transform: none"> and telephone voting is available only until 11:59&#160;p.m., EDT, the day before the Annual Meeting. You may also revoke your vote by providing written notice of revocation to our Corporate Secretary, Jean F. Holloway, or by attending the Annual Meeting and voting in person. Attendance during the Annual Meeting will not cause your previously granted proxy to be revoked unless you specifically so request. If you are a beneficial owner, you may revoke your vote by submitting a later-dated vote via the internet or by telephone (if those options are available to you), or you may revoke your vote by submitting a new voting instruction card to your broker, trustee, or nominee, or, if you have obtained a &#8220;legal proxy&#8221; from your broker, trustee, or nominee giving you the right to vote your shares, by attending the Annual Meeting </span><span style="text-transform: none">and voting.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What do I need to attend the virtual </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Attendance during the Annual Meeting will be limited to our stockholders as of March 22, 2023, the record date, their authorized proxy holders, and guests </span><span style="text-transform: none">of Artivion.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Attending the virtual Annual Meeting as a stockholder </i></span><span style="text-transform: none; font-style: italic"><i>of record.</i></span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">You will need your control number and the meeting password, artivion2023, to attend the </span><span style="text-transform: none">Annual Meeting.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Registering to attend the virtual Annual Meeting as a </i></span><span style="text-transform: none; font-style: italic"><i>beneficial owner.</i></span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">After obtaining a valid legal proxy from your broker, bank, or other agent, you may then register to attend the Annual Meeting by submitting proof of your legal proxy as described above in, &#8220;</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>How can I vote my shares during the virtual </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Annual Meeting?</b></span><span style="text-transform: none">&#8221;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Is my </i></b></span><span style="text-transform: none; font-style: italic"><b><i>vote confidential?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Electronic votes, proxy cards, voting instructions, ballots, and voting tabulations that identify individual stockholders are not secret; however, all such materials will be handled in a manner intended to reasonably protect your voting privacy. Your vote will not be disclosed, except as required by law and except as required to our transfer agent to allow for the tabulation of votes and certification of the vote and to facilitate a successful </span><span style="text-transform: none">proxy solicitation.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">6</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>How are votes counted and what vote is required to approve </i></b></span><span style="text-transform: none; font-style: italic"><b><i>each item?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Each outstanding share of common stock entitles the holder thereof to one vote on each matter considered during the Annual Meeting. Stockholders are not entitled to cumulate their votes in the election of directors or with respect to any other matter submitted to a vote of the stockholders pursuant to this </span><span style="text-transform: none">Proxy Statement.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Nominees for election as directors will be elected by a plurality of the votes cast by the holders of shares entitled to vote in the election. Since there are nine directorships to be filled, this means that the nine individuals receiving the most &#8220;For&#8221; votes will be elected. Shares voted &#8220;Withhold,&#8221; abstentions, and broker non-votes will therefore not be relevant to the outcome. A broker non-vote occurs when a broker holding shares for a beneficial owner does not vote on a particular proposal because the broker does not have discretionary voting authority and has not received voting instructions from the </span><span style="text-transform: none">beneficial owner.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The advisory votes cast &#8220;For&#8221; the approval of the compensation paid to Artivion&#8217;s Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion, must exceed the votes cast &#8220;Against&#8221; the approval of such compensation in order for it to be approved. Accordingly, abstentions and broker non-votes will not be relevant to </span><span style="text-transform: none">the outcome.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">With respect to the advisory vote on the frequency of stockholder advisory votes on the compensation of our named executive officers, the option receiving the most &#8220;For&#8221; votes will be deemed the option recommended by the stockholders. Accordingly, abstentions and broker non-votes will not be relevant to </span><span style="text-transform: none">the outcome.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The votes cast &#8220;For&#8221; ratification of the preliminary approval of the appointment of Ernst &amp; Young LLP (&#8220;Ernst &amp; Young&#8221;) as Artivion&#8217;s independent registered accounting firm must constitute a majority of shares present, either in person or by proxy, and entitled to vote on this proposal. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an </span><span style="text-transform: none">&#8220;Against&#8221; vote.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The votes cast &#8220;For&#8221; approval of additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash Incentive Plan must constitute a majority of shares present, either in person or by proxy, and entitled to vote on this proposal. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an </span><span style="text-transform: none">&#8220;Against&#8221; vote.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">There are no rights of appraisal or similar dissenters&#8217; rights with respect to any matter to be acted upon pursuant to this </span><span style="text-transform: none">Proxy Statement.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What happens if the Annual Meeting </i></b></span><span style="text-transform: none; font-style: italic"><b><i>is adjourned?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Assuming the presence of a quorum, if our Annual Meeting is adjourned to another time and place, no additional notice of the adjourned meeting will be given if the time and place of the adjourned meeting is announced during the Annual Meeting, unless the adjournment is for more than 120 days, in which case a new record date must be fixed, and notice of the adjourned meeting distributed. At the adjourned meeting, we may transact any items of business that might have been transacted during the </span><span style="text-transform: none">Annual Meeting.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Who should I contact if I experience technical difficulties accessing the virtual </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">American Stock Transfer &amp; Trust Company, LLC will provide technical support for all stockholders attending the Annual Meeting. Stockholders experiencing technical difficulties accessing the meeting may visit </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://go.lumiglobal.com/faq</span></span><span style="text-transform: none"> for assistance. We encourage you to access the Annual Meeting starting one hour prior to the start time, leaving ample time for the </span><span style="text-transform: none">check-in process.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What else should I know about the virtual process for the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Stockholders of record, or those who have received a &#8220;legal proxy,&#8221; will be able to submit questions related to the business of the meeting while attending the Annual Meeting, from the time the meeting is first called to order through the end of the question-and-answer period, and will be alerted prior to the end of the question-and-answer period. A replay of the Annual Meeting and a list of stockholder questions and Company answers will be available after </span><span style="text-transform: none">it concludes.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">7</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 144.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 462.29pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Who is soliciting my vote, and who will bear the costs of </i></b></span><span style="text-transform: none; font-style: italic"><b><i>this solicitation?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The Proxy Statement is being solicited on behalf of our Board of Directors. We will bear the entire cost of solicitation of proxies, including preparation, assembly, printing, and delivery of this Proxy Statement, via electronic means or paper means upon stockholder request. In addition, our non-employee directors, executive officers, employees, and agents may also solicit proxies in person, by telephone, by electronic mail, or by other means of communication. We will not pay any additional compensation to our non-employee directors, executive officers, or other employees for </span><span style="text-transform: none">soliciting proxies.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Where can I find the voting results of the </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Annual Meeting?</i></b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">We intend to announce preliminary voting results during the Annual Meeting and publish the final voting results in a Current Report on Form&#160;8-K filed within four business days after the </span><span style="text-transform: none">Annual Meeting.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>What is the deadline for submitting proposals for consideration at next year&#8217;s Annual Meeting of Stockholders or to nominate individuals to serve </i></b></span><span style="text-transform: none; font-style: italic"><b><i>as directors</i></b></span><span style="text-transform: none">?</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 6pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Appropriate stockholder proposals intended to be presented at Artivion&#8217;s 2024 Annual Meeting of Stockholders pursuant to Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) must be received by Artivion by Dece</span><span style="text-transform: none">mber 5,&#160;202</span><span style="text-transform: none">3 for inclusion in its Proxy Statement and form of proxy for such meeting. Stockholder proposals must comply with the requirements of Rule 14a-8 of the Exchange Act and any other applicable rules established by the Securities and Exchange Commission (the &#8220;SEC&#8221;). Proposals of stockholders intended to be presented during the 2024 Annual Meeting of Stockholders without inclusion of such proposals in our Proxy Statement relating to such annual meeting must be received not later than the close of business on the 60th day and not earlier than the close of business on the 120th day prior to the first anniversary of the preceding year&#8217;s </span><span style="text-transform: none">annual meeting. </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Therefore, for the 2024 Annual Meeting of Stockholders, all stockholder proposals submitted outside of the stockholder proposal rules promulgated pursuant to Rule 14a-8 under the Exchange Act, including nominations for individuals to serve as non-employee directors, must be received by Artivion by no later than March 17, 2024, but no earlier than January 17, 2024, in order to be considered timely. If such stockholder proposals are not timely received, proxy holders will have discretionary voting authority with regard to any such stockholder proposals that may come before the 2024 Annual Meeting of Stockholders. If the month and day of the next annual meeting is advanced or delayed by more than 30 calendar days from the month and day of the annual meeting to which this Proxy Statement relates, Artivion shall, in a timely manner, inform its stockholders of the change and the date by which proposals of stockholders must </span><span style="text-transform: none">be received.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">In addition to the foregoing, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March </span><span style="text-transform: none">17, 2024. </span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none"></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">8</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 837.66pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>PROPOSAL ONE </b></span><span style="text-transform: none; font-size: 14pt"><b>&#8211;</b></span><span style="text-transform: none"><b> ELECTION OF DIRECTORS</b></span><span id="aort-def14a_051623a347"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion directors elected during the Annual Meeting on May 16, 2023, will hold office until the next annual meeting, until their successors are duly qualified, or until their earlier death, resignation, </span><span style="text-transform: none">or removal. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Director Nominees</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Each of the nominees is currently a director of Artivion. Should any nominee for the office of director become unable to accept nomination or election, the persons named on the Proxy Card intend, unless otherwise specifically instructed in the Proxy Statement, to vote for the election of such other person, if any, as the Board of Directors </span><span style="text-transform: none">may recommend.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table sets forth the name and age of each nominee, the period during which each such person has served as a director of Artivion, the number of shares of Artivion&#8217;s common stock beneficially owned, directly or indirectly, by such person, and the percentage of outstanding shares of Artivion&#8217;s common stock such ownership represented at the close of business on March 22, 2023, according to information maintained by Artivion. None of the shares of stock noted below are subject to a pledge or similar arrangement. Except for J. Patrick Mackin, our President, Chief Executive Officer, and Chairman of the Board of Directors, none of the nominees holds any other position or office </span><span style="text-transform: none">with Artivion. </span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 3pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 3pt; table-layout: fixed; width: 476.52pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 111.26pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 61.38pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 54.49pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 117.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 131.74pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Name of Nominee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Director Since</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Age</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Shares of Artivion<br />Stock Beneficially<br />Owned</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Percentage of<br />Outstanding Shares<br />of Artivion Stock</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(5)</b></sup><span style="text-transform: none"><b><br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Thomas F. Ackerman</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2003</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">68</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">127,573</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Daniel J. Bevevino</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2003</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">63</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">127,738</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marna P. Borgstrom</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2018</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">69</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">26,765</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">James W. Bullock</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2016</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">66</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">46,324</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jeffrey H. Burbank</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2017</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">60</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">31,473</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Elizabeth A. Hoff</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">57</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">9,066</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2014</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">56</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">909,210</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.2</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jon W. Salveson</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2012</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">58</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">107,517</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Anthony B. Semedo</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">71</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 27pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">27,870</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 0pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 9pt; font-style: italic"><i>*</i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Ownership represents less than 1% of the outstanding shares of Artivion </span><span style="text-transform: none; font-size: 9pt">common stock.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 0pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Except as otherwise noted, the nature of the beneficial ownership for all shares is sole voting and </span><span style="text-transform: none; font-size: 9pt">investment power.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 0pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Includes 7,878 shares of unvested restricted stock granted on June </span><span style="text-transform: none; font-size: 9pt">1, 2022.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 0pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Amount includes 387,506 options that are either presently exercisable or will become exercisable within 60 days after Mar</span><span style="text-transform: none; font-size: 9pt">ch 22, 20</span><span style="text-transform: none; font-size: 9pt">23. This amount also includes 197,706 shares of unvested restricted stock subject to forfeiture held by Mr.&#160;Mackin as of M</span><span style="text-transform: none; font-size: 9pt">arch 22, 2</span><span style="text-transform: none; font-size: 9pt">023. This amount does not include 30,176 shares earned under 2021 and 2022 performance stock unit awards that had not </span><span style="text-transform: none; font-size: 9pt">vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none; font-size: 9pt">days thereafter.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 0pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt; font-style: italic"><i></i></span><span style="text-transform: none; font-size: 9pt">Includes 9,066 shares of unvested restricted stock granted on November </span><span style="text-transform: none; font-size: 9pt">8, 2022.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 72.45pt 10pt 88.55pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt; font-style: italic"><i></i></span><span style="text-transform: none; font-size: 9pt">There were</span><span style="text-transform: none; font-size: 9pt; font-style: italic"><i> </i></span><span style="text-transform: none; font-size: 9pt">40,875,444 outstanding shares of Artivion common stock as of March 22, 2023, the </span><span style="text-transform: none; font-size: 9pt">record date. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 2pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2023 Director Nominees</i></b></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 621pt; height: 161.76pt; text-align: left">
						<img src="aort-def14a_051623img004.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 619.84pt; margin-top: 0pt; height: 161pt" />

					</div>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">9</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2023 Director Nominee Skills</i></b></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 6pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 148.35pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 9.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 148.35pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 9.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 148.35pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 9.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 148.35pt">


							</td>

						</tr>
						<tr style="min-height: 26.55pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">CEO Experience</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 24.55pt; line-height: 24.55pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Financial and </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">Investor<br />Relations Expertise</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 24.55pt; line-height: 24.55pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Medical Device </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">and<br />Healthcare Expertise</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 24.55pt; line-height: 24.55pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Legal, Compliance, </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">and<br />Governance Experience</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 28.8pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">ESG Expertise</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.8pt; line-height: 26.8pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Regulatory, Quality, and Patient<br />(Product) </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">Safety Experience</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.8pt; line-height: 26.8pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Global Operations and Complex </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">Organizations Experience</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.8pt; line-height: 26.8pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Regulatory and </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">Healthcare<br />Policy Experience</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 28.35pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Public </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">Company<br />Board Experience</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.35pt; line-height: 26.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Strategic Planning<br />Expertise</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.35pt; line-height: 26.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Technology </span><span style="text-transform: none; color: #ffffff; font-size: 8pt">and<br />Cybersecurity Experience</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: middle; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 26.35pt; line-height: 26.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #024a76; vertical-align: middle; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; color: #ffffff; font-size: 8pt">Institutional Knowledge</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Director Nominee Qualifications and Biographical Information</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Thomas F. Ackerman</b></span><span style="text-transform: none"> has served as a director of Artivion since December&#160;2003. Until February 2017, Mr.&#160;Ackerman served as a consultant to Charles River Laboratories International, Inc. (NYSE: CRL) (&#8220;Charles River Laboratories&#8221;). Charles River Laboratories is a leading global provider of solutions that accelerate the early-stage drug discovery and development process, with a focus on in vivo biology, including research models and services required to enable in vivo drug discovery and development. Until early 2016, Mr. Ackerman served as a Senior Financial Advisor of Charles River Laboratories, a position he held since August 2015. From 2005 to 2015, he served as Executive Vice President and Chief Financial Officer of Charles River Laboratories. From 1999 to 2005, he served as Senior Vice President and Chief Financial Officer of Charles River Laboratories. From 1996 to 1999, Mr. Ackerman served as Vice President and Chief Financial Officer of Charles River Laboratories, where he was employed since 1988. Mr. Ackerman is a director of the University of Massachusetts Amherst Foundation and serves on the audit committee of Olin College of Engineering. Mr. Ackerman received a B.S. in Accounting from the University of Massachusetts and became a Certified Public Accountant in 1979. Mr. Ackerman&#8217;s license is </span><span style="text-transform: none">currently inactive.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Ackerman should serve as a director of Artivion because of his expertise in accounting and financial reporting, particularly in the </span><span style="text-transform: none">biotechnology industry.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Daniel J. Bevevino</b></span><span style="text-transform: none"> has served as a director of Artivion since December 2003. From 1996 until March 2008, Mr. Bevevino served as the Vice President and Chief Financial Officer of Respironics, Inc. (&#8220;Respironics&#8221;), a company that developed, manufactured, and marketed medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders. He was employed by Respironics beginning in 1988. In March 2008, Respironics was acquired by Royal Philips (NYSE: PHG) (&#8220;Philips&#8221;), whose businesses included a variety of medical solutions, including medical diagnostic imaging and patient monitoring systems, as well as businesses focused on energy efficient lighting and consumer products. From March 2008 to December 31, 2009, Mr. Bevevino was employed by Philips as Head of Post-Merger Integration &#8211; Respironics, as well as in various operating capacities, to help facilitate integration of the combined companies. He is currently an independent consultant providing interim chief financial officer services in the life sciences industry, and he currently serves as a director of one of the private companies for which he provides services. He began his career as a Certified Public Accountant with Ernst &amp; Young. Mr. Bevevino&#8217;s license is currently inactive. Mr. Bevevino received a B.S. in Business Administration from Duquesne University and an MBA from the University of </span><span style="text-transform: none">Notre Dame.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Bevevino should serve as a director of Artivion because of his expertise in accounting and financial reporting, particularly in the medical </span><span style="text-transform: none">device industry.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Marna P. Borgstrom </b></span><span style="text-transform: none">has served as a director of Artivion since June 2018. From 2005 until March 2022, Ms. Borgstrom served as President, Chief Executive Officer, and a board member of Yale New Haven Health System, an integrated health care delivery system with approximately $5.88 billion in annual revenue, 2,681 patient beds, and 29,486 employees. During her tenure with Yale New Haven Health System, Ms. Borgstrom was instrumental in the health system&#8217;s growth, which over the last decade included an increase in revenue of 126%, patient beds of 26%, and employees of 60%. Ms. Borgstrom also played a significant role in integrating Yale New Haven Health System into a cohesive operating entity, increasing efficiencies and significantly reducing costs. During the challenging pandemic, Ms. Borgstrom and her team evolved care pathways for COVID-19 patients, such that Yale New Haven Health System was able to keep patients and employees safe and report mortality rates of less than 50% of the national average, despite treating a larger number of, and more medically complex, COVID-19 cases. Additionally, Ms. Borgstrom currently serves on the board of Marion Parke, a privately held company based in Minneapolis, MN. Ms. Borgstrom received her Bachelor of Arts from Stanford University and a Masters in Public Health from </span><span style="text-transform: none">Yale University.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">10</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Ms. Borgstrom should serve as a director of Artivion because of her extensive experience as a senior executive leading a large, complex organization in the healthcare sector, coupled with her knowledge of healthcare regulation and policy and her recognition within the </span><span style="text-transform: none">healthcare industry.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>James W. Bullock</b></span><span style="text-transform: none"> has served as a director of Artivion since October 2016. Mr. Bullock previously served as the President and Chief Executive Officer of Zyga Technology, Inc. (&#8220;Zyga Technology&#8221;), a privately-held medical device company focused on products that treat conditions of the lumbar spine, until January 2018, when RTI Surgical, Inc. (formerly NASDAQ: RTIX) acquired Zyga Technology. Prior to that, he served for six years as President and Chief Executive Officer of Atritech, Inc. (&#8220;Atritech&#8221;). Atritech was a privately held cardiovascular manufacturing company that was acquired by Boston Scientific Corporation (NYSE: BSX). Prior to that, he served for nine years as President and Chief Executive Officer and was a member of the board of directors of Endocardial Solutions, Inc. (NASDAQ: ECSI) (&#8220;Endocardial Solutions&#8221;), a cardiac-focused medical device company that was acquired by St. Jude Medical, which was itself acquired by Abbott Laboratories (NYSE: ABT). He also served as President and Chief Executive Officer and was a member of the board of directors of Stuart Medical, Inc., and he began his career working in a variety of sales and marketing leadership positions at Baxter International, Inc. (NYSE: BAX) and American Hospital Supply Corporation. Currently, in addition to Artivion&#8217;s Board of Directors, Mr. Bullock also serves as Chairman of the board of directors of Stimdia, Inc., a privately held company that conducts research for the development of medical devices for use in the critical care treatment of ventilator induced diaphragmatic dysfunction. Mr. Bullock also serves as Chairman of the board of directors of Surgical Information Science, Inc. and as a director of Intershunt Technologies, Inc., both private health companies. Mr. Bullock received a Bachelor of Science in Public Administration from the University </span><span style="text-transform: none">of Arizona.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Bullock should serve as a director of Artivion because of his business acumen and substantial experience in the global medical device industry, particularly in the area of </span><span style="text-transform: none">company growth. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Jeffrey H. Burbank</b></span><span style="text-transform: none"> has served as a director of Artivion since October 2017. From 2019 until March 2022, Mr. Burbank served as the Chief Technology Officer at Fresenius Medical Care North America, a division of Fresenius Medical Care AG &amp; Co. (NYSE: FMS) (&#8220;Fresenius Medical Care&#8221;), the world&#8217;s largest provider of products and services for individuals with renal diseases. Prior to that, Mr. Burbank served as Chief Executive Officer and a member of the board of directors of NxStage Medical, Inc. (formerly NASDAQ: NXTM) (&#8220;NxStage Medical&#8221;), a leading medical technology company, positions he held since he founded NxStage Medical i</span><span style="text-transform: none">n 1998, until Fresenius Medical Care completed its acquisition of NxStage Medical in February 2019. Prior to founding NxStage Medical, Mr. Burbank was a co-founder of Vasca, Inc., a company that provided innovative implantable access devices, where he was the President and Chief Executive Officer, as well as Chairman of the board of directors. Mr. Burbank has over 30 years of senior leadership experience in the medical device industry, developing, marketing, and manufacturing products for end-stage renal disease patients. During his career he has been an inventor on over 50 U.S. patents for medical devices. Mr. Burbank received a Bachelor of Science in Industrial Engineering from </span><span style="text-transform: none">Lehigh University.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Burbank should serve as a director of Artivion because of his business acumen and substantial senior leadership experience in the global medical </span><span style="text-transform: none">device industry.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Elizabeth A. Hoff</b></span><span style="text-transform: none"> has served as a director of Artivion since October 2022. Ms. Hoff has 30 years of experience in the medical device and diagnostics industries and in the commercialization of transformational technologies. Ms. Hoff has served in various senior leadership roles related to, or in, the medical device field, including serving as the Executive Director of Business Development and Strategy at DM Clinical Research and as Chief Executive Officer or as an executive at several medical device start-up companies. Ms. Hoff also founded Hoff Professional Services where she offers consulting and executive coaching services to medical device leaders. Earlier in her career, she gained in-depth global experience in the aortic space, first at Guidant, leading Guidant&#8217;s endovascular expansion in Europe, and then as a Business Unit Leader at W. L. Gore, launching and leading the endovascular AAA and thoracic stent graft programs. She gained further senior executive experience at Medtronic as Vice President and General Manager, where she defined and drove a ten-fold expansion in Medtronic&#8217;s implantable cardiac diagnostic platform (now the LinQ product family). Ms. Hoff received her Bachelor of Arts in Managerial Studies and Psychology from </span><span style="text-transform: none">Rice University.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Ms. Hoff should serve as a director of Artivion because of her extensive senior leadership and business experience in the medical device industry across public and private companies, including in the aortic </span><span style="text-transform: none">technology space.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>J. Patrick Mackin</b></span><span style="text-transform: none"> was named President and Chief Executive Officer of Artivion in September 2014. He was appointed to the Artivion Board of Directors in October 2014, and he was appointed Chairman of the Board of Directors in April 2015. Mr. Mackin has more than 30 years of experience in the medical device industry. Prior to joining Artivion, </span><span style="text-transform: none">Mr.&#160;Mackin served </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">11</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">as President of Cardiac Rhythm Disease Management, the then-largest operating division of Medtronic&#160;plc (NYSE: MDT) (&#8220;Medtronic&#8221;), from August 2007 to August 2014. At Medtronic, he previously held the positions of Vice President, Vascular, Western Europe and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic in 2002, Mr. Mackin worked for six years at Genzyme, Inc. (&#8220;Genzyme&#8221;), serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products Division. Before joining Genzyme, Mr. Mackin spent four years at Deknatel/Snowden-Pencer, Inc., in various roles, and three years as a First Lieutenant in the U.S. Army. Mr. Mackin has served as a director of Opsens, Inc. (TSXV: OPS and OTCQX: OPSSF), a fiber optic sensors manufacturer, since 2016. Mr. Mackin served as a director of Wright Medical Group N.V. (NASDAQ:&#160;WMGI) (&#8220;Wright Medical&#8221;), a global medical device company focused on extremities and biologics, from July 2018 until November 2020, when Wright Medical was acquired by Stryker Corporation (NYSE: SYK). Mr. Mackin received an MBA from the Kellogg Graduate School of Management at Northwestern University and is a graduate of the U.S. Military Academy at </span><span style="text-transform: none">West Point.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr.&#160;Mackin should serve as a director of Artivion because of his business acumen and substantial senior leadership experience in the global medical device industry. In addition, the Board of Directors believes that it is appropriate and valuable to have the President and Chief Executive Officer of Artivion serve as a member of the Board </span><span style="text-transform: none">of Directors.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Jon W. Salveson </b></span><span style="text-transform: none">has served as a director of Artivion since May 2012. Mr. Salveson is the Vice Chairman, Investment Banking and Chairman of the Healthcare Investment Banking Group at Piper Sandler Companies (NYSE: PIPR), formerly Piper Jaffray Companies, a U.S. investment bank and asset management firm (&#8220;Piper Jaffray&#8221;). Mr. Salveson has served in his present position as Vice Chairman, Investment Banking since July 2010. Mr. Salveson was appointed Global Head of Investment Banking and a member of the Executive Committee of Piper Jaffray in 2004. He joined Piper Jaffray in 1993 as an associate, was elected Managing Director in 1999, and was named Group Head of Piper Jaffray&#8217;s international healthcare investment banking group in 2001. Mr. Salveson also serves on the Board of Directors of Nuwellis, Inc (NASDAQ: NUWE), an early-stage medical device company. Mr. Salveson recently served on the board of Asklepios Biopharmaceuticals, Inc., a private company specializing in gene therapy technologies, which was acquired by Bayer AG (ETR: BAYN) in 2020. Mr. Salveson received his undergraduate degree from St. Olaf College in 1987 and an M.M.M. in finance from the Kellogg Graduate School of Management at </span><span style="text-transform: none">Northwestern University.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Salveson should serve as a director of Artivion because of his extensive experience in the healthcare industry and the medical technology sector, and, particularly, his extensive experience in strategic advisory roles for global healthcare companies in hundreds </span><span style="text-transform: none">of transactions.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Anthony B. Semedo </b></span><span style="text-transform: none">has served as a director of Artivion since October 2021. Mr. Semedo has over 40 years of U.S. and international experience in the medical device industry. Until late 2019, Mr. Semedo served as Senior Vice President and President of Japan Operations at Medtronic, where he led multiple business units and functions. Through his tenure at Medtronic from 2002 to 2019, Mr. Semedo held several executive management positions, including Senior Vice President and President of the company&#8217;s Aortic, Peripheral, and Venous (APV) Division and Senior Vice President and President of Endovascular Innovations. During his time at Medtronic, Mr. Semedo also served as Vice President of Medtronic&#8217;s Japan Cardiovascular Business and as Global Vice President of Vascular Research and Development. Prior to 2002, Mr. Semedo spent time at Alaris Medical Systems, Eli Lilly &amp; Co., and Abbott Laboratories. Mr. Semedo received his Bachelor of Science in Engineering from the University </span><span style="text-transform: none">of Massachusetts.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">The Board of Directors has determined that Mr. Semedo should serve as a director of Artivion because of his extensive knowledge of and extensive leadership experience in the medical device industry, including in the aortic </span><span style="text-transform: none">technology space.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Required Vote</i></b></span><span style="text-transform: none; font-weight: normal; font-style: italic"><i> </i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Nominees for election as directors will be elected by a plurality of the votes cast by the holders of shares entitled to vote in the election. Since there are nine directorships to be filled, this means that the nine individuals receiving the most votes will be elected. Accordingly, abstentions and broker non-votes will not be relevant to </span><span style="text-transform: none">the outcome.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Recommendation </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; EACH OF<br />THE </b></span><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>NINE</b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b> NOMINEES FOR DIRECTOR LISTED IN THIS </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>PROPOSAL ONE.</b></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">12</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>CORPORATE GOVERNANCE AND BOARD OF DIRECTORS MATTERS</b></span><span id="aort-def14a_051623a348"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Our Board of Directors believes that the purpose of corporate gov</span><span style="text-transform: none">ernance is to </span><span style="text-transform: none; font-size: 10pt">serve the interests of the Company and the Company&#8217;s stockholders in a manner that is consistent with the Board of Directors&#8217; fiduciary duties and the Company&#8217;s mission and core values.</span><span style="text-transform: none"> The Board of Directors has adopted and adheres to corporate governance practices that the Board of Directors and senior management believe promote this purpose, are sound, and represent best practices applicable to the Company. The Board of Directors reviews these practices on an ongoing basis and revises them </span><span style="text-transform: none">as appropriate.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Director Independence</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In connection with its annual review in the first quarter of 2023, and based on the information available to it, the Board of Directors determined that none of Ms. Borgstrom, Ms. Hoff, or Messrs. Ackerman, Bevevino, Bullock, Burbank, Salveson, or Semedo has or had a material relationship with Artivion and that each qualified as an independent director under NYSE </span><span style="text-transform: none">Listing Standards.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In addition to qualifying as &#8220;independent&#8221; within the meaning of Section 303A.02 of the NYSE Listing Company Standards, each member of the Compensation Committee must be a &#8220;non-employee director&#8221; within the meaning of Rule&#160;16b-3 under the Exchange Act. In determining the independence of any director who will serve on the Compensation Committee, the Board of Directors will consider all factors relevant to determining whether such director has a relationship with the Company that is material to the director&#8217;s ability to be independent from management in connection with the duties of a Compensation Committee member, including, but not limited to (i) the source of compensation of such director, including any consulting, advisory, or other compensatory fee paid by the Company to the director and (ii) whether such director is affiliated with the Company, one of its subsidiaries, or an affiliate of one of </span><span style="text-transform: none">its subsidiaries. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In addition to qualifying as &#8220;independent&#8221; within the meaning of Section 303A.02 of the NYSE Listing Standards, each member of the Audit Committee must also meet the criteria of Section 303A.06 and Rule 10A-3 promulgated under the </span><span style="text-transform: none">Exchange Act. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Right to Retain Advisors</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Board of Directors has authorized the committees of the Board of Directors to retain their own advisors, such as auditors, compensation consultants, search firms, legal counsel, and others, to the extent the committees deem </span><span style="text-transform: none">it appropriate. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Leadership Structure</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Mr. Mackin, the President and Chief Executive Officer of Artivion, serves as Chair of the Board of Directors. The Board of Directors believes that this structure promotes fluid communication and coordination between the Board of Directors and management. The Board of Directors also believes that Mr. Mackin is well-suited to fill both his management and Board of Directors roles and that the Board of Directors benefits from him serving these </span><span style="text-transform: none">dual roles.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In order to foster the Board of Directors&#8217; independence from management, the leadership structure of the Board of Directors also includes a Lead Director, a position held by an independent director. Mr. Burbank assumed the role of Lead Director in March 2021. The Lead Director has frequent contact with Mr. Mackin and other members of management on a broad range of matters and has additional corporate governance responsibilities for the Board of Directors. The Lead Director also serves as liaison between Mr. Mackin and the independent directors, approves meeting agendas and schedules to ensure there is sufficient time for discussion of all agenda items, approves certain information sent to the Board of Directors, and has the authority to call meetings of the independent directors. Stockholders can seek to directly consult with </span><span style="text-transform: none">independent directors.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">13</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Role in Risk Oversight</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Board of Directors has an active role, as a whole and also at the committee level, in overseeing the management of our risks. Management is primarily responsible for risk management, and management reports directly to the committees and the Board of Directors with respect to risk management. The Board of Directors is responsible for general oversight of risks and regular review of information regarding our risks, including credit, information security, liquidity, regulatory, Environmental, Social, and Governance (&#8220;ESG&#8221;), human capital, and operational. In its risk-oversight role, the Board of Directors periodically reviews the Company&#8217;s strategic plan, as well as an assessment of potential material risks facing </span><span style="text-transform: none">the Company. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In particular, the Compensation Committee is responsible for ensuring that our compensation policies and practices do not incent excessive or inappropriate risk-taking by employees or non-employee directors. It also has oversight of Human Capital Management, and along with the Compliance and Audit Committees, culture. The Audit Committee, in coordination with Ernst &amp; Young, our independent registered public accounting firm, is primarily responsible for oversight of our internal controls, operation of our internal audit, risk assessment, and risk management, including information security oversight, and various financial and compliance functions. The Audit Committee&#8217;s information security oversight role includes responsibility for overseeing the Company&#8217;s global information security and information technology risks, controls, and procedures and utilizing independent cyber-security auditors to support that function where appropriate. More detail regarding the Audit Committee&#8217;s oversight of information security is located in the Report of the Audit Committee at page 21. The Corporate Governance Committee monitors risk by ensuring that proper corporate governance standards are maintained, that the Board of Directors is comprised of qualified directors, and that senior management is comprised of qualified executive officers. The Compliance Committee is primarily responsible for oversight of our healthcare compliance function, including our compliance with quality systems and regulatory assurance laws and regulations, as well as our compliance with other healthcare compliance laws and regulations. Together with the Audit Committee, the Compliance Committee also exercises oversight of Enterprise Risk Management and our compliance with certain laws and regulations, such as the European Union General Data Protection Regulation (&#8220;GDPR&#8221;) and the United States Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and such policies as our Code </span><span style="text-transform: none">of Conduct.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Board of Directors and Committee Meetings, Annual Meeting of Stockholders, and Attendance</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">During 2022, each director attended, either in person or virtually, at least 75% of the meetings of the Board of Directors and the committees of the Board of Directors on which the director served. In general, members of the Board of Directors become members of committees immediately following the Annual Meeting </span><span style="text-transform: none">of Stockholders.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Board of Directors held 18 meetings during 2022. All but one of the then-current members of the Board of Directors attended the 2022 Annual Meeting of Stockholders, which was held virtually. The Company does not have a policy requiring directors to attend the annual meeting, but it encourages </span><span style="text-transform: none">such attendance.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Standing Committees of the Board of Directors; Committee Assignments</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">During 2022, the Board of Directors had four standing committees: the Audit Committee; the Compensation Committee; the Corporate Governance Committee; and the Compliance Committee. During 2022, the Audit Committee met six times, the Compensation Committee met</span><span style="text-transform: none; font-family: Arial, sans-serif"><b> </b></span><span style="text-transform: none">ten times, the Corporate Governance Committee met seven times, the Compliance Committee met four times, the Compensation Committee and the Corporate Governance Committee met jointly two times, and the Audit Committee and the Compliance Committee met jointly </span><span style="text-transform: none">once time.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The four standing committees are described below, and the following table lists the members of each of the standi</span><span style="text-transform: none">ng committees as of the date of this </span><span style="text-transform: none">Proxy Statement.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">14</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 578.5pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 267.71pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 75.21pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.16pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.96pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.44pt">


							</td>

						</tr>
						<tr style="min-height: 21.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Director</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Audit Committee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation Committee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Corporate Governance Committee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compliance Committee</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 8.1pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin, Chairman, President,<br />and Chief Executive Officer</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 8.1pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Thomas F. Ackerman</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Chair</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>

						</tr>
						<tr style="min-height: 8.1pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Daniel J. Bevevino</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Chair</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 8.1pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marna P. Borgstrom</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Chair</span></p>

							</td>

						</tr>
						<tr style="min-height: 8.1pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">James W. Bullock</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 6.1pt; line-height: 6.1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730; </span></p>

							</td>

						</tr>
						<tr style="min-height: 7.35pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jeffrey H. Burbank, Lead Director</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 5.35pt; line-height: 5.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Chair</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 5.35pt; line-height: 5.35pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 14.35pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Elizabeth A. Hoff</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 12.35pt; line-height: 12.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 12.35pt; line-height: 12.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 12.35pt; line-height: 12.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jon W. Salveson</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 7pt; line-height: 7pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 7pt; line-height: 7pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>

						</tr>
						<tr style="min-height: 7.35pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Anthony B. Semedo</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 5.35pt; line-height: 5.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 5.35pt; line-height: 5.35pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8730;</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><b><i>Audit Committee </i></b></span><span style="text-transform: none">&#8212; The Audit Committee operates under a written charter that sets out the committee&#8217;s functions and responsibilities. The Audit Committee currently consists of three non-employee directors: Mr. Ackerman, Chair, Mr. Bevevino, and Mr. Burbank. Mr. Ackerman and Mr. Bevevino served on the Audit Committee for all of 2022. Mr. Burbank began serving on the Audit Committee in May 2022. Each of the members of the Audit Committee meets the independence requirements of Section&#160;303A.02 of the current NYSE Listing Standards and also meets the criteria of Section&#160;303A.06, as set forth in Rule 10A-3 promulgated under the Exchange Act, regarding listing standards related to audit committees. No member of the Audit Committee serves on the audit committee of more than three public companies. In addition, the Board of Directors has determined that all of the current members of the Audit Committee satisfy the definition of an &#8220;audit committee financial expert,&#8221; as promulgated by </span><span style="text-transform: none">the SEC.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Audit Committee charter gives the Audit Committee the authority and responsibility for the appointment, retention, compensation, and oversight of Artivion&#8217;s independent registered public accounting firm, including pre-approval of all audit and non-audit services to be performed by Artivion&#8217;s independent registered public accounting firm. The Audit Committee also oversees, and must review and approve, all significant related-party transactions. See Policies and Procedures for Review, Approval, or Ratification of Transactions with Related Parties beginning on page 17; see also the Report of the Audit Committee on </span><span style="text-transform: none">page 21. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The </span><span style="text-transform: none">Audit Committee:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews the general scope of Artivion&#8217;s annual audit and the nature of services to be performed for Artivion in connection with it, acting as liaison between the Board of Directors and the independent registered public </span><span style="text-transform: none">accounting firm;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews various Company policies, including those relating to accounting practices and internal control and information security systems </span><span style="text-transform: none">of Artivion; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews and monitors the performance of Artivion&#8217;s independent registered public accounting firm, and is responsible for engaging or discharging Artivion&#8217;s independent registered public accounting firm and for assisting the Board of Directors in its oversight of risk management and legal and financial regulatory </span><span style="text-transform: none">requirements; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Has the authority, pursuant to its charter, to delegate any of its decisions to a sub-committee of the Audit Committee consisting of two committee members, or to the Chair alone, provided that a full report of any action taken is promptly made to the full </span><span style="text-transform: none">Audit Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><b><i>Compensation Committee </i></b></span><span style="text-transform: none">&#8212; The Compensation Committee operates under a written charter that sets out the committee&#8217;s functions and responsibilities. The Compensation Committee currently consists of three non-employee directors: Mr. Bevevino, Chair, Mr. Bullock, and Mr. Semedo. Mr. Bevevino served on the Compensation Committee for all of 2022. Mr. Bullock and Mr. Semedo began serving on the Compensation Committee in May 2022. Each member of the Compensation Committee meets the independence requirements of Sections&#160;303A.02(a)(i) and (ii) of the current NYSE Listing Standards and is a non-employee director within the meaning of Rule 16b-3 under the </span><span style="text-transform: none">Exchange Act. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">15</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The </span><span style="text-transform: none">Compensation Committee:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews the performance of executive officers, including the Chief Executive Officer, and approves their </span><span style="text-transform: none">annual compensation;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Oversees the issuance of stock options, restricted stock awards, restricted stock units, performance stock units, and other stock rights and cash incentives under Artivion&#8217;s stock and </span><span style="text-transform: none">incentive plans; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Approves, in conjunction with the Corporate Governance Committee and Board of Directors, severance arrangements for </span><span style="text-transform: none">executive officers; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews, approves, and certifies the performance metrics upon which a portion of the compensation of Artivion&#8217;s Chief Executive Officer and other executive officers </span><span style="text-transform: none">is based; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Annually reviews, together with the Corporate Governance Committee, the Chief Executive Officer&#8217;s objectives and performance, recommends changes thereto, and together with the Corporate Governance Committee, sets the Chief Executive Officer&#8217;s compensation </span><span style="text-transform: none">package; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Oversees certain aspects of the Company&#8217;s ESG risks, including human </span><span style="text-transform: none">capital management. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">See Compensation Discussion and Analysis on page 24 for information concerning the Compensation Committee&#8217;s role, processes, and activities in overseeing </span><span style="text-transform: none">executive compensation.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Pursuant to its charter, the Compensation Committee has the authority to delegate any of its decisions to a sub-committee of the Compensation Committee consisting of two committee members, provided that a full report of any action taken is promptly made to the full </span><span style="text-transform: none">Compensation Committee. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Compensation Committee has the power to retain, determine the terms of engagement and compensation of, and terminate any consultant that advises the </span><span style="text-transform: none">Compensation Committee. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><b><i>Corporate Governance Committee </i></b></span><span style="text-transform: none">&#8212; The Corporate Governance Committee operates under a written charter that sets out the committee&#8217;s functions and responsibilities. The Corporate Governance Committee currently consists of three non-employee directors: Mr. Burbank, Chair, Ms. Borgstrom, and Mr. Salveson. Mr. Burbank and Mr. Salveson served on the Corporate Governance Committee for all of 2022. Ms. Borgstrom began serving on the Corporate Governance Committee in May 2022. Each of these individuals meets the independence requirements of Section&#160;303A.02 of the current NYSE </span><span style="text-transform: none">Listing Standards. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Corporate </span><span style="text-transform: none">Governance Committee:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Recommends potential candidates for the Board </span><span style="text-transform: none">of Directors;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Oversees the annual self-evaluations of the Board of Directors, its committees, and </span><span style="text-transform: none">individual directors;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Approves individuals for appointment as </span><span style="text-transform: none">executive officers; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Oversees succession planning for the Board of Directors and executive officers, including the Chief </span><span style="text-transform: none">Executive Officer;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Evaluates each year, together with the Compensation Committee, the performance of Artivion&#8217;s Chief Executive Officer and sets the Chief Executive </span><span style="text-transform: none">Officer&#8217;s compensation;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Recommends to the Board of Directors how the other committees of the Board of Directors should be structured, which non-employee directors should be members of those committees, and which non-employee director should chair those </span><span style="text-transform: none">committees; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reviews and makes recommendations to the Board of Directors regarding the development of, and compliance with, the Company&#8217;s corporate governance guidelines, ESG risk-mitigation efforts, and other governance policies, procedures, </span><span style="text-transform: none">and practices.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><b><i>Compliance Committee </i></b></span><span style="text-transform: none">&#8212; The Compliance Committee operates under a written charter that sets out the committee&#8217;s functions and responsibilities. The Compliance Committee currently consists of six non-employee directors: Ms. Borgstrom, Chair, Mr. Ackerman, Mr. Bullock, Ms. Hoff, Mr. Salveson, and Mr. Semedo. Ms. Borgstrom and Messrs. </span><span style="text-transform: none">Bullock, Salveson, </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">16</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">and Semedo each served on the Compliance Committee for all of 2022. Mr. Ackerman began serving on the Compliance Committee in May 2022. Ms. Hoff began serving on the Compliance Committee in October 2022. Each of these individuals meets the independence requirements of Section&#160;303A.02 of the current NYSE Listing Standards. The charter of the Compliance Committee requires that a majority of its members </span><span style="text-transform: none">be independent. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The </span><span style="text-transform: none">Compliance Committee:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Assists the Company in its oversight of Artivion&#8217;s compliance with healthcare laws and regulations, including regulations and laws related to regulatory affairs and quality assurance, and general healthcare compliance such as the </span><span style="text-transform: none">Anti-Kickback Statute;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Receives periodic reports from the Company&#8217;s senior management regarding quality and </span><span style="text-transform: none">regulatory compliance;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Provides input into certain regulatory affair</span><span style="text-transform: none">s and quality assurance and healthcare compliance </span><span style="text-transform: none">policies; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Assists, jointly with the Audit Committee, in the oversight of the Company&#8217;s enterprise risk assessment and compliance with certain policies and procedures such as the Company&#8217;s Code of Conduct and our policies with respect to GDPR and </span><span style="text-transform: none">the FCPA.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>PROCEDURES FOR STOCKHOLDERS WHO WISH TO SUBMIT RECOMMENDATIONS TO THE BOARD OF DIRECTORS</b></span><span id="aort-def14a_051623a349"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Stockholders may recommend potential candidates for director to the Corporate Governance Committee. The policy of the Corporate Governance Committee is to give the same consideration to nominees recommended by stockholders that it gives to individuals whose names are submitted by management or non-employee directors, provided such recommendations from stockholders are made in accordance with procedures described in this Proxy Statement under the FAQ &#8220;</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>What is the deadline for submitting proposals for consideration at next year&#8217;s Annual Meeting of Stockholders or to nominate individuals to serve as directors?</b></span><span style="text-transform: none">&#8221; When reviewing a potential candidate, the Corporate Governance Committee considers, among other things, demonstrated character, judgment, relevant business, functional, and industry experience, degree of intellectual and business acumen, and, when contemplating overall board diversity, ethnicity, race, and gender. The Board of Directors and the Corporate Governance Committee believe it is important that the members of the Board of Directors represent diverse backgrounds and viewpoints. The Corporate Governance Committee&#8217;s process for identifying and evaluating nominees typically involves consideration of external candidates, including self-nominees, upon a vacancy or at a meeting held in the first quarter of the year, and where appropriate, internal discussions, review of information concerning candidates, and interviews of selected candidates. From time to time, the Corporate Governance Committee has also engaged one or more executive search consulting firms to assist in the identification and recruitment of potential </span><span style="text-transform: none">director candidates.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Corporate Governance Committee has not received any recommended director nominees for election at the 2023 Annual Meeting from any Artivion stockholder or group of stockholders beneficially owning in excess of 5% of Artivion&#8217;s outstanding common stock. Stockholders may communicate with the Corporate Governance Committee or the Board of Directors by following the procedures set forth below at Communication with the Board of Directors and its Committees on </span><span style="text-transform: none">page 18.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The current Board of Directors&#8217; policy requires each director to offer to voluntarily resign upon a change in such director&#8217;s principal employment or line of business. The Corporate Governance Committee will then review whether such director continues to meet the needs of the Board of Directors and whether to make a recommendation to the Board of Directors that it should accept the director&#8217;s offer to resign. Upon her retirement as Chief Executive Officer of Yale New Haven Health in March 2022, Ms. Borgstrom tendered to the Board of Directors her offer of resignation. Likewise, upon his retirement in March 2022 from Fresenius Medical Care North America, Mr. Burbank tendered to the Board of Directors his offer of resignation. The Corporate Governance Committee considered Ms. Borgstrom&#8217;s and Mr. Burbank&#8217;s offers to resign and determined that it was in the best interests of Artivion for Ms. Borgstrom and Mr. Burbank to continue serving on the Board of Directors following their retirements.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The current Board of Directors&#8217; policy also limits the number of other public company boards on which Artivion directors may serve. Non-employee directors may serve on no more than three public company boards in addition to service on the Company&#8217;s Board of Directors, and the Chief Executive Officer&#8217;s service on the board of any other organization is restricted by his employment agreement with the Company and is subject to prior approval by the Board </span><span style="text-transform: none">of Directors.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">17</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>ARTIVION&#8217;S CODE OF CONDUCT</b></span><span id="aort-def14a_051623a350"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion has established a Code of Conduct that: clarifies the Company&#8217;s standards of conduct, including in potentially challenging situations; makes clear that Artivion expects all employees, executive officers, and non-employee directors to abide by applicable legal and regulatory requirements and to understand and appreciate the ethical considerations of their decisions; and reaffirms the Company&#8217;s long-standing commitment to a culture of corporate and individual accountability and responsibility for the highest ethical and </span><span style="text-transform: none">business practices.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In addition to the Code of Conduct, the Company&#8217;s Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Controller, Assistant Controller, and all other senior financial officers are also subject to the Company&#8217;s Code of Ethics for Senior Financial Officers. In the event that Artivion amends or waives any of the provisions of the Code of Conduct or Code of Ethics for Senior Financial Officers applicable to its Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Controller, or Assistant Controller, the Company will disclose that information on the Company&#8217;s website </span><span style="text-transform: none">at</span><span style="text-transform: none; font-style: italic"><i> </i></span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://investors.artivion.com/corporate-governance/cryolifes-code-conduct</span></span><span style="text-transform: none">.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>CORPORATE RESPONSIBILITY</b></span><span id="aort-def14a_051623a351"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In the second quarter of 2023, Artivion expects to publish its second annual Corporate Responsibility Report, which highlights the Company&#8217;s ESG initiatives. The Corporate Responsibility Report details several of Artivion&#8217;s ESG efforts, including, but not limited to: (1) environmental initiatives to drive sustainability and limit Artivion&#8217;s carbon footprint, including a disclosure relative to the Task Force on Climate-Related Financial Disclosures; (2) diversity, equity, and inclusion initiatives to create a welcoming and empowering workplace for every member of the global team as they strive to fulfill Artivion&#8217;s mission to make leading-edge aortic technologies available to patients around the world; and (3) Board of Directors level initiatives to enhance Board and workforce diversity, Board refreshment, and Board or Board committee oversight of some of the Company&#8217;s ESG initiatives, including human capital management. The Corporate Responsibility Report is available on the Company&#8217;s website </span><span style="text-transform: none">at </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://investors.artivion.com/corporate-responsibility-report-esg</span></span><span style="text-transform: none">. </span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>POLICIES AND PROCEDURES FOR REVIEW, APPROVAL, OR RATIFICATION OF TRANSACTIONS WITH RELATED PARTIES</b></span><span id="aort-def14a_051623a352"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Board of Directors has adopted policies and procedures for review, approval, or ratification of transactions with </span><span style="text-transform: none">related parties.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Types of Transactions Covered</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">It is our policy to enter into or ratify related party transactions only when the Board of Directors, acting through the Audit Committee or as otherwise in-line with the Company&#8217;s policies described herein, determines that the related party transaction in question is in, or is not inconsistent with, the best interests of Artivion and its stockholders. We follow the policies and procedures below for any transaction in which we are, or are to be, a participant and the annual amount involved exceeds $50,000 and in which any related party, as defined below, had, has, or will have a direct or indirect interest. Pursuant to the policy, compensatory arrangements with an executive officer or non-employee director that are approved or ratified by the Compensation Committee or compensation received under our employee benefit plans that are available to all employees do not require additional Audit </span><span style="text-transform: none">Committee approval.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company subjects the following related parties to these policies: non-employee directors (and nominees); executive officers; beneficial owners of more than 5% of our stock; any immediate family members of these persons; and any entity in which any of these persons is employed, or is a general partner or principal, or has a similar position, or in which the person has a 10% </span><span style="text-transform: none">or greater beneficial </span><span style="text-transform: none">ownership interest. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Standards Applied and Persons Responsible for Approving Related Party Transactions</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Corporate Secretary is responsible for submitting to the Audit Committee for its advance review and approval any related party transaction, other than ongoing transactions, into which we propose to enter. If the Corporate Secretary determines that it is not practicable or desirable to wait until the next regularly scheduled Audit Committee meeting, the Corporate Secretary will submit the related party transaction for approval or ratification to the Chair of the Audit Committee, who possesses delegated authority to act between Audit Committee meetings. The Chair will report any action </span><span style="text-transform: none">the Chair </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">18</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">takes under this delegated authority to the Audit Committee at its next regularly scheduled meeting and seek ratification of such approval. If any related party transaction occurs before the Audit Committee has approved it, the Corporate Secretary will submit the transaction to the Audit Committee for ratification as soon as reasonably practicable. If the Audit Committee does not ratify the transaction, the Audit Committee will direct management as to what action it proposes management take regarding </span><span style="text-transform: none">the transaction.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">When considering a related party transaction, the Audit Committee will examine all factors it deems relevant. The Audit Committee, or the Chair, will approve only those transactions that they have determined in good faith are in the best interests of Artivion and </span><span style="text-transform: none">its stockholders.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Corporate Secretary may delegate her duties under the policy to another officer of Artivion if the Corporate Secretary gives notice of the delegation to the Audit Committee at a regularly scheduled Audit </span><span style="text-transform: none">Committee meeting. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Review of Ongoing Transactions</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">At a meeting of the Audit Committee in the first quarter of each fiscal year, the Audit Committee reviews all related party transactions that are ongoing and have a remaining term of more than six months or remaining amounts payable to or receivable from Artivion of more than $50,000 annually. Based on all relevant facts and circumstances, the Audit Committee will determine whether it is in, or not inconsistent with, the best interests of Artivion and its stockholders to continue, modify, or terminate the ongoing related party transaction. Review of ongoing related party transactions is located at Director Independence beginning on </span><span style="text-transform: none">page 12.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</b></span><span id="aort-def14a_051623a353"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">None of our executive officers currently serve, or served during fiscal 2022, as a member of the compensation committee of any other company that has or had an executive officer serving as a member of our Board of Directors. None of our executive officers currently serve, or served during fiscal 2022, as a member of the board of directors of any other company that has or had an executive officer serving as a member of our </span><span style="text-transform: none">Compensation Committee.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>COMMUNICATION WITH THE BOARD OF DIRECTORS AND ITS COMMITTEES</b></span><span id="aort-def14a_051623a354"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Interested parties may communicate with the Board of Directors, the Lead Director, the non-employee directors as a group, committee chairs, committees, and individual directors by directing communications to the Corporate Secretary, who will forward them as appropriate, unless they clearly constitute unsolicited general advertising or inappropriate material. Please send all communications in care of Jean F. Holloway, General Counsel and Corporate Secretary, Artivion,&#160;Inc., 1655 Roberts Boulevard, NW, Kennesaw, </span><span style="text-transform: none">Georgia 30144.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>AVAILABILITY OF CORPORATE GOVERNANCE DOCUMENTS</b></span><span id="aort-def14a_051623a355"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">You may view current copies of the charters of the Audit, Compensation, Corporate Governance, and Compliance Committees, as well as the Company&#8217;s Code of Conduct and Corporate Governance Guidelines, on Artivion&#8217;s website </span><span style="text-transform: none">at</span><span style="text-transform: none; font-style: italic"><i> </i></span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://investors.artivion.com/corporate-governance/governance-highlights</span></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Notwithstanding anything to the contrary set forth in any of Artivion&#8217;s filings under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act that might incorporate other Artivion filings, including this Proxy Statement, in whole or in part, neither of the Reports of the Audit Committee and the Compensation Committee, set forth below, shall be incorporated by reference into any </i></span><span style="text-transform: none; font-style: italic"><i>such filings.</i></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">19</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span id="aort-def14a_051623a344"></span><span style="text-transform: none; color: #024a76; font-size: 14pt; font-family: Arial, sans-serif"><b>DIRECTOR COMPENSATION</b></span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Elements of Non-Employee Director Compensation</b></span><span id="aort-def14a_051623a356"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Restricted Stock Grants </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">A portion of the non-employee directors&#8217; annual compensation is issued as restricted stock. The shares of restricted stock are issued each year generally following the Annual Meeting of Stockholders. With respect to 2022 grants, the Compensation and Corporate Governance Committees recommended, and the Board of Directors approved, a grant date value of $150,000 per non-employee director, and in June 2022, the Company granted 7,878 shares of restricted stock to each of the non-employee directors serving at the time of grant, which will vest on June 1, 2023. With respect to Ms. Hoff, the Compensation and Corporate Governance Committees recommended, and the Board of Directors approved, a grant value of approximately $100,000 prorated based on her time served as a non-employee director in 2022, and in November 2022, the Company granted 9,066 shares to Ms. Hoff, which will vest on November 8, 2023. The amount and terms of the grants are subject to periodic re-evaluation jointly by the Compensation and Corporate Governance Committees. All equity grants to non-employee directors in 2022 were made pursuant to the Artivion, Inc. 2020 Equity and Cash Incentive Plan (the &#8220;2020 ECIP&#8221;). A non-employee director will forfeit any unvested portion of the award if s/he ceases to serve as a director, except under certain circumstances as described within the </span><span style="text-transform: none">2020 ECIP.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Board of Directors&#8217; Retainer and Committee Chair and Membership Fees</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Absent exceptional circumstances, every other year, the Compensation and Corporate Governance Committees each consider whether to adjust non-employee director compensation and recommend those adjustments, if any, to the Board </span><span style="text-transform: none">of Directors.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Each of the non-employee directors of Artivion receives an annual cash retainer for service on the Board of Directors, service on committees of the Board of Directors, service as Chair of a committee of the Board of Directors, and service as Lead Director, as applicable and as noted in the table below. Artivion pays all cash retainers on a prorated </span><span style="text-transform: none">monthly basis.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 552pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 165.6pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Board of Director Retainers</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Annual Board Service</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$55,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lead Director</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$40,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>

					</table>

				</div>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 552pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 165.6pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Committee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Committee Chair Retainer</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Committee Membership Retainer</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 13.28pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Audit</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$20,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$10,000</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$20,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$7,500</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Corporate Governance</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$10,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$5,000</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Compliance</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$10,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$5,000</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 47.15pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">In addition to annual Board </span><span style="text-transform: none">service retainer.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 47.15pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Includes committee </span><span style="text-transform: none">membership retainer.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 36.22pt; text-align: justify"><span style="text-transform: none">Effective June 1, 2022, the annual Board service retainer increased from $50,000 to $55,000. The Compensation and Corporate Governance Committees recommended, and the Board of Directors approved, this change upon the recommendation of the Compensation Committee&#8217;s independent compensation consultant, Willis Towers Watson &amp; Co. (&#8220;Willis Towers Watson&#8221;), and based on available benchmarking analysis provided by that consultant and other information provided </span><span style="text-transform: none">by management.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">20</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Fiscal</b></span><span style="font-variant: small-caps"><b> 2022 </b></span><span style="text-transform: none"><b>Director Compensation</b></span><span id="aort-def14a_051623a357"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table provides compensation information for the one-year period ended December 31, 2022, for each person who was a member of our Board of Directors in 2022, other than J. </span><span style="text-transform: none">Patrick Mackin.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 381.97pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 116.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 124.19pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 63.3pt">


							</td>

						</tr>
						<tr style="min-height: 22.5pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Retainers Earned or<br />Paid in Cash</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Annual Stock<br />Awards</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Total<br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 8.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">(a)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">(b)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">(c)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">(d)</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Thomas F. Ackerman</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">79,096</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">229,096</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Daniel J. Bevevino</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">82,917</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">232,917</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marna P. Borgstrom</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">63,750</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">213,750</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">James W. Bullock</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">65,043</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">215,043</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jeffrey H. Burbank</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111,875</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">261,875</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Elizabeth A. Hoff</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">15,641</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">115,641</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jon W. Salveson</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">65,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">215,000</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Anthony B. Semedo</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">62,292</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">212,292</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 119.6pt 0pt 128.8pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: justify"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Amounts shown include annual Board service retainer, committee Chair and committee membership retainers, and, for Mr. Burbank, a Lead Director retainer, earned by our non-employee directors during 2022. Note that the Annual Stock Awards, which are generally made on June 1, cover the one-year service period ending on May 31 the following year.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 119.6pt 0pt 128.8pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: justify"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Amount shown represents the aggregate grant date fair value of the 7,878 restricted shares granted to Messrs. Ackerman, Bevevino, Bullock, Burbank, Salveson, Semedo and Ms. Borgstrom, as calculated in accordance with FASB ASC Topic 718. We issued the awards on June 1, 2022, and we valued them at $19.</span><span style="text-transform: none; font-size: 9pt">04 per share, which was the closing price on the grant date. See Notes 1 and 15 of the Notes to Consolidated Financial Statements filed with Artivion&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 for assumptions used in valuing restricted stock awards. The restricted stock represented here vests on June 1, 2023; accordingly, these shares remained subject to vesting restrictions as of December </span><span style="text-transform: none; font-size: 9pt">31, 2022.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 119.6pt 10pt 128.8pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: justify"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 9pt">Amount shown represents the aggregate grant date fair value of the 9,066 restricted shares granted to Ms. Hoff, as calculated in accordance with FASB ASC Topic 718. We issued the award on November 8, 2022, and we valued them at $11.03 per share, which was the closing price on the grant date. See Notes 1 and 15 of the Notes to Consolidated Financial Statements filed with Artivion&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, for assumptions we used in valuing restricted stock awards. The restricted stock represented here vests on November&#160;8,&#160;2023; accordingly, these shares remained subject to vesting restrictions as of December </span><span style="text-transform: none; font-size: 9pt">31, 2022.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">J. Patrick Mackin, Chairman, President, and Chief Executive Officer received no compensation in 2022 for his services as a director of the Company. His compensation as an executive officer of the Company is detailed in the Summary Compensation Table on </span><span style="text-transform: none">page</span><span style="text-transform: none; font-family: Arial, sans-serif"><b> </b></span><span style="text-transform: none">44.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Director Stock Ownership Requirement</b></span><span id="aort-def14a_051623a358"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In November 2015, the Compensation and Corporate Governance Committees approved a change to the non-employee director stock ownership requirement to five times the then-current annual board service retainer for non-employee directors. The Board of Directors reevaluates this stock ownership requirement typically on a biennial basis and did so recently in November 2021, concluding at that time, based on information provided by Willis Towers Watson and management, that these requirements remained appropriate. All non-employee directors currently satisfy this standard except for Ms. Hoff, whose service on the Board began in October 2022. Ms. Hoff is expected to meet the requirement within the next </span><span style="text-transform: none">one-to-two years. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">21</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>REPORT OF THE AUDIT COMMITTEE</b></span><span id="aort-def14a_051623a359"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">The Board of Directors maintains an Audit Committee of three non-employee directors. The Board of Directors and the Audit Committee believe that the Audit Committee&#8217;s current member composition satisfies the rules of the NYSE that govern audit committee composition, including the requirement that each audit committee member be &#8220;Independent Directors&#8221; as that term is defined by Sections 303A.02 and 303A.06 of the NYSE Listing Standards and Rule 10A-3 promulgated under the Securities Exchange Act </span><span style="text-transform: none">of 1934.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">The Audit Committee oversees Artivion&#8217;s financial processes and the Company&#8217;s information security preparedness on behalf of the Board of Directors. Management has the primary responsibility for the financial statements and the reporting process, including the systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee reviewed the audited financial statements included in Artivion&#8217;s Annual Report on Form 10-K for fiscal 2022 and discussed them with management, including a discussion of the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements. The Board of Directors and the Audit Committee have adopted a written Audit Committee Charter. Since the first quarter of 2004, Artivion has retained an outside accounting firm to provide internal audit services. The internal audit function reports directly to the Audit Committee and, for administrative purposes, to the Chief </span><span style="text-transform: none">Financial Officer.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">During fiscal 2022, management completed the documentation, testing, and evaluation of Artivion&#8217;s system of internal controls over financial reporting and the associated information security preparedness in response to the requirements set forth in Section&#160;404 of the Sarbanes-Oxley Act of 2002 and related regulations. The Audit Committee was kept informed of the progress of the evaluation and provided oversight and advice to management during the process. In connection with this oversight, the Audit Committee received periodic updates provided by management and Ernst&#160;&amp; Young LLP, Artivion&#8217;s independent registered public accounting firm, at each regularly scheduled Audit Committee meeting. The Audit Committee also reviewed the report of management on internal controls over financial reporting contained in Artivion&#8217;s Annual Report on Form&#160;10-K for fiscal 2022, as well as Ernst&#160;&amp; Young LLP&#8217;s Reports of Independent Registered Public Accounting Firm included in Artivion&#8217;s Annual Report on Form&#160;10-K for fiscal 2022 related to its audit of (i)&#160;Artivion&#8217;s consolidated financial statements and (ii)&#160;the effectiveness of Artivion&#8217;s internal controls over financial reporting. As of December 31, 2022, the Audit Committee continued to oversee Artivion&#8217;s efforts related to Artivion&#8217;s internal controls over financial reporting and management&#8217;s preparations for the evaluation thereof for </span><span style="text-transform: none">fiscal 2022.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">The Audit Committee reviewed with Ernst&#160;&amp; Young LLP, who is responsible for expressing an opinion on the conformity of those audited financial statements with generally accepted accounting principles, their judgments as to the quality, not just the acceptability, of Artivion&#8217;s accounting principles and such other matters as are required to be discussed with the Audit Committee by the applicable requirements of the Public Company Accounting Oversight Board and the Securities and Exchange Commission. Ernst&#160;&amp; Young LLP also provided to the Audit Committee the written disclosures and the letter required by the applicable requirements of the Public Company Accounting Oversight Board regarding Ernst&#160;&amp; Young LLP&#8217;s communications with the Audit Committee concerning independence. The Audit Committee discussed with Ernst&#160;&amp; Young LLP and management that firm&#8217;s independence from management </span><span style="text-transform: none">and Artivion. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">The Audit Committee discussed with Ernst&#160;&amp; Young LLP the overall scope and plans for its audit. The Audit Comm</span><span style="text-transform: none">ittee m</span><span style="text-transform: none">et with Ernst&#160;&amp; Young LLP, with and without management present, to discuss the results of its examination, its evaluation of Artivion&#8217;s internal controls, and the overall quality of Artivion&#8217;s financial reporting.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">In connection with its review of Artivion&#8217;s accounting and financial controls, the Audit Committee discusses with management on a quarterly basis the adequacy of Artivion&#8217;s information security preparedness and the types of information technology risks, controls, and procedures and any related issues that could affect the adequacy of Artivion&#8217;s internal controls or general operations, including as they relate to information security. Assessments of Artivion&#8217;s information security program, including evaluations about its policies, procedures, infrastructure, access control, and change management, were performed by the independent external auditing firms Ernst &amp; Young LLP, Hancock Askew &amp; Co., LLP, and RWT </span><span style="text-transform: none">Crowe GmbH. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">22</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">In reliance on the reviews and discussions referred to above, the Audit Committee members did not become aware of any material misstatements in the audited financial statements and recommended to the Board of Directors that the audited financial statements be included in Artivion&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022, for filing with the Securities and Exchange Commission. The Audit Committee has preliminarily approved Ernst&#160;&amp; Young LLP as Artivion&#8217;s independent registered public accounting firm for fiscal 2023, pending final resolution of the terms of Artivion&#8217;s 2023 engagement letter with </span><span style="text-transform: none">the firm.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 331.2pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Audit Committee<br /></b></span><span style="text-transform: none">THOMAS F. ACKERMAN, CHAIR<br />DANIEL J. BEVEVINO<br />JEFFREY </span><span style="text-transform: none">H. BURBANK</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>This foregoing audit committee report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC, and shall not be deemed incorporated by reference by any general stat</i></span><span style="text-transform: none; font-style: italic"><i>ement incorporating by reference this Proxy Statement into any filing of the Company&#8217;s under the Securities Act of 1933, as amended, or under the Exchange Act, except to the extent the Company specifically incorporates this report </i></span><span style="text-transform: none; font-style: italic"><i>by reference.</i></span><span style="text-transform: none"> </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">23</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>PROPOSAL TWO &#8211; ADVISORY VOTE ON EXECUTIVE OFFICER COMPENSATION</b></span><span id="aort-def14a_051623a360"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion</span><span style="text-transform: none; font-size: 9pt"> </span><span style="text-transform: none">seeks a non-binding vote from its stockholders to approve the compensation paid to our Named Executive Officers, as disclosed in this Proxy Statement pursuant to Item&#160;402 of Regulation&#160;S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. This vote is commonly referred to as a &#8220;Say on Pay&#8221; vote because it gives stockholders an opportunity to express their approval or disapproval of the Company&#8217;s executive officer </span><span style="text-transform: none">pay practices.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As discussed in detail in the Compensation Discussion and Analysis that follows, our executive officer compensation programs are designed to attract, retain, motivate, and reward executive officer talent that is able, and appropriately incented to, deliver on Artivion&#8217;s short and long-term growth, on other strategic objectives, and on Artivion&#8217;s commitments to its stockholders, in particular, long-term value creation. We believe that the form and amount of compensation we provide to our current Named Executive Officers appropriately reflects their extensive management experience, continued high performance, and exceptional service to Artivion and </span><span style="text-transform: none">our stockholders.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">During 2022, in addition to the continued impact of the COVID-19 pandemic on the Company&#8217;s business (mostly from hospital-staffing shortages and hospital financial pressures), other unanticipated economic and regulatory challenges also impacted the Company&#8217;s business. Agile, resilient, and effective leadership from management was necessary&#8212;more than ever&#8212;to counteract these challenges and to continue to deliver on the Company&#8217;s growth objectives. Throughout the year, the Compensation Committee considered how to incent such leadership, maintain morale among the Company&#8217;s employees, including the executive team, and retain key leaders in light of the intense war for talent that persisted in 2022 and the decline in the Company&#8217;s stock price, which the Compensation Committee believed to be due mostly to macroeconomic factors or other factors over which management had limited-to-no control. The Compensation Committee particularly focused on ways that it could incent continued high performance from the Company&#8217;s executive leadership (in 2022 and beyond) during what was, and still is, a critical time for the Company given its growth objectives now and in the coming years, and in view of the above-referenced headwinds. To facilitate stockholders&#8217; review of the executive officer compensation program, we are providing details regarding the program and the performance and payouts related thereto.       </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">We invite you to consider the details of our executive officer compensation program as disclosed more fully throughout this Proxy Statement. Regardless of the outcome of this &#8220;Say on Pay&#8221; vote, Artivion welcomes input from its stockholders regarding executive officer compensation and other matters generally related to the Company&#8217;s success. We believe in a corporate governance structure that is responsive to stockholder concerns. We view this vote as a meaningful opportunity to gauge stockholder approval of our executive officer compensation policies. Given the information provided in this Proxy Statement, the Board of Directors asks you to approve the following </span><span style="text-transform: none">advisory resolution: </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8220;Resolved, that Artivion&#8217;s stockholders approve, on an advisory basis, the compensation paid to Artivion&#8217;s Named Executive Officers, as disclosed in this </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Proxy Statement.&#8221;</b></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Required Vote</i></b></span><span style="text-transform: none; font-weight: normal; font-style: italic"><i> </i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The votes cast for this proposal must exceed the votes cast against it in order for it to be approved. Accordingly, abstentions and broker non-votes will not be relevant to the outcome. As previously disclosed and approved by the stockholders, the Board of Directors currently submits a Say on Pay proposal annually. The annual frequency of this disclosure and approval was the subject of a vote of the stockholders at the Company&#8217;s 2017 Annual Meeting and was supported by more than 77% of stockholders who voted. The frequency of &#8220;Say on Pay&#8221; votes is up for consideration again by the stockholders at this year&#8217;s Annual Meeting (see Proposal Three </span><span style="text-transform: none">at </span><span style="text-transform: none">70</span><span style="text-transform: none">). </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Recommendation </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221;<br />THE APPROVAL OF THE COMPENSATION PAID TO ARTIVION&#8217;S NAMED </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>EXECUTIVE OFFICERS.</b></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">24</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>COMPENSATION DISCUSSION AND ANALYSIS</b></span><span id="aort-def14a_051623a361"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">This Compensation Discussion and Analysis describes the principles, objectives, and features of our executive compensation program as applied to our chief executive officer and the other named executive officers included in the Summary Compensation Table of this Proxy Statement (collectively, our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;). For 2022, our </span><span style="text-transform: none">NEOs were:</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 6pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 33.11pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 117.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 470pt">


							</td>

						</tr>
						<tr style="min-height: 18.45pt">
							<td style="border-width: 0pt; padding: 0pt 5.4pt 10pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">J. </span><span style="text-transform: none">Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">President, Chief Executive Officer, and Chairman of the Board </span><span style="text-transform: none">of Directors </span></p>

							</td>

						</tr>
						<tr style="min-height: 18pt">
							<td style="border-width: 0pt; padding: 0pt 5.4pt 10pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">D. </span><span style="text-transform: none">Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Executive Vice President and Chief </span><span style="text-transform: none">Financial Officer</span></p>

							</td>

						</tr>
						<tr style="min-height: 17.55pt">
							<td style="border-width: 0pt; padding: 0pt 5.4pt 10pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Jean </span><span style="text-transform: none">F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Senior Vice President, General Counsel, Chief Compliance Officer, and </span><span style="text-transform: none">Corporate Secretary</span></p>

							</td>

						</tr>
						<tr style="min-height: 16.65pt">
							<td style="border-width: 0pt; padding: 0pt 5.4pt 10pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">John </span><span style="text-transform: none">E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Senior Vice President, Global Sales </span><span style="text-transform: none">and Marketing</span></p>

							</td>

						</tr>
						<tr style="min-height: 16.65pt">
							<td style="border-width: 0pt; padding: 0pt 5.4pt 10pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Marshall </span><span style="text-transform: none">S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt 0pt 10pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Senior Vice President, Clinical Research and Chief </span><span style="text-transform: none">Medical Officer</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Executive Summary</b></span><span id="aort-def14a_051623a362"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Compensation Committee (referred to in this section as the &#8220;Committee&#8221;) generally considers and approves executive officer compensation each year at a meeting held in the first quarter of the fiscal year. These compensation decisions take into account a variety of information and analyses, including, but not limited to, alignment of compensation vehicles with the Committee&#8217;s Compensation Philosophy, prior-year Company and individual executive officer performance (including the Company&#8217;s share price), current-year performance expectations and key business objectives, any changes in roles and responsibilities of executives, the external environment for talent, and competitive market data and market trends from various sources, including from the Committee&#8217;s independent compensation consultant </span><span style="text-transform: none">and management.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2021 Say on Pay Vote and 2022 Program Decisions</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">At Artivion&#8217;s Annual Meeting of Stockholders on May 19, 2021, 97% of the stockholder votes cast were in favor of our NEOs&#8217; 2020 compensation. This advisory vote indicated strong stockholder support for our executive officer compensation program, including our NEO compensation, and is consistent with the fact that over the past four years, on average, 96% of stockholder votes cast were in favor of our </span><span style="text-transform: none">NEOs&#8217; compensation.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">The Committee considered these advisory vote results on the 2020 executive compensation plan as it made compensation decisions for 2022. Based in part on this consideration, and together with individual executive officer performance, retention considerations, and the Company&#8217;s actual and expected performance as of February 2022, including its share price, as well as competitive market data and recommendations from various sources, including from the Committee&#8217;s independent compensation consultant and management, in February&#160;2022, the Committee considered modifications to the Company&#8217;s 2022 executive officer compensation programs as explained in more detail below and approved those modifications in </span><span style="text-transform: none">April 2022. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.48pt; text-align: justify"><span style="text-transform: none">During much of 2021, the COVID-19 pandemic, including related hospital-staffing shortages and hospital financial pressures, as well as supply-chain challenges (collectively, the &#8220;impact of COVID-19&#8221;) continued to have an adverse impact on the Company&#8217;s operations and its financial results. During the first several months of 2022, it did appear that the impact of COVID-19 may have started to dissipate, particularly the unpredictability of that impact. In view of this, the Committee considered the appropriate metrics and financial goals for the Company&#8217;s 2022 incentive programs and, in particular, whether it should not use non-financial metrics as the Committee had for the 2021 programs. Ultimately, as explained in more detail below, the Committee determined to use only full-year financial metrics for the 2022 incentive programs. The Committee then further considered the performance metrics and targets</span><span style="text-transform: none"> that would continue to incent the highest levels of performance from management during what was a critical time for the Company given its growth objectives, its commitments to deliver on stockholder value creation, and its desire to retain members of management it deemed key to the continued financial and operational success of the Company. The following is a summary of the Committee&#8217;s significant considerations and decisions made regarding NEO compensation </span><span style="text-transform: none">for 2022:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 6pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">NEOs, except for Mr. Stanton who did not join Artivion until March 2021, received 2022 base salary increases of 3% (Mr. Stanton&#8217;s pro rata increase was 2.5%), based on considerations such as personal performance, Company performance, and </span><span style="text-transform: none">market positioning;</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">25</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee maintained the same percent-of-salary targets for 2022 cash bonuses that it used in 2021 to reflect Company performance and market positioning, at the following percentages of base salary: Mr. Mackin at 100%; Mr. Lee at 60%; and Ms. Holloway and Messrs. Davis and Stanton </span><span style="text-transform: none">at 50%;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">As explained in more detail below, the Committee adopted the same constant currency revenue metric for the annual cash bonus plan and as one of two of the metrics for the annual performance share plan, concluding, with input from its advisors and management, that it was appropriate to use this metric across both plans because it continued to be one of the most significant drivers of Company performance and stockholder value creation for 2022. The payout for the cash bonus was capped at 200% overall of target, inclusive of any adjustments for </span><span style="text-transform: none">personal performance;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">As explained in more detail below, the Committee returned to using adjusted EBITDA as the other metric for the annual performance share plan, concluding, with input from its advisors and management, that like constant currency revenue growth, adjusted EBITDA was an important indicator of Company performance and a significant driver of stockholder value creation for 2022. The performance share plan was capped at 150% with no modifier for personal performance;    </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee decided to maintain in 2022 the same types of annual equity vehicles (stock options, restricted stock awards, and performance stock units (&#8220;PSU&#8221;)) for officer annual long-term incentive awards that it had used in 2021 and prior years, as well as an equal allocation among the equity vehicles based on estimated grant date </span><span style="text-transform: none">fair value; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee slightly increased the target annual equity value from 2021 to 2022 for all NEOs both as a reward for exceptional individual performance during the pandemic years of 2020 and 2021, and to bring annual equity targets more in-line with&#8212;but in all cases still slightly below&#8212;market medians for such officers, which medians have increased over the past several years. The target equity values for NEOs annual equity in 2022 were as follows: Mr. Mackin&#8217;s was $2,634,735; Mr.&#160;Lee&#8217;s was $632,700; Ms. Holloway&#8217;s was $485,000; Mr. Davis&#8217;s was $477,000; and Mr. Stanton&#8217;s </span><span style="text-transform: none">was $465,000; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Due to the uncertainty related to the continued impact of COVID-19 on the Company&#8217;s business, in the first quarter of 2022, the Committee adopted a framework for the cash bonus and performance stock plans and later, in April 2022, adopted the metrics for the 2022 incentive plans. The Committee finalized and approved the full-year financial metrics for both the 2022 cash bonus and performance share plans as follows: (a) for the cash bonus plan, a single metric of constant currency revenue growth in 2022 versus 2021 with a target of 9%; and (b) for the performance share plan, (1) a metric of constant currency revenue growth in 2022 versus 2021 (the same metric and target as the cash bonus plan) weighted at 50%, and (2) a metric based on performance to target adjusted EBITDA, also weighted </span><span style="text-transform: none">at 50%; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">In February 2023, after considering the Company&#8217;s full-year financial results for 2022, the Committee determined that it was appropriate to make alterations to the adjusted EBITDA metric to account for two unanticipated external factors that were beyond management&#8217;s control and that negatively impacted the Company&#8217;s 2022 adjusted EBITDA&#8212;namely, the impact of foreign currency exchange rates (&#8220;FX&#8221;) (in the amount of $0.98M) and legal expenses (in the amount of $0.73M) that the Company was forced to incur to secure derogations that would allow it to continue to sell BioGlue in regions impacted by the Company&#8217;s loss of the BioGlue CE Mark at the end of 2021. The Committee also determined to adjust the revenue metric to exclude PerClot sales in 2021 and 2022 given that (1) the Company strategically divested the PerClot product line to Baxter Healthcare Corporation in 2021; (2) the exclusion of PerClot sales from 2022 and 2021 was required under the terms of the 2022 LTIP PSU (as defined below) and 2019 LTIP awards in order to ensure that management is appropriately incented to support strategic divestitures; and (3) for similar reasons, the Committee had excluded PerClot revenues for the second half of 2021 and 2020 when measuring revenue growth for the 2021 executive </span><span style="text-transform: none">incentive plans; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">As explained in the Company&#8217;s previous proxy filings, in 2019, the Committee approved the &#8220;2019 LTIP,&#8221; a long-term incentive, performance-based equity grant, that included three performance periods, or &#8220;tranches,&#8221; spanning a total of five years. In the first quarter of 2021, even though the last year of the performance period for tranche one was 2021, it became evident that the first tranche of the Company&#8217;s 2019 LTIP, representing 60% of the entire award that was scheduled to vest over the three year period from 2021-2023, would not payout as a result of the unanticipated impact of COVID-19 in 2020 on the Company&#8217;s business performance. As a result, the Committee concluded that the first tranche of the 2019 LTIP would have no retentive value or incentivizing impact on executive behavior for 2021 (or beyond), during a crucial multi-year period when it was even more critical for the executive team to be focused on revenue growth and long-term value creation. Nonetheless, the Committee decided to make </span><span style="text-transform: none">no mid-stream </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">26</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 808.68pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">adjustments to the 2019 LTIP and allowed the first tranche to payout at zero. The Committee decided, however, that the same considerations that led it to grant the 2019 LTIP in the first place&#8212;a focused incentive for management to deliver at least 9% constant currency revenue growth and an increasingly competitive external talent market&#8212;continued to be valid in 2021, particularly in light of the continued impact of COVID-19 into 2021. The Committee also wished to provide officers with the additional related incentive to drive recovery from COVID-19 in the Company&#8217;s 2021 business performance. Accordingly, the Committee decided to issue executives a one-year performance stock unit award (the &#8220;2021 LTIP PSU&#8221;) based on the same metrics that applied in the 2019 LTIP, with the exception of the elimination of the gross margin modifier. The Committee determined to eliminate the gross margin modifier for the 2021 LTIP PSU so that management would not be disincentivized from making continued significant investments in the business in 2021 to lay the groundwork for success in 2022 and beyond. The Committee also reduced the maximum target payout in the 2021 LTIP PSU to 200% (from 250% in the 2019 LTIP) for most NEOs to counterbalance the elimination of the gross margin modifier, as well as to level payouts among </span><span style="text-transform: none">all executives; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Based on those very same considerations, and to further incent executives to drive at least 9% constant currency revenue growth in 2022 and to align executives&#8217; interests with those of stockholders, the Committee decided to issue executives a second, one-year performance stock unit award (the &#8220;2022 LTIP PSU&#8221;) based on the same metrics and targets that applied in the 2019 LTIP, again with the exception of the elimination of the gross margin modifier and the change to the max</span><span style="text-transform: none">imum payout, and with the above-described, PerClot-related adjustment to constant currency revenue growth. As in 2021, the Committee determined that the 2022 LTIP PSU would be based on a number of shares, not overall value of shares at the time of grant, to reflect the fact that the share price in 2022 was lower than it had been in 2019 when the 2019 LTIP was granted. The target number of shares for NEOs under the 2022 LTIP PSU was one-third of the target number of shares in the first tranche of the 2019 LTIP as follows: Mr. Mackin&#8217;s was 20,202 shares; Mr. Lee&#8217;s was 3,367 shares; Ms. Holloway&#8217;s and Messrs. Davis&#8217;s and Stanton&#8217;s was 2,693 </span><span style="text-transform: none">shares; and </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For the 2022 LTIP PSU, the Committee adopted a design metric of performance stock unit awards at 100% of payout based on the constant currency revenue growth rate of 9% in 2022 as compared with 2021, with a maximum payout of 200% </span><span style="text-transform: none">of target.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Unrelated to these 2022 compensation decisions, in light of a significant decline in the Company&#8217;s stock price in September and October 2022, related primarily to factors that the Committee believed to be independent of management&#8217;s performance, in November 2022, the Committee decided to accelerate into November 2022 a portion of the executives&#8217; annual equity grants intended for 2023. These November 2022 grants, which consisted of Restricted Stock Units and stock options, were considered by the Committee to be part of executives&#8217; 2023 compensation, and, therefore, the value of these November 2022 awards was deducted from the total 2023 target equity award level to determine the value of awards issued in February 2023. The November 2022 awards are included in the 2022 Summary Compensation Table at </span><span style="text-transform: none">p. 44</span><span style="text-transform: none"> due to the actual timing of the awards and regulatory requirements. The Committee decided to accelerate a portion of the 2023 annual equity grants to enhance the retentive and motivational impact of equity awarded to management and to address concerns about executive retention, in light of significant declines in the value of executives&#8217; equity holdings in the Company and the competitive external marketplace for talent. In February 2023, the Committee approved the final portion of the 2023 annual equity grants, consisting of annual PSUs and LTIP performance-contingent shares. The table set forth on </span><span style="text-transform: none">p. 40</span><span style="text-transform: none"> reflects the executives&#8217; actual 2022 equity compensation, exclusive of these November 2022 </span><span style="text-transform: none">grant values.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Pay-for-Performance Alignment, Including Incentive Plan Designs and Metrics</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee believes it has developed a compensation program that ensures that the interests of the Company&#8217;s executive officers, including its NEOs, are aligned with those of its stockholders by strongly linking executive officer compensation with Company and personal performance at levels such that executive officers are incented to drive long-term value creation, especially given the Company&#8217;s growth objectives in the coming years. The key pay-for-performance aspects of the 2022 executive officer compensation program are </span><span style="text-transform: none">described below:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">50% or more of each NEO&#8217;s total target direct compensation is in the form of variable pay tied to individual and </span><span style="text-transform: none">Company performance;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Short-term incentives are designed to be based significantly on constant currency revenue growth, a factor that is believed to create significant stockholder value creation, and over which executive officers are believed to have substantial control and that is intended to incentivize executive officers to achieve Company target performance on this key </span><span style="text-transform: none">financial metric;</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">27</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Targets for short-term incentive opportunities are set at challenging levels designed to incentivize executive officers to achieve business growth at or above levels expected by stockholders, while setting up the Company for long-term success and </span><span style="text-transform: none">continued growth;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Annual long-term incentive opportunities are equity-based and include stock options, which only provide value to executive officers if the stock price increases beyond the grant date price, and performance stock units, which are designed to be earned only if specified results at challenging levels for revenue and adjusted EBITDA, as defined below, are attained, thereby incentivizing executive officer performance that furthers the Company&#8217;s strategic goals and drives stockholder value. Such performance stock units, however, are not fully earned if such challenging levels are not met, as was the case with the first tranche of the 2019 LTIP, and, as explained below, with the 2022 annual performance </span><span style="text-transform: none">share award; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">NEOs are subject to stock ownership requirements to ensure alignment with stockholders and to encourage executive officers to maintain a long-term view of Company </span><span style="text-transform: none">performance; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Our Clawback Policy is designed to diminish the likelihood that executive officers unjustly benefit in cash or equity from material misstatements in our </span><span style="text-transform: none">financial statements. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As described in this Proxy Statement, in 2022, the executive officer compensation program effectively delivered pay-for-performance </span><span style="text-transform: none">as follows:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">In 2022, we achieved above-target constant currency revenue growth of 9.8% (target was 9%), resulting in an above-target payout at 111.4% of target for the cash bonus program and for the revenue component of the annual performance share plan, as well as an above-target payout of 140% of target for the 2022 LTIP </span><span style="text-transform: none">PSU; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Our 2022 adjusted EBITDA was at 87.1% of target performance (i.e., $39,084,000 versus a target of $44,868,000), leading to a below-target payout at 65.6% of target for this component of the annual performance share plan, and, when combined with the 111.4% payout for the revenue component of the annual performance share plan, ultimately resulting in performance stock units paying out below-target at 88.5% of the target </span><span style="text-transform: none">award level. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Throughout this Proxy Statement, we refer to the revenue and adjusted EBITDA performance measures as reported in our 2022 Form 10-K filed on February 23, 2023, which is attached as Appendix A to this </span><span style="text-transform: none">Proxy Statement.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Roles and Responsibilities</b></span><span id="aort-def14a_051623a363"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Compensation Committee</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee determines and approves the compensation of Artivion&#8217;s executive officers, including the NEOs, except that it jointly determines and approves with the Corporate Governance Committee the compensation of Artivion&#8217;s Chief Executive Officer. The Committee is supported by the Chief Executive Officer, other executive officer management, an independent compensation consultant, and other advisors that the Committee, or management on its behalf, consults from time to time, as well as information and data supplied by each of these persons. The consultant attends Committee meetings when invited and provides input, information, and data as requested by the Committee. The Committee regularly meets in executive session without the Chief Executive Officer or any members of management present. For 2022, the Committee made compensation decisions based on its own considerations and analyses, the Compensation Philosophy of the Committee, as well as on information provided by and recommendations from the Committee&#8217;s independent compensation consultant, other advisors, and management. Our Chief Executive Officer does not exercise any decision-making authority over his own compensation or participate in Compensation or Corporate Governance Committee meetings or Board meetings regarding his own compensation, except to discuss his own performance and compensation with those Committees or the Board during his annual </span><span style="text-transform: none">performance review.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Independent Compensation Consultant</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee has the authority to engage consultants, including compensation consultants, to assist with its responsibilities. With respect to general executive officer compensation decisions made during fiscal 2022 and regarding 2022 compensation, the Committee retained Willis Towers Watson as its primary compensation consultant for general executive officer compensation matters.</span><span style="text-transform: none"> The compensation consultant reports directly to the Committee, is directed by the Committee, and provides only those services authorized by the Committee. The compensation consultant provides </span><span style="text-transform: none">no other </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">28</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">services to Artivion. The compensation consultant generally performs an annual review of officer compensation and biennial review of non-employee director compensation, analyzes the relationship between executive officer pay, including that of our Chief Executive Officer, and Company performance, compares executive officer and non-employee director compensation against such compensation of appropriate comparable companies and industry standards, informs the Committee of emerging practices and trends, assists with special projects at the request of the Committee, and attends Committee meetings when invited. In February 2022, and again in February 2023, the Committee assessed the independence of Willis Towers Watson pursuant to applicable SEC and NYSE rules and concluded that Willis Towers Watson was independent and its work for the Committee did not raise any conflict-of-interest concerns.  </span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Compensation Philosophy and Objectives</b></span><span id="aort-def14a_051623a364"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee&#8217;s Compensation Philosophy is to attract, retain, motivate, and reward executive officer talent that has the capability, and is appropriately incented, to deliver on the Company&#8217;s short and long-term growth and other strategic objectives and on the Company&#8217;s commitments to its stockholders, in particular long-term value creation. To that end, the Company has designed the compensation program to align with corporate strategy and short-term and long-term objectives, achieve market competitiveness, emphasize pay-for-performance, align with stockholder interests, balance the interests of key stakeholders, incent management to address unforeseen challenges, and recognize the unique attributes specific to Artivion and its executive officer team. Each primary component of compensation is intended to accomplish one or more of these objectives, as summarized in the </span><span style="text-transform: none">table below. </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 191.47pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 107.75pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 211.13pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation<br />Component</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Primary Purpose</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Form</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Linkage</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Base Salary</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Provide sufficiently competitive pay to attract, retain, motivate, and reward experienced and capable executive officer talent.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Cash</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Base salaries are determined based on individual executive officer performance, competitive market positioning, internal pay equity, and other factors; in addition, Company performance impacts the decision as to whether any salary adjustments are made when they are established in February of each year.   </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Short-Term Incentive&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Encourage and reward both individual achievement of performance objectives and aggregate Company performance against short-term financial and operating goals, maintain market competitiveness for top executive officer talent, and recognize the unique attributes an executive officer brings to the Company.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Cash</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Short-term incentive payouts are 100% performance-based, with the structure for fiscal 2022 having payouts based 100% on entire-year constant currency revenue growth during 2022. The payout can then be increased or reduced by up to 20% based on individual executive officer performance up to an overall cap of 200%.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">29</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 191.47pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 107.75pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 211.13pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation<br />Component</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Primary Purpose</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Form</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Linkage</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 169.65pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Long-Term Incen</span><span style="text-transform: none">tive &#8211;</span><span style="text-transform: none"> Annu</span><span style="text-transform: none">al Equ</span><span style="text-transform: none">ity</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Encourage and reward long-term stockholder value creation, retain highly capable executive officer talent, and facilitate long-term stock ownership among our executive officer team to further align executive officer and stockholder interests.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Performance Stock Units </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stock Options</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Restricted Stock </span><span style="text-transform: none">Units</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022 LTIP PSU</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Tranche 2 of the 2019 LTIP</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">PSUs and LTIP PSUs are earned only if specific levels of Company performance are achieved during the relevant performance period. For fiscal 2022, annual PSU payouts were based 50% on entire-year constant currency revenue growth during 2022 and 50% based on entire-year adjusted EBITDA during 2022, up to a cap of 150%. The 2022 LTIP PSU payouts were based 100% on entire-year constant currency revenue growth during 2022, and, in the case of tranche 2 of the 2019 LTIP, based on revenue growth with a modifier for gross margin. </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stock options deliver realizable value to executive officers only if the stock price increases beyond the grant date stock price; the realizable value of restricted stock awards is linked to Artivion&#8217;s stock price at and after the grant date.</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none"></span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Compensation Mix</b></span><span id="aort-def14a_051623a365"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee approves the primary components of the executive officer compensation program and generally intends for it to provide more variable pay opportunities than fixed pay opportunities and to place significant weight on long-term incentive opportunities. The Committee believes that this results in a pay program that aligns pay and performance. The following table summarizes the original target pay mix for the NEOs for fiscal 2022 as determined by the Committee in </span><span style="text-transform: none">February 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.25pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 309.75pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation Component</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Mackin</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Lee</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Holloway</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Davis</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stanton</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Salary ($)</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">478,344</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">397,338</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">379,813</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">384,216</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Short-Term Incentive (at target) ($)</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">287,006</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">198,669</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">189,907</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">192,108</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Long-Term Incentive</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup><span style="text-transform: none"> </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- Annual Equity (Grant Date Fair Value at target) ($)</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- 2022 LTIP PSU (Grant Date Fair Value at target) ($)</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,634,713</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">372,525</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">632,696</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">62,087</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">484,994</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">49,659</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">477,019</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">49,659</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">465,011</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">49,659</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Target Total Direct Compensation ($)</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4,506,502</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,460,134</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,130,660</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,096,397</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 2.5pt double; padding: 1.5pt 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,090,994</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">% Fixed</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">% Variable</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">16.6</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">83.4</span></p>

							</td>
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">32.8</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">67.2</span></p>

							</td>
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35.1</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">64.9</span></p>

							</td>
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">34.6</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">65.4</span></p>

							</td>
							<td style="border-top: #000000 2.5pt double; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35.2</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">64.8</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.45pt">
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">% Short-Term Compensation</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">% Long-Term Compensation</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">33.3</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">66.7</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">52.4</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">47.6</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">52.7</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">47.3</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">52.0</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">48.0</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">52.8</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">47.2</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1) </sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Salary was set by the Committee in </span><span style="text-transform: none">February 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Unlike in 2021, Short-Term Incentive (cash bonus) was tied only to </span><span style="text-transform: none">financial metrics. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Long-Term Incentive - Annual Equity and 2022 LTIP PSU (Grant Date Fair Value at target) is based on a grant date closing share price of $18.44.  </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Salary as a percentage of Target Total </span><span style="text-transform: none">Direct Compensation.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Short-Term Incentive plus Long-Term Incentive as a percentage of Target Total </span><span style="text-transform: none">Direct Compensation.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Salary plus Short-Term Incentive as a percentage of Target Total </span><span style="text-transform: none">Direct Compensation.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Long-Term Incentive as a percentage of Target Total </span><span style="text-transform: none">Direct Compensation.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">30</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Market Analysis</b></span><span id="aort-def14a_051623a366"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As part of its decision-making process, the Committee requests and reviews relevant market data regarding executive officer compensation levels, Company performance, and the relative relationship between executive officer pay and Company performance. However, the Committee views this data as one of many inputs into its decision-making process, which also includes other assessments of the Company&#8217;s performance, assessments of each executive officer&#8217;s performance, the need to address unforeseen challenges, significant changes in roles and responsibilities, internal pay equity among executive officers, and </span><span style="text-transform: none">retention considerations.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Each year, the Committee reviews and considers an executive officer compensation study prepared by Willis Towers Watson, additional compensation data provided by management, and internal equity information. The executive officer compensation study is typically completed in the fourth quarter of the fiscal year and is used to inform the Committee&#8217;s decisions regarding the subsequent fiscal year&#8217;s compensation. Accordingly, the relevant study and market information reviewed by the Committee with regard to fiscal 2022 officer compensation was presented to the Committee in the fourth quarter of fiscal 2021. We refer to this study as the &#8220;2021 Study.&#8221; The Committee reconsidered the 2021 Study for continued applicability at its first quarter 2022 meetings. As in prior years, the 2021 Study assessed both the competitiveness of pay levels, generally and by some specific positions, as well as the alignment of pay with Company performance.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company&#8217;s 2022 compensation peer group, which is described in more detail below, had median revenues, based on the latest figures available at the time the 2021 Study was prepared, of $278.1 million and median market capitalization as of June 2021 of $1.25 billion. In addition to using officer pay information as disclosed by companies in the compensation peer group, the 2021 Study used survey data drawn from two compensation surveys of U.S. companies, including medical device and healthcare companies with targeted revenues of $200 million - $1 billion, in order to approximate the Company&#8217;s estimated revenue for 2022. With respect to all NEOs included in the 2021 Study, the data in the study was a blend of the 2021 peer group and the survey information. In each case, Willis Towers Watson trended the compensation data forward to January 1, 2022 by a factor of 3.0%. We refer to the blended 2021 peer group and survey compensation data for all NEOs as the &#8220;2022 Peer Group Information.&#8221;  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following peer companies were used for the </span><span style="text-transform: none">2021 Study.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 259.78pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 182.15pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Peer Company</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>FYE Revenue</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b> </b></sup><span style="text-transform: none"><b>($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Tandem Diabetes Care, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">498.8</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Inogen, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">308.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Natus Medical Incorporated</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">415.7</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Orthofix Medical, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">406.6</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Glaukos Corp.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">225.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Nevro Corp.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">362.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Accuray Incorporated</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">396.3</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lantheus Holdings, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">339.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Tactile Systems Technology, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">187.1</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">SeaSpine Holdings Corp.&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">154.3</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">AngioDynamics, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">291.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Cardiovascular Systems, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">259.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">AtriCure, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">206.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">iRhythm Technologies, Inc.&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">265.2</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Cutera, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">147.7</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">OraSure Technologies, Inc.</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">171.7</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-top: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Median</i></span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">278.1</span></p>

							</td>

						</tr>
						<tr style="min-height: 10.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Artivion&#8217;s 2022 Revenues</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>313.8</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee believed that the pay practices of these companies provided a useful reference point for pay and performance comparisons at Artivion, especially considering Artivion&#8217;s </span><span style="text-transform: none">anticipated growth.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Latest FYE revenue, in millions, at the time the peer group </span><span style="text-transform: none">was developed.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">31</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 812.82pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following survey sources were used in the </span><span style="text-transform: none">2021 Study:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">2021 Willis Towers Watson US General Industry Executive Compensation </span><span style="text-transform: none">Survey; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">2021 Radford </span><span style="text-transform: none">Executive Survey.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The peer companies were recommended by Willis Towers Watson and considered and approved by the Committee. In approving the peer group, the Committee considered the fact that each company is (or was at the time) publicly-traded, operates in a similar industry, is similar in size, scope, and complexity, and is reasonably representative of our pool for executive officer talent, although Artivion routinely recruits from much larger medical device companies. The Committee also concluded that the companies are (or were at the time) within a reasonable range of Artivion&#8217;s historical, current, or projected revenues. Nonetheless, the Committee reviews and considers changes to the peer group and survey sources in connection with each year&#8217;s study. It does so to ensure that the peer group and survey sources continue to reflect appropriate reference points for Artivion. For example, in the third quarter of 2022, for purposes of evaluating the compensation to be paid to executives in fiscal year 2023, the Committee (at the recommendation of Willis Towers Watson) made several changes to the peer group that the Committee used for its current-year analysis, namely: (1) Natus Medical Incorporated was removed; (2) Tandem Diabetes Care, Inc. and OraSure Technologies, Inc. were removed; and (3) AxoGen, Inc. and Avanos Medical, Inc. were added to the peer group. These changes were made to the peer group to be used for benchmarking 2023 executive compensation to address, among other things, consolidation and other strategic transactions in the medical device industry in 2021 and 2022, certain differences th</span><span style="text-transform: none">at diminish the applicability or availability of the other entities&#8217; executive compensation information (e.g., PE or family-backed businesses), and to ensure an appropriate balance of medical device companies with whom the Company competes for talent, both in terms of revenue, projected revenue growth, market capitalization, and </span><span style="text-transform: none">workforce size.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>2022 Compensation Components</b></span><span id="aort-def14a_051623a367"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The primary components of Artivion&#8217;s executive officer compensation program are base salary, short-term incentives, and long-term incentives. Artivion also provides executive officers with tax-deferred savings opportunities, participation in Company-wide benefits programs, and </span><span style="text-transform: none">limited perquisites.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none"> </span><span style="text-transform: none; font-style: italic"><b><i>2022 </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Base Salary</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee generally reviews base salary levels each February as part of its overall review and approval of the executive officer compensation program. Based on its review in late 2021 and early 2022, the Committee determined it was appropriate to increase NEOs&#8217; base salaries 3.0% above 2021 levels, with Mr. Stanton&#8217;s increase being pro-rated </span><span style="text-transform: none">to 2.5%.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 323.6pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 139.38pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 67.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 58.7pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 57.9pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Comparison of 2021 and 2022 Base Salaries</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2021<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Increase<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">727,798</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">464,412</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">478,344</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">385,765</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">397,338</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">368,750</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">379,813</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">375,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">384,216</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.5</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Analysis</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2021 Study showed that the base salaries for our NEOs were within a competitive range of 93-108% of the median for similarly situated employees at companies in the Company&#8217;s peer group. Based on input from management and in consultation with Willis Towers Watson, the Committee approved merit increases for 2022 for all executive officers of 3.0%, with the exception of (i) executive officers whose employment responsibilities or job title had changed between 2021 and 2022 or (ii) executive officers that did not hold their position for the entirety of 2021. In approving salary increases for NEOs, the Committee considered current market positioning, both individual and Company performance during 2021, and the Company&#8217;s budget for salary increases generally for </span><span style="text-transform: none">all employees.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Short-Term Incentives &#8211; The 2022 Cash Bonus Plan</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee adopted the &#8220;2022 Cash Bonus Plan&#8221; as set forth above at </span><span style="text-transform: none">page 25</span><span style="text-transform: none">.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">32</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; Program Design</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The table below shows the performance metrics set for the 2022 Cash Bonus Plan as finalized in </span><span style="text-transform: none">April 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621.92pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.12pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 89.06pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 86.48pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Performance Goals</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Measure</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Weight<br />(%)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Threshold</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stretch</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Maximum</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">Revenue Growth Rate; Constant Currency (2022 v. 2021)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">12.5% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">16.0% growth</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Financial Metric Potential Payouts (%)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.95pt; line-height: 10.95pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">60</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">200</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The final payout can be increased or decreased, up to 20%, based on an individual executive officer&#8217;s performance.</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">See Appendix A to this Proxy Statement for further details regarding the revenue </span><span style="text-transform: none">performance measure.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee believed that the 2022 threshold and target performance levels for the constant currency revenue metric were challenging and would drive stockholder value creation. In addition, the 2022 revenue target performance level was within the range of 2022 product and service revenue guidance publicly announced </span><span style="text-transform: none">by Artivion. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For the 2022 Cash Bonus Plan, the performance metric was revised from 2021 by eliminating non-financial metrics, with a 100% payout for performance at target levels, a 200% total cap on payout, and the following additional </span><span style="text-transform: none">primary features:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Entire-Year, Financial Metric of Revenue Growth Rate, Constant Currency (2022 v. 2021) (100% </span><span style="text-transform: none">of payout):</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Payout levels shown in the above &#8220;2022 Performance Goals&#8221; </span><span style="text-transform: none">table; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Each individual executive officer&#8217;s short-term incentive was then subject to an increase of up to 20% based on the executive officer&#8217;s personal performance, subject to the 200% overall cap </span><span style="text-transform: none">discussed above.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><span style="text-transform: none">In arriving at its decision to approve the 2022 final metric and payouts, the Committee took into consideration </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee&#8217;s belief that the core plan design and its pay-for-performance orientation achieved the objectives of the Committee&#8217;s </span><span style="text-transform: none">Compensation Philosophy;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee&#8217;s belief that the achievement of target constant currency revenue growth was key to incentivizing executive officers to achieve Company performance that will further the Company&#8217;s strategic business plan and ultimately deliver value to stockholders, without encouraging excessive risk taking by </span><span style="text-transform: none">executive officers;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The plan&#8217;s similarity to the short-term incentive plans of the Company&#8217;s peer </span><span style="text-transform: none">group companies;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The still-present &#8220;war for talent&#8221; and challenging labor market </span><span style="text-transform: none">in 2022; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Artivion&#8217;s 2021 performance, and whether any changes to performance metrics were required to achieve 2022 business </span><span style="text-transform: none">goals; and </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Recent historical payout levels that the Committee believed indicated that performance goals over the last few years had been set at reasonably </span><span style="text-transform: none">challenging levels.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee sets short-term incentive opportunities, in conjunction with a review of base salaries, as part of executive officers&#8217; overall target total cash compensation. The Committee decided to use for 2022 a single financial metric, believing that such a metric would continue to motivate executive officers to achieve financial measures core to stockholder value creation, as well as contribute to the Company&#8217;s success in 2022 and beyond. The Committee also believed that, with the lessened, but more predictable, impact of COVID-19 on our business, using a personal performance metric modifier for the overall bonus would continue to reflect the Committee&#8217;s intent to align pay with performance. Overall, the Committee believed the 2022 Cash Bonus Plan was appropriately incentivizing given the executive officers&#8217; roles and authority within Artivion, and that the size of the incentives was appropriate based on the 2022 Peer Group Information and internal pay </span><span style="text-transform: none">equity considerations.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">33</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 811.44pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; </i></span><span style="text-transform: none; font-style: italic"><i>Plan Payout</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2022 Cash Bonus Plan payouts in early 2023 were based on actual financial performance results of Artivion relative to the predetermined goal, which exceeded the target for payout under the plan. Specifically, the Company achieved 9.8% constant currency revenue growth in 2022 as compared to 2021. That level of constant currency revenue growth resulted in a payout of 111.4% of target.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Mr. Mackin&#8217;s 2022 Cash Bonus Plan payout in early 2023 was also based on the same considerations. The Board of Directors reviewed Mr. Mackin&#8217;s individual performance relative to his individual goals for 2022 and, after receiving the Committee&#8217;s certification of the 2022 performance metric and the Committee&#8217;s recommendation, approved the Chief Executive Officer&#8217;s bonus payout at the amount set </span><span style="text-transform: none">forth below. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following tables show the performance results for the 2022 performance metrics, the payout, and that there were no adjustments to the short-term incentive paid to </span><span style="text-transform: none">each NEO.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 4pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto; table-layout: fixed; width: 524.37pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 221.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 87.97pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 85.38pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.44pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="5" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Annual Incentive Program (Cash Bonus Plan)<br />Actual vs. Target Performance</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Measure</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Weight<br />(%)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">Revenue Growth Rate; Constant<br />Currency (2022 v. 2021)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.8% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="5" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The final payout can be increased up to 20%, based on an individual executive officer&#8217;s performance. </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The final payout cannot exceed 200% of target payout.</span></p>

							</td>

						</tr>

					</table>

				</div>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 523.59pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 103.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 93.14pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69.46pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 95.1pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 79.66pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 82.8pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Annual Incentive Program (Cash Bonus Plan)<br />Actual vs. Target Payout</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Payout<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Payout<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Company<br />Performance<br />Payout % of<br />Target<br />(%)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Personal<br />Performance<br />Modifier<br />(%)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Total Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">835,090</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">319,725</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">287,006</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">221,317</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">198,669</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">211,556</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">189,907</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">214,008</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">192,108</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Long-Term Incentives &#8211; Annual Equity</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Based on input from management and in consultation with Willis Towers Watson, the Committee considered the Annual Long-Term Incentive Program, and in the design of the 2022 program, determined to continue with the 2021 program&#8217;s mix of equity awards as an equal one-third allocation of total value among stock options, restricted stock units, and performance stock units. This mix may be altered for executive officers located outside of the U.S. to accommodate local </span><span style="text-transform: none">tax issues. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee determined that the estimated grant date fair value of the awards under the Annual Long-Term Incentive Program in 2022 would be established at the levels disclosed in the table below to remain market competitive, as reflected in the 2021 Study. Market comparisons were based on the Company&#8217;s current financial statistics such as annual revenue and market cap, as well as the anticipated growth of the Company, as well as the continued increase in the complexity of the Company&#8217;s business following the acquisitions of JOTEC AG in fiscal 2017 and Ascyrus Medical LLC in fiscal 2020, the distribution agreement with Endospan, which commenced in 2019, and the Company&#8217;s rapid growth in international markets, in particular the Asia Pacific and Latin American markets during 2021 and continuing </span><span style="text-transform: none">into 2022. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">To determine the number of shares of restricted stock units, target performance stock units, and options to be granted, the Committee directed management to determine the number of units of restricted stock and target performance stock units using the closing share price of the Company&#8217;s stock on the grant date,</span><span style="text-transform: none"> and to also determine the number of stock options using the estimated fair value of the options as of the same date. Grants generally were made on the first permissible trading day following the Committee&#8217;s approval of such awards. In this instance, grant values approved by the Committee were converted to units using a stock price of $18.44, the closing price on February 23, 2022, the date the grants </span><span style="text-transform: none">were made. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">34</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 815.58pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For 2022, and as further described under Analysis below, the performance stock units are subject to two performance measures: (1) constant currency revenue growth in 2022 as compared to 2021, weighted at 50%; and (2) performance to target adjusted EBITDA in 2022, also weighted at 50%. See Appendix A to this Proxy Statement for further details regarding the revenue and adjusted EBITDA </span><span style="text-transform: none">performance measures.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table provides the 2022 equity awarded through the Annual Long-Term Incentive Program to the NEOs as approved by </span><span style="text-transform: none">the Committee. </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 534.75pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 229.76pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.66pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.66pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.66pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Annual Equity Grant Level</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance<br />Stock<br />Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stock<br />Options</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><span style="text-transform: none"><b><br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Restricted<br />Stock Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">47,627</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">126,546</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">47,627</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">11,437</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">30,389</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">11,437</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,767</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">23,295</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,767</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,623</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">22,911</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,623</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,406</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">22,334</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 26pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,406</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 65.55pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reflects the target performance stock unit award level. The actual number of shares earned under the performance stock units was based on performance factors determined by the Committee. Actual earned shares vest 50% on the first anniversary of the award date or the first available date after the Committee certifies the prior year&#8217;s financial metric results, whichever is later (determined to be February 23, 2023, the first anniversary of the award date); 25% on the second anniversary of the award date; and 25% on the third anniversary of the </span><span style="text-transform: none">award date.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 65.55pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)   </sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Stock options vest 1/3 per year beginning on the first anniversary of the </span><span style="text-transform: none">grant date.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 65.55pt 8pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Restricted stock units cliff vest on the third anniversary of the grant date.    </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 2pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; Program Design </i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In approving the 2022 long-term incentive grant values awarded through the Annual Long-Term Incentive Plan, in February 2022, the Committee considered the </span><span style="text-transform: none">following factors:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Updated market competitiveness analysis by the independent </span><span style="text-transform: none">compensation consultant;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Increased size, geographic scope, and business complexity of the Company following integration of JOTEC AG, the acquisition of Ascyrus Medical LLC, the distribution agreement with Endospan, Ltd., and continued expansion into Asia and Latin America, resulting in significant growth in </span><span style="text-transform: none">those regions; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">2021 personal and </span><span style="text-transform: none">Company performance;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee&#8217;s continued desire to have an even mix of value among stock options, restricted stock, and performance stock units for the </span><span style="text-transform: none">annual awards;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The compensation program&#8217;s design, which emphasizes pay-for-performance and aligns executive officer performance (and resulting compensation) with </span><span style="text-transform: none">stockholder interests;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Performance and retention incentives achieved through the use of annual equity </span><span style="text-transform: none">grants; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The parameters of Artivion&#8217;s stockholder-approved equity plan, the 2020 ECIP, and the availability of shares under </span><span style="text-transform: none">that plan.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee determined vesting schedules in consultation with Willis Towers Watson and management and believed that such vesting provided the appropriate long-term incentive and retention for executive officers&#8217; continued employment. All annual long-term incentive (time-based) awards vest over a </span><span style="text-transform: none">three-year period. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For PSUs, the Committee used a design metric of: (1) constant currency revenue growth in 2022 as compared to 2021, weighted at 50%; and (2) performance to target adjusted EBITDA in 2022, also weighted at 50%, concluding, with input from its advisors and management, that it was appropriate to do so because, in the Committee&#8217;s estimation, these were the most significant drivers of Company performance and stockholder value creation in 2022. The Committee capped maximum payouts under this program at 150% of the target award. See Appendix A for further details regarding the revenue and adjusted </span><span style="text-transform: none">EBITDA measures. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">35</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; Plan Payout &#8211; </i></span><span style="text-transform: none; font-style: italic"><i>PSUs Earned</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In arriving at its decision in February 2023 to certify the PSUs earned by NEOs, the Committee took into consideration the Company&#8217;s actual performance results relative to the above-described metrics. The following table presents the threshold, target, and maximum performance levels associated with threshold, target, and maximum award opportunities, which fall on a sliding scale for the 2022 annual PSU award grants. The table also provides the actual performance level for 2022, as certified by the Committee, together with the associated level of shares that </span><span style="text-transform: none">were earned.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621.92pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 216.65pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.75pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.19pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 75.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 65.83pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Performance Stock Units &#8211; Annual Award<br />Actual vs. Threshold/Target/Maximum Performance&#160;</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Measure</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Threshold<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Maximum<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">Revenue Growth Rate; Constant<br />Currency (2022 v. 2021)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">12.5% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.8% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">111.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Financial Metric Potential Payouts (%)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">60</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022 Adjusted EBITDA</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$38,138,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$44,868,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$51,599,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$39,084,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">65.6</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Financial Metric Potential Payouts (%)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">60</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">150</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- Each performance measure is weighted at 50%.   </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The combined resulting final payout was 88.5% of target.</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">See Appendix A for further details regarding the revenue and adjusted </span><span style="text-transform: none">EBITDA measures.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2022 PSU payouts in early 2023 were based on the same constant currency revenue growth results set forth above with respect to the 2022 Cash Bonus Plan, combined with the adjusted EBITDA results set forth in the above table, resulting in a payout of 88.5% </span><span style="text-transform: none">of target.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The performance stock unit awards will vest based on the executive officer&#8217;s continued service: 50% of the shares earned vested on February 23, 2023 (following the Committee&#8217;s certification of the adjusted payout of shares under the performance metric); 25% of the shares earned will vest on February 23, 2024; and the remaining 25% of the shares earned will vest on February 23, 2025, assuming the executive officer continues to be employed by the Company on those dates, the Committee takes no action to waive the employment requirement, or the executive officer has retired in accordance with the definition of Retirement set forth in Artivion&#8217;s PSU </span><span style="text-transform: none">grant agreement.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table shows the target payout and the adjusted payout of PSUs granted to each NEO based upon the 2022 </span><span style="text-transform: none">performance metrics.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 396.49pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 129.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.86pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.86pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.86pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Annual Incentive Program (Annual PSU Plan)<br />Actual vs. Target Payout</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">42,148</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">47,627</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">88.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">10,122</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">11,437</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">88.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">7,756</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,767</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">88.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">7,630</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,623</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">88.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">7,440</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 24pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,406</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">88.5</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Long-Term Incentives &#8211; 2022 LTIP PSU and Program Design</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As previously discussed, in February 2022, the Committee also decided to award executives the 2022 LTIP PSU, pursuant to the metrics, number of shares, and maximum payouts as set forth above </span><span style="text-transform: none">at 28.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For 2022, and as further described under Analysis below, the 2022 LTIP PSU was subject to a single performance measure&#8212;constant currency revenue growth in 2022 as compared to 2021. See Appendix A to this Proxy Statement for further details regarding the revenue </span><span style="text-transform: none">performance measure.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">36</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table provides the 2022 target shares awarded through the 2022 LTIP PSU to the NEOs as approved by the Committee. The target number of shares under the 2022 LTIP PSU was one-third of the target number of shares in the first tranche of the 2019 LTIP (which, again, was completely forfeited as of December </span><span style="text-transform: none">31, 2021). </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 293.59pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 117.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 175.72pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 LTIP PSU Grant Level</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Stock Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 63pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">20,202</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 63pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,367</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 63pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 63pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 63pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 31.05pt 10pt 46.57pt; text-transform: none; color: #000000; text-indent: -15.52pt; text-align: justify"><!--[if IE]><FONT style=" width: 15.524999999999999pt; text-indent: -13.5pt; display: inline-block;"><![endif]--><span style="width: 15.52pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 7pt">Reflects the target 2022 LTIP PSU award level. The actual number of shares earned under the 2022 LTIP PSU plan was based on a performance factor determined by the Committee. Actual earned shares cliff vest on the first anniversary of the award date or the first available date after the Committee certifies the prior year&#8217;s financial metric results, whichever is later (determined to be February 23, 2023, the first anniversary of the award date).  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; Plan Payout &#8211; 2022 LTIP </i></span><span style="text-transform: none; font-style: italic"><i>PSUs Earned</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In arriving at its decision in February 2023 to certify the 2022 LTIP PSUs earned by NEOs, the Committee took into consideration the Company&#8217;s actual performance results relative to the above-described financial metrics (see page 26). The following table presents the threshold, target, and maximum performance levels associated with threshold, target, and maximum award opportunities, which fall on a sliding scale for the 2022 LTIP PSU award grants. The table also provides the actual performance level for 2022, as certified by the Committee, together with the associated level of shares that </span><span style="text-transform: none">were earned.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.94pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 209.06pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.12pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.19pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 75.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.08pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 LTIP PSU Award<br />Actual vs. Threshold/Target/Maximum Performance&#160;</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Measure</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Threshold<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Maximum<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">Revenue Growth Rate; Constant<br />Currency (2022 v. 2021)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">8.5% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">11.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.8% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Financial Metric Potential Payouts (%)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">200</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">See Appendix A for further details regarding the </span><span style="text-transform: none">revenue measure.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2022 LTIP PSU payouts in early 2023 were based on actual financial performance results of Artivion relative to the pre-determined goals set forth above, which exceeded the target for payout under the plan. This level of constant currency reven</span><span style="text-transform: none">ue growth resulted in a payout of 140% of target.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2022 LTIP PSU awards vested on February 23, 2023 (following the Committee&#8217;s certification of the adjusted payout of shares under the </span><span style="text-transform: none">performance metric).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table shows the target payout and the adjusted payout of 2022 LTIP PSUs granted to </span><span style="text-transform: none">each NEO. </span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 0pt; table-layout: fixed; width: 408.42pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 129.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 LTIP PSU Award<br />Actual vs. Target Payout</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,282</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">20,202</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,713</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,367</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,770</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,770</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,770</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">37</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Annual Target Total Direct Compensation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee believed that the blend of annual salary, cash bonus, stock options, restricted stock units, and PSUs (including the 2022 LTIP PSU) appropriately achieved the performance, stockholder alignment, and retention objectives of Artivion&#8217;s compensation program. The Committee believes that the use of multiple award types is a common practice among industry peers and that the use of PSUs creates an even stronger alignment between pay and performance. The Committee believes that, in addition to incenting long-term performance, annual equity awards encourage continuous performance and retention by reflecting Company success (and changes in the stock price) year </span><span style="text-transform: none">over year. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee used a value-based approach, rather than number of shares, to determine the size of 2022 annual equity grants, as it believed that such an approach more accurately matched the intended value of the equity and intended compensation. For the 2022 LTIP PSU, the Committee used number of shares for the reasons set forth above at page 26. The Committee applied vesting schedules for the 2022 equity awards that it believes provided the appropriate annual long-term incentive to retain </span><span style="text-transform: none">executive officers.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In determining the individual components of the executive officers&#8217; 2022 annual compensation (i.e., salary, target short-term incentive, and annual long-term incentive), the Committee evaluated the resulting target annual total direct compensation against market benchmarks, as set forth below, accounting for the Committee&#8217;s desire to have target annual total direct compensation generally within a competitive range of the Company&#8217;s peer group median. The following table summarizes the NEOs&#8217; 2022 target annual total direct compensation, the peer group median, and the primary rationale for each NEO&#8217;s compensation at the </span><span style="text-transform: none">level shown.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 580.92pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 114.54pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 121.97pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 87.97pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 256.43pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Target Total<br />Direct Compensation<br />Opportunity</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Peer Median</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Primary Rationale</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4,506,524</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4,135,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Within a competitive range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,460,137</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,370,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Within a competitive range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,130,667</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,115,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Within a competitive range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,096,379</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,120,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Within a competitive range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,090,379</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,105,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">Within a competitive range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Equity grant value based on a grant date closing stock price of $18.44 for the restricted stock and performance stock units (Annual and 2022 LTIP PSU), as well as a grant date Black-Scholes Option Value of $6.94. Performance stock units are included at target </span><span style="text-transform: none">award levels/values.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Based on data provided by Willis Towers Watson in the </span><span style="text-transform: none">2021 Study.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 10pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Competitive range for Chief Executive Officer, Chief Financial Officer, and Senior Vice Presidents total direct compensation is intended to be positioned at the market median; however, including the 2022 LTIP PSU grant value, total direct compensation is intended to fall between the market median and 75</span><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">th</sup><span style="text-transform: none"> percentile, driven by superior performance. Willis Towers Watson provided guidance for compensation for all the NEOs in the 2021 Study.    </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2019 Long-Term Incentives &#8211; Tranche Two of the 2019 LTIP and Program Design</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As previously discussed, in February 2019, the Committee approved the 2019 LTIP, a long-term incentive, performance-based equity grant, that included three performance periods, or &#8220;tranches,&#8221; spanning a total of five years. The second tranche of the 2019 LTIP covered </span><span style="text-transform: none">fiscal 2022. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For the second tranche of the 2019 LTIP, and as further described under Analysis below, the 2019 LTIP was subject to a single performance measure&#8212;constant currency revenue growth in 2022 as compared to 2021 subject to a gross margin modifier. See Appendix A to this Proxy Statement for further details regarding the revenue </span><span style="text-transform: none">performance measure.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table provides the target shares awarded through the 2019 LTIP to the NEOs as approved by the Committee. The target number of shares under tranche two of the 2019 LTIP was one-fifth of the target number of shares in all three tranches of the </span><span style="text-transform: none">2019 LTIP. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">38</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 293.59pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 117.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 175.72pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Tranche Two of the 2019 LTIP PSU Grant Level</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Stock Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 59pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">20,202</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 59pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,367</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 59pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 59pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 59pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 10pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reflects the target tranche two 2019 LTIP award level. The actual number of shares earned under tranche two of the 2019 LTIP was based on a performance factor determined by the Committee. Actual earned shares cliff vested on the fourth anniversary of the original 2019 LTIP award date or the first available date after the Committee certifies the prior year&#8217;s financial metric results, whichever is later (determined to be March 1, 2023, the fourth anniversary of the original 2019 LTIP award date).  </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Analysis &#8211; Plan Payout &#8211; 2019 LTIP PSUs Earned</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In arriving at its decision in February 2023 to certify the tranche two 2019 LTIP PSUs earned by NEOs, the Committee took into consideration the Company&#8217;s actual performance results relative to the above-described financial metrics (see page 26). The following table presents the threshold, target, and maximum performance levels associated with threshold, target, and maximum award opportunities, which fall on a sliding scale for the tranche two 2019 LTIP award grants. The table also provides the actual performance level for 2022, as certified by the Committee, together with the associated level of shares that </span><span style="text-transform: none">were earned.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.94pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 209.06pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.12pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.19pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 75.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.08pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Tranche Two of the 2019 LTIP Award<br />Actual vs. Threshold/Target/Maximum Performance</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance Measure</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Threshold<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Maximum<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Performance</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">Revenue Growth Rate; Constant<br />Currency (2022 v. 2021)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">8.5% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">11.0% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.8% growth</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">160.0</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Financial Metric Potential Payouts (%)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">100</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">250</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The final payout was subject to a gross margin modifier of 85% as a result of the Company&#8217;s 2022 gross margin be</span><span style="text-transform: none">ing &lt; 66</span><span style="text-transform: none">%</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">- The resulting final payout was 136.0% of target, except for the Company&#8217;s CEO, Mr. Mackin, who is subject to a different payout scale. Mr. Mackin&#8217;s final payout was 108.0%</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">See Appendix A for further details regarding the </span><span style="text-transform: none">revenue measure.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The tranche two 2019 LTIP payouts in early 2023 were based on actual financial performance results of Artivion relative to the pre-determined goals set forth above, which exceeded the target for payout under the plan. This level of constant currency revenue growth resulted in a payout of 160% of target for all NEOs except for the Company&#8217;s CEO, Mr. Mackin, who is subject to a different payout scale and lower payouts at maximum performance (for Mr. Mackin, the maximum is 166.66% of target). In addition, payouts were subject to an 85% gross margin modifier as a result of the Company failing to achieve a gross margin of at least 66% in fiscal 2022 (the Company&#8217;s gross margin was 65%), which resulted in a final payout of 136% for all NEOs except for Mr. Mackin, whose final payout was 108%. Unprecedented levels of inflation primarily drove the Company&#8217;s underperformance on gross margin, a factor over which management had no control. Nonetheless, the Committee determined to make no adjustments for inflation, given the plan&#8217;s design and that the 2022 LTIP PSU was not subject to a gross </span><span style="text-transform: none">margin modifier.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The tranche two 2019 LTIP awards vested on March 1, 2023 (following the Committee&#8217;s certification of the adjusted payout of shares under the </span><span style="text-transform: none">performance metric).</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">39</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 810.06pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table shows the target payout and the adjusted payout of 2019 LTIP PSUs granted to </span><span style="text-transform: none">each NEO. </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 8pt; table-layout: fixed; width: 408.42pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 129.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 92.84pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Tranche Two of the 2019 LTIP Award<br />Actual vs. Target Payout</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Actual<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Target<br />Payout<br />(Shares)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Payout<br />% of Target<br />(%)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">21,818</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">20,202</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">108</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,579</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,367</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">136</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,663</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">136</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,663</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">136</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,663</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 25pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">136</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>November 2022 Acceleration of a Portion of the 2023 Annual Equity Grant</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">During 2022, the Company faced several unanticipated negative economic and regulatory headwinds, including, but not limited to, the cessation of the Company&#8217;s pivotal PROACT Xa clinical trial. Cumulatively, by late-October 2022, these factors had caused a decline in the Company&#8217;s stock price, related primarily to factors independent of management&#8217;s performance. The Company&#8217;s stock price trended similar to those of other medical device companies, particularly small cap medical technology companies such as ours. This decline reduced significantly the retentive value of executives&#8217; equity holdings, which by late-October 2022 had declined by more than 50% since January 2021, with nearly six years of </span><span style="text-transform: none">options underwater.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Accordingly, in Q4 2022, as set forth in the 8-K issued by the Company on November 9, 2022, the Committee, based on input from Willis Towers Watson, decided to accelerate into November 2022 a portion of the executives&#8217; 2023 annual equity grant in the form of RSUs and options. The acceleration of the grant was meant to enhance the retentive and motivational impact of the award and to address concerns about executive retention, in light of significant declines in the value of executives&#8217; equity holdings</span><span style="text-transform: none"> in the Company and the competitive external marketplace for talent at an important time for the Company in terms of execution on its strategy. The November 2022 grant was not intended to be additional compensation for 2022 or to be additive to an executives&#8217; 2023 compensation; nor did it change the performance period for executives&#8217; 2023 compensation, which is still the full 2023 calendar year. It was only intended to be an acceleration of a portion of the fiscal 2023 annual equity grant, the remainder of which would be granted in February 2023 dependent upon share count and </span><span style="text-transform: none">business considerations.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee determined to make the remainder, if any, of the annual equity grant in February 2023 as performance shares, consistent with its Compensation Philosophy and prior practices to use three different equity vehicles to incent executive performance and align executives&#8217; interests with those of stockholders. In February 2023, the Committee approved this remainder of the 2023 annual grant in performance shares, with metrics nearly identical to those associated with the February 2022 annual PSU grant, as set forth in the below table. This resulted in, inclusive of the November 2022 grant, 2023 annual executive grants at target within the range of the 50</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile of updated market/peer references for 2023 executive compensation. As in prior years, the 2023 annual equity grant (inclusive of the November 2022 grant), when combined with a 2023 LTIP PSU identical to the 2022 LTIP PSU and tranche 3 of the 2019 LTIP, gave executives the potential through superior performance to earn equity payouts up to the </span><span style="text-transform: none">75</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">th</sup><span style="text-transform: none"> percentile.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 318.78pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 115.4pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.68pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.68pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Comparison of 2021 and 2022 Summary Compensation<br />Totals Exclusive of November 2022 Accelerated<br />2023 Annual Equity Grant</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2021<br />($)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022<br />($)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,749,584</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,968,804</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,526,173</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,580,495</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,598,214</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,220,362</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,145,538</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,185,904</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">947,228</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,180,033</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This amount represents the total compensation for 2021 as reported in the Summary Compensation Table on </span><span style="text-transform: none">page 44.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 10pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This amount represents the total compensation for 2022 as reported in the Summary Compensation Table on page 44, exclusive of the 2023 accelerated annual RSU and options grants. The total grant date fair values of those accelerated 2023 RSU and option grants were as follows: Mr. Mackin&#8217;s was $2,580,004; Mr. Lee&#8217;s was $809,998; Ms. Holloway&#8217;s was $495,000; Mr. Davis&#8217;s was $492,001; and Mr. Stanton&#8217;s </span><span style="text-transform: none">was $428,998.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">40</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 382.08pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 109.53pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.85pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.85pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.85pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2023 Annual Equity Grant Level</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Performance<br />Stock<br />Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stock<br />Options</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><span style="text-transform: none"><b><br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Restricted<br />Stock Units</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>(#)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">39,466</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">280,435</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">116,954</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">15,072</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">88,043</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">36,718</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,638</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">53,804</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">22,439</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">8,571</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">53,478</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">22,303</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">7,163</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">46,630</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 22pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">19,447</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reflects the target performance stock unit award level. The actual number of shares earned under the performance stock units is based on performance factors determined by the Committee. Actual earned shares vest 50% on the first anniversary of the award date or the first available date after the Committee certifies the prior year&#8217;s financial metric results, whichever is later; 25% on the second anniversary of the award date; and 25% on the third anniversary of the </span><span style="text-transform: none">award date.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 0pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)   </sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Stock options vest 1/3 per year beginning on the first anniversary of the </span><span style="text-transform: none">grant date.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 20.7pt 10pt 34.5pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Restricted stock units cliff vest on the third anniversary of the </span><span style="text-transform: none">grant date.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company will provide greater detail regarding the 2023 annual equity grant in its 2024 </span><span style="text-transform: none">proxy statement. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Equity and Cash Incentive Plans</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In May 2015, the stockholders approved certain amendments to the 2009 Equity and Cash Incentive Plan (the &#8220;2009 ECIP&#8221;) that were recommended by the Board of Directors based on management&#8217;s recommendation and in consultation with Willis Towers Watson. The 2015 amendments included new provisions for cash-based incentive payments that were intended to comply with the requirements to be &#8220;qualified performance-based compensation&#8221; under Section 162(m) (&#8220;Section 162(m)&#8221;) of the Internal Revenue Code (as amended, the &#8220;Code&#8221;). In May 2016, the stockholders approved certain further amendments to the 2009 ECIP that were also recommended by the Board of Directors based on management&#8217;s recommendation and in consultation with Willis Towers Watson. The 2016 amendments included a separate, lower cap for awards to individual non-employee directors and a higher annual cap for awards to individual employees. In May 2018, the stockholders approved a proposal for authorization of an additional 1.9 million shares for the 2009 ECIP, which were registered in February 2019. The 2009 ECIP expired May </span><span style="text-transform: none">21, 2021. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">At the 2020 Annual Meeting, the stockholders approved the 2020 ECIP and 2,675,000 shares of initial funding. All equity and incentive cash compensation delivered for work or performance in 2022 was issued under the 2020 ECIP.  </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Deferred Compensation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Artivion, Inc. Executive Deferred Compensation Plan allows certain key employees of Artivion, including the NEOs, to defer receipt of up to 75% of each of their salaries, commissions, and/or the cash portion of any bonus awarded pursuant to the short-term executive officer incentive plan. The plan&#8217;s administrative committee, subject to ratification and approval of the Committee, establishes the maximum and minimum percentages of bonus awards that plan participants may defer in each plan year. For 2022, these percentages ranged from 0 to 75% for each of base salary and commissions and were 0% of the annual cash bonus. Because this plan provides for tax-deferred growth of deferred compensation, it is an incentive that the Company uses to attract and retain executive </span><span style="text-transform: none">officer-level talent.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>2022 Perquisites </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">It is Artivion&#8217;s policy not to provide perquisites to its executive officers without prior approval of the Committee.</span><span style="text-transform: none; font-family: Arial, sans-serif"><b> </b></span><span style="text-transform: none">To the extent that perquisites are incidental to a business-related expense, such as personal use of a business club, the NEOs are generally required to reimburse Artivion for any incremental cost of such personal benefit. Other than these incidental personal benefits, none of our NEOs receive any perquisites that are not also provided on a non-discriminatory basis to all full-time employees, except for Mr. Mackin, whose compensation is discussed at Employment, Separation and Release, and Change of Control Agreements below, and except for supplemental disability insurance and airline club memberships provided to certain of the NEOs. In keeping with Artivion&#8217;s practice with respect to all full-time employees, NEOs are also eligible to receive certain benefits upon achieving employment milestones, including receiving $5,000 upon reaching 15 years of service with Artivion and $10,000 upon reaching 20 and 25 years of service </span><span style="text-transform: none">with Artivion.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">41</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Employment, Separation and Release, and Change of Control Agreements</b></span><span id="aort-def14a_051623a368"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Employment Agreement with J. Patrick Mackin</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In July 2014, the Board of Directors appointed Mr. Mackin as President and Chief Executive Officer effective Se</span><span style="text-transform: none">ptember 3, 20</span><span style="text-transform: none">14, and Artivion and Mr. Mackin entered into an employment agreement (the &#8220;Mackin Agreement&#8221;). The Mackin Agreement addresses Mr. Mackin&#8217;s role and responsibilities as our President and Chief Executive Officer, his rights to compensation and benefits during active employment, and his termination benefits. The Board of Directors determined that it was appropriate to provide Mr. Mackin with an employment agreement due to the Company&#8217;s desire to attract and retain high-performing individuals for </span><span style="text-transform: none">this role.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The material terms of the Mackin Agreement and his potential termination payments are further described and quantified at Potential Payments Upon Termination or Change of Control &#8211; J. Patrick Mackin beginning on </span><span style="text-transform: none">page 54. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Employment Agreements with Other Named Executive Officers</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion is not party to employment agreements with Messrs. Lee, Davis, or Stanton or with Ms. Holloway that provide any guarantee of employment. They are </span><span style="text-transform: none">at-will employees. </span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Change of Control Agreements with Other Named Executive Officers</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">On November 21, 2016, Artivion entered into change of control agreements with Mr. Lee, Ms. Holloway, and Mr.&#160;Davis. In August 2022, Artivion entered into new change of control agreements with Mr. Lee, Ms. Holloway, and Mr. Davis; however, these new agreements contained only minor, non-substantive revisions to reflect Artivion&#8217;s rebranding and reincorporation in Delaware. Mr. Mackin&#8217;s change of control arrangements are set forth in t</span><span style="text-transform: none">he Mackin Agreement. The change of control agreements, which automatically renew absent Company action, generally provide that the Company will pay a severance payment if the NEO is terminated by the Company without cause or the NEO terminates his or her own employment for good reason during a period extending from six months before to two years after a change of control of Artivion. This is a &#8220;double-trigger&#8221; provision that requires not only a change of control of Artivion but also an employment action before payments are required pursuant to the agreements. The Committee approved termination payments under the agreements for certain NEOs based on their officer status and ability to influence decisions regarding whether or not a change of control transaction should be pursued, with Mr. Lee receiving a payment of 2 times base salary and cash bonus plus healthcare coverage and Ms. Holloway and Mr. Davis each receiving a payment of 1.5 times base salary and cash bonus plus </span><span style="text-transform: none">healthcare coverage.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Additional Policies and Practices</b></span><span id="aort-def14a_051623a369"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Clawback Policy</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion has a standalone Clawback Policy that requires the Company to recover excess incentive compensation&#8212;in cash bonus or equity form&#8212;that was paid to any current or former officer during the three fiscal years prior to a material accounting restatement of the Company&#8217;s financial statements as a result of noncompliance with any financial reporting requirement under federal securities law, unless the Committee determines that the cost of recovery exceeds the amount to be recovered. The Clawback Policy does not require fault or negligence on the part of the officer for the clawback </span><span style="text-transform: none">to occur. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Additionally, Mr. Mackin, under the Mackin agreement, also must repay any portion of severance payments he has received from the Company if he fails to comply with certain post-employment </span><span style="text-transform: none">protective covenants.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Stock Ownership Guidelines</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Artivion maintains stock ownership guidelines for executive officers that have been recommended and approved by the Committee, along with the Corporate Governance Committee, and approved by the Board of Directors. The current stock ownership guidelines were adopted in November 2015 and require the following stock </span><span style="text-transform: none">ownership requirements:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">a.</span></span><!--[if IE]></FONT><![endif]--><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">Section 16 Officers</span></span><span style="text-transform: none">: Each Section 16 officer of the Company shall continuously hold a value of the Company&#8217;s common stock equal to the value of a multiple of that officer&#8217;s then-current base salary at Artivion. The multiples applicable to such officers are </span><span style="text-transform: none">as follows:</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">42</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">i.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Chief Executive Officer and President: 4 times </span><span style="text-transform: none">base salary;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">ii.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Executive Vice Presidents and Senior Vice Presidents: 2 times base </span><span style="text-transform: none">salary; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">iii.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">All other Section 16 officers: 1 times </span><span style="text-transform: none">base salary.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">b.</span></span><!--[if IE]></FONT><![endif]--><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">Retention requirements</span></span><span style="text-transform: none">: Each Section 16 Officer who has not yet acquired ownership of the required value of common stock set forth above must retain at least 50% of the net number of shares acquired upon the exercise of any employee stock option or the vesting of any performance shares, restricted stock, or restricted stock units (the net number of shares acquired shall be the number of shares remaining after shares are tendered, sold, or netted to pay any applicable exercise price and </span><span style="text-transform: none">withholding taxes).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">c.</span></span><!--[if IE]></FONT><![endif]--><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">Waivers</span></span><span style="text-transform: none">: The Chairs of the Committee and the Corporate Governance Committee shall have the authority to grant waivers from these stock ownership requirements in compelling circumstances such as </span><span style="text-transform: none">undue hardship.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">d. </span></span><!--[if IE]></FONT><![endif]--><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">Qualifying shares</span></span><span style="text-transform: none">: For purposes of satisfying these stock ownership requirements, the following shall be included: shares owned directly or indirectly (1) through a stock purchase plan sponsored by the Company; (2) by the person&#8217;s spouse; (3) in a revocable trust of which the person or the person&#8217;s spouse is the trustee; (4) any other shares related to or underlying vested or unvested restricted stock awards and performance share awards (after performance metric has been certified); or (5) vested restricted stock units and vested PSUs (at actual, earned levels and only if and to the extent that any applicable performance criteria have been satisfied). It shall not include shares held through any other form of indirect beneficial ownership or shares underlying unexercised options or unvested PSUs whose performance metric requirements were </span><span style="text-transform: none">not met.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">These guidelines became effective for all currently employed NEOs on November 17, 2015. As shown in the below table, as of March 22, 2023, all of our NEOs are in compliance with the guidelines, except for Mr. Stanton whose employment with the Company began in March 2021. Mr. Stanton is expected to meet the guidelines within the </span><span style="text-transform: none">next year. </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 179.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="6" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer Stock Ownership</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022 Base<br />Salary ($)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Multiple</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Required Value<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Owned<br />Shares</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Value of Owned<br />Shares</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4x</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$2,998,528</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 19pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">521,704</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">6,182,190</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$478,344</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2x</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$956,688</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 19pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">362,574</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,296,496</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$397,338</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2x</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$794,676</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 19pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">127,767</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,514,044</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$379,813</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2x</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$759,626</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 19pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">123,262</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,460,652</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$384,216</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2x</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$768,432</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 19pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">48,358</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 12pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">573,045</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This amount represents the base salary as reported in the Summary Compensation Table on </span><span style="text-transform: none">page 44.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount includes: (1) shares held of record by the spouses of executive officers and directors as of March 22, 2023; and (2) shares of unvested restricted common stock subject to forfeiture held as of March 22, 2023. This amount does not include unexercised stock options or shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March </span><span style="text-transform: none">22, 2023.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Based on the closing price of the Company&#8217;s common stock on the NYSE on March 22, 2023 </span><span style="text-transform: none">of $11.85.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Anti-Hedging Policy</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 28.17pt; text-align: justify"><span style="text-transform: none">All Artivion employees, including NEOs, are expressly prohibited in the Artivion, Inc. Insider Trading Policy and Guidelines with Respect to Certain Transactions in Securities (the &#8220;Insider Trading Policy&#8221;), which is available for review at </span><span style="text-decoration: underline; text-transform: none; color: #000000"><span style="text-decoration: underline">https://investors.artivion.com/corporate-governance/cryolifes-code-conduct</span></span><span style="text-transform: none">, from engaging in derivative securities or hedging transactions with respect to the Company&#8217;s securities. Specifically, NEOs are prohibited from engaging in transactions in publicly traded options, such as puts and calls, and other derivative securities with respect to the Company&#8217;s securities. This prohibition extends to any hedging or similar transaction designed to decrease the risks associated with holding Company securities, including but not limited to prepaid variable contracts, equity swaps, collars, and exchange funds. Stock options, stock appreciation rights, and other securities issued pursuant to Company benefit plans or other compensatory arrangements with the Company are not subject to </span><span style="text-transform: none">this prohibition.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Furthermore, short sales, which are the sale of a security that must be borrowed to make delivery, and &#8220;selling short against the box,&#8221; which is transacting a sale with a delayed delivery, are prohibited with respect to Company securities under the Insider Trading Policy and NEOs may not engage in </span><span style="text-transform: none">such transactions.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">43</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Equity Grants and Inside Information</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 40.59pt; text-align: justify"><span style="text-transform: none">The Committee generally adheres to a policy that the Company will not make equity grants at times when insiders, which includes members of the Committee, are in possession of material, non-public information, including during regular financial blackout periods. If the Committee approves the grant of equity at such times, it is the Committee&#8217;s general policy to delay the grant and pricing of the option and/or issuance of the awarded equity until two full trading days after the public dissemination of all such material, </span><span style="text-transform: none">non-public information.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Tax Impact of Compensation Decisions</b></span><span id="aort-def14a_051623a370"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Section 162(m) </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Section 162(m) of the Internal Revenue Code (&#8220;Section 162(m)&#8221;) places a limit of $1 million per year on the amount of compensation paid to certain of our executive officers that is deductible by the Company for federal income tax purposes. Following changes to the law in 2018, Section 162(m) no longer contains an exception for &#8220;performance-based&#8221; compensation for arrangements that are not considered &#8220;grandfathered.&#8221; The Committee makes compensation decisions as appropriate to implement the Company&#8217;s Compensation Philosophy, with tax factors (including deductibility to the Company under Section 162(m)) being only one of many factors considered in implementing </span><span style="text-transform: none">Compensation Philosophy</span><span style="text-transform: none">.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Section 409A</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Since Section 409A of the Code, which deals with deferred compensation arrangements, was enacted, the Committee&#8217;s policy has been to structure all executive officer compensation arrangements to comply, to the extent feasible, with the provisions of Section 409A so that executive officers do not have to pay additional tax and Artivion does not incur additional withholding obligations. The Committee intends to continue </span><span style="text-transform: none">this practice. </span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Forward-Looking Statements</b></span><span id="aort-def14a_051623a371"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Statements made in this Proxy Statement that look forward in time or that express management&#8217;s beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the views of management at the time such statements are made and are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. These statements include those regarding future plans and intentions of the Committee and/or Board of Directors related to compensation decisions and expectations that certain performance targets for management are achievable.</span><span style="text-transform: none; font-family: Arial, sans-serif"><b> </b></span><span style="text-transform: none">These future events may not occur as and when expected, if at all, and, together with the Company&#8217;s business, are subject to various risks and uncertainties. Along with risks specific to our business, management&#8217;s ability to attain certain performance targets is subject to risks affecting the economy generally and other factors that are beyond our control.</span><span style="text-transform: none; font-family: Arial, sans-serif"><b> </b></span><span style="text-transform: none">For additional risks impacting the Company&#8217;s business, see the Risk Factors section of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 at page A-1. The Company assumes no obligation, and expressly disclaims any duty, to update publicly any such forward-looking statements, whether as a result of new information, future event, </span><span style="text-transform: none">or otherwise.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Report of the Compensation Committee</b></span><span id="aort-def14a_051623a372"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Committee reviewed and discussed the Compensation Discussion and Analysis with management. In reliance on this review and discussion, the Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in Artivion&#8217;s 2023 Proxy Statement on Schedule 14A, for filing with </span><span style="text-transform: none">the SEC.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 331.2pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Compensation Committee</b></span><span style="text-transform: none"><br /></span><span style="text-transform: none">DANIEL J. BEVEVINO, CHAIR<br />JAMES W. BULLOCK<br />ANTHONY </span><span style="text-transform: none">B. SEMEDO</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">44</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 807.3pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span id="aort-def14a_051623a390"></span><span style="text-transform: none; color: #024a76; font-size: 14pt; font-family: Arial, sans-serif"><b>EXECUTIVE </b></span><span style="text-transform: none; color: #024a76; font-size: 14pt; font-family: Arial, sans-serif"><b>OFFICER COMPENSATION</b></span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Summary Compensation Table</b></span><span id="aort-def14a_051623a373"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: uppercase">T</span><span style="text-transform: none">he following table sets forth information with respect to each of the Named Executive Officers&#160;&#8212; Mr. Mackin, our Chief Executive Officer; Mr. Lee, our Chief Financial Officer; and Ms. Holloway and Messrs. Davis and Stanton, who were the three most highly compensated of the other executive officers of Artivion employed at the end of </span><span style="text-transform: none">fiscal 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 98.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 37.26pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 55.89pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 52.78pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 76.93pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 50.71pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 52.44pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Name and Principal<br />Position</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Year</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Salary</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(1)</b></sup><span style="text-transform: none; font-size: 8pt"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Bonus</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(2)</b></sup><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b><br /></b></sup><span style="text-transform: none; font-size: 8pt"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Stock<br />Awards</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(3)</b></sup><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b><br /></b></sup><span style="text-transform: none; font-size: 8pt"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Option<br />Awards</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(4)</b></sup><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b><br /></b></sup><span style="text-transform: none; font-size: 8pt"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Non-Equity Incentive Plan Compensation</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(5)</b></sup><span style="text-transform: none; font-size: 8pt"><b> ($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Change in<br />Pension Value<br />and Non-qualified<br />Deferred<br />Compensation<br />Earnings</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b><br /></b></sup><span style="text-transform: none; font-size: 8pt"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>All Other<br />Compen-<br />sation</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(6)</b></sup><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b><br /></b></sup><span style="text-transform: none; font-size: 8pt"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Total</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(7)</b></sup><span style="text-transform: none; font-size: 8pt"><b><br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(e)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(f)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(g)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(h)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(i)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(j)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="3" style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">J. Patrick Mackin,</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Chairman, President and Chief Executive Officer</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3,751,480</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,168,245</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">835,090</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">44,361</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">7,548,808</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">727,798</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">79,985</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,273,674</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">824,838</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">799,850</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">43,439</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">4,749,584</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">605,796</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">441,625</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,577,937</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">745,597</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">44,503</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3,415,458</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="4" style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">D. Ashley Lee,</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Executive Vice President, Chief Financial Officer, and Chief Operating Officer</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">478,344</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">949,165</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">615,900</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">319,725</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">27,359</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,390,493</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">464,412</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">30,623</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">496,448</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">194,261</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">306,233</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">34,196</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,526,173</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">384,019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">169,082</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">421,465</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">183,332</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">25,976</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,183,874</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="5" style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Jean F. Holloway,</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">397,337</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">669,471</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">409,167</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">221,317</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18,070</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,715,362</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">385,765</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">21,198</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">786,827</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">169,759</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">211,978</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">22,687</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,598,214</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">318,987</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">117,040</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">338,820</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">146,664</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">40,231</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">961,742</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="3" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">John E. Davis, Senior Vice President, Global Sales and Marketing</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">379,812</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">662,992</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">405,000</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">211,556</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18,545</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,677,905</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">368,750</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">20,263</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">385,958</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">150,011</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">202,628</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">17,928</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,145,538</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">306,942</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">111,878</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">323,906</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">140,003</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">17,572</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 2.5pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">900,301</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="3" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Marshall S. Stanton, Senior Vice President, Clinical Research and Chief Medical Officer</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">384,216</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">623,985</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">369,500</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">214,008</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">17,322</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,609,031</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">295,673</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">16,880</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">449,530</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">168,802</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">16,343</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">947,228</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For 2022, the amount represents the base salary as approved in February 2022. Mr. Stanton&#8217;s base salary for 2021 is prorated based on the term of his employment. For 2020, the amount represents the base salary as approved in February 2020 and later reduced to 2019 base salary levels for a seven-month period and again reduced by 25% for a six-month period (which was replaced by phantom stock).  </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For 2022 and 2021, amounts represent the personal performance component of the annual award paid pursuant to the applicable short-term incentive plan for that year and the 2020 ECIP. For 2020, amounts represent the entire annual cash bonus award paid pursuant to the applicable short-term incentive plan and the 2009 ECIP. Amounts include all additional or discretionary cash bonuses paid during the applicable year, if any. Mr. Stanton&#8217;s cash bonus for 2021 is prorated based on the term of </span><span style="text-transform: none">his employment.&#160; </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount reflects the aggregate grant date fair value of restricted stock and performance stock unit awards as calculated in accordance with FASB ASC Topic 718, disregarding the estimate of forfeitures. See Notes 1 and 15 of the Notes to Consolidated Financial Statements filed with Artivion&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 for assumptions we used in valuing these awards. The annual PSU awards paid out at 88.5% of target, the 2022 LTIP PSU awards paid out at 140% of target, and the tranche 2 of the 2019 LTIP awards paid out at 136% of target, except for Mr. Mackin, whose award paid out at 108% of target. If the 2022 performance-based shares (i.e., the 2022 annual PSU and 2022 LTIP PSU) were awarded at maximum payouts, it would change the stock awards to the following amounts: for Mr.&#160;Mackin $4,515,164; for Mr. Lee $1,116,130; for Ms. Holloway $798,744; for Mr. Davis $790,606; and for Mr.&#160;Stanton $749,100. For 2022, and for the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, the amounts include a 2023 annual RSU grant that was accelerated to November 2022. The grant date fair values of those accelerated 2023 RSU grants were as follows: Mr. Mackin&#8217;s was $1,290,003; Mr. Lee&#8217;s was $405,000; Ms. Holloway&#8217;s was $247,502; Mr. Davis&#8217;s was $246,002; and Mr. Stanton&#8217;s </span><span style="text-transform: none">was $214,500. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount reflects the aggregate grant date fair value of stock option awards as calculated in accordance with FASB ASC Topic 718, disregarding the estimate of forfeitures. See Notes 1 and 15 of the Notes to Consolidated Financial Statements filed with Artivion&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 for assumptions we used in valuing the stock option awards. For 2022, and for the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, the amounts include a 2023 annual option grant that was accelerated to November 2022. The grant date fair values of those accelerated 2023 option grants were as follows: Mr. Mackin&#8217;s was $1,290,000; Mr. Lee&#8217;s was $405,000; Ms. Holloway&#8217;s was $247,500; Mr. Davis&#8217;s was $246,000; and Mr. Stanton&#8217;s was $214,500.  </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">45</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For 2022, the amounts represent the revenue performance components of the awards earned pursuant to the applicable short-term incentive plan. For 2021, the amounts represent the non-financial and revenue performance components of the awards earned pursuant to the applicable short-term incentive plan. For 2020, the amounts represent the revenue and adjusted net income performance components of the awards earned pursuant to the applicable short-term incentive plan. Mr.&#160;Stanton&#8217;s cash bonus for 2021 is prorated based on the term of </span><span style="text-transform: none">his employment.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The amounts in this column include matching contributions and true-ups under the Company&#8217;s 401(k) plan, reimbursement of club dues, and disability insurance premiums for Named Executive Officers. Fiscal 2020 amounts also include for Mr. Mackin, an $18,000 auto allowance and for Ms. Holloway, a $20,813 relocation allowance. Fiscal 2021 amounts also include for Mr. Mackin, an $18,004 auto allowance and for Mr. Stanton, a $3,496 relocation allowance. Fiscal 2022 amounts also include for Mr. Mackin, an $18,000 </span><span style="text-transform: none">auto allowance.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For 2022, and for the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, the total amounts include a portion of the 2023 annual equity grant accelerated to November 2022, split equally between RSUs and options. The total grant date fair values of those accelerated 2023 RSU and option grants were as follows: Mr. Mackin&#8217;s was $2,580,004; Mr. Lee&#8217;s was $809,998; Ms. Holloway&#8217;s was $495,000; Mr. Davis&#8217;s was $492,001; and Mr. Stanton&#8217;s was $428,998. The NEOs total 2022 compensation, exclusive of the 2023 accelerated annual RSU and options grants was as follows: Mr. Mackin&#8217;s was $4,968,804; Mr. Lee&#8217;s was $1,580,495; Ms. Holloway&#8217;s was $1,220,362; Mr. Davis&#8217;s was $1,185,904; and Mr. Stanton&#8217;s was $1,180,033.    </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">46</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Grants of Plan-Based Awards</b></span><span id="aort-def14a_051623a374"></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.65pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 85.55pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 41.4pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 45.54pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 46.23pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 47.6pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 44.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 46.22pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 44.84pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 41.74pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 52.44pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 41.4pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 41.4pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 41.4pt">


							</td>

						</tr>
						<tr style="min-height: 57.6pt">
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Name</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Grant<br />Date</b></span></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Estimated Possible Payouts<br />Under Non-Equity Incentive<br />Plan Awards</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(1)</b></sup></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Estimated Possible<br />Payouts Under Equity<br />Incentive Plan Awards</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>All Other<br />Stock<br />Awards:<br />Number<br />of Shares<br />of Stock<br />or Units<br />(#)</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(3)</b></sup></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>All Other<br />Option<br />Awards:<br />Number of<br />Securities<br />Underlying<br />Options<br />(#)</b></span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt"><b>(4)</b></sup></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Exercise<br />or Base<br />Price of<br />Option<br />Awards<br />($/Sh)</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Closing<br />Market<br />Price on<br />Committ-<br />ee Action<br />Date<br />($/Sh)</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Grant<br />Date Fair<br />Value of<br />Stock<br />and<br />Option<br />Awards<br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Threshold<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Target<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Maximum<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Threshold<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Target<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Maximum<br />(#)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(e)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(f)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(g)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(h)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(i)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(j)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(k)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(l)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(m)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="7" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">449,779</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">749,632</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,499,264</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">47,627</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">878,242</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">116,954</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,290,003</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">126,546</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">878,229</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">280,435</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">1,290,001</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">28,576</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">47,627</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">71,441</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">878,242</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(5)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">20,202</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">40,404</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">372,525</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="7" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">172,204</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">287,006</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">574,012</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11,437</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">210,898</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">36,718</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">405,000</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">30,389</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">210,900</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">88,043</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">404,998</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">6,862</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11,437</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">17,156</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">210,898</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(5)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">337</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3,367</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">6,734</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">62,087</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="7" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">119,201</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">198,669</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">397,338</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,767</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">161,663</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">22,439</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">247,502</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">23,295</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">161,667</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">53,804</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">247,498</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,260</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,767</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">13,151</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">161,663</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(5)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">269</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,386</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">49,659</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="7" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">113,944</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">189,907</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">379,814</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,623</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">159,008</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">22,303</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">246,002</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">22,911</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">159,002</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">53,478</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">245,999</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,174</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,623</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">12,935</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">159,008</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(5)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">269</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,386</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">49,659</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="7" style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">115,265</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">192,108</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">384,216</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,406</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">155,007</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">19,447</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">214,500</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">22,334</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">154,998</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">11/8/22</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">46,630</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">214,498</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,044</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">8,406</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">12,609</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">155,007</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt">2/23/22</span><sup style="text-transform: none; font-size: 6pt; font-family: Arial, sans-serif; line-height: 6pt"><b>(5)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">269</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2,693</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">5,386</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">49,659</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">These columns represent the awards granted to Named Executive Officers in February 2022 under our 2022 short-term incentive program (the Cash Bonus Plan) using the metrics of the 2022 Cash Bonus Plan approved by the Committee. Threshold for constant currency revenue growth is 4.0%, which pays out at 60% of ta</span><span style="text-transform: none">rget. The personal performance modifier was designed to increase an award by 20%. The total cash bonus payout is capped at 200% of target. The threshold is calculated at target personal performance (no modifier up or down). While this table reflects the grant date value of the awards, the Committee adjusted the cash bonus program payout to 111.4% of target for all executive officers based on </span><span style="text-transform: none">Company performance. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">These rows represent awards of performance stock units to our Named Executive Officers pursuant to the 2020 ECIP.&#160;Threshold for (i) the revenue component is 4.0% constant currency growth, which pays out at 60% of target and (ii) the adjusted EBITDA component is $38,138,000, which pays out at 60% of target, each weighted at 50%, resulting in a combined threshold payout at 60% of target. The total PSU bonus payout is capped at 150% of target. In regard to the annual PSU awards, granted February&#160;23,&#160;2022, shares earned pursuant to this grant and its requisite performance metrics, 50% vested on the first anniversary of the grant date or the first available grant date following the Committee&#8217;s certification of the 2022 financial performance, whichever is later (for the 2022 award, 50% vested on February&#160;23,&#160;2023, the first anniversary of the grant date following the Committee&#8217;s certification), 25% will vest </span><span style="text-transform: none">on the </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">47</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">second anniversary of the grant date, and 25% will vest on the third anniversary, assuming continuous employment through the vesting date. While this table reflects the grant date value of the awards, the Committee adjusted the 2022 annual PSU award payouts to be awarded at 88.5% of target based on </span><span style="text-transform: none">Company performance.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, this column includes a 2023 annual RSU grant that was accelerated to </span><span style="text-transform: none">November 2022. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This column represents awards of stock options pursuant to the 2020 ECIP. One-third of the shares became exercisable on the first anniversary of the grant date, and an additional one-third will become exercisable on each subsequent anniversary thereof until all shares are exercisable on the third anniversary of the grant date, assuming continuous employment through the vesting date.&#160;For the February 2022 grant, the exercise price of $18.44 per share is equal to the closing price of our common stock on the NYSE on the date of issuance, February 23, 2022, and the value of the options is based on an option value of $6.94.&#160;For the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, this column includes a 2023 annual option grant that was accelerated to November 2022. For the November 2022 grant, the exercise price of $11.03 per share is equal to the closing price of our common stock on the NYSE on the date of issuance, Nov</span><span style="text-transform: none">ember 8, 20</span><span style="text-transform: none">22, and the value of the options is based on an option value of $4.60. These options have a </span><span style="text-transform: none">seven-year term.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">These rows include the 2022 LTIP PSU granted to our NEOs on February 23, 2022. Threshold for the constant currency revenue component is 8.5% growth, which pays out at 10% of target. The total 2022 LTIP PSU bonus payout is capped at 200% of target. In regard to the 2022 LTIP PSU awards, granted February 23, 2022, shares earned pursuant to this grant and its requisite performance metrics cliff vest on the first anniversary of the grant date or the first available grant date following the Committee&#8217;s certification of the 2022 financial performance, whichever is later (for the 2022 awards, this was February 23,2023, the first anniversary of the grant date following the Committee&#8217;s certification). While this table reflects the grant date value of the awards, the Committee adjusted the 2022 LTIP PSU award payouts to be at 140% of target based on </span><span style="text-transform: none">Company performance.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table</i></b></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Equity Awards</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Equity awards, including long-term performance annual awards, granted in fiscal 2022 to our Named Executive Officers were subject to the terms of the 2020 ECIP and the equity </span><span style="text-transform: none">grant agreements.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Actual Cash Compensation in Proportion to Target Total Direct Compensation </i></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 450.22pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 142.82pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 108.67pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 108.67pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Salary (actual as paid) and Bonus Payouts (as adjusted and paid) in<br />Proportion to Target Total Direct Compensation</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>% Salary </b></span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Short-Term Incentive (Cash Bonus)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b> </b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>% Bonus</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>% Non-Equity<br />Incentive Plan</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">16.6</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">18.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">32.8</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">21.9</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35.1</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">19.6</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">34.6</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">19.3</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35.2</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.0</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">19.6</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 86.25pt 0pt 97.75pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Consistent with the Summary Compensation Table on page 44, the Bonus represents the personal performance component of the annual award paid pursuant to the short-term </span><span style="text-transform: none">incentive plan.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 86.25pt 0pt 97.75pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amounts represent the constant currency revenue performance component of the awards earned pursuant to the applicable short-term incentive plan and the </span><span style="text-transform: none">2020 ECIP.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">48</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 810.75pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Outstanding Equity Awards on December 31, 2022</b></span><sup style="text-transform: none; font-size: 10pt; line-height: 10pt"><b>(</b></sup><span style="text-transform: none"><b>*</b></span><sup style="text-transform: none; font-size: 10pt; line-height: 10pt"><b>)</b></sup><span id="aort-def14a_051623a375"></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.07pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 95.44pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 58.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 67.27pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 57.38pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 61.98pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.21pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 82.8pt">


							</td>

						</tr>
						<tr style="min-height: 9.9pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option Awards</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 7.9pt; line-height: 7.9pt">&#8203;</p>

							</td>
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Stock Awards</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 64.35pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Exercisable<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Unexercisable<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option<br />Exercise<br />Price<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option<br />Expiration<br />Date</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Shares or Units<br />of Stock<br />that Have<br />Not Vested<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Market Value of<br />Shares or Units<br />of Stock<br />that Have<br />Not Vested<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Equity Incentive<br />Plan Awards:<br />Number of<br />Unearned Shares,<br />Units, or Other<br />Rights that Have<br />Not Vested<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Equity Incentive<br />Plan Awards: Market<br />or Payout Value of<br />Unearned Shares,<br />Units, or Other<br />Rights that Have<br />Not Vested<br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 8.5pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(e)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(f)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(g)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(h)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(i)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">65,549</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">10.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2023</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">59,225</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16.30</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/21/2024</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">75,615</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21.55</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/12/2025</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">61,842</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/5/2026</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">57,531</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">28,765</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">26.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2027</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">31,173</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">62,346</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">24.90</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/17/2028</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">126,546</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/23/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">280,435</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11/8/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">42,020</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">509,282</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">28,415</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">344,390</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,103</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">86,088</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">33,125</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">401,475</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18,202</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(9)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">220,608</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">47,627</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">577,239</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">42,150</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">510,858</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">28,283</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">342,790</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">116,954</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(14)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">1,417,482</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">36,822</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">10.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2023</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">25,665</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16.30</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/21/2024</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21,877</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21.55</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/12/2025</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">15,257</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/5/2026</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">14,146</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,073</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">26.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2027</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,342</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">14,683</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">24.90</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/17/2028</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">30,389</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/23/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">88,043</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11/8/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,946</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">96,306</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,987</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">84,682</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">1,746</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21,162</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,801</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">94,548</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">4,286</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(9)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">51,946</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11,437</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">138,616</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">10,122</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">122,679</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">4,714</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">57,134</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">36,718</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(14)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">445,022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21,229</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16.30</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/21/2024</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">19,092</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21.55</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/12/2025</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">12,787</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/5/2026</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11,317</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,658</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">26.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2027</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,416</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">12,831</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">24.90</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/17/2028</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">23,295</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/23/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">53,804</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11/8/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,357</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">77,047</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,589</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">67,739</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">1,397</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16,932</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,817</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">82,622</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3,746</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(9)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">45,389</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">9,638</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(10)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">116,813</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">8,767</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">106,256</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,759</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">94,039</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3,770</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">45,692</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">22,439</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(14)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">271,961</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0 0pt; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 9pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">49</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.07pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 95.44pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 58.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 67.27pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 57.38pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 61.98pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 62.21pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 77.62pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 82.8pt">


							</td>

						</tr>
						<tr style="min-height: 9.9pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option Awards</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 7.9pt; line-height: 7.9pt">&#8203;</p>

							</td>
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Stock Awards</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 64.35pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Exercisable<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Unexercisable<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option<br />Exercise<br />Price<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Option<br />Expiration<br />Date</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Number of<br />Shares or Units<br />of Stock<br />that Have<br />Not Vested<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Market Value of<br />Shares or Units<br />of Stock<br />that Have<br />Not Vested<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Equity Incentive<br />Plan Awards:<br />Number of<br />Unearned Shares,<br />Units, or Other<br />Rights that Have<br />Not Vested<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt"><b>Equity Incentive<br />Plan Awards: Market<br />or Payout Value of<br />Unearned Shares,<br />Units, or Other<br />Rights that Have<br />Not Vested<br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 8.5pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(e)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(f)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(g)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(h)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 5pt; line-height: 5pt">(i)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">8,745</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">10.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2023</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">13,562</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16.30</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/21/2024</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">15,910</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">21.55</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/12/2025</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">12,787</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3/5/2026</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,401</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,401</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">26.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/19/2027</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,670</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11,338</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">24.90</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/17/2028</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">22,911</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/23/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">53,478</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11/8/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,357</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">77,047</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">5,335</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">64,660</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">1,333</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">16,156</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,024</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">73,011</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3,310</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(9)</sup></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">8,623</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">40,117</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">104,511</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,631</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">92,488</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3,770</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">45,692</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">22,303</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(14)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">270,312</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">22,334</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">18.44</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">2/23/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">46,630</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11.03</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">11/8/2029</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">6,357</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">77,047</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">8,406</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">101,881</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">7,439</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">90,161</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">3,770</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">45,692</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">19,447</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(14)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">235,698</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 3.15pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 7pt">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">8,511</span><sup style="text-transform: none; font-size: 5pt; line-height: 5pt">(15)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 7pt">173,199</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1.15pt; line-height: 1.15pt">&#8203;</p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none"></span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><span style="text-transform: none">* </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">All values in this table are based on the closing price of the Company&#8217;s common stock on the NYSE on December 30, 2022 (the last trading day of 2022) </span><span style="text-transform: none">of $12.12.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">50</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 622.38pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 26.22pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 119.02pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 121.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 63.13pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 235.98pt">


							</td>

						</tr>
						<tr style="min-height: 18.75pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Type of Grant</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Grant Date</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Vesting Rate</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Vesting Dates</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Conditions</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(1)</sup></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based stock options</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/19/2020</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2021</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2023</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(2)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based stock options</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/17/2021</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(3)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based stock options</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/23/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2024</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2025</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(4)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based stock options</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">11/8/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11/8/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11/8/2024</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11/8/2025</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 27.7pt">
							<td rowspan="5" style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(5)</sup></p>

							</td>
							<td rowspan="5" style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">5-Year LTIP</span></p>

							</td>
							<td rowspan="5" style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">3/1/2019</span></p>

							</td>
							<td rowspan="3" style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">60% paid in three tranches </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 20.7pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">First Tranche &#8211; of this portion, 55.5% on third anniversary of performance period, upon certification of financial performance </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 20.7pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Second Tranche &#8211; of this portion, 22.25% on fourth anniversary of performance period</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Third Tranche &#8211; of this portion, 22.25% on fifth anniversary of performance period</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 5pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Upon performance certification for FY 2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 5pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance for fiscal years 2019-2021. This portion of the LTIP, representing 60% of the entire award, was entirely forfeited.</span></p>

							</td>

						</tr>
						<tr style="min-height: 27.65pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 5pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">1/1/2023</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 5pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance for fiscal years 2019-2021. This portion of the LTIP, representing 60% of the entire award, was entirely forfeited.</span></p>

							</td>

						</tr>
						<tr style="min-height: 27.65pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">1/1/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance for fiscal years 2019-2021. This portion of the LTIP, representing 60% of the entire award, was entirely forfeited.</span></p>

							</td>

						</tr>
						<tr style="min-height: 52.15pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">20% on fourth anniversary of performance period, upon certification of financial performance</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Upon performance certification for FY 2023 </span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance for fiscal 2022, which the Compensation Committee will certify in Spring 2023.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 52.15pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">20% on fifth anniversary of performance period, upon certification of financial performance</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Upon performance certification for FY 2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance for fiscal 2023, which the Compensation Committee will certify in Spring 2024.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(6)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock award</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/19/2020</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">100% cliff vesting</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2023</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(7)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Performance stock units</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/19/2020</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">50% on first anniversary of grant date, following certification of financial performance </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on second anniversary of grant date</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on third anniversary of grant date</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2021</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/19/2023</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance metrics for fiscal 2020, which the Compensation Committee determined in February 2021, and then as later adjusted by the Compensation Committee. Number of shares shown reflects the total number of shares awarded (100% of target) pursuant to the performance metric. Number of shares shown reflects the total number of shares remaining unvested after the first tranche vested on 2/19/2021.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(8)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock award</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/17/2021</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">100% cliff vesting</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(9)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Performance stock units</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/17/2021</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">50% on first anniversary of grant date, following certification of financial performance </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on second anniversary of grant date</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on third anniversary of grant date</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance metrics for fiscal 2021, which the Compensation Committee determined in February 2022 (as described further above within the Compensation Discussion and Analysis). Number of shares shown reflects the total number of shares awarded (109.9% of target) pursuant to the performance metric, as none of the shares had time-vested as of 12/31/2021. The first tranche of earned shares vested on 2/17/2022.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">51</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 622.38pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 26.22pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 119.02pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 121.09pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 63.13pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 235.98pt">


							</td>

						</tr>
						<tr style="min-height: 18.75pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Type of Grant</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Grant Date</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Vesting Rate</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Vesting Dates</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Conditions</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(10)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock (one-time retention grant)</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/17/2021</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/17/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares shown reflects the total number of shares awarded, as none of the shares had time-vested as of 12/31/2021. The first tranche of shares vested on 2/17/2022. Under the terms of the grant agreement, Ms.&#160;Holloway&#8217;s retention grant will continue to vest one-third each year even if she leaves the Company by reason of death, disability, or retirement as an attorney in the medical device industry. </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(11)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock unit award</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/23/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">100% cliff vesting</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2025</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(12)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Performance stock units</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/23/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">50% on first anniversary of grant date, following certification of financial performance </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on second anniversary of grant date</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><!--[if IE]><FONT style=" width: 10.35pt; text-indent: -9.0pt; display: inline-block;"><![endif]--><span style="width: 10.35pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">25% on third anniversary of grant date</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2024</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2025</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance metrics for fiscal 2022, which the Compensation Committee determined in February 2023 (as described further above within the Compensation Discussion and Analysis). Number of shares shown reflects the total number of shares awarded (88.5% of target) pursuant to the performance metric, as none of the shares had time-vested as of 12/31/2022. The first tranche of earned shares vested on 2/23/2023.</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(13)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Performance stock units (2022 LTIP PSU)</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">2/23/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">100% cliff vesting</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">2/23/2023</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Number of shares based on certification of performance metrics for fiscal 2022, which the Compensation Committee determined in February 2023 (as described further above within the Compensation Discussion and Analysis). Number of shares shown reflects the total number of shares awarded (140% of target) pursuant to the performance metric, as none of the shares had time-vested as of 12/31/2022. All earned shares vested on 2/23/2023.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(14)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock unit award</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">11/8/2022</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">100% cliff vesting</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">11/8/2025</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting date required.</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(15)</sup></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Service-based restricted stock (new-hire grant)</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">3/16/2021</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">33</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">1/3</sup><span style="text-transform: none; font-size: 8pt">% per year</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3/16/2022</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3/16/2023</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">3/16/2024</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 8pt">Continued employment through vesting dates required. </span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none"></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">52</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 821.79pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Option Exercises and Stock Vested</b></span><sup style="text-transform: none; font-size: 10pt; line-height: 10pt"><b>(1)</b></sup><span id="aort-def14a_051623a376"></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 166.98pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 122.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 93.14pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 13.79pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 127.18pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 97pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Option Awards</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stock Awards</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Number of Shares<br />Acquired on Exercise<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Value Realized<br />on Exercise</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Number of Shares<br />Acquired on Vesting<br />(#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Value Realized<br />on Vesting</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b><br /></b></sup><span style="text-transform: none"><b>($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(e)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 37pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">42,553</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 24pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">287,729</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 38pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">78,031</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 19pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,488,355</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 37pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 24pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 38pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">17,133</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 19pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">330,123</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 37pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 24pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 38pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">19,113</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 19pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">359,854</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 37pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 24pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 38pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">13,794</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 19pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">266,756</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 37pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 24pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 38pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,603</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 19pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">45,553</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table provides information regarding stock option exercises and vesting of restricted stock and performance stock units </span><span style="text-transform: none">during 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Value Realized on Exercise is equal to the number of shares acquired multiplied by the difference between the exercise price and the share price on the NYSE at the time of exercise without regard to any proceeds that may have been received upon any sale of the </span><span style="text-transform: none">underlying shares.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Value Realized on Vesting is equal to the number of shares acquired multiplied by the closing share price on the NYSE on the date of vesting, without regard to any proceeds that may have been received upon any sale of the </span><span style="text-transform: none">underlying shares.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 16pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Nonqualified Deferred Compensation</b></span><span id="aort-def14a_051623a377"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Artivion, Inc. Executive Deferred Compensation Plan allows certain key employees of Artivion, including the Named Executive Officers, to defer receipt of some or all of their salaries, commissions, and/or the cash portion of any bonus awarded pursuant to the short-term executive officer incentive plan. The plan&#8217;s administrative committee, subject to ratification and approval of the Compensation Committee, establishes the maximum and minimum percentages of bonus awards that plan participants may defer in each plan year. These percentages ranged from 0 to 75% for base salary and commissions and were 0% for the annual cash bonus for 2022. Plan participants may establish their respective deferral amounts for their base salaries and commissions prior to the beginning of each calendar year, and prior to July for their short-term incentive compensation for that year, which is calculated and paid after the completion of the </span><span style="text-transform: none">plan year.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The plan provides for tax-deferred growth of deferred compensation and, pursuant to the terms of the plan, Artivion agrees to distribute to participants the deferred amounts, credited/debited with hypothetical gains and/or losses linked to the performance of investment options selected by participants from among the non-proprietary investment options available under the plan. The plan does not have investment options that provide for above-market or preferential earnings. Distribution of all deferred compensation, including any gains or losses, occurs upon death, disability, retirement, or termination. Plan participants may elect to receive the distribution in a lump sum or in annual installments of up to 15 years, or via a combination thereof upon death, disability, or retirement. Also, a plan participant may elect to receive distributions while still employed by Artivion if at least two years have elapsed from the plan year in which the deferred amounts would have otherwise been paid to the plan participant if not for the deferral. Distributions made while the plan participant is still employed by Artivion, and distributions made pursuant to termination, will be paid in a lump sum to the plan participant. Hardship withdrawals during any plan year may be made upon the occurrence of an unforeseeable emergency for a particular plan participant or if a plan participant receives a hardship distribution under Artivion&#8217;s 401(k) plan. All deferred amounts and deemed earnings </span><span style="text-transform: none">thereon are fully vested at </span><span style="text-transform: none">all times. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 9pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table presents components of nonqualified deferred compensation under the Executive Deferred Compensation Plan for each Named </span><span style="text-transform: none">Executive Officer. </span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
					<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 116.6pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 100.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 100.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 100.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 100.87pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 100.87pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer<br />Contributions in<br />Fiscal 2022</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Company<br />Contributions in<br />Fiscal 2022<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Aggregate<br />Earnings in<br />Fiscal 2022</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Aggregate<br />Withdrawals and<br />Distributions in<br />Fiscal 2022<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Aggregate<br />Balance at<br />December 31,<br />2022</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 10.3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(d)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(e)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 6pt; line-height: 6pt">(f)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 27pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">24,837</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(101,923)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">213,740</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">366,930</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(132,391)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,241,442</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(89,000)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">383,114</span></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1pt 0pt 1pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 26pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1pt 23pt 1pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">53</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Contributions to the deferred compensation plan that relate to an executive officer&#8217;s deferrals from salary and/or annual short-term incentives are included in the amounts reflected in the &#8220;Salary&#8221; and &#8220;Bonus&#8221; columns, as applicable, of the Summary Compensation Table for fiscal 2022 on </span><span style="text-transform: none">page 44.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A participant&#8217;s account under the Executive Deferred Compensation Plan is deemed to be invested in hypothetical investment options selected by the participant from among a menu of non-proprietary mutual funds. The account is credited/debited with gains and/or losses linked to the performance of those hypothetical investment options. The plan does not have investment options that provide for above-market or preferential earnings; accordingly, the amounts provided in this column are not included in column (h) of the Summary Compensation Table for fiscal 2022 on </span><span style="text-transform: none">page 44.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amounts shown include the executive officer&#8217;s contributions, withdrawals, and associated hypothetical gains/losses during 2022, as well as deferrals of salary and annual incentives (together with associated hypothetical earnings) from prior years&#8217; participation in the plan. The amounts shown in this column, with the exception of aggregate earnings, have been reported in the &#8220;Salary&#8221; and &#8220;Bonus&#8221; columns, as applicable, of the Summary Compensation Table of prior year Company Proxy Statements, if the individuals were listed as Named Executive Officers in those prior year periods. The total year prior contributions to the Executive Deferred Compensation Plan are as noted in the </span><span style="text-transform: none">table below.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 393.29pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 200.1pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Name</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Amount<br />Previously<br />Reported<br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 9pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">657,756</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1,373,833</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">472,114</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>

					</table>

				</div>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 393.29pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 313.95pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 79.35pt">


							</td>

						</tr>
						<tr style="min-height: 16.65pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Investment Options Provided and Associated Return Rates</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Investment Option</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Annual Return for FY 2022</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Equity Income Division&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">(2.07)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">LargeCap S&amp;P 500 Index Division 2, 12</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4.61</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">LargeCap Growth I Division 14, 15</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9.63</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">American Century VP Mid Cap Value Division 1</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">(0.90)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Vanguard VIF Mid Cap Index Division 1, 2, 17</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.31</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Fidelity VIP MidCap Division 1</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.87</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Franklin Small Cap Value VIP Division 1, 4</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.56</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Calvert VP Russell 2000 Small Cap Index Division 1, 2</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.20</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">ClearBridge Variable Small Cap Growth Division&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4.04</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Real Estate Securities Division 13</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">(0.53)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">American Funds Insurance Series New World Fund Division&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.32</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime Strategic Income Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.27</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2010 Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.31</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2020 Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.50</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2030 Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.82</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2040 Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.08</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2050 Division 5, 6, 7, 8, 9, 10</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.22</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Principal LifeTime 2060 Division&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">3.17</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Fidelity VIP Government Money Market Division&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.92</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">PIMCO VIT High Yield Division</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.83</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">PIMCO VIT Total Return Division</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.63</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">54</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Potential Payments Upon Termination or Change of Control</b></span><span id="aort-def14a_051623a378"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">We have entered into certain agreements and maintain certain plans that will require us to provide compensation to the Named Executive Officers in the event of specified terminations of their employment or upon a change of control </span><span style="text-transform: none">of Artivion.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Employment, Separation and Release, and Change of Control Agreements</i></b></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Employment Agreement with J. Patrick Mackin.</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Pursuant to the Mackin Agreement, Mr. Mackin will receive certain compensation upon the termination of his employment, other than termination for cause or voluntary termination without </span><span style="text-transform: none">good reason. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Mackin Agreement has an initial term of three years following the effective date, extended by one day for each day beginning on the second anniversary of the effective date such that it will remain a one-year term. The Mackin Agreement provides that commencing January&#160;1, 2015, Mr. Mackin is entitled to participate in annual long-term incentive opportunities as determined by the Compensation Committee consistent with those provided to similarly situated Artivion executive officers and in accordance with Artivion&#8217;s plans and applicable award agreements. Benefits currently include participation in Artivion&#8217;s plan-based awards with other Artivion executive officers for performance stock units, stock options, and restricted stock subject to continued employment and achievement of corporate and Board of Directors objectives set by the </span><span style="text-transform: none">Compensation Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Mackin Agreement provides for an initial target cash bonus of 60% of base salary, a $200,000 signing bonus and new hire grants of options to purchase 400,000 shares of Company common stock, and a performance share grant with respect to 250,000 shares of Company common stock, the performance metric thereto having been determined satisfied by the Compensation Committee as of December 31, 2015. In the event Mr. Mackin&#8217;s employment is terminated without cause or Mr. Mackin resigns for good reason, he is entitled to a cash severance payment of 1.5 times the sum of his base salary and annual cash bonus for the year of termination (or the prior year bonus if termination is prior to the date bonuses are awarded) paid in regular payroll installments over 18 months plus continued Company medical coverage for the same period. If Mr. Mackin&#8217;s employment is terminated without cause, or Mr. Mackin resigns for good reason during the period beginning six months prior to and ending two years following a change of control of the Company, Mr. Mackin is entitled to receive a termination payment, in lieu of the severance described in the prior sentence, of 2.5 times the sum of his base salary and annual cash bonus for the year of termination (or the prior year bonus if termination is prior to the date bonuses are awarded), paid in a lump sum. The agreement also includes various post-employment prohibitions regarding competing with us, soliciting our employees and customers, and disclosing our </span><span style="text-transform: none">confidential information.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For purposes of the Mackin Agreement, &#8220;cause&#8221; generally means (i) an intentional act of fraud, embezzlement, theft, or any other material violation of law that occurs during or in the course of the executive officer&#8217;s employment, (ii)&#160;intentional damage of Company assets, (iii) intentional disclosure of Company confidential information contrary to the Company&#8217;s policies, (iv) material breach of the executive officer&#8217;s obligations under the agreement, (v) intentional engagement by the executive officer in any activity that would constitute a breach of his duty of loyalty or of his assigned duties, (vi) intentional breach by the executive officer of any Company policies or procedures, (vii) willful and continued failure by the executive officer to perform his assigned duties, other than as a result of incapacity due to physical or mental illness, (viii) executive officer is prevented from performing certain duties contemplated by the agreement by reason of an agreement with a prior employer, or (ix) willful conduct by the executive officer that is demonstrably and materially injurious to the Company, monetarily </span><span style="text-transform: none">or otherwise.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For purposes of the Mackin Agreement, &#8220;good reason&#8221; generally means (i) the assignment to the executive officer, without his consent, of any duties materially inconsistent with his position, authority, duties, or responsibilities, including changes in status, offices, or titles and any change in the executive officer&#8217;s reporting requirements that would cause him to report to an executive officer&#160;who is junior in seniority to the executive officer to whom he previously reported, (ii) requiring the executive officer to be based other than within 25 miles of Company headquarters as of the effective date, or (iii) any other action that results in a material diminution in his position, authority, duties, responsibilities, or aggregate base salary and </span><span style="text-transform: none">cash bonus.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">55</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Change of Control Agreements with Other Named Executive Officers</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">On November 21, 2016, Artivion entered into change of control agreements with each of Messrs. Lee and Davis and Ms. Holloway. In August 2022, Artivion entered into new change of control agreements with Mr. Lee, Ms. Holloway, and Mr. Davis; however, these new agreements contained only minor, non-substantive revisions to reflect Artivion&#8217;s rebranding and reincorporation in Delaware. The change of control agreements provide that the Company will pay severance payments if Messrs. Lee or Davis or Ms. Holloway are terminated by the Company without cause or if s/he terminates the employment for good reason during a period extending from six months before to two years after a change of control of Artivion. This is a &#8220;double trigger&#8221; provision that requires not only a change of control of Artivion but also an adverse </span><span style="text-transform: none">employment action.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Terms of the Change of Control Agreements</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The current term of the agreement for each of Messrs. Lee and Davis and Ms. Holloway ends December 31,&#160;2022. Each of these agreements will automatically renew at the end of the term and every year thereafter, for an additional one-year term, unless Artivion provides notice at</span><span style="text-transform: none"> least 30 days prior to the end of the then-current term that the agreement will not </span><span style="text-transform: none">be extended. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The severance payment is an amount equal to 2 times for Mr. Lee and 1.5 times for each of Ms. Holloway and Mr. Davis the sum of the executive officer&#8217;s base salary as of the date of termination and his or her bonus compensation for the year in which the termination of employment occurs, or if the bonus for that year has not yet been awarded, the most recently awarded bonus compensation. The agreements also provide for 18 months of </span><span style="text-transform: none">medical coverage.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Change of control, as defined in the agreement, means a change in the ownership of Artivion, a change in the effective control of Artivion, or a change in the ownership of a substantial portion of the assets of Artivion. Specifically, any of the following types of events would constitute a change of control under </span><span style="text-transform: none">the agreements:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any person, including a syndicate or group, acquires ownership of Artivion stock that, taken together with Artivion stock held by such person or group, constitutes more than 50% of the total voting power of the stock </span><span style="text-transform: none">of Artivion; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any person, including a syndicate or group, acquires ownership of stock of Artivion possessing 30% or more of the total voting power of </span><span style="text-transform: none">Artivion stock;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A majority of the members of Artivion&#8217;s Board of Directors are replaced during any 12-month period by individuals whose appointment or election is not endorsed by a majority of the Board of Directors prior to the date of appointment or </span><span style="text-transform: none">election; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 62.1pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">o</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any person, including a syndicate or group, acquires assets from Artivion that have a total gross fair market value equal to more than 40% of the total gross fair market value of all Artivion assets immediately prior to </span><span style="text-transform: none">such acquisition.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The agreements are not employment agreements and each respective officer&#8217;s employment is </span><span style="text-transform: none">&#8220;at will.&#8221;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">We will not be required to make a severance payment in connection with the change of control agreements if we terminate an executive officer&#8217;s employment for &#8220;cause,&#8221; </span><span style="text-transform: none">which means:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">An act of fraud, embezzlement, theft, or any other material violation of law that occurs during or in the course of the executive officer&#8217;s employment </span><span style="text-transform: none">with Artivion;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Intentional or grossly negligent damage by the executive officer to </span><span style="text-transform: none">Artivion assets; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Intentional or grossly negligent disclosure by the executive officer of Artivion&#8217;s confidential information contrary to </span><span style="text-transform: none">Artivion policies; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Material breach of the executive officer&#8217;s obligations under the agreement or other agreements </span><span style="text-transform: none">with Artivion; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Engagement by the executive officer in any activity that would constitute a breach of his or her duty of loyalty or of his or her </span><span style="text-transform: none">assigned duties; </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Breach by the executive officer of any of Artivion&#8217;s policies </span><span style="text-transform: none">and procedures;</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">56</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The willful and continued failure by the executive officer to perform his or her assigned duties, other than as a result of incapacity due to physical or mental </span><span style="text-transform: none">illness; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Willful conduct by the executive officer that is demonstrably and materially injurious to Artivion, monetarily </span><span style="text-transform: none">or otherwise.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">An executive officer may terminate his or her employment for &#8220;good reason&#8221; in connection with a change of control without forfeiting his or her severance pay if any of the following events occur during the term of </span><span style="text-transform: none">the agreement:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The assignment to the executive officer, without his or her consent, of any duties materially inconsistent with his or her position, authority, duties, or responsibilities, including changes in status, offices, or titles and any change in the executive officer&#8217;s reporting requirements that would cause him or her to report to an officer&#160;who is junior in seniority to the officer to whom he or she previously </span><span style="text-transform: none">reported; or</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 41.4pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-size: 8pt; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any other action by Artivion or an acquiring company that results in a material diminution in his or her position, authority, duties, responsibilities, or aggregate compensation, excluding for this purpose an isolated, insubstantial, and inadvertent action taken in good faith and which is remedied by Artivion or an acquiring company within 30 days after receipt of notice from the </span><span style="text-transform: none">executive officer.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The change of control agreements provide that we will pay any severance payment due in a lump sum not later than 30 days following the date of termination in the event of a termination following a change of control, or 30 days following a change of control in the event of a termination occurring within the six-month period preceding the change of control. We will delay payment of the severance payment until six months after the executive officer&#8217;s termination if necessary to prevent him or her from having to pay additional tax under Section 409A of the Code. We will also subject any severance payment to normal payroll tax withholding and compliance with </span><span style="text-transform: none">non-compete obligations.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><i>Agreement Not to Solicit or Compete</i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Messrs. Lee and Davis and Ms. Holloway agree not to solicit any actual or prospective customers of Artivion with whom they have had contact for a competing business or to solicit employees of Artivion to leave Artivion. Messrs. Lee and Davis and Ms. Holloway agree, subject to applicable professional and ethical obligations and other legal requirements, not to join a competing business during the term of the agreement and for a period of one year following the termination of employment. Artivion or an acquiring company is not required to make the severance payment, and the officer is required to repay any portion of the severance payment already received, if he or she solicits customers or employees of Artivion during the term of the agreement and for a period of one year following the termination </span><span style="text-transform: none">of employment.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Termination and Change of Control Payments</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The amount of compensation we would be required to pay to each Named Executive Officer under certain termination and change of control scenarios is provided in the tables beginning on page 57. Amounts included in the tables are estimates and are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Due to the number of factors that affect the nature and amount of any benefits provided upon the events discussed below, any actual amounts paid or distributed may differ materially. The tables provided in this section for all Named Executive Officers assume that the relevant termination or change of control event occurred on December 31, 2022, the last business day of Artivion&#8217;s 2022 </span><span style="text-transform: none">fiscal year.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">57</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif">J. Patrick Mackin, Chairman, President, and Chief Executive Officer</span><sup style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif; line-height: 9pt">(1)</sup></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621.69pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 73.04pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="8" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer Benefits and Payments Upon Termination ($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Voluntary<br />Retirement</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Good<br />Reason or<br />Involuntary<br />Not for<br />Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>For Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Death</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Disability</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Change<br />of Control<br />Without<br />Regard to<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Certain<br />Termination<br />Events<br />Following/<br />Preceding a<br />Change of<br />Control</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(9)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Cash Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">835,090</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">2,444,201</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">835,090</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">835,090</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">835,090</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,073,668</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Stock Option Exercisability</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">428,906</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">428,906</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accrued<br />Vacation Pay</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Medical Benefits</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">39,637</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">39,637 </span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">39,637</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">39,637</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Spread Value of Vested Options</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Vesting of Restricted Stock and Performance Stock Units</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,410,213</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4,410,213</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(8)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>835,090</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>2,483,838</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>835,090</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>874,727</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>874,727</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>4,839,119</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>8,952,424</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table assumes that all termination and change of control events occurred on December 31, 2022. See Employment, Separation and Release, and Change of Control Agreements &#8211; Employment Agreement with J. Patrick Mackin above at page 54 for a description of the </span><span style="text-transform: none">Mackin Agreement.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents the Company-performance component of the 2022 annual incentive plan cash bonus that Mr. Mackin was entitled to on December 31, 2022. No amount is included for the personal performance component of the annual </span><span style="text-transform: none">incentive plan.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents 1.5 times the sum of Mr. Mackin&#8217;s 2022 annual base salary and his entire cash bonus for 2021, as the 2022 bonus had not been determined or distributed as of December 31, 2022. The Mackin Agreement provides for severance payments to be paid in 18 monthly installments, beginning 30 days following the employment termination date (subject to any delay in payment necessary to comply with Section 409A of the Code). Mr. Mackin&#8217;s estate would receive these severance payments upon his subsequent death. No other NEO has an </span><span style="text-transform: none">employment agreement.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown is equal to 2.5 times the sum of Mr. Mackin&#8217;s 2022 annual base salary and his entire 2021 bonus, as the 2022 bonus had not been determined or distributed as of December 31, 2022. The Mackin Agreement provides for severance pa</span><span style="text-transform: none">yments to be paid in 18 monthly installments, beginning 30 days following the employment termination date (subject to any delay in payment necessary to comply with Section 409A of the Code). This scenario assumes that following the change of control, Mr.&#160;Mackin terminated his employment for good reason, or we terminated his employment without cause. Mr. Mackin would also receive the amount shown if we terminated his employment without cause at any time within the six months prior to the change </span><span style="text-transform: none">of control. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that the exercisability of outstanding options accelerates upon a change of control. The accelerated options had value on December 31, 2022, to the extent that the exercise prices of the options were lower than the closing price of our common stock on the NYSE on December 30, 2022, of $12.12.&#160;The value for each option is calculated as the difference between the exercise price of the option and the closing price of our common stock at the end of the fiscal year, to the </span><span style="text-transform: none">extent positive.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Under the terms of the Mackin Agreement, if Mr. Mackin terminates his employment for good reason, we terminate his employment without cause, or he dies or becomes disabled, we would continue to provide him and his family with health benefits coverage, at our expense, for up to 18 months (or until he is provided comparable benefits by another employer).&#160;Amount shown represents the value of 18 months of coverage under our health plans, using costs in effect as of December </span><span style="text-transform: none">31, 2022. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Upon retirement or change of control, the timing right to exercise already vested options changes. No change is made to the value of options already vested. No other NEO has an </span><span style="text-transform: none">employment agreement.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(8)  </sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that all unvested shares of restricted stock and performance stock units become fully vested upon a change of control. The accelerated restricted stock and performance stock units are valued at the closing price of our common stock on the NYSE on December 30, 2022, of $12.12, and the 2022 performance stock units are assumed to have been earned at </span><span style="text-transform: none">target level.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(9)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Under the terms of the Mackin Agreement, amounts shown that are otherwise payable to Mr. Mackin would be reduced if and to the extent that doing so would cause payments that are contingent on a change of control to not be subject to the excise tax under Section 4999 of the Code and thereby produce a greater net after-tax amount </span><span style="text-transform: none">to him.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">58</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>D. Ashley Lee, Executive Vice President, Chief Financial Officer, and Chief </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Operating Officer</b></span><sup style="text-transform: none; font-size: 8pt; font-family: Arial, sans-serif; line-height: 8pt"><b>(1) </b></sup></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="8" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer Benefits and Payments Upon Termination ($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Voluntary<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Good<br />Reason or<br />Involuntary<br />Not for<br />Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>For Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Death</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Disability</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Change<br />of Control<br />Without<br />Regard to<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Certain<br />Termination<br />Events<br />Following/<br />Preceding a<br />Change of<br />Control</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Cash Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">319,725</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">319,725</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">319,725</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">319,725</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">319,725</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,630,401</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Stock Option Exercisability</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">165,192</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">165,192</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accrued<br />Vacation Pay</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Medical Benefits</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">40,379 </span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">40,379 </span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">40,379 </span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">40,379</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Spread Value of Vested Options</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Vesting of Restricted Stock and Performance Stock Units</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,112,095</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,112,095</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>319,725</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>360,104</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>319,725</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>360,104</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>360,104</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>1,277,287</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>2,948,067</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table assumes that all termination and change of control events occurred on December </span><span style="text-transform: none">31, 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents the Company-performance components of the 2022 annual incentive plan cash bonus that Mr. Lee was entitled to on December 31, 2022. No amount is included for the personal performance component of the annual </span><span style="text-transform: none">incentive plan.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents 2 times the sum of Mr. Lee&#8217;s 2022 annual base salary and his entire cash bonus for 2021, as the 2022 bonus had not been determined or distributed as of December 31, 2022. This amount assumes that following a change of control, Mr. Lee terminated his employment for good reason or we terminated his employment without cause. Mr. Lee would also receive the amount shown if we terminated his employment without cause at any time within the six months prior to the change </span><span style="text-transform: none">of control. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that the exercisability of outstanding options accelerates upon a change of control. The accelerated options had value on December 31, 2022, to the extent that the exercise prices of the options were lower than the closing price of our common stock on the NYSE on December 30, 2022, of $12.12. The value for each option is calculated as the difference between the exercise price of the option and the closing price of our common stock at the end of the fiscal year, to the </span><span style="text-transform: none">extent positive.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Under the terms of Mr. Lee&#8217;s change of control agreement, upon a change of control event, if Mr. Lee terminates his employment for good reason or we terminate his employment without cause, we would continue to provide him and his family with health benefits coverage, at our expense, for up to 18 months (or until he is provided comparable benefits by another employer).&#160;Amount shown represents the value of 18 months of coverage under our health plans, using costs in effect as </span><span style="text-transform: none">of December&#160;31,&#160;2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Upon retirement or change of control, the timing right to exercise already vested options changes. No change is made to the value of options </span><span style="text-transform: none">already vested.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that all unvested shares of restricted stock and performance stock units become fully vested upon a change of control. The accelerated restricted stock and performance stock units are valued at the closing price of our common stock on the NYSE on December 30, 2022, of $12.12, and the 2022 performance stock units are assumed to have been earned at </span><span style="text-transform: none">target level. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">59</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 5pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Jean F. Holloway, Senior Vice President, General Counsel, Corporate Secretary, and Chief </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Compliance Officer</b></span><sup style="text-transform: none; font-size: 8pt; font-family: Arial, sans-serif; line-height: 8pt"><b>(1)</b></sup></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="8" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer Benefits and Payments Upon Termination ($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Voluntary<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Good<br />Reason or<br />Involuntary<br />Not for<br />Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>For Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Death</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Disability</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Change<br />of Control<br />Without<br />Regard to<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Certain<br />Termination<br />Events<br />Following/<br />Preceding a<br />Change of<br />Control</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Cash Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">221,317</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">221,317</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">221,317</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">221,317</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">221,317</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">945,770</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Stock Option Exercisability</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">58,646</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">58,646</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accrued<br />Vacation Pay</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Medical Benefits</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Spread Value of Vested Options</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Vesting of Restricted Stock and Performance Stock Units</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">924,489</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">924,489</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>221,317</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>249,654</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>221,317</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>249,654</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>249,654</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>983,135</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>1,957,242</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table assumes that all termination events occurred on December </span><span style="text-transform: none">31, 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents the Company-performance components of the 2022 annual incentive plan that Ms. Holloway was entitled to on December 31, 2022. No amount is included for the personal performance component of the annual </span><span style="text-transform: none">incentive plan.</span><sup style="text-transform: none; font-size: 7pt; line-height: 7pt"> </sup></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents 1.5 times the sum of Ms. Holloway&#8217;s 2022 annual base salary and her entire cash bonus for 2021, as the 2022 bonus had not been determined or distributed as of December 31, 2022. This amount assumes that following a change of control, Ms. Holloway terminated her employment for good reason, or we terminated her employment without cause. Ms. Holloway would also receive the amount shown if we terminated her employment without cause at any time within the six months prior to the change </span><span style="text-transform: none">of control.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that the exercisability of outstanding options accelerates upon a change of control. The accelerated options had value on December 31, 2022, to the extent that the exercise prices of the options were lower than the closing price of our common stock on the NYSE on December 30, 2022, of $12.12.&#160;The value for each option is calculated as the difference between the exercise price of the option and the closing price of our common stock at the end of the fiscal year, to the </span><span style="text-transform: none">extent positive.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Under the terms of Mr. Lee&#8217;s change of control agreement, upon a change of control event, if Mr. Lee terminates his employment for good reason or we terminate his employment without cause, we would continue to provide him and his family with health benefits coverage, at our expense, for up to 18 months (or until he is provided comparable benefits by another employer).&#160;Amount shown represents the value of 18 months of coverage under our health plans, using costs in effect as </span><span style="text-transform: none">of December&#160;31,&#160;2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Upon retirement or change of control, the timing right to exercise already vested options changes. No change is made to the value of options </span><span style="text-transform: none">already vested.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that all unvested shares of restricted stock and performance stock units become fully vested upon a change of control. The accelerated restricted stock and performance stock units are valued at the closing price of our common stock on the NYSE on December 30, 2022, of $12.12, and the 2022 performance stock units are assumed to have been earned at </span><span style="text-transform: none">target level.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">60</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 5pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>John E. Davis, Senior Vice President, Global Sales </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>and Marketing</b></span><sup style="text-transform: none; font-size: 8pt; font-family: Arial, sans-serif; line-height: 8pt"><b>(1)</b></sup></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="8" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Executive Officer Benefits and Payments Upon Termination ($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Voluntary<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Good<br />Reason or<br />Involuntary<br />Not for<br />Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>For Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Death</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Disability</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Change<br />of Control<br />Without<br />Regard to<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Certain<br />Termination<br />Events<br />Following/<br />Preceding a<br />Change of<br />Control</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Cash Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">211,556</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">211,556</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">211,556</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">211,556</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">211,556</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">904,056</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Stock Option Exercisability</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">74,732</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">74,732</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accrued<br />Vacation Pay</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Medical Benefits</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">28,337</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Spread Value of Vested Options</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Vesting of Restricted Stock and Performance Stock Units</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">783,994</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">783,994</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>211,556</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>239,893</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>211,556</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>239,893</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>239,893</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>858,726</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>1,791,119</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table assumes that all termination events occurred on December </span><span style="text-transform: none">31, 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents the Company-performance components of the 2022 annual incentive plan that Mr. Davis was entitled to on December 31, 2022. No amount is included for the personal performance component of the annual </span><span style="text-transform: none">incentive plan.</span><sup style="text-transform: none; font-size: 7pt; line-height: 7pt"> </sup></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount shown represents 1.5 times the sum of Mr. Davis&#8217;s 2022 annual base salary and his entire cash bonus for 2021, as the 2022 bonus had not been determined or distributed as of December 31, 2022. This amount assumes that following a change of control, Mr. Davis terminated his employment for good reason, or we terminated his employment without cause. Mr. Davis would also receive the amount shown if we terminated his employment without cause at any time within the six months prior to the change </span><span style="text-transform: none">of control.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that the exercisability of outstanding options accelerates upon a change of control. The accelerated options had value on December 31, 2022, to the extent that the exercise prices of the options were lower than the closing price of our common stock on the NYSE on December 30, 2022, of $12.12.&#160;The value for each option is calculated as the difference between the exercise price of the option and the closing price of our common stock at the end of the fiscal year, to the </span><span style="text-transform: none">extent positive.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(5)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Under the terms of Mr. Davis&#8217;s change of control agreement, upon a change of control event, if Mr. Davis terminates his employment for good reason or we terminate his employment without cause, we would continue to provide him and his family with health benefits coverage, at our expense, for up to 18 months (or until he is provided comparable benefits by another employer).&#160;Amount shown represents the value of 18 months of coverage under our health plans, using costs in effect as </span><span style="text-transform: none">of December&#160;31,&#160;2022. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(6)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Upon retirement or change of control, the timing right to exercise already vested options changes. No change is made to the value of options </span><span style="text-transform: none">already vested.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(7)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that all unvested shares of restricted stock and performance stock units become fully vested upon a change of control. The accelerated restricted stock and performance stock units are valued at the closing price of our common stock on the NYSE on December 31, 2022, of $12.12, and the 2022 performance stock units are assumed to have been earned at </span><span style="text-transform: none">target level.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">61</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 5pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Marshall S. Stanton, Senior Vice President, Clinical Research and Chief </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Medical Officer</b></span><sup style="text-transform: none; font-size: 8pt; font-family: Arial, sans-serif; line-height: 8pt"><b>(1)</b></sup></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 110.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 72.94pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="8" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 8pt"><b>Executive Officer Benefits and Payments Upon Termination ($)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Voluntary<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Good<br />Reason or<br />Involuntary<br />Not for<br />Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>For Cause<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Death</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Disability</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Change<br />of Control<br />Without<br />Regard to<br />Termination</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Certain<br />Termination<br />Events<br />Following/<br />Preceding a<br />Change of<br />Control</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Cash Compensation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Stock Option Exercisability</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">50,827</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">50,827</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accrued Vacation Pay</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Medical Benefits</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Spread Value of Vested Options</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 8pt">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Accelerated Vesting of Restricted Stock and Performance Stock Units</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">653,632</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">653,632</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8212;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8212;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8212;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8212;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8212;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>704,459</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 9pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>704,459</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This table assumes that the change of control event occurred on December </span><span style="text-transform: none">31, 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">While Mr. Stanton does not have a Change of Control Agreement with the Company, under the 2020 ECIP, he is entitled to accelerated vesting of certain unvested equity awards upon a change </span><span style="text-transform: none">of control.</span><sup style="text-transform: none; font-size: 7pt; line-height: 7pt"> </sup></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that the exercisability of outstanding options accelerates upon a change of control. The accelerated options had value on December 31, 2022, to the extent that the exercise prices of the options were lower than the closing price of our common stock on the NYSE on December 31, 2022, of $12.12.&#160;The value for each option is calculated as the difference between the exercise price of the option and the closing price of our common stock at the end of the fiscal year, to the </span><span style="text-transform: none">extent positive.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(4)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The 2020 ECIP provides that all unvested shares of restricted stock and performance stock units become fully vested upon a change of control. The accelerated restricted stock and performance stock units are valued at the closing price of our common stock on the NYSE on December 31, 2022, of $12.12, and the 2022 performance stock units are assumed to have been earned at </span><span style="text-transform: none">target level.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">62</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Compensation Risk Assessment</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Compensation Committee has determined that our compensation policies and practices for our employees, including our Named Executive Officers, are not reasonably likely to have a material adverse effect on us because unacceptable risks that may be encouraged, directly or indirectly, through a compensation method are mitigated through policy or practice, the Company&#8217;s training programs, the Company&#8217;s internal controls, or external factors such as risk of civil or criminal prosecution, which are made known to employees </span><span style="text-transform: none">through training.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Our Compensation Committee routinely assesses our compensation policies and practices and takes this consideration into account as part of </span><span style="text-transform: none">its review.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Securities Authorized for Issuance Under Equity Compensation Plans</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 26.57pt; text-align: justify"><span style="text-transform: none">The following table provides information as of December&#160;31, 2022, with respect to shares of Artivion common stock that may be issued under existing equity </span><span style="text-transform: none">compensation plans.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 552pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 166.4pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 128.53pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 128.53pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 128.53pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td colspan="4" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Securities Authorized for Issuance Under All Equity Compensation Plans</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Plan category</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Number of<br />Securities to be<br />Issued Upon<br />Exercise of<br />Outstanding Options,<br />PSUs, and RSUs</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(2)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Weighted Average Exercise Price<br />of Outstanding<br />Options, PSUs,<br />and RSUs</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(3)</b></sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Number of Securities Remaining Available<br />for Future Issuance<br />Under Equity<br />Compensation Plans<br />(Excluding Securities<br />Reflected in Column (a))</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">&#160;</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Equity compensation plans approved by stockholders</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">3,508,680</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 44pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$17.31</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,966,101</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none">Equity compensation plans not approved by stockholders</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 44pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 10.35pt; text-transform: none; color: #000000; text-indent: -10.35pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>3,508,680</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 44pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>$17.31</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 37pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>1,966,101</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 34.5pt 0pt 47.15pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Plans include the 2020 ECIP and the Employee Stock Purchase Plan (&#8220;ESPP&#8221;). As of December 31, 2022, 998,798 shares remain available for grant in the 2020 ECIP and 967,303 shares remain available for grant in </span><span style="text-transform: none">the ESPP.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 34.5pt 0pt 47.15pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amounts in column (a) include 2,123,170 Stock Options, 733,928 Restricted Stock Units (RSUs), and 651,582 Performance Stock Units (PSUs) (including shares whose performance period has not concluded, which are calculated at maximum payout which is 311,550 shares above target). The amounts in column (a) do not include 210,375 Restricted Stock Awards (RSAs) that were unvested and outstanding as of December </span><span style="text-transform: none">31, 2022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 34.5pt 10pt 47.15pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amounts in column (b) only reflect outstanding </span><span style="text-transform: none">Stock Options.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">63</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; color: #024a76; font-size: 14pt; font-family: Arial, sans-serif"><b>OTHER INFORMATION</b></span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>CEO Pay Ratio Disclosure</b></span><span id="aort-def14a_051623a379"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Pursuant to a mandate of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(u) of Regulation S-K, we are providing disclosure of the ratio of the median employee&#8217;s annual total compensation to the total annual compensation of the principal executive officer (&#8220;PEO&#8221;). The Company&#8217;s PEO is </span><span style="text-transform: none">Mr. Mackin. </span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 429.06pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 248.39pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.33pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 90.33pt">


							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>PEO<br />($)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Median<br />Employee</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(1)</b></sup><span style="text-transform: none"><b><br />($)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Total Compensation</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">7,548,808</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">57,944</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.95pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>PEO to Median Employee Pay Ratio &#160;</b></span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>130.3 : 1</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 95.45pt 0pt 109.25pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Median employee was determined among all persons employed by Artivion or any of its subsidiaries as of December 31, 2022. Base salary, commission payments, cash bonus, and equity awards were considered when determining the median employee. All 2022 compensation not paid in U.S. dollars was converted to U.S. dollars using the exchange rate as of December&#160;31,&#160;2022. All equity was recorded at grant date fair value. Base salary was annualized for those employees that were not employed for the full year </span><span style="text-transform: none">of 2022.&#160; </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 95.45pt 10pt 109.25pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Total Compensation includes all components recorded in the Summary Compensation Table. For the reasons described on </span><span style="text-transform: none">page 39</span><span style="text-transform: none">, Mr. Mackin&#8217;s Total compensation includes a portion of the 2023 annual equity grant accelerated to November 2022. Mr. Mackin&#8217;s Total Compensation, exclusive of the 2023 accelerated annual equity grant was $4,968,804, which results in a PEO to Median Employee Pay Ration of 85.8.  </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">64</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:PvpTableTextBlock"><p id="xdx_80F_eecd--PvpTableTextBlock_dU_zJebkmYsyoIk" style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Pay Versus Performance Disclosure</b></span><span id="aort-def14a_051623a380"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table sets forth a comparison of compensation reported in the summary compensation table to compensation actually paid to our Principal Executive Officer (PEO) and other Named Executive Officers (NEOs) as well as information on our </span><span style="text-transform: none">Company performance.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table id="xdx_30F_zIQ7LRjGRw7i" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 46.22pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 85.56pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 81.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 87.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 44.16pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 49.68pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Year</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Summary<br />Compensation<br />Table Total<br />for PEO</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation<br />Actually Paid<br />to PEO</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Average<br />Summary<br />Compensation<br />Table Total for<br />non-PEO NEOs</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Average<br />Compensation<br />Actually Paid<br />to non-PEO NEOs</b></span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Value of initial fixed $100<br />Investment based on:</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Net<br />Loss<br />($mm)</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br />Revenue<br />Growth</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br />Shareholder<br />Return</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Index Total<br />Shareholder<br />Return</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">&#160;</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(d)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--PeoTotalCompAmt_pp0p0_c20220101__20221231_fKGEp_zoEf4kskIFbe" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-01to2022-12-31" id="Fact000015" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,548,808</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--PeoActuallyPaidCompAmt_pp0p0_c20220101__20221231_fKGEp_z1Qu7XcqCYK7" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-01to2022-12-31" id="Fact000017" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,718,496</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20220101__20221231_fKGIp_zWbcOm2Qgv33" title="Non-PEO NEO Average Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,848,198</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20220101__20221231_fKGIp_zGEWrtomBJeb" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,352,869</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zeV9wWgxdR33" title="Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">45</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 4pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zEulPXXfnq6d" title="Peer Group Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">97</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20220101__20221231_zwE0TSosjIAe" title="Net Income (Loss)" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">($<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" sign="-" unitRef="USD">19</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20220101__20221231_z2GZLXsNRON5" title="Company Selected Measure Amount"><ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9.8</ix:nonFraction></span>%</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--PeoTotalCompAmt_pp0p0_c20210101__20211231_fKGEp_zogi3BWxgRc5" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,749,584</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20210101__20211231_fKGEp_zw41mpR1JMY9" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000033" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,712,538</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20210101__20211231_fKGIp_zHDqLJh0MDl9" title="Non-PEO NEO Average Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,304,288</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20210101__20211231_fKGIp_zQIPmXlQUGqc" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,108,935</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zs0vTC43Gq5f" title="Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">75</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zSoyXi06F3w4" title="Peer Group Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">144</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20210101__20211231_zM8zwXu2Q7ve" title="Net Income (Loss)" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">($<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" sign="-" unitRef="USD">15</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_90A_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20210101__20211231_z2x0iOTB9I02" title="Company Selected Measure Amount"><ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9.4</ix:nonFraction></span>%</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--PeoTotalCompAmt_pp0p0_c20200101__20201231_fKGEp_zfaorajeEQfj" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000047" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,415,458</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20200101__20201231_fKGEp_zxRIlHQvgEQ2" title="PEO Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000049" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">327,652</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20200101__20201231_fKGIp_zykulp7Uwsib" title="Non-PEO NEO Average Total Compensation Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">977,089</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20200101__20201231_fKGIp_zEjATAkTc7Jl" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">454,525</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zoIbfM7FYZh" title="Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">87</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zqLvhC5aqkVg" title="Peer Group Total Shareholder Return Amount" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">140</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20200101__20201231_zDVfMXJUcW8h" title="Net Income (Loss)" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">($<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" sign="-" unitRef="USD">17</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20200101__20201231_znjCMgMagXTf" title="Company Selected Measure Amount">-<ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">8.1</ix:nonFraction></span>%</span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0F_zXuwvGsg1JYb" style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup>(a)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F17_z8EHFZeEHNwc" style="text-transform: none"><ix:footnote id="Footnote000062" xml:lang="en-US"><span id="xdx_90B_eecd--PeoName_c20220101__20221231_z8Zb0dfd6r86" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_901_eecd--PeoName_c20210101__20211231_zEA5j1JW9Cg1" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_90C_eecd--PeoName_c20200101__20201231_zlAEDYuREUAa" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="ecd:PeoName"><ix:nonNumeric contextRef="From2021-01-012021-12-31" name="ecd:PeoName"><ix:nonNumeric contextRef="From2020-01-012020-12-31" name="ecd:PeoName">Mr. Mackin</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span> served as our
only PEO for each year.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0A_zEGcUCL90B93">(b)</sup></span></td><td style="width: 5pt"></td><td id="xdx_985_eecd--NamedExecutiveOfficersFnTextBlock_c20220101__20221231_zdIo2erIY1Q1" style="text-align: justify"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock"><!--[if IE]></FONT><![endif]--><span id="xdx_F13_zIKeKCvIt5N" style="text-transform: none"><ix:footnote id="Footnote000079" xml:lang="en-US">Our Non-PEO NEOs in 2022
and 2021 were <span id="xdx_90A_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_z0L4uNyhE8j9" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_90A_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zT6vzkGwhwP" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember" name="ecd:PeoName"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember" name="ecd:PeoName">Messrs. Lee</ix:nonNumeric></ix:nonNumeric></span></span>, <span id="xdx_90D_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zqrgItmHd5Z6" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_904_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zVADqc2qEF3e" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_DavisMember" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DavisMember" name="ecd:PeoName">Davis</ix:nonNumeric></ix:nonNumeric></span></span>, <span id="xdx_908_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zedUaqxKrJb5" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_902_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zCNkddbB5pG2" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_StantonMember" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_StantonMember" name="ecd:PeoName">Stanton</ix:nonNumeric></ix:nonNumeric></span></span> and <span id="xdx_906_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zFbNFkeHXJw2" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><span id="xdx_908_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zGlhLReROcUd" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember" name="ecd:PeoName">Ms. Holloway</ix:nonNumeric></ix:nonNumeric></span></span>. Our Non-PEO NEOs in 2020 were <span id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zPtaDtEIxdV4" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember" name="ecd:PeoName">Messrs. Lee</ix:nonNumeric></span>, <span id="xdx_904_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zZCOthiqP5qi" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_DavisMember" name="ecd:PeoName">Davis</ix:nonNumeric></span>, <span id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--SimpsonMember_z8JdtL9iGCM4" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_SimpsonMember" name="ecd:PeoName">Simpson</ix:nonNumeric></span> and <span id="xdx_90C_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zhzx4i2n1YXb" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember" name="ecd:PeoName">Ms. Holloway</ix:nonNumeric></span>.
Mr. Stanton joined the company in March 2021.</ix:footnote></span></ix:nonNumeric></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zDeE3TEmiumj">(c)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F1B_zTQ5gViHTxil" style="text-transform: none"><ix:footnote id="Footnote000080" xml:lang="en-US">Shareholder returns reflect
$100 invested as of market close on December 31, 2019, the final trading day of fiscal 2019; Index Shareholder Return reflects NASDAQ
Medical Equipment Index.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0F_z9iyaN5pmf4g">(d)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F18_znPDQAJLT9c8" style="text-transform: none">Company selected measure
of revenue growth is used in incentive plans. Result is measured in constant currency and adjusted to appropriately reflect baseline.
For 2022, the incentive plan measure for constant currency revenue growth was adjusted to exclude PerClot sales in 2021 and 2022. For
2021, the incentive plan measure for revenue growth reflected the 2<span style="font-size: 7pt; line-height: 7pt"><sup>nd</sup></span>
half in 2021 as compared to the 2<span style="font-size: 7pt; line-height: 7pt"><sup>nd</sup></span> half in 2019. For 2020, revenue,
as opposed to revenue growth, was used as a metric in the Company&#8217;s annual cash bonus plan, but due to the impact of COVID-19 on
the Company&#8217;s business, the revenue result (along with adjusted net income which was also used that year as a metric) would have
resulted in no payout under the cash bonus program. Accordingly, the payout under the cash bonus program for 2020 was based on executive
officer performance to other goals as set forth in the Company&#8217;s 2021 Proxy Statement.</span></td>
</tr></table>
				<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_84A_eecd--AdjToPeoCompFnTextBlock_dU_zz9HsyXm2gid" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">The following table sets forth a reconciliation from the Summary Compensation Table (&#8220;SCT&#8221;) to Compensation Actually Paid (&#8220;CAP&#8221;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, </span><span style="text-transform: none; font-size: 9pt">and 2022.</span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left">
					<table id="xdx_302_zeiDQBUh9fag" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>PEO</b></span></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>Average NEO</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SCT Total Compensation</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,548,808</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,749,584</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,415,458</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,848,198</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,304,288</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">977,089</ix:nonFraction> </b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000091" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,919,725</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000092" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,098,512</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,323,534</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,176,295</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">658,199</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000096" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">499,129</ix:nonFraction>)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year End Fair Value of Equity Awards Made During Year (f)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,689,996</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,402,215</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,931,021</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">955,981</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">508,720</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">429,985</ix:nonFraction> </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000103" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,385,504</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">495,663</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000105" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,326,940</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000106" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">239,756</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000107" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">72,575</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">371,199</ix:nonFraction>)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in </b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>the Ye</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ar (h)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000109" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">215,079</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,913</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000111" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">368,352</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000112" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">32,529</ix:nonFraction>)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,701</ix:nonFraction> </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" id="Fact000114" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">73,105</ix:nonFraction>)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Total Adjustments Related to Eq</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>uity Awards&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,830,312</ix:nonFraction>)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,037,046</ix:nonFraction>)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,087,806</ix:nonFraction>)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">495,329</ix:nonFraction>)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">195,353</ix:nonFraction>)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">522,447</ix:nonFraction>)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Compensation Actually Paid Total (i)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-01to2022-12-31" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,718,496</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,712,538</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">327,652</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-01to2022-12-31" id="Fact000124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,352,869</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-01-012021-12-31" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,935</ix:nonFraction> </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" title="::XDX::454525" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b><span style="-sec-ix-hidden: xdx2ixbrl0126">$454,642 </span></b></span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F06_zMiytBuyFtDi">(e)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none"><ix:footnote id="Footnote000127" xml:lang="en-US">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zTDKLCPrF6n1">(f)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none"><ix:footnote id="Footnote000128" xml:lang="en-US">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F02_zALNNCrU0SY9">(g)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none"><ix:footnote id="Footnote000129" xml:lang="en-US">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zgUPQyOqT1Z6">(h)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none"><ix:footnote id="Footnote000130" xml:lang="en-US">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</ix:footnote></span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zJbnKXFx12Pe">(i)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><!--[if IE]></FONT><![endif]--><span id="xdx_F16_z57fmLv8s6if" style="text-transform: none"><ix:footnote id="Footnote000131" xml:lang="en-US">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A9_z9wUemXSmvDk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_853_zC2XhQ6om367" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_819_zzX4v1wC0FK7" style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><span style="text-transform: none">&#160;</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">65</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Narrative Related to Pay Versus Performance Table</i></b></span></p>
				<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_80A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zbxBrHxhJyQg" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Because a majority of total compensation provided to the PEO and the average paid to the Non-PEO NEOs is via equity-based grants that vest over multi-year periods, the primary driver of changes in &#8220;Compensation Actually Paid&#8221; totals for the PEO and the average for the Non-PEO NEOs is the change in the Company&#8217;s </span><span style="text-transform: none">stock price.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 416.48pt; height: 322.64pt; text-align: left">
						<img src="aort-def14a_051623img005.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 416.29pt; margin-top: 0pt; height: 322pt" />

					</div>

				</div>
				</ix:nonNumeric><p id="xdx_81F_zSuPInYywfx9" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company grants Performance Share Units (PSUs) to executive officers annually. Shares are earned as determined by performance results for the year of grant. Earned shares vest 50% once performance results are certified, and 25% each on the 2</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">nd</sup><span style="text-transform: none"> and 3</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">rd</sup><span style="text-transform: none"> anniversaries of the grant date. Earned PSUs as % of target for each grant are shown in </span><span style="text-transform: none">table below.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 112.24pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.12pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.12pt">


							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>GRANT</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>EARNED</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2017</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">90%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2018</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">80%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">82%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">100%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">110%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">89%</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company granted performance-contingent shares under its LTIP during 2019. The first 60% of the 2019 LTIP grant was to be earned on the basis of revenue growth achieved during 2019-2021 period. This entire tranche of the 2019 LTIP grant was forfeited due to results achieved. The second 20% of the 2019 LTIP grant was earned on the basis of constant currency revenue growth achieved during 2022. As discussed in the CD&amp;A in this proxy statement, the earned award for this tranche was above target and vested in early 2023. The final 20% of the 2019 LTIP grant will be earned on the basis of constant currency revenue growth achieved </span><span style="text-transform: none">during 2023.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company also granted performance-contingent shares under its LTIP during 2021 and 2022. Each grant was earned on the basis of performance results for the year of grant. Earned shares vested early in the year </span><span style="text-transform: none">following grant. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">66</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Earned LTIP shares as % of target are shown in the </span><span style="text-transform: none">table below.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 6pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 6pt; table-layout: fixed; width: 174.16pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.12pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 61.92pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 56.12pt">


							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>GRANT</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>PERIOD</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>EARNED</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2019-2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">136%*</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2023</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">TBD</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">118%</span></p>

							</td>

						</tr>
						<tr style="min-height: 15pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">140%</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: center"><span style="text-transform: none; font-size: 8pt">*PEO at 108% </span><span style="text-transform: none; font-size: 8pt">of target</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company grants time-based restricted share unit (RSU) awards to executive officers annually and also at time of hire for certain officers. Annual time-based grants cliff-vest on the third anniversary of the </span><span style="text-transform: none">grant date. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company grants stock option awards to executive officers annually. Stock option grants vest pro-rata over the first three anniversaries of grant and expire on the seventh anniversary </span><span style="text-transform: none">of grant.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">During November of 2022, the Company granted RSUs and stock options to officers. As discussed in the CD&amp;A, these grants are an acceleration of annual grants that otherwise would have been made to officers in the first quarter </span><span style="text-transform: none">of 2023.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Fair values at time of grant, at year-end 2020 to 2022, and on vesting dates for awards that vested during 2020, 2021, and 2022 were all determined using the Black-Scholes model. The table below summarizes the option fair values and related assumptions used to calculate Compensation Actually Paid for fiscal years 2020, 2021, </span><span style="text-transform: none">and 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621.57pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 98.66pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 101.43pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.29pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 84.29pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 58.99pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 97.29pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 96.59pt">


							</td>

						</tr>
						<tr style="min-height: 39.2pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Valuation<br />Purpose<br />for PVP&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br />Stock<br />Price </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br />Option<br />Exercise<br />Price </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Expected<br />Term<br />(years)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Stock<br />Price<br />Volatility</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Risk-free<br />Rate</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Option<br />Fair<br />Value</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 13.28pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Year-end 2019</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$27.09</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$16.30 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.14 &#8211; 4.18</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">40%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.59% - 1.66%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$8.41 - $12.46</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2020 Vesting</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$20.24- $26.20</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$16.30 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.00 &#8211; 3.00</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.54% - 1.34%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$4.03 - $11.16</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Year-end 2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$23.61</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$21.55 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.20 &#8211; 4.14</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">35%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.14% - 0.28%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$3.97 - $5.78</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2021 Vesting</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$24.44 - $25.54</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$21.55 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.00 &#8211; 3.00</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">40%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.14% - 0.23%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$4.46 - $7.15</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Year-end 2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$20.35 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$24.90 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.18 &#8211; 4.13</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">40%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">0.77% - 1.13%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$2.34 - $5.37</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022 Vesting</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$17.50 - $21.69</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$24.90 - $29.62</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.00 &#8211; 3.00</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">40%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.50% - 1.70%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$2.36 - $2.99</span></p>

							</td>

						</tr>
						<tr style="min-height: 13.05pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Year-end 2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$12.12 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$11.03 - $26.24</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.14 &#8211; 4.86</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">40%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">4.01% - 4.38%</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">$0.58 - $5.29</span></p>

							</td>

						</tr>

					</table>

				</div>
				<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" continuedAt="Con000135-01" escape="true" name="ecd:TabularListTableTextBlock"><p id="xdx_80D_eecd--TabularListTableTextBlock_dU_zIxA8D6CU2J9" style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Most Important Financial Measures Related To 2022 Officer Compensation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As discussed in the CD&amp;A, the annual short-term incentive plan used revenue growth (constant currency) as the primary financial measure for 2022. Annual PSUs granted during 2022 were earned based on revenue growth (constant currency) and adjusted EBITDA. LTIP shares earned during 2022 were based on revenue growth (constant currency) and, with respect to the 2019 LTIP, </span><span style="text-transform: none">gross margin.</span></p>
				</ix:nonNumeric><div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 0pt; table-layout: fixed; width: 277.15pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 277.15pt"><ix:continuation continuedAt="Con000135-02" id="Con000135-01">


							</ix:continuation></td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"><ix:continuation continuedAt="Con000135-03" id="Con000135-02">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Key Financial Measures</b></span></p>

							</ix:continuation></td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"><ix:continuation continuedAt="Con000135-04" id="Con000135-03">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_90C_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__1_fKDEp_zXE5NDaQp76a" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2022-01-012022-12-31_1" name="ecd:MeasureName">Revenue Growth (constant currency)</ix:nonNumeric></span></span></p>

							</ix:continuation></td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"><ix:continuation continuedAt="Con000135-05" id="Con000135-04">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><span id="xdx_902_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__2_fKDEp_zZH5LmhgGgWg" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2022-01-012022-12-31_2" name="ecd:MeasureName">Adjusted EBITDA</ix:nonNumeric></span></span></p>

							</ix:continuation></td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<ix:continuation id="Con000135-05"><p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_906_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__3_fKDEp_zI4ZLYJ8kb9k" class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2022-01-012022-12-31_3" name="ecd:MeasureName">Gross Margin</ix:nonNumeric></span></span></p>
        </ix:continuation><p id="xdx_816_zYj16uuKpJga" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#160;</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">67</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Additional Analysis of Compensation Actually Paid and Company Performance</i></b></span></p>
				<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock"><p id="xdx_802_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zpULkLwNq9D4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As discussed in other sections of this proxy statement, in November 2022, the Compensation Committee decided to accelerate equity grants to officers that otherwise were expected to be made in the first quarter of 2023. The grant date and year-end 2022 fair values of these November 2022 grants have a significant impact on both the Summary Compensation Total and Compensation Actually Paid. The chart below shows 2022 Officer Compensation (SCT and CAP values) both as reported and excluding the impact of equity grants made in </span><span style="text-transform: none">November 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 415.93pt; height: 307.46pt; text-align: left">
						<img src="aort-def14a_051623img006.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 415.15pt; margin-top: 0pt; height: 307.04pt" />

					</div>

				</div>

			</ix:nonNumeric></div>

		</div>
		<p id="xdx_814_z0AmaiWgJIf1" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify">&#160;</p>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">68</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>CERTAIN BENEFICIAL OWNERSHIP</b></span><span id="aort-def14a_051623a381"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The name and business address of each person or entity who beneficially owned more than 5% of the outstanding shares of common stock of Artivion on March 22, 2023, based on information available to us, together with the number of shares owned and the percentage of outstanding shares that ownership represents, is set forth in the following table. The table also shows information concerning beneficial ownership by the Named Executive Officers and by all current non-employee directors and executive officers as a group. The number of shares beneficially owned is determined under the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under those rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares that the individual has the right to acquire within 60&#160;days after March 22, 2023, through the exercise of any stock option or other right. Unless otherwise indicated, each person has sole investment and voting powers, or shares such powers with his or her spouse, with respect to the shares set forth in the following table. To Artivion&#8217;s knowledge, none of the shares shown in the table below is subject to a pledge or </span><span style="text-transform: none">similar arrangement.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 3pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 3pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 322.34pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 139.72pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 158.93pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Beneficial Owner</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Number of Shares of Artivion Common Stock Beneficially Owned (#)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Percentage of<br />Outstanding Shares of<br />Artivion Common<br />Stock (%)</b></span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt"><b>(14)</b></sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. Patrick Mackin</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">909,210</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2.2</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">D. Ashley Lee</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">471,406</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">1.2</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jean F. Holloway</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">218,447</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">John E. Davis</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">195,299</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(4)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marshall S. Stanton</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">55,803</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(5)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Thomas F. Ackerman</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">127,573</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Daniel J. Bevevino</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">127,738</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Marna P. Borgstrom</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">26,765</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">James W. Bullock</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">46,324</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jeffrey H. Burbank</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">31,473</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Elizabeth A. Hoff</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">9,066</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Jon W. Salveson</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">107,517</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Anthony B. Semedo</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">27,870</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">*</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Blackrock, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">7,220,385</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(6)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">17.7</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">The Vanguard Group, Inc.</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,809,140</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(7)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">6.9</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Macquarie Group Limited</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,662,637</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(8)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">6.5</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Wellington Management Group, LLP</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,275,255</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(9)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">5.6</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Morgan Stanley</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,189,557</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(10)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">5.4</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Juniper Investment Company</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,090,864</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(11)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">5.1</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none">All current directors, Named Executive Officers, and other executive officers as a group (18 persons)</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(12)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">2,707,089</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(13)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">6.6</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 496.8pt 4pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><span style="text-transform: none">&#160;&#160;</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-style: italic"><i>*</i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Ownership represents less than 1% of outstanding Artivion </span><span style="text-transform: none">common stock.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount includes 387,506 options that are either presently exercisable or will become exercisable within 60 days after March 22, 2023. This amount also includes 197,706 shares of unvested restricted stock subject to forfeiture which Mr.&#160;Mackin holds as of March 22, 2023. This amount does not include 30,176 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none">days thereafter. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount includes 108,832 options that are either presently exercisable or will become exercisable within 60&#160;days after March 22, 2023. This amount also includes 5,000 shares held by Mr. Lee&#8217;s spouse and 17,560 held in Mr. Lee&#8217;s trust. This amount also includes 55,956 shares of unvested restricted stock subject to forfeiture which Mr. Lee holds as of March 22, 2023. This amount does not include 7,203 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none">days thereafter. </span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup><span style="text-transform: none"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Amount includes 90,680 options that are either presently exercisable or will become exercisable within 60 days after March 22, 2023. This amount also includes 42,842 shares of unvested restricted stock subject to forfeiture that Ms. Holloway holds as of March 22, 2023. This amount does not include 5,753 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none">days thereafter.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">69</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(4)</sup><span style="text-transform: none; font-size: 8pt; font-style: italic"><i> </i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Amount includes 72,037 options that are either presently exercisable or will become exe</span><span style="text-transform: none; font-size: 8pt">rcisable within 60 days after March 22, 2023. This amount also includes 36,950 shares of unvested restricted stock subject to forfeiture that Mr. Davis holds as of March 22, 2023. This amount does not include 5,471 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none; font-size: 8pt">days thereafter.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(5)</sup><span style="text-transform: none; font-size: 8pt; font-style: italic"><i> </i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Amount includes 7,445 options that are either presently exercisable or will become exercisable within 60 days after March 22, 2023. This amount also includes 36,364 shares of unvested restricted stock subject to forfeiture that Mr. Stanton holds as of March 22, 2023. This amount does not include 3,719 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none; font-size: 8pt">days thereafter.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(6)</sup><span style="text-transform: none; font-size: 8pt; font-style: italic"><i> </i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13G filed on January 20, 2023 by BlackRock, Inc. (&#8220;BlackRock&#8221;). Per this schedule, BlackRock has the sole power to vote, or to direct the vote of, and sole power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for BlackRock is BlackRock, Inc., 55 East 52</span><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">nd</sup><span style="text-transform: none; font-size: 8pt"> Street, New York, </span><span style="text-transform: none; font-size: 8pt">NY 10055.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(7)</sup><span style="text-transform: none; font-size: 8pt"> </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13G filed on February 9, 2023 by The Vanguard Group, Inc. (&#8220;Vanguard&#8221;). Per this schedule, Vanguard has the power to vote, or to direct the vote of, and power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for Vanguard is The Vanguard Group, Inc., 100 Vanguard Blvd, Malvern, </span><span style="text-transform: none; font-size: 8pt">PA 19355.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(8)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13G filed on February 14, 2023 by Macquarie Group Limited (&#8220;Macquarie&#8221;). Per this schedule, Macquarie has the power to vote, or to direct the vote of, and power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for Macquarie is Macquarie Group Limited, 50 Martin Place, Sydney, New South </span><span style="text-transform: none; font-size: 8pt">Wales, Australia.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(9)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13G filed on February 6, 2023 by Wellington Management Group, LLP (&#8220;Wellington&#8221;). Per this schedule, Wellington has the power to vote, or to direct the vote of, and power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for Wellington is c/o Wellington Management Company LLP, 280 Congress Street, Boston, </span><span style="text-transform: none; font-size: 8pt">MA 02210.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(10)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13G filed on February 8, 2023 by Morgan Stanley. Per this schedule, Morgan Stanley has the power to vote, or to direct the vote of, and power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for Morgan Stanley is 1585 Broadway New York, </span><span style="text-transform: none; font-size: 8pt">NY 10036.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(11)</sup><span style="text-transform: none; font-size: 8pt; font-style: italic"><i> </i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Information based on Schedule&#160;13D filed on September 26, 2022 by Juniper Investment Company, LLC (&#8220;Juniper&#8221;). Per this schedule, Juniper has the power to vote, or to direct the vote of, and power to dispose, or to direct the disposition of, these shares of Artivion common stock. The address for Juniper is 555 Madison Avenue, 24th Floor, New York, New </span><span style="text-transform: none; font-size: 8pt">York, 10022.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(12)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">The business address for all Artivion non-employee directors and employees is: c/o Artivion,&#160;Inc., 1655 Roberts Boulevard, NW, Kennesaw, </span><span style="text-transform: none; font-size: 8pt">GA 30144.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: left"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(13)</sup><span style="text-transform: none; font-size: 8pt; font-style: italic"><i> </i></span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">Amount includes:</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: left"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">783,571 options that are presently exercisable or will become exercisable within 60&#160;days after March </span><span style="text-transform: none; font-size: 8pt">22, 2023;</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: left"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">22,560 shares held of record by the spouses or trusts of executive officers and </span><span style="text-transform: none; font-size: 8pt">directors; and</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">477,898 shares of unvested restricted common stock subject to forfeiture that all current directors, Named Executive Officers, and other executive officers hold as a group as of March </span><span style="text-transform: none; font-size: 8pt">22, 2023.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">This amount does not include 67,286 shares earned under 2021 and 2022 performance stock unit awards that had not vested as of March 22, 2023, and that will not vest within 60 </span><span style="text-transform: none; font-size: 8pt">days thereafter.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 6pt; line-height: 6pt">(14)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-size: 8pt">40,875,444 outstanding shares of Artivion common stock as of the record date, March </span><span style="text-transform: none; font-size: 8pt">22, 2023.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">70</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>PROPOSAL THREE &#8211; &#8220;SAY WHEN ON PAY&#8221; ADVISORY VOTE ON THE FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXEC</b></span><span style="text-transform: none"><b>UTIVE OFFICERS</b></span><span id="aort-def14a_051623a382"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following proposal gives you, as a stockholder, the opportunity to inform us as to how frequently you wish the Company to include a proposal (i.e., a &#8220;Say on Pay&#8221; Proposal) to permit stockholders to cast an advisory vote on the compensation of our named executive officers in our annual proxy statements. In accordance with Section 14A of the Securities Exchange Act, as amended, which were made pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, public companies are now required to submit a proposal to their stockholders regarding the frequency of &#8220;Say on Pay&#8221; votes at least every six years for a non-binding </span><span style="text-transform: none">advisory vote.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">We believe that a Say on Pay vote provides a meaningful way for stockholders to communicate with the Company regarding their approval or disapproval of executive pay practices. While we hope that the advisory Say on Pay vote is a useful communication tool for our stockholders, we believe that the vote is only effective to the extent it fosters continued and specific dialogue between our Company and our stockholders. The Board of Directors recommends that you vote for a one-year Say on Pay vote frequency for the stockholders&#8217; advisory executive compensation vote. However, stockholders are not being asked to approve the Board of Directors&#8217; recommendation. Instead, you may choose between a Say on Pay vote every one year, two years, or three years, or you may abstain from </span><span style="text-transform: none">the vote.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Required Vote</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The outcome of this advisory vote will be determined by a plurality of votes cast by the holders of shares entitled to vote in the election. Accordingly, abstentions and broker non-votes will not be relevant to </span><span style="text-transform: none">the outcome.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Recommendation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>&#8220;FOR&#8221;</b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b> A ONE-YEAR FREQUENCY FOR<br />STOCKHOLDER ADVISORY VOTES ON </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>EXECUTIVE COMPENSATION.</b></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">71</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>PROPOSAL FOUR &#8211; RATIFICATION OF THE PRELIMINARY APPROVAL OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span><span id="aort-def14a_051623a383"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>General Information</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Audit Committee has preliminarily approved the appointment of Ernst &amp; Young as the independent registered public accounting firm for the fiscal year ending December 31, 2023, subject to the negotiation of fees and other terms for the 2023 engagement. The Board of Directors recommends the Company&#8217;s stockholders ratify the preliminary approval of Ernst &amp; Young as the independent registered public accounting firm for the fiscal year ending December 31, 2023. Representatives of Ernst &amp; Young are expected to attend the 2023 Annual Meeting, and representatives of the firm will have the opportunity to make a statement at the meeting if they desire to do so and will be available to respond to </span><span style="text-transform: none">appropriate questions.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The submission of the preliminary approval of Ernst &amp; Young for ratification by stockholders is not legally required; however, the Board of Directors believes that such submission is consistent with best practices in corporate governance and is an opportunity for stockholders to provide direct feedback to the Board of Directors on an important issue of corporate governance, the selection of our independent registered public accounting firm. If the stockholders do not ratify the approval of Ernst &amp; Young, the preliminary selection of such firm as the independent registered public accounting firm for the Company will be reconsidered by the Audit Committee, provided that the Audit Committee retains sole authority with respect to all decisions regarding the engagement of the Company&#8217;s independent registered public accounting firm, including the decision as to whether or not the 2023 appointment will stand, regardless of whether the stockholders vote to ratify </span><span style="text-transform: none">the approval.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Fees Incurred for Work Performed by the Independent Registered Public Accounting Firm for Fiscal 2022 and Fiscal 2021</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table presents Ernst &amp; Young&#8217;s professi</span><span style="text-transform: none">onal service fees for the audit of the Company&#8217;s annual financial statements for fiscal years ending 2022 and 2021, as well as fees for other services rendered during </span><span style="text-transform: none">those periods.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 296.92pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 125.46pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 3.44pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 82.11pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 3.44pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 82.45pt">


							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>&#160;</b></span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>2021</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Audit fees</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(1)</sup></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$2,135,896</span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$2,129,355</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Audit-related fees</span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Tax fees</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$154,152</span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$95,665</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">All other fees</span></p>

							</td>
							<td colspan="2" style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>
							<td colspan="2" style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 3pt 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#8212;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.8pt">
							<td style="border-top: #000000 0.5pt solid; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>Total</b></span></p>

							</td>
							<td colspan="2" style="border-top: #000000 0.5pt solid; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>$2,290,048</b></span></p>

							</td>
							<td colspan="2" style="border-top: #000000 0.5pt solid; padding: 1.5pt 3pt 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>$2,225,020</b></span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 162.15pt 0pt 175.95pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1) </sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Includes work performed for the audit of our annual consolidated financial statements, the review of financial statements included in our quarterly Form&#160;10-Q reports, the audit of internal control over financial reporting, and the services that an independent auditor would customarily provide in connection with statutory requirements, regulatory filings, and similar engagements for the fiscal year, such as comfort letters, attest services, consents, and assistance with review of documents filed with </span><span style="text-transform: none">the SEC.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 162.15pt 10pt 175.95pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Includes tax compliance and </span><span style="text-transform: none">reporting services.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Company&#8217;s Audit Committee approved all of the services described above. The Audit Committee has determined that the payments made to Ernst &amp; Young for these services are compatible with maintaining such </span><span style="text-transform: none">firm&#8217;s independence.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Audit Committee&#8217;s Preapproval Policies and Procedures</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Audit Committee has the sole authority to appoint or replace, compensate, and oversee the work of any independent registered public accounting firm, who must be, when required, a registered firm as defined by law whose purpose is the preparation or issuance of an audit report or related work. The independent registered public accounting firm&#8217;s reports and other communications are to be delivered directly to the Audit Committee, and the Audit Committee is responsible for the resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting, if any. The Audit Committee annually evaluates the qualifications and performance of the independent registered public accounting firm, including those of its lead partner, and reports on such evaluation to the Board </span><span style="text-transform: none">of Directors. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">72</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Audit Committee preapproves all audit and non-audit services performed by the independent registered public accounting firm and all engagement fees and terms in connection therewith, except as otherwise permitted by federal law and regulations. To date, no services have been approved by the Audit Committee pursuant to 17 CFR 210.2-01(c)(7)(i)(C), which provides a limited exception to the requirement that services be approved in advance by the Audit Committee if certain conditions </span><span style="text-transform: none">are met.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Required Vote</i></b></span><span style="text-transform: none; font-weight: normal; font-style: italic"><i> </i></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The votes cast &#8220;For&#8221; this proposal must constitute a majority of shares present, either in person or by proxy, and entitled to vote on this proposal. If you abstain from voting, it will have the same effect as an </span><span style="text-transform: none">&#8220;Against&#8221; vote.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none; font-style: italic"><b><i>The Board of </i></b></span><span style="text-transform: none; font-style: italic"><b><i>Directors&#8217; Recommendation </i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE<br />RATIFICATION OF T</b></span><span style="text-transform: uppercase; font-family: Arial, sans-serif"><b>he PRELIMINARY approval of </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>ERNST &amp; YOUNG LLP AS OUR<br />INDEPENDENT REGISTERED PUBLIC </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>ACCOUNTING FIRM.</b></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">73</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>PROPOSAL FIVE &#8211; APPROVAL OF ADDITIONAL FUNDING OF 3,040,000 SHARES FOR THE ARTIVION, INC. 2020 EQUITY AND CASH INCENTIVE PLAN</b></span><span id="aort-def14a_051623a384"></span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>General Information</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The Artivion, Inc., 2020 Equity and Cash Incentive Plan (the &#8220;ECIP&#8221;), attached hereto as Appendix B, is the governing vehicle through which the Company awards equity and cash incentive compensation to employees and non-employee directors. We are recommending that the stockholders approve additional funding of 3,040,000 shares for </span><span style="text-transform: none">the ECIP.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Our Board of Directors proposes the addition of 3,040,000 shares of authorized but unissued shares of our common stock (&#8220;Common Stock&#8221;) to the 459,921 shares currently remaining in the ECIP (2,675,000 shares of Common Stock were approved by stockholders in 2020 for the ECIP when the plan was created, and those shares were added the 1,493,473 shares remaining under the 2009 ECIP). The ECIP expires in May 2030, but we believe that the ECIP will be depleted of shares by the end of 2023 if not replenished through </span><span style="text-transform: none">this proposal.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">We believe that approval of the additional 3,040,000 shares to the ECIP is in the best interests of the Company and our stockholders because it will enable us to continue to grant equity-based compensation to our key employees, as well as our non-employee directors. Our Board of Directors believes that the achievement of long-term objectives and employee retention are fostered through equity awards that vest over time. By approving the addition of these shares to the ECIP, our stockholders will enable us to continue to offer competitive compensation packages that are linked to Common Stock performance and to continue recruiting and retaining highly qualified employees, including officers, and non-employee directors, through our long-term incentive plans, annual non-employee director grants, and through special one-time equity grants. Our Board of Directors further believes that, if this proposal is not approved, our ability to align the interests of key employees with stockholders through equity-based compensation will be compromised, which will impair our ability to achieve our business objectives, disrupt our compensation program, and impede our ability to recruit and retain high quality employees and directors. In addition, if we cannot offer equity compensation, we would have to increase our use of cash compensation, which could have an adverse impact on our operations and </span><span style="text-transform: none">business plans.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In advising stockholders to vote for this proposal, the Board of Directors and the Committee, in consultation with management and Willis Towers Watson, the Committee&#8217;s independent compensation advisory firm, considered many factors, including stockholder support at the 2020 annual meeting for the ECIP including the addition of 2,675,000 shares into the plan, the remaining shares available for grant under the ECIP, the number of previously awarded shares, options and other awards outstanding under the ECIP, our equity utilization rates, our compensation program design, the Compensation Committee&#8217;s Compensation Philosophy, and our business plans and operations. In addition, our Board and the Committee believe this proposal is reasonable when compared to peer group practices, stockholder concerns, and proxy advisory firm guidelines. The Board and the Committee also believe that the funding level will ensure we have the means to provide competitive long-term incentive compensation to retain key employees, attract new talent, and further align the interests of equity recipients with those </span><span style="text-transform: none">of stockholders.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Material Differences Following Amendment of the ECIP</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Following stockholder approval of this Proposal Five, the only material difference to the ECIP will be an increase in the total number of </span><span style="text-transform: none">authorized shares</span><span style="text-transform: none"> under the ECIP from 2,675,000</span><span style="text-transform: none"> shares to </span><span style="text-transform: none">5,715,000</span><span style="text-transform: none"> shares. In all other material respects, the terms of the ECIP will remain </span><span style="text-transform: none">the same. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">74</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Key Terms of the ECIP</i></b></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 620.42pt; margin-top: 4pt; margin-bottom: 6pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 209.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 60.72pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 350.28pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Plan Term</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">10 years, or until May </span><span style="text-transform: none">20, 2030</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Eligible Participants</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">All non-employee directors and employees (including consultants and agents) of the Company or its subsidiaries who are selected by </span><span style="text-transform: none">the Committee </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Shares Authorized</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">5,715,000 shares following approval of </span><span style="text-transform: none">3,040,000 increase</span></p>

							</td>

						</tr>
						<tr style="min-height: 49pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Maximum Additional Shares Authorized as a Percent of Outstanding Shares (a</i></span><span style="text-transform: none; font-style: italic"><i>s </i></span><span style="text-transform: none; font-style: italic"><i>of March </i></span><span style="text-transform: none; font-style: italic"><i>22, 2023)&#160;</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 47pt; line-height: 47pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Approximately 7.4% (8.6% including the remaining shares in </span><span style="text-transform: none">the plan) </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Award Types</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Options (Incentive Stock Options and Non-Qualified Options), Stock Appreciation Rights, Stock Unit Awards, Restricted Stock Awards, Restricted Stock Unit Awards, and Performance </span><span style="text-transform: none">Share Awards</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Individual </i></span><span style="text-transform: none; font-style: italic"><i>Share Limits</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The maximum number of Options and/or SARs granted in a given fiscal year is 800,000 for any employee and 75,000 for any non</span><span style="text-transform: none">-employ</span><span style="text-transform: none">ee </span><span style="text-transform: none">director; and</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">The maximum number of awards other than Options and/or SARs granted in a given fiscal year is 500,000 for any employee and 500,000 for any </span><span style="text-transform: none">non-employee director</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Vesting Period</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Determined by the Committee, but no less than 12 months from date </span><span style="text-transform: none">of grant, </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">except for the Committee&#8217;s discretion to provide for accelerated vesting or exercisability in connection with death, disability, retirement, or certain change of control </span><span style="text-transform: none">events, and </span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">except that up to five percent (5%) of the aggregate number of shares of Stock authorized for issuance under the Plan can become vested or exercisable without regard to service or 12-month </span><span style="text-transform: none">vesting requirements</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Stock Option </i></span><span style="text-transform: none; font-style: italic"><i>Exercise Period</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Determined by the Committee, but no more than seven years from the date </span><span style="text-transform: none">of grant</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Stock Option </i></span><span style="text-transform: none; font-style: italic"><i>Exercise Price</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Not less than the fair market value on date of grant, defined as the closing price on the NYSE on the day of </span><span style="text-transform: none">the grant </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-style: italic"><i>Prohibited</i></span></p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 0pt; vertical-align: top; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border: #000000 0.5pt solid; padding: 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none; font-family: Times New Roman, Times, serif">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Repricing without </span><span style="text-transform: none">stockholder approval,</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Reload options,</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Acceleration of payment or vesting of any award other than for death, disability, retirement, or change in </span><span style="text-transform: none">control, or</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 20.7pt; text-indent: -18.0pt; display: inline-block;"><![endif]--><span style="width: 20.7pt; text-indent: 0; display: inline-block"><span style="text-transform: none">&#8226;</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Dividend and Dividend Equivalents on Options </span><span style="text-transform: none">and SARs</span></p>

							</td>

						</tr>

					</table>

				</div>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">75</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Current Awards Outstanding</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Set forth below is information regarding shares currently outstanding under the ECIP, as well as the shares remaining for grant under the ECIP. The Company made the final portion of its annual equity grants to employees on Febr</span><span style="text-transform: none">uary 22, 2</span><span style="text-transform: none">023, and those awards are included in the </span><span style="text-transform: none">below data.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Selected Data as of March </span><span style="text-transform: none">22, 2023:</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table style="table-layout: fixed; width: 621.69pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 519.57pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 102.12pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stock Options outstanding</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(1)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,897,280</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Weighted average exercise price of Options outstanding</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$18.14</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Weighted average remaining contractual life of Options outstanding</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">4.76 years</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Shares Outstanding</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 20.7pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Restricted Share Awards outstanding</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(2)</sup></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 20.7pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Restricted Share Units outstanding</span></p>
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Performance Share Units outstanding (at target performance)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">1,281,027</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Shares remaining for grant under the ECIP</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">(3)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: top; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">459,921</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(1)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">No stock Options outstanding have Dividend </span><span style="text-transform: none">Equivalent Rights.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(2)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">RSAs are included because they have not formally vested, even though ownership rights, such as voting, </span><span style="text-transform: none">have transferred.</span></p>
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">(3)</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">This number does not include 911,524 shares available under the Employee Stock Purchase Plan. Under the ECIP, stock-based awards are granted from a pool of available shares, with stock Options counting as 1 share and restricted shares, performance shares, and restricted share units (full value awards) counting as 1.5 shares. Artivion has no equity plans with outstanding awards other than </span><span style="text-transform: none">the ECIP.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For additional information regarding stock-based awards previously granted, please see the Company&#8217;s consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended Dece</span><span style="text-transform: none">mber 31, 2022, which is attached as Appendix A to this </span><span style="text-transform: none">Proxy Statement.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Outstanding awards and shares available for future grants under the ECIP (&#8220;overhang&#8221;) total 3,638,228 and represent 8.9% of our 40,875,444 outstanding shares of Common Stock, as of the proxy record date. If the additional shares are approved by our Stockholders, the additional 3,040,000 shares under the plan would increase our overhang at such time </span><span style="text-transform: none">to 16.3%</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For the number of securities authorized for issuance under all equity compensation plans as of December 31, 2022, </span><span style="text-transform: none; font-style: italic"><i>see</i></span><span style="text-transform: none"> table </span><span style="text-transform: none; font-style: italic"><i>Securities Authorized for Issuance Under All Equity Compensation Plans</i></span><span style="text-transform: none"> at </span><span style="text-transform: none">page 62.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Based on the factors considered by our Board of Directors, we estimate that the 459,921 shares available for grant under</span><span style="text-transform: none; color: #ff0000"> </span><span style="text-transform: none">the ECIP as of March&#160;22, 2023 (the record date), plus the addition of 3,040,000 shares, will provide a sufficient number of shares to enable us to continue to make equity grants the Board of Directors believes are necessary to best achieve corporate goals for at least </span><span style="text-transform: none">two-to-three years.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Because of the discretionary nature of any future awards under the ECIP, the amount of such awards is not determinable at this time with respect to the Company&#8217;s non-employee directors, executive officers (including the named executive officers), or the company&#8217;s other employees. Information regarding bonus opportunities, Options, and restricted stock units granted in fiscal 2022 to certain executive officers of the Company under the Company&#8217;s existing plans is set forth in the table captioned </span><span style="text-transform: none; font-style: italic"><i>Grants of Plan-Based Awards </i></span><span style="text-transform: none">at page 46, and information regarding outstanding Options and restricted stock under those plans is set forth in the table captioned </span><span style="text-transform: none; font-style: italic"><i>Outstanding Equity Awards at December&#160;31, 2022</i></span><span style="text-transform: none"> at page 48. Information regarding restricted stock granted in fiscal 2022 to the Company&#8217;s non-employee directors pursuant to the ECIP is set forth under </span><span style="text-transform: none; font-style: italic"><i>Fiscal 2022 Director Compensation</i></span><span style="text-transform: none"> at </span><span style="text-transform: none">page 20.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Required Vote</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The votes cast &#8220;For&#8221; this proposal must constitute a majority of shares present, either in person or by proxy, and entitled to vote on this proposal. If you abstain from voting, it will have the same effect as an </span><span style="text-transform: none">&#8220;Against&#8221; vote.</span></p>
				<p style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>The Board of Directors&#8217; Recommendation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE APPROVAL OF ADDITIONAL<br />FUNDING OF 3,040,000 SHARES FOR THE ARTIVION, INC. 2020 EQUITY AND CASH </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>INCENTIVE PLAN</b></span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">76</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: uppercase"><b>HOUSEHOLDING</b></span><span id="aort-def14a_051623a385"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For those stockholders who request paper copies of the Proxy documents and share the same last name and address, they may receive only one copy of our Annual Report and Proxy Statement, unless we receive contrary instructions from any stockholder at that address. This is referred to as &#8220;householding.&#8221; If you are receiving only one copy of the Annual Report and Proxy Statement and prefer to receive multiple copies, additional copies will be provided to you promptly upon written or oral request. All communications should be directed as indicated on the instructions that were included on the notice mailing or to Jean F. Holloway, Corporate Secretary, Artivion, Inc., 1655 Roberts Boulevard, NW, Kennesaw, Georgia 30144, </span><span style="text-transform: none">(770) 419-3355.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">If you are a beneficial owner, you can request additional copies of the Annual Report and Proxy Statement, or you can request householding by notifying your broker, bank, </span><span style="text-transform: none">or nominee. </span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>TRANSACTION OF OTHER BUSINESS</b></span><span id="aort-def14a_051623a386"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As of the date of this Proxy Statement, the Board of Directors is not aware of any matters other than those set forth herein and in the Notice of Annual Meeting of Stockholders that will come before the meeting. Should any other matters arise requiring the vote of stockholders, it is intended that proxies will be voted in respect thereto in accordance with the best judgment of the person or persons voting </span><span style="text-transform: none">the proxies.</span></p>
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>WHERE YOU CAN FIND ADDITIONAL INFORMATION</b></span><span id="aort-def14a_051623a387"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Upon the written request of any record or beneficial owner of common stock of Artivion whose proxy was solicited in connection with the 2023 Annual Meeting, Artivion will furnish such owner, without charge, a copy of its Annual Report on Form&#160;10-K without exhibits for its fiscal year ended December&#160;31, 2022. Requests for a copy of such Annual Report on Form&#160;10-K should be addressed to Jean F. Holloway, Corporate Secretary, Artivion,&#160;Inc., 1655 Roberts Boulevard, NW, Kennesaw, Georgia 30144. Copies of this Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2022, may also be obtained without charge through the SEC&#8217;s website </span><span style="text-transform: none">at www.sec.gov.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">In addition, we file annual, quarterly, and current reports, proxy statements, and other information with the SEC. You may read and copy any document we file with the SEC at the SEC&#8217;s Public Reference Room located at 100 F Street, NE, Washington, D.C. 20549. You may call the SEC at 1-800-SEC-0330 for further information about the SEC&#8217;s public reference rooms. Our SEC filings are also available to the public at the SEC&#8217;s website at www.sec.gov and through our website </span><span style="text-transform: none">at </span><span style="text-decoration: underline; text-transform: none"><span style="text-decoration: underline">https://investors.artivion.com/</span></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">It is important that proxies be voted promptly. Stockholders who do not expect to attend the meeting in person are urged to vote their proxies online, by telephone, or by mail, following the instructions at the beginning of this </span><span style="text-transform: none">Proxy Statement.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">By Order of the Board </span><span style="text-transform: none">of Directors:</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 121.99pt; height: 41.4pt; text-align: left">
						<img src="aort-def14a_051623img002.gif" alt="" style="vertical-align: top; margin-left: 0pt; width: 121.89pt; margin-top: 0pt; height: 41.4pt" />

					</div>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 369.15pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">J. PATRICK MACKIN<br />Chairman, President, and Chief </span><span style="text-transform: none">Executive Officer</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Date: April </span><span style="text-transform: none">3, 2023</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">A-1</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>APPENDIX A </b></span><span style="text-transform: none; font-size: 14pt"><b>&#8211; </b></span><span style="text-transform: none"><b>ARTIVION&#8217;S 2022 ANNUAL REPORT AND NON-GAAP FINANCIAL MEAS</b></span><span style="text-transform: none"><b>URE INFORMATION</b></span><span id="aort-def14a_051623a389"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The 2022 annual Cash Bonus and Annual Equity Grant used GAAP revenues, adjusted for currency. The 2022 Annual Equity Grant also used achievement of pre-determined levels of adjusted EBITDA, prior to the adjustment made by the Compensation Committee. The use of this non-GAAP adjusted performance measure was intended to create a stronger performance incentive by focusing on controllable variables within the core business and to minimize unintended consequences by excluding items that were highly variable or difficult to predict during the </span><span style="text-transform: none">goal-setting process.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The table below provides a reconciliation of 2022 adjusted EBITDA to 2022 net loss under GAAP:  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: center"><span style="text-transform: none; font-style: italic"><b><i>2022 Adjusted EBITDA Reconciliation </i></b></span><span style="text-transform: none; font-style: italic"><b><i>(in Thousands)</i></b></span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: center">
					<table style="margin: 4pt auto 10pt; table-layout: fixed; width: 446.73pt; border-collapse: collapse">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 375.27pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 9.35pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 49.96pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 12.13pt">


							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-family: Arial, sans-serif"><b>2022 Adjusted EBITDA, non-GAAP</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>$</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-family: Arial, sans-serif"><b>39,084</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Business development, integration, and severance income</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">5,852</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">&#160;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Depreciation and amortization expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(22,442</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)&#160;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Interest expense, net</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(18,077</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Stock-based compensation expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(12,344</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)&#160;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Income tax expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(4,208</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)&#160;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Loss on foreign currency revaluation</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">&#160;</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(3,085</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)&#160;</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Corporate rebranding expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none"> (1,908</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Impact of foreign exchange rates</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(</span><span style="text-transform: none">980</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">BioGlue legal expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(728</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Litigation expense</span></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(259</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">Other, net</span></p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 10.4pt; line-height: 10.4pt">&#8203;</p>

							</td>
							<td style="border-bottom: #000000 0.5pt solid; padding: 1.5pt 0pt; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(97</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>
						<tr style="min-height: 12.4pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022 Net loss, GAAP</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">$</span></p>

							</td>
							<td style="border-top: #000000 0.5pt solid; padding: 1.5pt 0pt; background-color: #d9e3ea; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom; border-collapse: collapse; border-bottom-width: 0pt">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none">(19,192</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">)</span></p>

							</td>

						</tr>

					</table>

				</div>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">These numbers are intended to be, and should be, evaluated in the context of the full information provided in our Annual Report on Form 10-K, including the financial statements presented in accordance with GAAP, the footnotes thereto, and the accompanying management&#8217;s discussion and analysis, as well as in our other filings with </span><span style="text-transform: none">the SEC.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-1</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 4pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>APPENDIX B </b></span><span style="text-transform: none; font-size: 14pt"><b>&#8211; </b></span><span style="text-transform: none"><b>ARTIVION, INC. 2020 EQUITY AND CASH INCENTIVE PLAN</b></span><span id="aort-def14a_051623a388"></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-family: Arial, sans-serif"><b>ARTIVION, INC.<br />2020 EQUITY AND CASH </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>INCENTIVE PLAN</b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 1<br />GENERAL</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">1.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Purpose</b></span><span style="text-transform: none">.  The Artivion, Inc. 2020 Equity and Cash Incentive Plan (the &#8220;Plan&#8221;) has been established by Artivion, Inc. (the &#8220;Company&#8221;)</span><sup style="text-transform: none; font-size: 8pt; line-height: 8pt">1</sup><span style="text-transform: none"> to (i) attract, retain, and reward persons eligible to participate in the Plan; (ii) motivate Participants (as defined in Section 1.2 below), by means of appropriate incentives, to achieve annual and long-term goals; (iii) provide equity compensation to Directors of the Company; (iv) provide incentive compensation opportunities to employee Participants that are competitive with those of companies with whom the Company competes for talent; and (iv) further align Participants&#8217; interests with those of the Company&#8217;s stockholders through compensation that is based on the Company&#8217;s common stock; and thereby promote the long-term interests of the Company and its Subsidiaries, as Subsidiaries are defined in Section 11(i), including the growth in value of the Company&#8217;s equity and enhancement of long-term stockholder return. Pursuant to the Plan, Participants may receive Options, SARs, Other Stock Awards, or Cash-Based Awards, each as defined herein (collectively referred to as &#8220;Awards&#8221;).  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">1.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Participation</b></span><span style="text-transform: none">.  Subject to the terms and conditions of the Plan, the Committee (as defined in Section 8) shall determine and designate, from time to time, from among the Eligible Grantees, as defined in Section 11(f), those persons who will be granted one or more Awards under the Plan, and thereby become &#8220;Participants&#8221; in the Plan.  In the discretion of the Committee, a Participant may be granted any Award permitted under the provisions of the Plan, and more than one Award may be granted to a Participant.  Subject to the provisions of Section 8.2(e), Awards may be granted as alternatives to or replacement of awards outstanding under the Plan, or any other plan or arrangement of the Company or a Subsidiary (including a plan or arrangement of a business or entity, all or a portion of which is acquired by the Company or </span><span style="text-transform: none">a Subsidiary).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">1.3</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Operation, Administration, and Definitions</b></span><span style="text-transform: none">.  The operation and administration of the Plan, including the Awards made under the Plan, shall be subject to the provisions of Section 7 (relating to operation and administration). Capitalized terms in the Plan shall be defined as set forth in the Plan (including the definition provisions of Section 11 of </span><span style="text-transform: none">the Plan).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 2<br />OPTIONS </span><span style="text-transform: none">AND SARS</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Definitions</b></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The grant of an &#8220;Option&#8221; entitles the Participant to purchase shares of Stock at an Exercise Price established by the Committee. Options granted under this Section 2 may either be Incentive Stock Options (&#8220;ISOs&#8221;) or Non</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">Qualified Options (&#8220;NQOs&#8221;), as determined in the discretion of the Committee.  An &#8220;ISO&#8221; is an Option that is intended to satisfy the requirements applicable to an &#8220;incentive stock option&#8221; described in Section 422(b) of the Code.  An &#8220;NQO&#8221; is an Option that is not intended to be an &#8220;incentive stock option&#8221; as that term is described in Section 422(b) of </span><span style="text-transform: none">the Code.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A stock appreciation right (a &#8220;SAR&#8221;) entitles the Participant to receive, in cash or Stock (as determined in accordance with Subsection 2.5), value equal to (or otherwise based on) the excess of: (a) the Fair Market Value (as defined in Section 11) of a specified number of shares of Stock at the time of exercise; over (b) an Exercise Price established by </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Exercise Price</b></span><span style="text-transform: none">.  The Exercise Price of each Option and SAR granted under this Section 2 shall be not less than 100% of the Fair Market Value of a share of Stock on the date of grant of the Award, unless a higher price is established by the Committee or determined by a method established by the Committee at the time the Option or SAR </span><span style="text-transform: none">is granted.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.3.</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Exercise</b></span><span style="text-transform: none">.  An Option and an SAR shall be exercisable in accordance with such terms and conditions and during such periods as may be established by the Committee, before or </span><span style="text-transform: none">after grant.</span></p>

			</div>
			<div style="border-width: 0pt; padding: 0pt; max-height: 796.95pt; left: 41.4pt; bottom: 72.45pt; width: 621pt; position: absolute">
				<hr style="border-width: 0pt; background-color: #000000; margin-left: 0pt; width: 72pt; margin-top: -1pt; margin-bottom: 0pt; height: 1pt" />
				<p style="font: 9pt/normal Arial, sans-serif; margin: 0pt 0pt 0pt 13.8pt; text-transform: none; color: #000000; text-indent: -13.8pt; text-align: justify"><!--[if IE]><FONT style=" width: 13.800000000000002pt; text-indent: -12.000000000000004pt; display: inline-block;"><![endif]--><span style="width: 13.8pt; text-indent: 0; display: inline-block"><sup style="text-transform: none; font-size: 7pt; line-height: 7pt">1</sup></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none"></span><span style="text-transform: none">On January 4, 2022, the Company&#8217;s Board of Directors approved amending the Plan to reflect the Company&#8217;s name change from CryoLife, Inc. to Artivion, Inc., and the Company&#8217;s reincorporation from Florida </span><span style="text-transform: none">to Delaware. </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-2</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 818.34pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.4</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Payment of Option Exercise Price</b></span><span style="text-transform: none">.  The payment of the Exercise Price of an Option granted under this Section 2 shall be subject to </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Subject to the following provisions of this Subsection 2.4, the full Exercise Price for shares of Stock purchased upon the exercise of any Option shall be paid at the time of such exercise (except that, in the case of an exercise arrangement approved by the Committee and described in paragraph 2.4(c), payment may be made as soon as practicable after </span><span style="text-transform: none">the exercise).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Exercise Price shall be payable in cash or by tendering (by actual delivery of shares) unrestricted shares of Stock that are acceptable to the Committee, valued at Fair Market Value as of the day the shares are tendered, or in any combination of cash or shares, as determined by </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To the extent permitted by applicable law, a Participant may elect to pay the Exercise Price upon the exercise of an Option by irrevocably authorizing a third party to sell shares of Stock (or a sufficient portion of the shares) acquired upon exercise of the Option and remit to the Company a sufficient portion of the sale proceeds to pay the entire Exercise Price and any tax withholding resulting from </span><span style="text-transform: none">such exercise.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.5</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Settlement of Award</b></span><span style="text-transform: none">.  Shares of Stock delivered pursuant to the exercise of an Option or an SAR shall be subject to such conditions, restrictions and contingencies as the Committee may establish in the applicable Award Agreement.  Settlement of SARs may be made in shares of Stock (valued at their Fair Market Value at the time of exercise), in cash, or in a combination thereof, as determined in the discretion of the Committee.  The Committee, in its discretion, may impose such conditions, restrictions and contingencies with respect to shares of Stock acquired pursuant to the exercise of an Option or an SAR as the Committee determines to </span><span style="text-transform: none">be desirable.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">2.6</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Restrictions on Options and SAR Awards</b></span><span style="text-transform: none">.  Each Option and SAR shall be subject to </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The term of any Option or SAR granted under the Plan shall not exceed seven years from the date </span><span style="text-transform: none">of grant.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b) </span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">No option or SAR shall carry dividend rights or dividend </span><span style="text-transform: none">equivalent rights.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any such Award shall be subject to such conditions, restrictions and contingencies as the Committee </span><span style="text-transform: none">shall determine.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 3<br />OTHER </span><span style="text-transform: none">STOCK AWARDS</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">3.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Definitions</b></span><span style="text-transform: none">.  The term &#8220;Other Stock Awards&#8221; means any of </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A &#8220;Stock Unit&#8221; Award is the grant of a right to receive shares of Stock in </span><span style="text-transform: none">the future.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A &#8220;Performance Share&#8221; Award is a grant of a right to receive shares of Stock or Stock Units, which is contingent on the achievement of performance or other objectives during a </span><span style="text-transform: none">specified period.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A &#8220;Restricted Stock&#8221; Award is a grant of shares of Stock, and a &#8220;Restricted Stock Unit&#8221; Award is the grant of a right to receive shares of Stock in the future, with such shares of Stock or right to future delivery of such shares of Stock subject to a risk of forfeiture or other restrictions that will lapse upon the achievement of one or more goals relating to completion of service by the Participant, or achievement of performance or other objectives, as determined by </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">3.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Restrictions on Other Stock Awards</b></span><span style="text-transform: none">.  Each Stock Unit Award, Restricted Stock Award, Restricted Stock Unit Award and Performance Share Award shall be subject to such conditions, restrictions and contingencies as the Committee </span><span style="text-transform: none">shall determine.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION </span><span style="text-transform: none">4<br />CASH</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">BASED AWARDS</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">4.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Definitions</b></span><span style="text-transform: none">.  The term &#8220;Cash-Based Award&#8221; means a right or other interest granted to a Participant under Section 4.2 of the Plan that may be denominated or payable in cash, other than an Award pursuant to which the amount of cash is determined by reference to the value of a specific number of shares of Stock. For the avoidance of doubt, dividend equivalents constitute </span><span style="text-transform: none">Cash</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">Based Awards.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-3</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">4.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Grant of Cash-Based Awards</b></span><span style="text-transform: none">.  T</span><span style="text-transform: none">he Committee is authorized to grant Awards to Participants in the form of Cash</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan, subject to such vesting and other conditions as the Committee shall determine in its sole discretion.  At the time of the grant of Cash-Based Awards, the Committee may place restrictions on the payout or vesting of Cash-Based Awards that shall lapse, in whole or in part, only upon the attainment of Performance Goals.  The Committee shall determine the terms and conditions of such Awards at the date of grant.  The maximum dollar amount that may be covered by all Cash-Based Awards granted to any individual during any fiscal year under the Plan is $2 million for employees and $500,000 for non-employee directors.  At the discretion of the Committee, Cash-Based Awards under this Plan may be issued jointly under this Plan and any other cash incentive or similar plan of the Company; provided, however, that if a Cash-Based Award is issued under this Plan and another plan of the Company, to the extent of a conflict in the provisions of this Plan and the other plan, the terms of this Plan </span><span style="text-transform: none">shall control.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION </span><span style="text-transform: none">5<br />PERFORMANCE</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">BASED COMPENSATION</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none; line-height: 11.5pt">5.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif; line-height: 11.5pt"><b>Grant of Performance-Based Compensation</b></span><span style="text-transform: none; line-height: 11.5pt">.  The Committee may determine that any Awards granted to a Covered Employee shall be considered performance-based compensation, in which case the provisions of this Section 5 shall apply.  When Awards are made under this Section 5, the Committee shall establish in writing (i) the objective Performance Goals that must be met, (ii) the period during which performance will be measured, (iii) the maximum amounts that may be paid if the Performance Goals are met, and (iv) any other conditions that the Committee deems appropriate.  </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none; line-height: 11.5pt">5.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif; line-height: 11.5pt"><b>Pre-establishment of Performance Goals</b></span><span style="text-transform: none; line-height: 11.5pt">.  Performance Goals will, barring unusual or compelling circumstances, be pre-established by the Committee in writing not later than 90 days after the commencement of the period of service to which the Performance Goal relates, provided that the outcome is substantially uncertain at the time the Committee actually established </span><span style="text-transform: none; line-height: 11.5pt">the goal. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none; line-height: 11.5pt">5.3</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif; line-height: 11.5pt"><b>Adjustments to Performance Goals</b></span><span style="text-transform: none; line-height: 11.5pt">.  The Committee in its sole discretion shall have the authority to make adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or any Subsidiary of the Company or the financial statements of the Company or any Subsidiary of the Company, in response to anticipated or actual changes in applicable laws or regulations, including changes in generally accepted accounting principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment or product line of a business, as applicable. In addition, the Committee may specify that certain equitable adjustments to the Performance Goals will be made during the applicable performance period, provided such specification occurs </span><span style="text-transform: none; line-height: 11.5pt">in writing.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none; line-height: 11.5pt">5.4</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif; line-height: 11.5pt"><b>Certification of Performance Results</b></span><span style="text-transform: none; line-height: 11.5pt">.  The Committee shall certify the satisfaction of the Performance Goal for the applicable performance period specified in the Award agreement after the performance period ends and prior to any payment with respect to the Award. The Committee shall determine the amount, if any, to be paid pursuant to each Award based on the achievement of the Performance Goals and the satisfaction of all other terms of the </span><span style="text-transform: none; line-height: 11.5pt">Award agreement.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none; line-height: 11.5pt">5.5</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif; line-height: 11.5pt"><b>Payment Upon Death or Disability or Other Circumstances</b></span><span style="text-transform: none; line-height: 11.5pt">.  The Committee may authorize that Awards under this Section 5 shall be payable, in whole or in part, in the event of the Participant&#8217;s death or disability, or under </span><span style="text-transform: none; line-height: 11.5pt">other circumstances.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 6<br />STOCK SUBJECT TO </span><span style="text-transform: none">THE PLAN</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Awards Subject to Plan</b></span><span style="text-transform: none">.  Awards granted under the Plan shall be subject to </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Subject to the following provisions of this Subsection 6.1, the maximum number of shares of Stock that may be delivered to Participants and their beneficiaries under the Plan shall be </span><span style="text-transform: none">5,715,000</span><span style="text-transform: none"> shares of Stock, plus the remainder of any shares available and issuable under the Plan as of May 16, 2023, less the number of non-forfeited shares of Stock subject to outstanding Awards that have been granted but not yet vested. Shares of Stock issuable hereunder may, in whole or in part, be authorized but unissued shares or shares of Stock that shall have been or may be reacquired by the Company in the open market, in private transactions or otherwise. Notwithstanding the foregoing, with respect to SARs that are settled in Stock, the aggregate number of shares of Stock subject to the SAR grant shall be counted against the shares available for issuance under the Plan as one share for every share subject thereto, regardless of the number of shares used to settle the SAR upon exercise. For every share of Stock awarded hereunder in respect of Other Stock Awards, the maximum number of shares reserved for grant hereunder shall be reduced by </span><span style="text-transform: none">1.5 shares.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-4</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Subject to adjustment in accordance with Subsections 6.2 and 6.3, the following additional maximums are imposed under the Plan: the maximum number of shares of Stock that may be covered by Awards granted to any one individual pursuant to Section 2 (relating to Options and SARs) shall be 800,000 for employees and 75,000 for non-employee directors during any fiscal year and the maximum number of shares of Stock that may be covered by Other Stock Awards granted to any one individual pursuant to Section 3 shall be 500,000 for employees and 500,000 for non-employee directors during any fiscal </span><span style="text-transform: none">year; and</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">To the extent any shares of Stock covered by an Award are not delivered to a Participant or beneficiary because the Award is forfeited or canceled, or the shares of Stock are not delivered because the Award is settled in cash, such shares shall not be deemed to have been delivered for purposes of determining the maximum number of shares of Stock available for delivery under the Plan.  To the extent that shares of Stock subject to Other Stock Awards, and the issuance of which reduced the maximum number of shares authorized for issuance under the Plan by 1.5 shares, are forfeited or cancelled, or if such an Award terminates or expires without a distribution of shares to the Participant, the number of shares of Stock remaining for Award grants hereunder shall be increased by 1.5 for each share forfeited, cancelled or otherwise not delivered. Shares of Stock shall not again be available if such shares are surrendered or withheld as payment of either the exercise price of an Award and/ or withholding taxes in respect of an Award.  Awards that are settled solely in cash shall not reduce the number of shares of Stock available for Awards. Upon the exercise of any Award granted in tandem with any other Award, such related Awards shall be cancelled to the extent of the number of shares of Stock as to which the Award is exercised and, notwithstanding the foregoing, such number of shares shall no longer be available for Awards under the Plan.  The maximum number of shares of Stock available for delivery under the Plan shall not be reduced for shares subject to plans assumed by the Company in an acquisition of an interest in </span><span style="text-transform: none">another company.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Adjustments for Changes in Capitalization</b></span><span style="text-transform: none">.  If the outstanding shares of Stock are changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of any recapitalization, reclassification, stock split, stock dividend, combination, subdivision or similar transaction, or if the Company makes an extraordinary dividend or distribution to its stockholders (including without limitation to implement a spinoff) (each, a &#8220;Corporate Transaction&#8221;) then, subject to any required action by the stockholders of the Company, the number and kind of shares of Company stock availabl</span><span style="text-transform: none">e under the Plan or subject to any limit or maximum hereunder shall automatically be proportionately adjusted, with no action required on the part of the Committee or otherwise. Subject to any required action by the stockholders, the number and kind of shares covered by each outstanding Award, and the price per share in each such Award, shall also be automatically proportionately adjusted for any increase or decrease in the number of issued shares of the Company resulting from a Corporate Transaction or any other increase or decrease in the number of such shares, or any decrease in the value of such shares, effected without receipt of consideration by the Company.  Notwithstanding the foregoing, no fractional shares shall be issued or made subject to an Option, SAR or Other Stock Award in making the foregoing adjustments.  All adjustments made pursuant to this Section shall be final, conclusive and binding upon the holders of Options, SARs and Other </span><span style="text-transform: none">Stock Awards.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.3</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Certain Mergers and Other Extraordinary Events</b></span><span style="text-transform: none">.  If the Company merges or consolidates with another corporation, or if the Company is liquidated or sells or otherwise disposes of substantially all of its assets while unexercised Options or other Awards remain outstanding under this Plan, (A) subject to the provisions of clause (C) below, after the effective date of the merger, consolidation, liquidation, sale or other disposition, as the case may be, whether or not the Company is the surviving corporation, each holder of an outstanding Option or other Award shall be entitled, upon exercise of that Option or Award or in place of it, as the case may be, to receive, at the option of the Committee and in lieu of shares of Stock, (i) the number and class or classes of shares of Stock or other securities or property to which the holder would have been entitled if, immediately prior to the merger, consolidation, liquidation, sale or other disposition, the holder had been the holder of record of a number of shares of Stock equal to the number of shares of Stock as to which that Option may be exercised or are subject to the Award or (ii) shares of stock of the company that is the surviving corporation in such merger, consolidation, liquidation, sale or other disposition having a value, as of the date of payment under Subsection 6.3(i) as determined by the Committee in its sole discretion, equal to the value of the shares of Stock or other securities or property otherwise payable under Subsection 6.3(i); (B) whether or not the Company is the surviving corporation, if Options or other Awards have not already become exercisable, the Board of Directors may waive any limitations set forth in or imposed pursuant to this Plan so that all Options or other Awards, from and after a date prior to the effective date of that merger, consolidation, liquidation, sale or other disposition, as the case may be, specified by the Board of Directors, shall be exercisable in full; and (C) all outstanding Options or SARs may be cancelled by the Board of Directors as of the effective date of any merger, consolidation, liquidation, sale or other disposition, provided that with respect to a merger or consolidation the Company is not the surviving company, and provided further that any optionee or SAR holder shall have the right immediately prior to such event to exercise his or her Option or SAR to the extent such optionee or holder is otherwise able to do so in accordance with this Plan or his or her individual Option or SAR agreement; </span><span style="text-transform: none">provided, further, </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-5</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">that any such cancellation pursuant to this Section 6.3 shall be contingent upon the payment to the affected Participants of an amount equal to (i) in the case of any out</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">of</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">the</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">money Option or SAR, cash, property or a combination thereof having an aggregate value equal to the value of such Option or SAR, as determined by the Committee or the Board of Directors, as applicable, in its sole discretion, and (ii) in the case of an in</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">the</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">money Option or SAR, cash, property or a combination thereof having an aggregate value equal to the excess of the value of the per-share amount of consideration paid pursuant to the merger, consolidation, liquidation, sale or other disposition, as the case may be, giving rise to such cancellation, over the exercise price of such Option or SAR multiplied by the number of shares of Stock subject to the Option </span><span style="text-transform: none">or SAR.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Any adjustments pursuant to this Subsection 6.3 shall be made by the Board or Committee, as the case may be, whose determination in that respect shall be final, binding and conclusive, regardless of whether or not any such adjustment shall have the result of causing an ISO to cease to qualify as </span><span style="text-transform: none">an ISO.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.4</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Changes in Par Value</b></span><span style="text-transform: none">.  In the event of a change in the shares of the Company as presently constituted, which is limited to a change of all of its authorized shares with par value into the same number of shares with a different par value or without par value, the shares resulting from any such change shall be deemed to be the shares within the meaning of </span><span style="text-transform: none">this Plan. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.5</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Limitation on Grantees&#8217; Rights</b></span><span style="text-transform: none">.  Except as hereinbefore expressly provided in this Section 6, a Participant shall have no rights by reason of any subdivision or consolidation of shares of stock of any class or the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class or by reason of any dissolution, liquidation, merger, or consolidation or spin</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">off of assets or stock of another corporation, and any issue by the Company of shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Stock subject to an Award, unless the Committee shall </span><span style="text-transform: none">otherwise determine.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.6</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Company Right and Power</b></span><span style="text-transform: none">.  The grant of any Award pursuant to this Plan shall not adversely affect in any way the right or power of the Company (A) to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, (B) to merge or consolidate, (C) to dissolve, liquidate or sell or transfer all or any part of its business or assets or (D) to issue any bonds, debentures, preferred or other preference stock ahead of or affecting </span><span style="text-transform: none">the Stock.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">6.7</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Fractional Shares</b></span><span style="text-transform: none">.  If any action described in this Section 6 results in a fractional share for any Participant under any Award hereunder, such fraction shall be completely disregarded, and the Participant shall be entitled only to the whole number of shares resulting from </span><span style="text-transform: none">such adjustment.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 7<br />OPERATION </span><span style="text-transform: none">AND ADMINISTRATION</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Effective Date; Duration</b></span><span style="text-transform: none">.  The Plan is effective as of the date of its initial approval by the stockholders of the Company at the 2020 Annual Meeting of Shareholders, to be held on May&#160;20, 2020. The Plan will have a duration of ten years from May 20, 2020, and provided that in the event of Plan termination, the Plan shall remain in effect so long as any Awards under it are outstanding; provided further, however, that no Award may be granted under the Plan on a date that is more than ten years from May 20, 2020.   </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Vesting</b></span><span style="text-transform: none">.  Notwithstanding anything in the Plan to the contrary, all Options, SARs, and Other Awards (including, but not limited to, performance-based awards) shall vest or become exercisable no earlier than twelve months from the date on which such Award is granted, except for the Committee&#8217;s discretion to provide for accelerated vesting or exercisability in connection with death, disability, retirement, or events as described above at Section 6.3, and except that up to five percent (5%) of the aggregate number of shares of Stock authorized for issuance under the Plan may be issued pursuant to Options, SARs, and Other Awards without regard to the service vesting and exercisability requirements of this Section 7.2. The term of any Award granted under the Plan will not exceed seven years from the date </span><span style="text-transform: none">of grant. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.3</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Uncertificated St</b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>ock</b></span><span style="text-transform: none">.  To the extent that the Plan provides for issuance of stock certificates to reflect the issuance of shares of Stock, the issuance may be effectuated on a non</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">certificated basis, to the extent not prohibited by applicable law or the applicable rules of any </span><span style="text-transform: none">stock exchange.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.4</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Tax Withholding</b></span><span style="text-transform: none">.  All distributions under the Plan are subject to withholding of all applicable taxes, and the Committee may condition the delivery of any shares or other benefits under the Plan on satisfaction of the applicable withholding obligations. The Committee, in its discretion, and subject to such requirements as the Committee may impose prior to the occurrence of such withholding, may permit such withholding obligations to be satisfied through cash payment by the Participant, through the surrender of shares of Stock which the Participant already owns, or through the surrender of unrestricted shares of Stock to which the Participant is otherwise entitled under the Plan, but only to the extent of the minimum amount required to be withheld under </span><span style="text-transform: none">applicable law.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-6</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.5</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Use of Shares</b></span><span style="text-transform: none">.  Subject to the overall limitation on the number of shares of Stock that may be delivered under the Plan, the Committee may use available shares of Stock as the form of payment for compensation, grants or rights earned or due under any other compensation plans or arrangements of the Company or a Subsidiary, including the plans and arrangements of the Company or a Subsidiary assumed in </span><span style="text-transform: none">business combinations.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.6</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Dividends and Dividend Equivalents</b></span><span style="text-transform: none">.  An Award, excluding Options and SAR Awards,  may provide the Participant with the right to receive dividend payments or dividend equivalent payments with respect to Stock subject to the Award (both before and after the Stock subject to the Award is earned or vested), which payments may be either made currently or credited to an account for the Participant, and may be settled in cash or Stock as determined by the Committee.  Any such settlements, and any such crediting of dividends or dividend equivalents or reinvestment in shares of Stock, may be subject to such conditions, restrictions and contingencies as the Committee shall establish, including the reinvestment of such credited amounts in Stock equivalents.  In the event an Award is conditioned on the achievement of one or more Performance Goals, any dividend payments or dividend equivalent payments will only be earned, vested or acquired to the extent the underlying Stock subject to the Award is earned, vested </span><span style="text-transform: none">or acquired. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.7</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Payments</b></span><span style="text-transform: none">.  Awards may be settled through cash payments, the delivery of shares of Stock, the granting of replacement Awards, or any combination thereof as the Committee shall determine.  Any Award settlement, including payment deferrals, may be subject to such conditions, restrictions and contingencies as the Committee shall determine.  The Committee may permit or require the deferral of any Award payment, subject to such rules and procedures as it </span><span style="text-transform: none">may establish.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.8</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Transferability</b></span><span style="text-transform: none">.  Except as otherwise provided by the Committee, Awards under the Plan are not transferable except as designated by the Participant by will or by the laws of descent </span><span style="text-transform: none">and distribution.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.9</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Form and Time of Elections</b></span><span style="text-transform: none">.  Unless otherwise specified herein, each election required or permitted to be made by any Participant or other person entitled to benefits under the Plan, and any permitted modification, or revocation thereof, shall be in writing filed with the Committee at such times, in such form, and subject to such restrictions and limitations, not inconsistent with the terms of the Plan, as the Committee </span><span style="text-transform: none">shall require.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.10</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Agreement with Company</b></span><span style="text-transform: none">.  An Award under the Plan shall be subject to such terms and conditions, not inconsistent with the Plan, as the Committee shall, in its sole discretion, prescribe. The terms and conditions of any Award to any Participant, other than cash awards, shall be reflected in such form of a written or electronic document as is determined by the Committee.  A copy of such document shall be made available to the Participant, and the Committee may, but need not, require that the Participant sign a copy of such document or otherwise indicate his or her consent. Such document is referred to in the Plan as an &#8220;Award Agreement&#8221; regardless of whether any Participant signature </span><span style="text-transform: none">is required. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.11</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Action by Company or Subsidiary</b></span><span style="text-transform: none">.  Any action required or permitted to be taken by the Company or any Subsidiary under this Plan shall be by action of its Board of Directors, or by action of one or more members of the Board (including a committee of the Board) who are duly authorized to act for the Board, or (except to the extent prohibited by applicable law or applicable rules of any stock exchange) by a duly authorized officer of </span><span style="text-transform: none">such company.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.12</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Gender and Number</b></span><span style="text-transform: none">.  Where the context admits, words in any gender shall include any other gender, words in the singular shall include the plural and the plural shall include </span><span style="text-transform: none">the singular.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.13</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Limitation of </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Implied Rights</b></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Neither a Participant nor any other person shall, by reason of participation in the Plan, acquire any right in or title to any assets, funds or property of the Company or any Subsidiary whatsoever, including, without limitation, any specific funds, assets, or other property which the Company or any Subsidiary, in its sole discretion, may set aside in anticipation of a liability under the Plan.  A Participant shall have only a contractual right to the Stock or amounts, if any, payable under the Plan, unsecured by any assets of the Company or any Subsidiary, and nothing contained in the Plan shall constitute a guarantee that the assets of the Company or any Subsidiary shall be sufficient to pay any benefits to </span><span style="text-transform: none">any person.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Plan does not constitute a contract of employment, and selection as a Participant will not give any participating employee the right to be retained in the employ of the Company or any Subsidiary, nor any right or claim to any benefit under the Plan, unless such right or claim has specifically accrued under the terms of the Plan. Except as otherwise provided in the Plan, no Award under the Plan shall confer upon the holder thereof any rights as a stockholder of the Company prior to the date on which the individual fulfills all conditions for receipt of </span><span style="text-transform: none">such rights.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-7</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 814.2pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.14</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Evidence</b></span><span style="text-transform: none">.  Evidence required of anyone under the Plan may be by certificate, affidavit, document or other information which the person acting on it considers pertinent and reliable, and shall be signed, made or presented by the proper party </span><span style="text-transform: none">or parties.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.15</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Termination of Employment Following Change in Control</b></span><span style="text-transform: none; font-style: italic"><i>.</i></span><span style="text-transform: none">  In the event that the employment of a Participant who is an employee of the Company or a Subsidiary is terminated by the Company during the six</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">month period following a Change in Control, all of such Participant&#8217;s outstanding Options and SARs may thereafter be exercised by the Participant, to the extent that such Options and SARs were exercisable as of the date of such termination of employment (x) for a period of six&#160;months from such date of termination or (y) until expiration of the stated term of such Option or SAR, whichever period is </span><span style="text-transform: none">the shorter.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.16</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Section 409A</b></span><span style="text-transform: none; font-style: italic"><i>.</i></span><span style="text-transform: none">  It is intended that all Options and SARs granted under the Plan shall be exempt from the provisions of Section&#160;409A of the Code and that all Other Stock Awards under the Plan, to the extent that they constitute &#8220;non-qualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code, will comply with Section&#160;409A of the Code (and any regulations and guidelines issued thereunder). The Plan and any Award Agreements issued hereunder may be amended in any respect deemed by the Board or the Committee to be necessary in order to preserve compliance with Section&#160;409A of the Code or any successor section of </span><span style="text-transform: none">the Code.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.17</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Regulations and </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>Other Approvals</b></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The obligation of the Company to sell or deliver</span><span style="text-transform: none"> Stock with respect to any Award granted under the Plan or make any other distribution of benefits under the Plan shall be subject to all applicable laws, rules and regulations, including all applicable federal and state securities laws (including, without limitation, the requirements of the Securities Act of 1933) and all applicable requirements of any securities exchange or similar entity, and the obtaining of all such approvals by governmental agencies as may be deemed necessary or appropriate by </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Each Award is subject to the requirement that, if at any time the Committee determines, in its absolute discretion, that the listing, registration or qualification of Stock issuable pursuant to the Plan is required by any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the grant of an Award or the issuance of Stock, no such Award shall be granted or payment made or Stock issued, in whole or in part, unless listing, registration, qualification, consent or approval, as applicable, has been effected or obtained free of any conditions not acceptable to </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">In the event that the disposition of Stock acquired pursuant to the Plan is not covered by a then current registration statement under the Securities Act of 1933 and is not otherwise exempt from such registration, such Stock shall be restricted against transfer to the extent required by the Securities Act of 1933, as amended, or regulations thereunder, and applicable state securities laws, and the Committee may require a Participant receiving Stock pursuant to the Plan, as a condition precedent to receipt of such Stock, to represent to the Company in writing that the Stock acquired by such Participant is acquired for investment only and not with a view </span><span style="text-transform: none">to distribution.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(d)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">With respect to persons subject to Section 16 of the Securities and Exchange Act of 1934, as amended, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of </span><span style="text-transform: none">Rule 16b-3.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">7.18</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Awards to Employees Subject to Taxation Outside of the United States</b></span><span style="text-transform: none">.  Without amending the Plan, Awards may be granted to Participants who are foreign nationals or who are employed outside the United States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the purposes of the Plan. Such different terms and conditions may be reflected in Addenda to the Plan or in the applicable Award Agreement. However, no such different terms or conditions shall be employed if such terms or conditions constitute, or in effect result in, an increase in the aggregate number of shares which may be issued under the Plan or a change in the definition of </span><span style="text-transform: none">Eligible Grantee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 8<br />COMMITTEE</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">8.1</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Administration</b></span><span style="text-transform: none">.  The authority to control and manage the operation and administration of the Plan shall be vested in a committee (the &#8220;Committee&#8221;) in accordance with this Section 8.  The Committee shall be selected by the Board and shall consist solely of two or more members of the Board who are non-employee Directors within the meaning of Rule 16b</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">3 under the Securities Exchange Act of 1934, as amended.  If the Committee does not exist, or for any other reason determined by the Board, the Board may take any action under the Plan that would otherwise be the responsibility of the Committee. Unless otherwise determined by the Board, Artivion&#8217;s Compensation Committee shall be designated as the </span><span style="text-transform: none">&#8220;Committee&#8221; hereunder.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-8</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">8.2</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Powers of Committee</b></span><span style="text-transform: none">.  The Committee&#8217;s administration of the Plan shall be subject to </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Subject to the provisions of the Plan, the Committee will have the authority and discretion to select from among the Eligible Grantees those persons who shall receive Awards, to determine the time or times of receipt, to determine the types of Awards and the number or value of shares or amount of cash covered by the Awards, to establish the terms, conditions, performance criteria, restrictions, and other provisions of such Awards, and (subject to the restrictions imposed by Section&#160;9) to cancel or suspend Awards, and to waive or otherwise modify any vesting or other restrictions contained in awards. The Committee may also, without obtaining stockholder approval, amend any outstanding award to provide the holder thereof with additional rights or benefits of the type otherwise permitted by the Plan, including without limitation, extending the term thereof; provided, however, that in no event may the term of any Option or SAR exceed </span><span style="text-transform: none">seven years.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Committee will have the authority and discretion to interpret the Plan, to establish, amend, and rescind any rules and regulations relating to the Plan, to determine the terms and provisions of any Award Agreement made pursuant to the Plan, and to make all other determinations that may be necessary or advisable for the administration of </span><span style="text-transform: none">the Plan.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any interpretation of the Plan by the Committee and any decision made by it under the Plan is final and binding on </span><span style="text-transform: none">all persons.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(d)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">In controlling and managing the operation and administration of the Plan, the Committee shall take action in a manner that conforms to the certificate of incorporation and by-laws of the Company, and applicable state </span><span style="text-transform: none">corporate law.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(e)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Subject to Section&#160;6.2 hereof, neither the Board, the Committee nor their respective delegates shall have the authority to (i) re</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">price (or cancel and regrant) any Option, SAR or, if applicable, other Award at a lower exercise, base or purchase price, (ii) take any other action (whether in the form of an amendment, cancellation or replacement grant, or a cash</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">out of underwater options) that has the effect of repricing an Option, SAR or other Award, or (iii) grant any Option, SAR or other Award that contains a so-called &#8220;reload&#8221; feature under which additional Options, SARs or other Awards are granted automatically to the Grantee upon exercise of the original Option, SAR or Award, without in each instance first obtaining the approval of the </span><span style="text-transform: none">Company&#8217;s stockholders.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(f)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Anything in the Plan to the contrary notwithstanding, neither the Board nor the Committee may accelerate the payment or vesting of any Option, SAR or other Award except in the event of death, disability, retirement or a Change </span><span style="text-transform: none">in Control. </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">8.3</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Delegation by Committee</b></span><span style="text-transform: none">.  Except to the extent prohibited by applicable law or the applicable rules of a stock exchange, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers hereunder, including without limitation, the power to designate Participants hereunder and determine the amount, timing and terms of Awards hereunder, to any person or persons selected by it, including without limitation, any executive officer of the Company. Any such allocation or delegation may be revoked by the Committee at </span><span style="text-transform: none">any time.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">8.4</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Information to be Furnished to Committee</b></span><span style="text-transform: none">.  The Company and Subsidiaries shall furnish the Committee with such data and information as it determines may be required for it to discharge its duties. The records of the Company and Subsidiaries as to an employee&#8217;s or Participant&#8217;s employment, termination of employment, leave of absence, reemployment and compensation shall be conclusive unless the Committee determines such records to be incorrect. Participants and other persons entitled to benefits under the Plan must furnish the Committee such evidence, data or information as the Committee considers desirable to carry out the terms of </span><span style="text-transform: none">the Plan.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><!--[if IE]><FONT style=" width: 62.099999999999994pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 40pt; text-indent: 0; display: inline-block"><span style="text-transform: none">8.5</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Indemnification</b></span><span style="text-transform: none; font-style: italic"><i>.</i></span><span style="text-transform: none">  Each person who is or shall have been a member of the Committee, or the Board, shall be indemnified and held harmless by the Company against and from any loss,</span><span style="text-transform: none"> cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company&#8217;s approval, or paid by him or her in satisfaction of any judgment in any such action, suit or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall be in addition to any other rights of indemnification or elimination of liability to which such persons may be entitled under the Company&#8217;s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold </span><span style="text-transform: none">them harmless.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-9</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 9<br />AMENDMENT </span><span style="text-transform: none">AND TERMINATION</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">The Plan may be terminated or amended by the Board of Directors at any time, except that the following actions may not be taken without </span><span style="text-transform: none">stockholder approval:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(i)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">any increase in the number of shares that may be issued under the Plan (except by certain adjustments provided for under </span><span style="text-transform: none">the Plan);</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(ii)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">any change in the class of persons eligible to receive Awards under </span><span style="text-transform: none">the Plan;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(iii)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">any change in the requirements of Section 2.2 hereof regarding the Exercise Price of Options </span><span style="text-transform: none">and SARs;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(iv)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">any re</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">pricing or cancellation and regrant of any Option or, if applicable, other Award at a lower exercise, base or purchase price, whether in the form of an amendment, cancellation or replacement grant, or a cash-out of underwater options or any action that provides for Awards that contain a so</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">called &#8220;reload&#8221; feature under which additional Options or other Awards are granted automatically to the Grantee upon exercise of the original Option or </span><span style="text-transform: none">Award; or</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(v)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">any other amendment to the Plan that would require approval of the Company&#8217;s stockholders under applicable law, regulation </span><span style="text-transform: none">or rule.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">Notwithstanding any of the foregoing, adjustments pursuant to paragraph 6.2 shall not be subject to the foregoing limitations of this </span><span style="text-transform: none">Section 9.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Options, SARs and other Awards may not be granted under the Plan after the date of termination of the Plan, but Options and SARs granted prior to that date shall continue to be exercisable according to their terms and other Awards shall continue to vest in accordance with </span><span style="text-transform: none">their terms.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION 10<br />CHANGE </span><span style="text-transform: none">IN CONTROL </span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Subject to the provisions of paragraph 6.2 (relating to the adjustment of shares), and except as otherwise provided in the Plan or the Award Agreement reflecting the applicable Award, upon the occurrence of a Change in Control as defined in </span><span style="text-transform: none">Section 11:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">All outstanding Options (regardless of whether in tandem with SARs) shall become </span><span style="text-transform: none">fully exercisable.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">All outstanding SARs (regardless of whether in tandem with Options) shall become </span><span style="text-transform: none">fully exercisable.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">All Stock Units, Restricted Stock, Restricted Stock Units, Performance Shares and other Awards, other than Cash-Based Awards, shall become fully vested.  Whether or not Cash</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">Based Awards shall vest upon a Change in Control shall be determined by the Committee in its discretion, either at or </span><span style="text-transform: none">after grant.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION </span><span style="text-transform: none">11<br />DEFINED TERMS</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 15.52pt; text-align: justify"><span style="text-transform: none">In addition to the other definitions contained herein, the following definitions </span><span style="text-transform: none">shall apply:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(a)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Award</b></span><span style="text-transform: none">.  The term &#8220;Award&#8221; shall mean any award or benefit granted under the Plan, including, without limitation, the grant of Options, SARs, Other Stock Awards and </span><span style="text-transform: none">Cash-Based awards.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(b)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Board</b></span><span style="text-transform: none">.  The term &#8220;Board&#8221; shall mean the Board of Directors of </span><span style="text-transform: none">the Company.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(c)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Change in Control</b></span><span style="text-transform: none">.  &#8220;Change in Control&#8221; means a change in the ownership or effective control of, or in the ownership of a substantial portion of the assets of, the Company, as described in paragraphs (i) through </span><span style="text-transform: none">(iii) below.</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-10</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(i)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Change in Ownership of the Company</b></span><span style="text-transform: none">.  A change in the ownership of the Company shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), acquires ownership of the Company stock that, together with the Company stock held by such person or group, constitutes more than 50% of the total voting power of the stock of </span><span style="text-transform: none">the Company.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(A)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">If any one person or more than one person acting as a group (within the meaning of paragraph (iv) below), is considered to own more than 50% of the total voting power of the stock of the Company, the acquisition of additional the Company stock by such person or persons shall not be considered to cause a change in the ownership of the Company or to cause a change in the effective control of the Company (within the meaning of paragraph </span><span style="text-transform: none">(ii) below).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(B)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">An increase in the percentage of the Company stock owned by any one person, or persons acting as a group (within the meaning of paragraph (iv) below), as a result of a transaction in which the Company acquires its stock in exchange for property, shall be treated as an acquisition of stock for purposes of this </span><span style="text-transform: none">paragraph (i).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(C)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Except as provided in (B) above, the provisions of this paragraph (i)&#160;shall apply only to the transfer or issuance of the Company stock if such stock remains outstanding after such transfer </span><span style="text-transform: none">or issuance.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(ii)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Change in Effective Control of </b></span><span style="text-transform: none; font-family: Arial, sans-serif"><b>the Company</b></span><span style="text-transform: none">.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(A)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A change in the effective control of the Company shall occur on the date that either of (1) or (2) </span><span style="text-transform: none">below occurs:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(1)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">Any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the </span><span style="text-transform: none">Company; or</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(2)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A majority of the members of the Board are replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the Board prior to the date of the appointment </span><span style="text-transform: none">or election.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(B)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A change in effective control of the Company also may occur with respect to any transaction in which either of the Company or the other entity involved in a transaction experiences a Change of Control event described in paragraphs (i) </span><span style="text-transform: none">or (iii).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(C)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">If any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), is considered to effectively control the Company (within the meaning of this paragraph (ii)), the acquisition of additional control of the Company by the same person or persons shall not be considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph </span><span style="text-transform: none">(i) above).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(iii)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</b></span><span style="text-transform: none">.  A change in the ownership of a substantial portion of the Company&#8217;s assets shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value (within the meaning of paragraph (iii)(B)) equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition </span><span style="text-transform: none">or acquisitions.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(A)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A transfer of the Company&#8217;s assets shall not be treated as a change in the ownership of such assets if the assets are transferred to one or more of </span><span style="text-transform: none">the following:</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(1)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to the </span><span style="text-transform: none">Company stock;</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(2)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">An entity, 50% or more of the total value or voting power of which is owned, directly </span><span style="text-transform: none">or indirectly, by </span><span style="text-transform: none">the Company;</span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-11</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(3)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">A person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below) that owns, directly or indirectly, 50% or more of the total value or voting power of all of the outstanding stock of the </span><span style="text-transform: none">Company; or</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 161.3pt; text-align: justify"><!--[if IE]><FONT style=" width: 227.7pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(4)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in </span><span style="text-transform: none">paragraph (iii)(A)(3).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">For purposes of this paragraph (iii)(A), and except as otherwise provided, a person&#8217;s status is determined immediately after the transfer </span><span style="text-transform: none">of assets.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 129.9pt; text-align: justify"><!--[if IE]><FONT style=" width: 186.29999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(B)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For purposes of this paragraph (iii), gross fair market value means the value of all the Company assets, or the value of the assets being disposed of, determined without regard to any liabilities associated with </span><span style="text-transform: none">such assets.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 95.5pt; text-align: justify"><!--[if IE]><FONT style=" width: 144.89999999999998pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(iv)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none">For purposes of this Section 11(c), persons shall be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase, or acquisition of assets, or similar business transaction with the Company.  If a person, including an entity shareholder, owns stock in the Company and another entity with which the Company enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction, such shareholder shall be considered to be acting as a group with the other shareholders in a corporation only to the extent of the ownership in that corporation prior to the transaction giving rise to the change and not with respect to the ownership interest in the other corporation.  Persons shall not be considered to be acting as a group solely because they purchase or own stock of the Company at the same time, or as a result of the same public offering of the </span><span style="text-transform: none">Company&#8217;s stock.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(d)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Code</b></span><span style="text-transform: none">.  The term &#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended. A reference to any provision of the Code shall include reference to any successor provision of </span><span style="text-transform: none">the Code.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(e)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Covered Employee</b></span><span style="text-transform: none">.  The term &#8220;Covered Employee&#8221; means an Eligible Grantee who is, or who is anticipated to become, between the time of grant and payment of the Award, a &#8220;covered employee,&#8221; as such term is defined in Section 162(m)(3) of the Code (or any successor </span><span style="text-transform: none">section thereof).</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(f)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Eligible Grantee</b></span><span style="text-transform: none">. The term &#8220;Eligible Grantee&#8221; shall mean any director, officer, employee, consultant, or agent of the Company or a Subsidiary, as determined by the Committee in its sole discretion. An Award may be granted to an eligible grantee, in connection with hiring, retention or otherwise, prior to the date the eligible grantee first performs services for the Company or the Subsidiaries, provided that such Award shall not become vested prior to the date the eligible grantee first performs such services or the director assumes </span><span style="text-transform: none">his position.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(g)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Fair Market Value</b></span><span style="text-transform: none">.  For purposes of determining the &#8220;Fair Market Value&#8221; of a share of Stock as of any date, then the &#8220;Fair Market Value&#8221; as of that date shall be the closing sale price of the Stock on that date on the New York </span><span style="text-transform: none">Stock Exchange.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(h)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Performance Goals</b></span><span style="text-transform: none">.  The term &#8220;Performance Goals&#8221; means performance goals based on the attainment by the Company or any Subsidiary of the Company (or any division or business unit of any such entity), or any two or more of the foregoing, of performance goals established by the Committee in its sole discretion, based on one or more of the following criteria, which shall not be required to be calculated in accordance with GAAP and which may be adjusted measures: (1) return on total stockholders&#8217; equity; (2) earnings per share of Stock; (3) earnings before any or all of interest, taxes, minority interest, depreciation and amortization; (4) economic profit; (5) sales or revenues; (6) return on assets, capital or investment; (7) market share; (8) control of operating or non-operating expenses; (9) reductions in certain costs (including reductions in inventories or accounts receivable or reductions in operating expenses); (10) operating profit; (11) operating cash flow; (12) free cash flow; (13) return on capital or increase in pretax earnings; (14) net earnings; (15) margins; (16) market price of the Company&#8217;s securities; (17) pre-tax earnings; (18) net after</span><span style="text-transform: none; font-family: Arial, sans-serif"><b>-</b></span><span style="text-transform: none">tax earnings per share; (19) working capital targets; (20) working capital and the ratio of sales to net working capital; (21) earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;); (22) sales of one or more products or service offerings; (23) control of operating and/or non-operating expenses; (24) any combination of, or a specified increase in, any of the foregoing; and (25) general comparisons with other peer companies or industry groups or classifications with regard to one or more of the foregoing criteria. The relative weights of the criteria that comprise the Performance Goals shall be determined by the Committee in its sole discretion. In establishing the Performance Goals for a performance period, the Committee may establish different Performance Goals for individual Participants or groups of Participants.  Subject to the limitations in Section 5, the Committee in its sole discretion shall have the authority to make equitable adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or any Subsidiary of the Company </span><span style="text-transform: none">or the </span></p>

			</div>

		</div>
		<div style="page-break-before: always">
			<p style="margin: 0pt; font-size: 5pt">&#8203;</p>

		</div>
		<div class="qes_page" style="border: black 1pt solid; margin: auto; height: 910.8pt; width: 703.8pt; position: relative; overflow: hidden">
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 838.35pt; left: 41.4pt; width: 621pt; position: absolute; height: 31.05pt">
				<div style="display: table-cell; vertical-align: bottom; width: 621pt; height: 31.05pt">

				<!--[if IE]><TABLE><TR style=" width: 621pt; height: 31.05pt;"><TD vAlign="bottom" style=" width: 621pt; height: 31.05pt;"><![endif]-->
					<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt; text-transform: none; color: #000000; text-align: left">
						<table style="table-layout: fixed; width: 620.99pt; margin-top: 4pt; margin-bottom: 0pt; border-collapse: collapse">
							<tr style="margin: 0; height: 0">
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>
								<td style="border-width: 0; margin: 0; padding: 0; width: 206.99pt">


								</td>

							</tr>
							<tr style="min-height: 0pt">
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">ARTIVION, INC. | 2023 Proxy Statement</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="font: 12pt/normal Times New Roman, Times, serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif">B-12</span></p>

								</td>
								<td style="border-width: 0pt; padding: 0pt; vertical-align: top; border-collapse: collapse">
									<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 0pt; line-height: 0pt">&#8203;</p>

								</td>

							</tr>

						</table>

					</div>


				<!--[if IE]></TD></TR></TABLE><![endif]-->
				</div>

			</div>
			<div class="qes_textframe" style="border-width: 0pt; padding: 0pt; top: 41.4pt; left: 41.4pt; width: 621pt; position: absolute; height: 796.95pt">
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none">financial statements of the Company or any Subsidiary of the Company, in response to changes in applicable laws or regulations, including changes in generally accepted accounting principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business, as applicable, or otherwise as the Committee deems appropriate.  Performance Goals may include a threshold level of performance below which no Award will be earned, a level of performance at which the target amount of an Award will be earned and a level of performance at which the maximum amount of the Award will be earned.  &#8220;Performance Goals&#8221; shall also mean any other factors directly tied to the performance of the Company and/or one or more divisions and/or Subsidiaries or other performance criteria designated by </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(i)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Subsidiaries</b></span><span style="text-transform: none">.  The term &#8220;Subsidiary&#8221; means any present or future subsidiary corporation of the Company within the meaning of Section 424(f) of the Code, and any present or future business venture designated by the Committee in which the Company has a significant interest, as determined in the discretion of </span><span style="text-transform: none">the Committee.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 62.1pt; text-align: justify"><!--[if IE]><FONT style=" width: 103.49999999999999pt; text-indent: 0.0pt; display: inline-block;"><![endif]--><span style="width: 33pt; text-indent: 0; display: inline-block"><span style="text-transform: none">(j)</span></span><!--[if IE]></FONT><![endif]--><span style="text-transform: none; font-family: Arial, sans-serif"><b>Stock</b></span><span style="text-transform: none">.  The term &#8220;Stock&#8221; shall mean shares of common stock of </span><span style="text-transform: none">the Company.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">SECTION </span><span style="text-transform: none">12<br />GOVERNING LAW</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">This Plan shall be governed by, and construed in accordance with, the laws of the State </span><span style="text-transform: none">of Delaware.</span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none">&#8226;&#8195;&#8195;&#8195;</span><span style="text-transform: none">&#8226;</span><span style="text-transform: none">&#8195;&#8195;&#8195;&#8226;&#8195;&#8195;&#8195;</span><span style="text-transform: none">&#8226;</span></p>

			</div>

		</div>




<p style="margin: 0">&#160;</p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

	<div style="border: black 1pt solid; margin: auto; padding: 36pt; height: 790pt; width: 630pt; position: relative; overflow: hidden">

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 85.8pt 0pt 84.95pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 85.8pt 0pt 84.95pt; text-align: center"></p>

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 85.8pt 0pt 84.95pt; text-align: center"><span style="font-size: 12pt; color: #231F20">ANNUAL MEETING OF STOCKHOLDERS OF</span></p>



<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><img src="proxy001.jpg" alt="" />&#160;</p>

<p style="margin-top: 8pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>May 16, 2023</b></span></p>

<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>GO
GREEN</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2in; text-align: justify; color: #231F20"><span style="font-size: 8pt">e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy material, statements
and other eligible documents online, while reducing costs, clutter and paper waste. Enroll today via www.astfinancial.com to enjoy
online access.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 156.55pt 0pt 155.65pt; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><b><span style="text-decoration: underline">NOTICE
OF INTERNET AVAILABILITY OF PROXY MATERIAL</span></b></span><b><span style="font-size: 10pt; color: #231F20">:</span></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2in; text-align: center; text-indent: 0; color: #231F20">The Notice of Meeting, proxy statement and proxy card<br />
are available at http://www.astproxyportal.com/ast/01609</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 176.1pt 0pt 175.2pt; text-align: center; text-indent: -0.1pt; color: #231F20">&#160;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 2in; text-align: center; text-indent: 0; color: #231F20"><span style="font-size: 18pt">Please
sign, date and mail <br />
your proxy card in the <br />
envelope provided as soon <br />
as possible.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 156.55pt 0pt 154.3pt; text-align: center; color: #231F20">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><img src="proxy002.jpg" alt="" /><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;Please detach along perforated line and mail in the envelope provided.&#160;</span><img src="proxy002.jpg" alt="" /></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 2%; background-color: Black"></td><td style="width: 46%; text-align: left; padding-left: 0.25in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">20930403030000000000 3</span></td><td style="text-align: left; width: 52%; padding-left: 60pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">051623</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-size: 6pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: #231F20"><span style="font-size: 6pt">THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE ELECTION OF THE DIRECTOR NOMINEES NAMED BELOW, FOR APPROVAL
OF THE COMPENSATION PAID TO ARTIVION&#8217;S NAMED EXECUTIVE OFFICERS, FOR ONE-YEAR FREQUENCY OF THE COMPENSATION OF ARTIVION&#8217;S
NAMED EXECUTIVE OFFICERS, FOR RATIFICATION OF THE PRELIMINARY APPROVAL OF ERNST &amp; YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023, AND FOR APPROVAL OF ADDITIONAL FUNDING OF 3,040,000
SHARES FOR THE ARTIVION, INC. 2020 EQUITY AND CASH INCENTIVE PLAN.</span></p>

<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-size: 4pt">&#160;</span></p>

<p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK
INK AS SHOWN HERE </b></span><b><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span></b></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->
<div style="position: relative; float: left; width: 46%"><table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top"><td colspan="4" style="border-right: Black 1pt solid; padding-top: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20">1.
                                       ELECTION OF DIRECTORS</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-right: Black 1pt solid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20"><b>NOMINEES:</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top"><span style="font-size: 12pt">&#160;&#9744;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20"><b>FOR ALL NOMINEES</b></span></td>
    <td colspan="2" rowspan="5" style="border-right: Black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Thomas F. Ackerman</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Daniel J. Bevevino</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Marna P. Borgstrom</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">James W. Bullock</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Jeffrey H. Burbank</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Elizabeth A. Hoff</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8.65pt; text-indent: -8.65pt; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">J. Patrick Mackin</span></p>
	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8.65pt; text-indent: -8.65pt; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Jon W. Salveson</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8.65pt; text-indent: -8.65pt; color: #231F20"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">O&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 8pt">Anthony B. Semedo</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top"><span style="font-size: 12pt">&#160;&#9744;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>WITHHOLD AUTHORITY<br />
    FOR ALL NOMINEES</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top"><span style="font-size: 12pt">&#160;&#9744;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20"><b>FOR ALL EXCEPT </b></span><span style="font-size: 8pt"><br />
    <span style="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">(See instructions below)</span></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-right: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-right: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-right: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-right: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.8in; text-indent: -0.8in; padding-top: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #231F20"><b><span style="text-decoration: underline">INSTRUCTIONS</span>:&#160;</b>To withhold authority to vote for any individual nominee(s), mark <b>&#8220;FOR ALL EXCEPT&#8221; </b>and fill in the circle next to each nominee you wish to withhold, as shown here: </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&#9679;</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="border-right: Black 1pt solid; padding-left: 0.7in; text-indent: -0.7in">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20">To change the address on your account, please check the box at right and indicate your new address in
the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; vertical-align: middle"><span style="font-size: 8pt">&#160;</span><span style="font-size: 12pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 43%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 36%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 11%"><span style="font-size: 1pt">&#160;</span></td></tr>
</table>


</div>
<div style="position: relative; float: right; width: 52%">

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 76%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 6%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #231F20">FOR</span></td>
    <td style="width: 6%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #231F20">&#160;AGAINST&#160;</span></td>
    <td style="width: 6%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #231F20">ABSTAIN</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="padding-left: 0.125in; text-indent: -0.125in"><span style="font: 8pt Arial, Helvetica, Sans-Serif">2. To approve, by non-binding vote, the compensation paid to Artivion&#8217;s Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion.</span></td>
    <td style="text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="font-size: 12pt">&#9744;</span></span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt">&#160;</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt">1 YEAR&#160;</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt">&#160;2 YEARS&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt">&#160;3 YEARS&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6pt">&#160;ABSTAIN</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3. To approve, by non-binding vote, the frequency of stockholder advisory votes on the compensation of our
named executive officers.</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-size: 12pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">FOR</span></td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">&#160;AGAINST&#160;</span></td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">ABSTAIN</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="padding-left: 0.125in; text-indent: -0.125in"><span style="font: 8pt Arial, Helvetica, Sans-Serif">4. To ratify the preliminary approval of Ernst &amp; Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2023.</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">FOR</span></td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">&#160;AGAINST&#160;</span></td>
    <td style="text-align: center"><span style="font: 7pt Arial, Helvetica, Sans-Serif; color: #231F20">ABSTAIN</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="padding-left: 0.125in; text-indent: -0.125in"><span style="font: 8pt Arial, Helvetica, Sans-Serif">5. To approve additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash Incentive Plan.</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td>
    <td style="text-align: center"><span style="font-size: 12pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="padding-left: 0.125in; text-indent: -0.125in"><span style="font: 8pt Arial, Helvetica, Sans-Serif">6. In their discretion, upon such other matters as may properly come before the meeting.</span></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&#160;&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>THE PROXIES SHALL VOTE AS SPECIFIED ABOVE, OR IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR EACH
OF THE LISTED NOMINEES, FOR APPROVAL OF THE COMPENSATION PAID TO ARTIVION&#8217;S NAMED EXECUTIVE OFFICERS, IN FAVOR OF THE RATIFICATION
OF ERNST &amp; YOUNG LLP, AND FOR APPROVAL OF THE ARTIVION, INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN. SHOULD A NOMINEE
BE UNABLE TO SERVE, THIS PROXY MAY BE VOTED FOR A SUBSTITUTE SELECTED BY THE BOARD OF DIRECTORS.</b></span></p>
</div>
<br />
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; width: 20%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20">Signature
    of Stockholder</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-right: Black 1pt solid; width: 5%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20">&#160;&#160;Date:</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 5%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-right: Black 1pt solid; width: 20%; padding-top: 3pt; padding-bottom: 3pt; padding-left: 0.125in; text-align: left; vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20">Signature
    of Stockholder</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-right: Black 1pt solid; width: 5%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">&#160;&#160;<span style="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">Date:</span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 5%; padding-top: 3pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-size: 8pt">&#160;</span></td>
    <td rowspan="2" style="width: 96%; padding-left: 0.375in; text-indent: -0.375in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #231F20"><b>Note:
    </b></span><span style="font-size: 8pt; color: #231F20">&#160;&#160;Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder
should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer
is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership,
please sign in partnership name by authorized person.</span></td>
    <td style="width: 2%"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="background-color: Black"><span style="font-size: 8pt">&#160;</span></td>
    <td style="background-color: Black"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

</div>
<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: black 1pt solid; margin: auto; padding: 36pt; height: 790pt; width: 630pt; position: relative; overflow: hidden">

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 98%; text-align: right; padding-right: 1in"><span style="font-family: Arial, Helvetica, Sans-Serif">0</span></td>
    <td style="width: 2%; background-color: Black">&#160;</td></tr>
</table>

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 89.4pt 0pt 89.65pt; text-align: center; color: #231F20"><span style="font-size: 14pt"><b>ARTIVION, INC.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 89.4pt 0pt 89.65pt; text-align: center; color: #231F20">&#160;</p>

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 89.4pt 0pt 89.75pt; text-align: center; color: #231F20"><span style="font-size: 12pt">PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS <br />
FOR USE AT THE ANNUAL MEETING ON MAY 16, 2023</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.55pt 0pt 5.95pt; text-align: justify; text-indent: 25.7pt; color: #231F20">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.55pt 0pt 5.95pt; text-align: justify; text-indent: 25.7pt; color: #231F20"><span style="font-size: 12pt">The undersigned stockholder hereby appoints J. PATRICK MACKIN, JEAN F. HOLLOWAY, and JASON P. GRIER, or
either of them, with full power of substitution, to act as proxy for, and to vote the stock of, the undersigned at the Annual Meeting
of Stockholders of ARTIVION, INC. to be held live via the Internet at https://web.lumiagm.com/295739807 (password: artivion2023)
at 9:00 a.m. Eastern Time on May 16, 2023, and any adjournments thereof.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.9pt 0pt 5.95pt; text-align: justify; text-indent: 27.7pt; color: #231F20">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.9pt 0pt 5.95pt; text-align: justify; text-indent: 27.7pt; color: #231F20"><span style="font-size: 12pt">The undersigned acknowledges receipt of Notice of the Annual Meeting and Proxy Statement, each dated April
3, 2023, and grants authority to said proxies, or their substitutes, and ratifies and confirms all that said proxies may lawfully
do in the undersigned&#8217;s name, place and stead. The undersigned instructs said proxies to vote as indicated below and in their discretion
on any other matter that may properly come before the meeting or any adjournment of the meeting.</span></p>

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 89.4pt 0pt 86.45pt; text-align: center; color: #231F20">&#160;</p>

<p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 89.4pt 0pt 86.45pt; text-align: center; color: #231F20"><span style="font-size: 12pt">(Continued and to be signed on the reverse side)</span></p>



<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 2%; background-color: Black"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">&#160;</span></td>
    <td style="width: 48%; padding-left: 0.12in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">1.1</span></td>
    <td style="width: 48%; text-align: right; padding-right: 0.12in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">14475</span></td>
    <td style="width: 2%; background-color: Black"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>
</div>
<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>

    <!-- Field: /Page -->
	</body>

</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>aort-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaaLObP9w5dzielBtm9zHcl6TyohEaeBkSDgwR/2YRgF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:aort="http://cryolife.com/20221231" elementFormDefault="qualified" targetNamespace="http://cryolife.com/20221231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cryolife.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="aort-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aort-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aort-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="aort_MessrsLeeMember" name="MessrsLeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_DavisMember" name="DavisMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_StantonMember" name="StantonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_MsHollowayMember" name="MsHollowayMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_SimpsonMember" name="SimpsonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" name="AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" name="AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" name="AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" name="AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="aort_TotalAdjustmentsRelatedToEquityAwardsMember" name="TotalAdjustmentsRelatedToEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>aort-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cryolife.com/role/Cover" xlink:href="aort-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cryolife.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_aortAverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_aortAverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_aortAverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:label="loc_aortAverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_TotalAdjustmentsRelatedToEquityAwardsMember" xlink:label="loc_aortTotalAdjustmentsRelatedToEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortTotalAdjustmentsRelatedToEquityAwardsMember" xlink:type="arc" order="40" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MessrsLeeMember" xlink:label="loc_aortMessrsLeeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortMessrsLeeMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_DavisMember" xlink:label="loc_aortDavisMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortDavisMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_StantonMember" xlink:label="loc_aortStantonMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortStantonMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MsHollowayMember" xlink:label="loc_aortMsHollowayMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortMsHollowayMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_SimpsonMember" xlink:label="loc_aortSimpsonMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortSimpsonMember" xlink:type="arc" order="40" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aort-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MessrsLeeMember" xlink:label="aort_MessrsLeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_MessrsLeeMember" xlink:to="aort_MessrsLeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_MessrsLeeMember_lbl" xml:lang="en-US">Messr Lee</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_DavisMember" xlink:label="aort_DavisMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_DavisMember" xlink:to="aort_DavisMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_DavisMember_lbl" xml:lang="en-US">Messr Davis</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_StantonMember" xlink:label="aort_StantonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_StantonMember" xlink:to="aort_StantonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_StantonMember_lbl" xml:lang="en-US">Messr Stanton</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MsHollowayMember" xlink:label="aort_MsHollowayMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_MsHollowayMember" xlink:to="aort_MsHollowayMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_MsHollowayMember_lbl" xml:lang="en-US">Ms Holloway</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_SimpsonMember" xlink:label="aort_SimpsonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_SimpsonMember" xlink:to="aort_SimpsonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_SimpsonMember_lbl" xml:lang="en-US">Messr Simpson</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:to="aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_lbl" xml:lang="en-US">Average Subtract Grant Fair Value Of Equity Awards Made During Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:to="aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_lbl" xml:lang="en-US">Average Add Year End Fair Value Of Equity Awards Made During Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xml:lang="en-US">Average Add Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:label="aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:to="aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_lbl" xml:lang="en-US">Average Add Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Year That Vested In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_TotalAdjustmentsRelatedToEquityAwardsMember" xlink:label="aort_TotalAdjustmentsRelatedToEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aort_TotalAdjustmentsRelatedToEquityAwardsMember" xlink:to="aort_TotalAdjustmentsRelatedToEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aort_TotalAdjustmentsRelatedToEquityAwardsMember_lbl" xml:lang="en-US">Total Adjustments Related To Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Award Underlying Securities Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Award Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Award Grant Date Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aort-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cryolife.com/role/Cover" xlink:href="aort-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cryolife.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MessrsLeeMember" xlink:label="loc_aortMessrsLeeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortMessrsLeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_DavisMember" xlink:label="loc_aortDavisMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortDavisMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_StantonMember" xlink:label="loc_aortStantonMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortStantonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_MsHollowayMember" xlink:label="loc_aortMsHollowayMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortMsHollowayMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_SimpsonMember" xlink:label="loc_aortSimpsonMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_aortSimpsonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_aortAverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_aortAverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_aortAverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:label="loc_aortAverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortAverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aort-20221231.xsd#aort_TotalAdjustmentsRelatedToEquityAwardsMember" xlink:label="loc_aortTotalAdjustmentsRelatedToEquityAwardsMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_aortTotalAdjustmentsRelatedToEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>aort-def14a_051623img001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img001.gif
M1TE&.#EA( -U /<  !PV-A0X20@M60PT7 PZ7 TV51([60\R308M: HU9 LZ
M9 8T; HU:P8[; L[; 8T9!([9P,N<P$N? 0H>@4U= 8[= L[<P,U? @W>P,Z
M? DZ? DU=!(^<"(^2!=$6Q!#42A56 M":!M,8Q9%: 5"? E#=A9)=AM4>!Q4
M92A9:2),="9=?R15=BY99SAH:BEE>C9G>#9L:RYA74IN=$B!?0$MA  NC  F
MA0$TA ([A  UC $ZC0H\A@ NDP NFP EE@ UE  ZDP UFP ZFPD\D0 NHP N
MJ@ EIP THP ZHP TJP [J@PYJ@ MM@ SL@ [L@ SN@ YN!0^I@ ?D@5"A 1"
MC M%AA5*AAE6A0-!E -!FPM&EA-+F!=6EPY0D25=A"9:B2I=DAUCDRIEAC5J
MA39U@39SC#IVBRAHES1LERQTF3=WERUPC0)!HP=%J1I:IP-!M!91L!YDI!UG
MMR9GIBIWJC5YIB5JMC9XM2MQLR9;HD-WAT1\E%1WC4U]KRUSQ2MDV"%8SSB#
MFCF$I3R.O3V#NSR1OCN5MC6,K$J'BTF(FE>7FE.-D&>9F661ED>*H$F*H4F'
MIU2*I5J>IEJ=JE:6ITJ5ME::M4F/KF2<JVZ9M5FENE*DLV>FJ7:KJ'>VJV6I
MN':KN'FVMVNQNF*CFSJ,R#R2QSB-STB7QE.9QTB5UDJCR%BGR5>KTF:LQVBW
MRW>XR&FXTFBYV'6ZV6RKT'.ZZ5:8XGG$R7K%UV[(V7C(YW/'[H.ZM86UNX.Y
MNH:VM).SM9RUK)'%NJC&N(F[R(NVRX.]](K'R)7)R(?(UI;*UIG5VI#2T*?-
MUZ/5W:?8V+7:V:K0RJOEVKKEV[;NS8?*Y8G5YIG;YY;6]H[0[ZK6Y*77YK#7
M[I;F[ZKFZKCGZ+CRZJGG]KKK];3J]JKU^[7U]KOV^JOXYLGNW,CIZ-3NZLCW
MZ-?WZL?J]\3V_<+Y_<S]_\KV]M3^_=O__=?Y]=;L]N3_^^S__.?[]?7_]?[^
M]?3__?____WW_O#Z[,G;W"'Y!       (?\+26UA9V5-86=I8VL.9V%M;6$]
M,"XT-30U-#4 (?\+34=+.$))33 P,##_.$))300E       0S<_Z?:C'O@D%
M<':NKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O_V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M24T$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8     _P ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!$0      !     "   "0    D      .$))300>       $     #A"2?]-
M!!H      T\    &              !U   #(     T 00!R '0 :0!V &D
M;P!N %\ 3 !O &< ;P    $                          0
M   #(    '4                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   '4     4F=H=&QO;F<   ,@    !G/_;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    =0    !2
M9VAT;&]N9P   R     #_W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;O]E    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M-]5L.#U\/?U=G__9 #A"24T$(0      5P    $!    #P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <    !0 00!D*0!O &( 90 @ %  : !O '0
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MXI0 M?F#@9 $)I0[";GE(Z[E.T9T7WE1C6M4$$B&!)U*  W6\ TT4[P/>%
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M=,4R0U %Q'9M"X6!.L  "G &TB 8KS=<&5$)&+!>Z@,$@"-FT,8#[Y,$0#
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M"P;%!?T."(3*]T9KH:T#?C#F9%6@T(  FIFD_N+9!B>>H[B5@&-S?__P"M9
M#O! #R_Q$F9E#MZ@"ZOP!EN=SNC6J4!@!0)I74.J!!*0 (EPLPHI%P-1W4S)
MP1S<. ^E=)A(ATB0 PP WCD"!IJ:A'P$?D+0EY  6SOV2@LQ%J0>%D?-G?P@
M#XWCD8FS [6*3)=DQA\ZR81$#_9:T09M!NECB1^FYCA@ 191$B;QF0\R[OF
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MW NW %=U$5[R7Y:G-^ID);-S>3E'+'UN'B9X.88XF1W1%26@@"JCGF\Q$5S
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M4(ARZ8@B%,8=B0!XN <8<( =V)$WJ;9WZQ$=D(!/H9>/NI?4$"J,,A<7F46
M00AP*#MO:H^^FJH+<(>"<(<)\*=(BKMT*0S!$97M8R2A"(LW:93_>\2SF:LY
M2Z(+N+BD35J&)C&[U3L90P0""O &Q%NJ10P[4WL>4IJ,-Y&_IN,9Z LB/-F3
M8$.7H]@_S[# N%@'4%2@ZI@HCZB!'>!&-<(F%QR(=*  ,/F5GZN9'+ 'B'P;
MLQ&7CS Y<*JX?^F',ZB QRD0\GN\-SDU))J'I5)$%]Q'\'G&?<B&\V@@U)@,
MQZL)J$@"&V" >*!"_7@>Z*$*J:B))? !##!'>6B +Z/()C1&J<H!25C+VQ$0
M GD,XQ([FMR'2B"-UENRER@*I]B!"DB#^D"#"N ([)@*)X "%DF"1?"MN^NI
MGW*N'VF:2<L^Q>B'1@N5>+" Y=&"MJ*F__C*C6Q(/)5<29!4()'B&IUQAK54
M++&"P =K0I4!%!5*/&[!@]+(LY<\$+VQ"&& M7J*BTZHC=+AKP6*D!JPA)X)
M(8G@JF]BF]QKN=X0APO0'OD[#Z=(F(1#NP&(ASG\%Z!H$/QX2,00HD7( ,C
M*(BH#%UY@J2 " JP P9!G-8 %R>1D+[((!]8 @60!X&@!1Z@FP)YJJFZ&!Q
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ML0L5?9B'7XV('7F*10F""-:61OL$\QO/M6D(O\L;V0F53:[A!R87I:!@P,V
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M]UY\\NG=Y4IDY7>LW?RD8T&(H+$HD8%VR0&H0)#VM\\\/(0WQ)%UVHD5AA:
MNG8^'D+$7)<CO@C$FSK*4UU=?*O$:!)8Z<!#)4?Q&'AWZF3 ED1Z@5XD$CX
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M&15*TAJ[- 8Z13#4&817$/-%[&-H:=1:+H80?=Q#'#;H05U:TA/.#&$)8DO
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M3CB!$F##N>0A[8!'X)4E153%--6-)ZZ8QU@%F=+0"EW3'/PB670&$  B%9I
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MAC=4P.;6R0X!7EN\0S(YZYXZZ'A(*),!,H6&BF%P8_6DWKM1K8<^D"(/"BK
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M]"45"($;Q!3X(4'O.F#&TP[B79!H<YLGM\<] ,B>G)/[Z+)X  5A1'N*%(5
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M !& KH&(K<WJ:EH(< >[!NJ*;D0XBYX4(5U2PPU-YJA\8QX6X$G,JS0@R#J
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M)(! "QXL!_PZ[[13JK3'^I 1JQ(BJ@N=JB*<A8 B!WY9T^:!@%#%AB'+5R4
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M%#L/C:?7/F8H]1I1&"F!1&="7="47AR6=X\8.OB0A%+#(>&$1CM4 =(0/SC
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M=EDB(="(/7[:@0ERHBLTMLR"%U"-?A;ERI@@+G[W8(0"LO.1_^W&-2#IUUN
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M3<BT/U0T# =P 32"9$+A+:G8-'0V3*HV&9LR!YR0"^1@#O(P#_.%#Y8Q#^]
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M$O=P!7?H)WMMP3MP?'!@!!< "Y-L&N9  #:  YJ\'C[@K#N0!B3:WB9AH/M
M!D/[,TF@R4ESE0;W$.P0 ,"9;4JA&QCA  = #0V1#[/N3R5Q#RB ?N](0%9
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M4Y$!B-P=0794R<$ 5%F))#&OYIEND0<%&W2TW-$U1PZL68'L%N+Q(]8<0GP
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)0+WHY6 ! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>aort-def14a_051623img002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img002.gif
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M[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ^OS\_/W]_?___P
M                     "'Y!       (?\+26UA9V5-86=I8VL.9V%M;6$]
M,"XT-30U-#4 (?\+34=+.$))33 P,##_.$))300E       0NX_P& AFA+\!
M'L3I -I9'#A"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O_V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG  #_       ,8W)O<%)E8W1,969T
M;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T
M5&]P;&]N9P      .$))30/M       0 .8    !  $ Y@    $  3A"24T$
M)@      #@             _@   .$))300-       $    6CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))32<0       *  $
M         3A"24T#]       $@ U     0 M    !@       3A"24T#]P
M    '   ______________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      T4
M   &              "6   !N@    @ 30!! %, 5 !% %( +0 R     0
M                       !              &Z    E@
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9_\
M         $QE9G1L;VYG          !"=&]M;&]N9P   )8     4F=H=&QO
M;F<   &Z    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;V[_9P          3&5F=&QO
M;F<          $)T;VUL;VYG    E@    !29VAT;&]N9P   ;H    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M VGKSW.$'-QF-K=YXS[7/KG^KG;ZV?\ 'J?2!--]I'OMRLC>3W].U^-7_P"
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M'&>%H1 <($3@I$+OU%85$R^V5$X?V<&VPR%P4'5$3[Z\=E]$*Q(18$1$6.4
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MD4,P@$/#>HT [L , P4SDDNYR^R],N6/@6#T ]$L__Q\096-,WBB)1%&!'K
M%MR'98 7@1J/E;)$IT^$&;X8!2Q2D0IDW"\"#O0.-+)"27$7I0,6M9<J]'80
M@M$'P90D!_$Q' 824#,*Y5%N79$?BS<11^ Z3'%@=X<1GW)Q A$F.!5[48.
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MRP(U%: >[X VQ-$#/6 "5G<6 N  (H #1) %D< ,S' *<. $/8 #(E!UN>D
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9Y$B2)4V>/ D/Y4J6+5V^A!E3YDR' 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>aort-def14a_051623img003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img003.gif
M1TE&.#EAI@'- /<   ('<0((D0 (J@ )M@(5N@@4JA(MNA8LHS1*MC=/I%)E
ML0 ,Q  +R@$3PP$4RP0;R0 ,U  *V@(4T@$4VP,<W <;UQ(;S@@ERA4IRAHX
MR@HGV14JVADVV0LUU28[RB0[V"8PUP(+YP(4Y ,;XP$3[ ,<[ L9Z0,-]0(4
M] <;]Q0<^A <YPPD[ DGYQ4IZ TSZ1LS[1<WZ0PC] LD_ PK^P<G]A,K\Q,D
M_10K_!HL_A8G]0XS^1LT\Q,S_!PT_1P[_!<Y]2,[[",XYB(U_B(\_"<Z]BHQ
M^!E$TB=&VC1(V2M6USE7VS%-R35GUAQ%YQQ'^1E5\R=(Z#1)YRI4ZC95Z21#
M]"1#_2M$_B1*_2Q+_2E']#-,_3=*^"Q3_2E7^#14_#I4_31;_3Q;_3=8]#EE
MZ3QC_3EG^#MT^RYI\458UD=IV4ITVU=YVU)OT&I[S45:Z41:^DA*^$AHZ%9J
MZ4EUZ5=XZ4-C_41K_$AG]U5I^DQT_$EX^5-S_5-[_%AZ^&5[YV9[^FQS\(1_
M]%:*V&:'VFZ2U':KUUJ'ZDR'^EF&^EJ5^%&4[6B)ZFF7Z7:8Z&6#_6>(^'6*
M^FF7^7.<_7B7^7:)YE*F\'JGZWBE^GNS^VNM\E.IUG+,[U2+T8ZPV8::^H>6
M\HBHZ9:JXXFVYY>XZ82K_(NL_(>F^).L_):J^(JU^)R[_9:W^:2\_:>Y^;6\
M_*:S\HZ3X*K.VYG&ZXO%^9K%^)/2\:C(ZK;*ZZG5ZK?7ZZ3#]:3#_*O#_*O,
M_:?)][/+]+/$_+3-_+O,_;K)]JO5^;33_+S4_+W;^[?7][CD^;+K\I_FX,79
MZ\3*^<3<]</4^\/;_,O;_,G6^-/=_-C9_,O0[M?IZ=CWZL3B_,SD_,SK^\CG
M]M/C_=OD_=3K_=SL_-;I]<KU^=3S_-SS_-GW]\?IZ^?Z[/7][/O][??]Y>/M
M_.OM_>7H^/3K_N3T]>OS].3[]>S]]>3T_>OT_.3[_.S\^_7]]/S]]?/U_/WV
M_?7\^_____CU]>;LZ]KHWR'Y!       (?\+26UA9V5-86=I8VL.9V%M;6$]
M,"XT-30U-#4 (?\+34=+.$))33 P,##_.$))300E       0NX_P& AFA+\!
M'L3I -I9'#A"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O_V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG  #_       ,8W)O<%)E8W1,969T
M;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T
M5&]P;&]N9P      .$))30/M       0 .8    !  $ Y@    $  3A"24T$
M)@      #@             _@   .$))300-       $    6CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))32<0       *  $
M         3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"A
MF9H !@       0 R_P    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M T4    &              #-   !I@    @ 30!! %, 5 !% %( +0 S /\
M  $                          0             !I@   ,T
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ,T     4F=H
M=&QO;F<   &F    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V?_<F]U<$E$;&]N9P
M   &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E
M9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    S0    !29VAT;&]N9P   :8    #
M=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M  $       9A;'1486=4_T585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M   /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E
M;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T
M;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E
M=/]L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
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M &( 90 @ %  : !O '0 ;P!S &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@
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MH6]#RZTJ_1!%!(Q@C##>([,]:($&_# ! (ABE#B^\"$-G55886B&)("#),X
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M#CSB#9]@!!%  D-0"M@P/:F@ C[ "S:X9RYQ$OGP"3Z0 KQ05YY33//P"3=
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M1) )Y8 ,@" #67 ,[%.P92%Y#X0%,> +3Q(2Z+ /ST &+_ "AZ!6Z=$.4L
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M!&;@#SXK(CVQ#H^ !4C@!%V0"&ZQ$6D!)9\0 CD@EY2G4;)K&<;P!A,@ 2]
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M#"B@TD*\E-@'5AB#$JB"7F H>KBB#9" .:"&Z6HC?92A?7 &(G" #NB  LB
M/SB&//G"KK.$*. !>*L,7+D';S@%&8   7B 1J D_5M&9Y""(["%:E"%(K
M-[ &5$0(>J@$%<B!:"@$H!.%E.G&Q',S?)"'7A"#&-B#N\*#8: <>Z"$&X #
M:_ '44""D9R'4(B!4,"&<_ ':R %.8 !( "$8< E<$@E(%@%! F:EVR2$'NY
MJ;A('W6/)N$Y/? !,? %H436?)T/0 B!&$@3K7A22H@")\"$1/B!'[""'UB!
M_P&XF4CP!GY3$F.2!BHHBP@ !';HI<_(AVIX!5AP!N'LT?B;#RFKA!=(@4F0
M+L=:&P39AS80 "9X3(=*B6; @Q)@@4EH!]SHACS  1W  '!-V>!X%U1  @+0
M@*UAM *)4ZO8AW*PA!BH GB[H'P(ER^0 1$8 $LHAUQID3R="GI@!0Q8A&)@
M@P58@3GP!])R$G9( B- I QH $K0ATSZR_JHBI3!!2:X 2RX QC  VG8%GMX
MA!OX@DLH! Q(@V! $%<P BHPA%%@A#0@ !GH@V*@' R2*4UI GL8(X)*/$N1
M"O;(.WQ]CS8C!TSX@3 HOO:K)O=X"5=[ Q+ @W' D_^4T0P@J(5R< Q3J(,H
MT($0<(!!P#[R&H]]Z 5<(X @< 8S6QZ7A ?\ZC)BH ,B0 7?P,7LR=/="H
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MFE">H4&(^GHRY'N/?;A:'T"&V]7/%@""#1B !E#>]E-DF8")9Y"#)T"$-ZB
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M\3[2W)(?Q,!#$3!!OKQJA2;D@,,$OB".O7*60TJ$2#7P< 9D)+2.4N%.,MZ
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M$$/@@S1(3B?WFA\,1!@#XNF4<#S.#C0".,3%^B7@@>S#*-  *T *J^S"%N3
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M\I3"#VP!.5RA>8T#)ES!)5"<AWXHB":$-53"!@P !(C "-C_  ^P@F#)B4C
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M=/$&'LT"'/ !+FP:L2FOT?)$M;[ #G0A\[G8@.W!%CA#C2"K]A8G/L2#)K3
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M "2 &[B! C#! 3#!))P!(F2".-@U3K$B/Z>V$>H,3Y0%,78!"@!  !P <@N
M!CP!&BR#)K$P<(^LO]4#*X3! ##   0 =R-!(]@Q3,CT=$LL3-2#,5#"(_B!
M&Q3"*.C".%3B>.=M1PP%7)+#-X1#NB4B(/UU?"?FL:X*N_9WXI[5N?"W@*?F
CKV094!YXVN:%IQ@X@ROE"$.&OT6XA5\XAF>XAF]XG00$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>aort-def14a_051623img004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img004.gif
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M_/W]_O[__O[______P
M
M
M
M
M
M
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M1K<1,*T! KC[W?#6@ 90<&PLR/K(S)[UDUO]AVE7.PHTH($(/$#P@A<<TTJ
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MFM8%E"R_5GS%F8Q%6FR9.B  =B$ =ZQII7S*J7QJJYP6J*QI"F 7<ZQI<#P
MLF8:M6RE: '(,R<4@US(89MI9*#(\\G(C>QNCVS#JX7 5&QPEJRV*7#"HO6:
MSQR%LYO,3%>]H:Q$HTR9==P7K5P)X<P7XPQJY7P7K>P%9B$ .X #9H'+F1;.
MYWQJNHREO;RG@?P2P6S!F$8$Q@R715S"W,S,II7"UPS-Z]NXT]S-U0S!"3V_
MVHQSS'?#V*N>@F#*\8P#.*#1 2  ;9S19S$ '.W1(%UJ(KW1'7T6)UT)\!P
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M $6P!IO?^9\?^J2O!H5 <0\P].<6!&.0!^&&M^F6^3X@!&M0"117='=G?FX
M"%BP DR)!6J'AW30!!A0_(#@!@EW] S7!,$__.!N_)(/",F__ 3@>I7_(/P
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M.C6#;$&@#W4/(PTZ4=:L(*$+Q6AO*MG+ TU$(0(8'0(HY%&.A/1;_*H$20,
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M=\NEBE@J1+V]XH,]5\+;X XT?__19P"E8.';=(B4:I3R[\N4D=']%;0;S*?
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M1'],)%P,R/F01'TL2$HZQW64R(F$P/]V[(]K S"#(KB"X -Z]$BRL,>%C$7
M>TA@*H@71$@#ND:1I(]4+,GW49643,AP9,FFJ4&"?$F() YTI,B>]$G.L\@'
M*XC[PJRY&;./5,:0K,E9L<"<-!LNE$G[6<FEQ(YG=$KW&;RHW".%I,KJX*JK
MU!5?_,FQ)$N]"4KR* B[:ZPXG$.D'$6E[$K[<$FPA*Z""$"MK)^IC$OJR$><
MI$MK*XC[P\L"XLJ]S#:2_$OR$,NR9,S&+#I.'!*,/#5(,@*W?$N -,S[L,K$
M/+J3',R\Q,S,G ]9Y$S K 0[^$S"I$G1!!72+$W%C$C'E,W9]*7/(\;"3*!Q
M$T7+/$*X9,W_ZQC(U]R54).^U,0:O?S-6]$/AQ3.R"P(PC-.K<'-Y#P4Q6M.
MV-Q)F LITB$N'2 VVK2DGOL1G=.1=3S+\"@_Q)N\19A'WEP_WZ1.ZG#-Z[S(
M'8K.^PG-^*2.7:1/\@O,^V2;Z:1.#.O/ (G-:8,UA4@ \01/H1,(@?&"!S4(
ME K&\Q2@U?2XC22(0K!,'W ]#81/_7R-Y?3+ D5/@H@P ,T:Y!11 I@\$Y4L
M@A U%54; :7.S831WUA,@4E0A3B !M4;/$@E=H$0(>TQ9P-&"_6.@L"JY;.
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MPT+=ML[/E@Z$Q"I5/:*L5ZRLS=ZLI*%KR8)G,E8"AF8)L6;LJ7 6D**A#=J
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MS]*CW[=*6GF06P02F.]=.("9\QB1@[<LV_5BYSD7-(2K ^TB$)&4DZ6PURF
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M:Y<C2E9UQ\(( ?@ZGG$E^N!*L3+59O9VB>F"Q:AY^?1M42UM"8!"_V9U(@B
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MJ1,2(4R:M?5W,O:3)>(EUIB<&^-B#PI!9^F"!__*K!#V@AD?G:Q]X(,XV0$
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M1,T)AE5$)8P@@<2'>:@EM8!5%[3L U,RA"W.CD'08D-&ORTNN?_.O1"Z#.&
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MZ[.'/G9J-_Q&#DM"E?\]LIFS<"4N.=D=X,"D%A6(L:.M? 487Z&45'8EH/U
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MT$:<UZ?!ZUQD7,9/(<543,?8<<.KRJI9?(36VL-Q[!D+X<9BC)0+Z<=%7!#
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M[3[Q7MWC>IX5WXVNZ9KQ]K[Q)=_IU>/P60SQ"&_R])HL%G_Q#P ![$GR+4_
M.C(% T\:[<2P(O_"$F_S07]K# _=W;OR&B_T&]85,#_G6A[_Z4D_XZC\X1X0
MLXW.H3R0Z?X.]5LO>@L.ZOBJ ?2!]%Q_\]O%]-@M!+9.]CS.$'$0ZR,!Y%IK
MJ4+P[$"_]G<O= SA!BE@[64: 2E ZG:/]RW1$%Z1ZE%[D$\_^)O1$'\0!1]
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M_'IG--^<6V1IKGRG;PQ,>XHU=^FD+OVVY=3V^V?1-_O&?_S1/>8<F./1'_3
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...^C!^S4PA"(D5D   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>aort-def14a_051623img005.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img005.gif
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MT__UU?_WW??QW]#<\./CX^SL[.WKX__YY?_Z[?WVY/3T]/_\]?___P
M
M
M
M                     "'Y!       (?\+26UA9V5-86=I8VL.9V%M;6$]
M,"XT-30U-#4 (?\+34=+.$))33 P,##_.$))300E       0])?[A:TYL+\L
M.BD(XWYE6SA"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O_V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG  #_       ,8W)O<%)E8W1,969T
M;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T
M5&]P;&]N9P      .$))30/M       0 .8    !  $ Y@    $  3A"24T$
M)@      #@             _@   .$))300-       $    6CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))32<0       *  $
M         3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"A
MF9H !@       0 R_P    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$1       $     (   )    "0
M   X0DE-!!X       0     .$))300:      -'    !@           /\
M!)$   7E    "0!- $$ 4P!4 $4 4@ M #< ,@    $
M         0             %Y0  !)$                      0
M                   0     0       &YU;&P    "    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P  !)$     4F=H=&QO;F<   7E    !G-L
M:6-E<U9L3',    !3V)J8P    $       5S;&G_8V4    2    !W-L:6-E
M241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0
M  Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0
M  I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   $D0    !29VAT;&]N9P  !>4    #=7)L5$585     $
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M%-[W?I<CV5;/324Z>QG[H^Y+8S]T?<LT=2Z@=L48IWDAA&1802UXH=[OL/\
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M )[L7IV]G[P^]6><Q0QSB("@8WWZ^+#@G*429&]5>HS]X?>F?54\R]C7&(U
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MI=:+?V-GP1/V:[C_ (MR,1<@#U(0= 3X/-],^LCNHYU."QKZ'9!=MM+:7!I
M?D[MH;[OTC-W_&+K,:JG&QJL9CMS*6-K:7$20T!@W1'@O.?JI_XH<#^L_P#\
M]6KTO<SQ"L<WBACF! 4#&][ZR[L>"<I1)D;U0VTUO>+:WBNX?GB""/W+6_X1
MBJ=1R0[I>;5:!7=]GNALR' ,=[JG_G?]6M'<SQ"J=7],]+RS#7%E-CW_L@.
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MVJWA?TO&_P"/K_\ /C52^J=E;O_ZQ=/ <"=UFD_\#:K>$]AR\8;@?T]>D_\
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M924__]DX0DE-!"$      %<    ! 0    \ 00!D &\ 8@!E "  4 !H &\
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M;@@ 5+6@<<. J_KV;.$V#!I0BK_7@)WHHN<XCA3Y;>3*65\7I'&A <8YJ8E
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MXC>[:BLG.C_BZ=5A&KD XX-2#6KU09<.-ZZ3/A_T(#@)N_!2Y!(QVB'<\)#
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M[U.^8MEJICT0ZUOMTCTH8&*([H,FO.5<;^"J9^F)6!W% .'%3[4]<;V6\:$
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M,3_.&-/1 A1P@-\JXF HHMA%?\><6=0F; EJA@UHE_ PKN$XRVUC<)SC+&1
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MBO$@B&OB@L@Y>\K'C.<B3R9  Q"!21]C%N2Y9F&")S/ LW5[L'L!%"J!"Y0
MI'TCK*J $DY!%W8[N96[KUDAH+F"%98[NJ5[N@&;M4DND,'E?OE&J&N4+@2!
M-AFX:>_&EF3W>>(Z+!RD,]1[O=F[O=W[O>$[ON5[ONF[ONW[OO$[O]N[%MJ;
M%D !"W1@!G+#!IQ@$FCA%A!<OQ5\P1F\P1W\P2$\PB5\PC' GM&( 17@ C3
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MRC22 08;(!*OC I) !N.',8:\S'&E(+)@B8)^4(-4  ,4\Z-/\[_3Y$+#\
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MGBZ/>10?14%W9GQ!%#;!"V1*\S&5PH@L^' W"6A3 @KP)*<@,B-M=G.;%+A
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M# $Z;@&'>""'H/.&<QB';XB'=@B'=:B'>;B'<FB'?$B'?4B(?PB(=TB(;Z@
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MS965>F%F1F4&:HUQT4\4RV%7"WU0!KF7-,,+$?>(TNXJ&E]J)BU]-$]X)[>
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M<]JEI0P15(*W<ACK^-H;L=PUT]SOAA;%I)DY0Q7\\6HI$E0/(:UKP-W5#17
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MA!7PE-/X%ZH7W6!S<"=<[09_3 .?'-F.IZ50!2C>:54 \$N"[U $\E*A#,7
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M*"7):$0&$+1#E^ &#ZUIVED<1!J0AE2D(R5I24UZ4I22YA:TF(0W@^@"&^@
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M@ 0OM8<^[5?W<-9%GYW,B^)K.&$@#JIP!#5\X>QA"=SI;0\;8M"3D)#DX_H
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MD6.HA!00 4=YTA_0 \ULQSDUF&2(A3U *!7_0IXW<L3_F\O">,[O*)$]X(.
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M_=B+*WQ@J&=TO'SBQ)*_'O3"$EF8(J"NQR*;K+++NE2FF<\^A2>ST^;G++1
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M"Q8/6]1%A=A-"_Z42"W=-R%*&83::[R+(!2.,HB4!F@:1NA+P=#42]AA(V1
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MDN_XGM(M;*9-IAOA=BR1GMNY02.2GM0MG%+YVN_]XF_^ZN_^\F__^N__ G
M"_  $W !&_ !([  JP+LIH<J)/ #0W $2_ $4_#W+C #=T>:H("AW0 55$(%
M@W ($W#8VE(B*6N3GO )4TE=:L>RB0PS::7R.I,E]13QD@3'[-5>]-4L4)G[
MS9_'7 "142@*J1!+'2O!MH3WBO#]'DKZ FYG?J:T >NT2NL1/F.U(NEI-M4+
M4=\2>_'_%X-Q&(OQ_W;Q%Y?Q& /P!6-P=S@P&I\Q&L.Q"+^Q!*OQ&@L%FOB
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MT(_00PDOT=:,<528;M*)%J"&T9'35O$4=- %"W65UK)B'=3!6G4MTI9%]K@
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MG1#!6*33.,V++G*'A+1E)Z(F*5NQ*3FN#+%/>>Q3-Z@S!A$4R8;3XH@$/C.
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M)KY1)J^WE6R)@UG)*/\TB177]#"""&"NIUEI1(/9")=M"2G2L0BY(SY*PSU
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MR%"H2%(5&17H59:7BVE7)W2-XFWJRNZRI\98[7I=HGF*0(B#,3@#CM7EY-$
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M'GS@B8@@=,OB=4AE&GS6'@K390N_&O#1:[D!0ZTUXXT[_CCD6&WL,^4506!
M 2UKOCGGG7M.,@$(\!$Y8ANCD88<<=3AH2 X(U2(SH/0,<<8:>3F<XI'_D@,
M(LLF3",>-[I-YK1M95M53VUE</Q.VP9->N1>NP027ESWG:Y=5[*[()/$-<)W
M44SR\;M7PS"21P6!+PS6M$^#+Y.]#B>,=F -X]LN]/GKOS__@TY>>>52]+D!
M$K"  WQ>_[3R/S/03 YV (3K6B,(0 A+#)0[UE>(P8?N(&)&.F&.C:!#/[DH
M Q$5*!KR$L&C(87'2 EDG$NX_]:UE]!0AM93$-BPI*""Y2%P^*E*B_B0 4:
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M!?."\!PF"C&BPF-"*YE?N]$%2#G#B[PL9OXC2@:$(Q%EP*PH"85,7V(AA Q
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M%VC AW/+@,8('TMQYY1WX*''T3",S&(+E1G5T@@>%.!Q$4\>&?=A9? -R&:
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MAG E%8U 3S/8L[C*L&L*K'_8JVKJL, $L8-2(0IH68_Z4ZI5"-?:78L E1B
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MT2[MLJW<ILL*S/WLT3WMA?\]W2 >XG^ZQ!H$YQI !$1[7NE5Q,7HTERQ?'I
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MW=6C_MXQ_'CXH,_/IU^_+VZ\NIO:%SUK#Z)$B.-O0 (+Y @Z "30  \&%]3
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MCCL\.(_8PS^,0SO, PFY.;AKM)ZCDC*P.66@1(SHOSS(@UD Q2SDN/K#"%G
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MX$I0'$D'U*!<G ^PE,K_GVI"47-';RG GMP(L$"$H'Q)Z^$\HVP?3>RYH].
M#/!!LAC#MUL+09!(NER&8J@%NRS,M5BW#,Q(@]@\IH0*L" &RJQ,R[Q,S%R+
MS-S,R^P]SOQ,S/1,T!Q-TBQ-T]3,T^1,T0S-U"S-U03-6% %V9Q-VJQ-V[Q-
MW,Q-W=Q-58B%U.R]4' $X1Q.XBS.(RA.Y$Q.Y5Q.YD3.4&A-Z%3-Z&3-Z:Q.
MZ]S,V.1-[=Q.[N1-WSS-X&Q.\1Q/\BQ/1WC.Z^S,]$3-]6Q/TGS-U,S.[IQ/
M^MS.[Z1,^,3,\#1/_NQ/\D3/WW3/RLS/TZ3%H5@+D>M+(JB+LPC,82B$#4C*
M_\>TA<3T2-6!QB6IA4+0@,0K1\69.\*TT&582@DMB*.HT*&L!7\K4<1A"A=]
M41B-41F=41JM41N]41S-41W=41[M41_]T1RM!1<5TB"%42(%4B1-4AF]!25E
MBB-M4BB-4BF=TA]]4AM]4BNETBN5T2S=T2[M4BTUTC =4S(M4UL 4Q]%4R>-
M434-TR^5TC<U4SEU4>0;"N H@[HC/7_\4,2,S,?LT[OT'0Q5DK"@BGG)@ K0
M #Y A+M0"Q7U4Q,%5-Y+41152@J%U!:=4TW=5$[M5"IMTQ<%54_55";UT5+]
MU%%-554-558MTE5]55B-55F=U5D555J]51JM4Z$8AO]:,-0\0-0,L)*9K$M,
M)586O= GP9Z6&89&<+^ZPP \[!45I8! E=:BC 41)<H03=&B+,RVP55P%=-P
M'5=-M55RG5%S/5=U18IT7==8;5<<A5=WY51Y-5-0;5<TK5=/U==Y35)=+8I>
ML$"[PX![W, 15;=MM=1N%5& S$M[L@6QF!>R0T.G6 L(/=:#75'%' 9!B-#"
M+(9+K5:AF$P!+5F3/5F435F575F6;5F7?5F8C5F9G5F:K5F;O5F<S5F=W5F>
M;5D#C8JU: N)%4.G6(J+5<R0]5;2&=0\X3_WTSOBB,NYS%9 +4RIQ5@0Q=A
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M:^"X8!2WX$+["PNZ"&;I765F;F;J#8NVV ,\6(,_[N6W_66Z$&;ULV5UT3@
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MVQ]],??\TT>$8OC96R#YY>^(X,_?G?[UN6&4/9AZ@KA&_=/&)*:P)@[4N-P
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M("%FAC&+C,I$E=0<!B+^%T"14-6J$!0)>A8A6,(F1ZM!!,Q8,C#8]>Q! WM
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M28R)ZD$0B#Q,Q>,S_>>G#^'L%PM"X?PA/./!%62.R$:M6NRO\)[B&( A$W"
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&NPP! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>aort-def14a_051623img006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aort-def14a_051623img006.gif
M1TE&.#EAXP5:!/8       L+"P -%@ .&!(2$AP<'  :+"8F)BHJ*C(R,CP\
M/  U6@ Y8@ \: ! ;@!%=@!&> !(>T%!04Q,3%)24EI:6F-C8VQL;'-S<WQ\
M?.U],>2G?0!+@ !4CP!PP&2@S&NDS'"FS72HS7NKSFRMVW6RW7RVWX.#@XR,
MC).3DYR<G*6EI:NKJ[2TM+R\O..KA..NB_2SAO6XCO:\E?:_F?;!G??#H/?(
MJ(*YX(F]XI#!Y,3$Q,S,S-34U-G9V>+BXNOKZ_/S\____P
M
M
M
M                                                 "'Y!
M(?\+26UA9V5-86=I8VL.9V%M;6$],"XT-30U-#4 (?\+34=+.$))33 P,##_
M.$))300E       0])?[A:TYL+\L.BD(XWYE6SA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O_V8    )<')O;V9#35E+
M #A"24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M    %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
M  !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V
M8F]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  #_       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M .8    !  $ Y@    $  3A"24T$)@      #@             _@   .$))
M300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R_P    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M1       $     (   )    "0      X0DE-!!X       0     .$))300:
M      -'    !@           /\ !%H   7C    "0!- $$ 4P!4 $4 4@ M
M #< -     $                          0             %XP  !%H
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !%H
M    4F=H=&QO;F<   7C    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&G_8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N
M9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E
M;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &
M8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M    3&5F=&QO;F<          $)T;VUL;VYG   $6@    !29VAT;&]N9P
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M*       #     (_\        #A"24T$%       !     (X0DE-! P
M%#D    !    H    '8   '@  #=0   %!T &  !_]C_[0 ,061O8F5?0TT
M ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!3_#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# S_P  1" !V * # 2(  A$! Q$!_]T !  *_\0!
M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MQV!PK=;)(VMYT:YX@?RMNU%9]!OP"AD9#* TO!(>2!$<AKK.Y'[B2EJ+S<7
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M2?N2WCP/W'^Y+>/ _<?[DE*W_P D_<EO_DG[DMX\#]Q_N2WCP/W'^Y)2M_\
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M?&>N';U'J1 ^C?D$#X/L7IKWYK&.+KGN-;"2&8S"7;!7I6-_N]3U6^FO,^M
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M_<=_T?\ R29[W;'>QW!\/_)+Y9224__9 #A"24T$(0      5P    $!
M#P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0 00!D &\ 8B4
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M0M&13H4U:R'C OA"J7SL @$(@ P9EP +L "#1'$!!A2 M:0(D8A=RQD,60@
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MPTI/;X 5A \(C,V7]7 %SQ1B NQ8 =5^D:]).:^%K8M@]B+EQ T& @]<$.'
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M23Y,:B%#4UG3K_U\Q]H(4\BC8A.@_V7>_%47(8"J.<UOR[!@ZKR$S'D\>CQ
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MI3*^0S[^J2*K. S4<!7PL>BJJ!*LGNR8Y*JJGT1A.POT,E0C :CV+#Y0-PB
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M8T'\FI@!*/*M0+SR&).^%SXI,BJ BA@@ )'%C0X63(:PL.*3"O1$#DG"!2G
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MEW'2>T2[@R"D8%LYDU]FWZ>"EX:P-JYD;H\ 4('O9#>1=JV;<ADA2_P1]!%
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M])(,1 C^>%[1I3[9J(VE=X8=5EN*-(?0<'Q'J0RT)7ZP=FC%M8I,UWQF]$D
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ME@HG+H-!09X(EIB:AI.5C10LM)N)BY:/*YL]*I^-$AFLA#Z^CA/!0#\9! $
MH:.$PZB-JLF"KQ,'LIF'IMH Q]V"0#[2U  !H06- 1<\/X4ME.*[O/U"BA<L
M$4!PS9\W% ?<!:BP T,!:@'_Z.WP(03%0UFZ^@TK!H#;H&RID!$*DN+B-I%"
MOL7"M8+'R)+N.J(48LN2,Y<&#=9L9&''O9R" *9:56A=NVH*Y)U,%H3%A)4
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M:>8T-18PLH>KM"3;?XE["(IV 9UZMA:<&UO+Q$!;L\_:J95;%*Q*K=!ZQKR
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M (([XP(IP .,ISSYAPE=XT7_UTR.9T-D="TK^![M1X(_*!DF:#LND(+(11E
MX (JP%B:,$PR"$,5E7XV*#.\$TGPHS!$XX- J(5OEW(T\7O&TE2YA0)C2#?&
M<GBE5WSK@X/VI8.T!PN5)$679&*:9$IUN#_^8X=YJ(=[R(=]Z(=_V$D\* H+
MV Y?*%%9Y#1D&"W(DGA?U /JDG9J>(7R4T=R"%]T"(B9J(F;R(F=Z(F?"(J>
M*(BAX&E3-Q.B5P&-V"P/$RT[]2P8P'15"$DV]#ZS2$F5N&B8&(J[R(N]Z(N_
M"(S!*(P39$:P0(CW4'BIB$A>=?\!VX)2KQB%LAB);5B,KP"'462)OJ6+P\B-
MW>B-WPB.X2B.>#2*H""$K3!,%1!\H^=_K<!*Q22&$NB!A]@[_=1W0H!+;DA0
M6;B%_0@8Y\@*R3AZAY>!KS!,2O4Q8[B$DB=0AH)/]PA&][B/U.>/%0D9O/>
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MKGF9J1Y*K.>ZL(7#J Z15!9 >56XD5V9#9/@@8QT"[Y1F+6T(_FZK]3J4I#
M60 +283#JV#IJTX*K-B$LN7*L# ;+ND*$1 KL55HGZ, 5>\Z#"IQ"4*A<:
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M;-G<;=&FSLGZ]7K9P9L_CSZ]>F=EAW<LOH+0H>7-'PV*/GT]2/'CY\'"UUV
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M]0GIGMDK%ZXMPK&P'%>L\%,3_FVJ?__'USY#X.I!;(5V/Y1_!P%\<'=_J%&
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MR](KQ:MWRQ/@HHI<J'ASK!>K"4H\%L&<L"%* 7:ZFJ+L"3\ P1(P 2IWK1)
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M.J4'H.XMCX6A[>X@,>O<8(V^J*1ZCNWMT^2\3MZ;+.A"2>DI$$4WZ+$@V]<
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M;_[YZ(O?0_K)A/!Z>2"P/SX,J=>/T ORYZ___OSW[____'/?^PPSMV"AY (
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MVRHD>J "QWTVC5H3J^=^2$2BG16M:IT$6]O*HM69UA:_W>(#ZHK7YHZ&  5
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MT0&NXD:LX=LLHAW>VA\.XOPAXC5]WS<RUR<>X:]].C#.U?/\XK$=XP+>XYC
M K9DXT:"X[R$8IT9;K/1W4Y^(R:.Y#<BX:RYXN9=X%MFU)AMY*LYXY.MY ?
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M\WX_/L2 Q<W'G.>?_.#/+;E^[NFI!^;A(.910^;&6- #E'EL'MR+KI +93F
M> @F]>IV]^CZ6[LPSMXMN-KKS>>3;>6(\.>"'>AG/.AI'+MPC>M*PUETF&N1
M\]UM%7<@7EH[]G8VE.!RJ^N_+JEW_L58WO]86BX.3UW&Q2[4QW[)R6[H7816
MS@Y#I!7MP29W\#[M\A[E\S32I%+2N2/N->OK<<R]-NX:H4YXHPX-I8XTIPY-
M6EU*<?A<"A4S\7YR1S?>U^3B=AZCG#!UFY[,P>[0'#_.S7W>U"WA$8.KPP[:
MF/S*#82#VQ)^@J)K%6_O?8;M_W;QVN[MAK#QNU[+VSZU4;W(:0VXYD[8Z,[*
MA;[&I816MW9'TBYL3D_QTYYO**X,Q*9M[^9NY:;U6\_U77_U7L]DT(;U8$_V
M0S;V98_V::_V:\_V;<]DV7X,UYT['9=G@R1&4U_OZ'?M,M][<(\*5H_V9^_V
M@T_XA6_XL";XAZ__^(O/]HG/^(\/^63O^%N_[*& 'O==^=>#5NWG/7*5]S6?
M"(83[W#G]Z4 ^)&/^I\V^:G/^JWO^J\?8K O^[-/^[5O^Y9."F9^/1W'^?2>
M.1;_]/3^](OSW56O^*L?8;>?_,K/_,WO_,\/_<6&_-%/_4\V_1IV_7!6^M:2
MZNG)=FOUW\[3=#<V[^=#=^D7Z[@_"CN2^4CM_M7)_N\O_W$;_[+6_5C[_7(2
M.;M7=SNP@>4/"!8G+#U"AH="/BXI%2H^0(B1DI.4E4 ^F)"5FYR=GI^@H:*C
MI*6FIZBIJJNLK:ZOL+&RL[2AEYFUN;J[O+V^O\#!PL/$Q:%!F(^[R)A!_\S*
MQM&H0$ K%B@L/H<N*!D9+9,[*"<9+D&;XB<8YI([)^3LN[?0TO7V]_CY^OO\
M_<#SFOP)'$BPH,&#"!.">O9C63)GR0(JC!:DVH5!V@RE^R;D'**-+3Q2 AEN
MW#>1N0!.7,FRI<N7,&-.4BFSILV;.'/J=$4SY<-G$G>>JKCBP@IZ&E%@L, "
MB,A+C# >\B&ND3*J*"JDV)%1"-0*&0A-Y68U:*V>0M.J7<NV+4&T;N/*G4NW
M;BNXL^9!Q&6W$U&C2(6(6]KTJ0]&80L9^D'6$23&65'L:&@(2(^H8A=7==P+
M;]_/H$.+5NMYM.G3J%,/+ WKV=[ J7NLR%"AMO_M"A<D6SI\VS9G0XHB3X[T
MM7?97ZQ5*U_.O+E/OLZC2Y].G12R'K!EN0;:G,=LXQ4PZ*9T207XWT)^5)7<
MM;(/\\;1\TI>O;[]^ZKIX]_/O[_;>93ELEU$T\FV0C9SZ>??@@PV^)*"#D8H
MX83\<*>+7A9&Y]V!BL4%(84@AB@B<@2.:.*)*,Y7HH /)0*=<^*HD)F'*Z9H
MXXTXGO)ACCSV:...T_Q48W/NR-CA?T/ZJ.22-P+)Y)-0[L>00\UD&"4_3EZI
MY9;+9<GEEV""=EUVL0SX8IC2>(GFFFR2EF2;<,9)XYEY"4FGG"3>B>>>?-JD
M9I^ !KH/@%3Z\)I9@I[_]6:BC#;:SY^.1BHIBWK"@N&BD[(":::<=IK*IIZ&
M*NHG5M)R::6CD@)JJJRVZA6FKL8J*WFPNF(FF;-ZLFJNO#:Z:Z_  EKJ++<B
M&NQNJ!ZK+*>_+NLLFK?T8*RE=N+ZK'O)7JLMH,UNZRV3A.I2[+>2=$ONN3B:
MB^ZZ)ZH[4XNU/NLNN_12.&^]^#8XY8753JOMO?D&S!_  A=<'\&&C,LNP@8W
M[!S##D>LVK#:]4LOQ!)G/!K&&G?<%\/S=!2OLQQ[;+)<)9^L\EH4EVGQPB.O
M+'-T*<]LLY_)!*AHE3$K6_/-0#_8<]!$B^D#=O[R]/*Z/Q?M]$%-/RVU0 PK
M_\STT%-G[6:V6G>]M0\ZTV(UNE%[;;8Q99^M=C M4\LSU\NF#680+>2VPI%X
M@H026^E@$-+&6,=:-S8\ -HW"WNO=7A'HK7]RMCGR@WFX CVV???<9$$.-RS
M!N%";C/NR8-)+,S5 ^F)VP4RO)P?*[DK6(%7FV1A*^<,Y7@_*=L)X8TG21!Z
MR^4..9B']GHKC#$B.WO3U3U([DSZL +ON;E0R>C$IY[6XJ,Y;NO29 <N$&2R
M5T![\Z!#OZ1LM(FW0R7B>!./6Y>;=CPKR9=_?G2>@UZXEM*C'@JL-Q+2S05[
M8;$?)J0E#_!%3GS^H HCT!.[_:VD/,?1#NZT1+<+8/\@ Q>H0%,F 3R3A.0<
M&)2/0E)H+06VCB 2U H]\L<\EK P:4,1PN>>Q\'/?7 I*TA=$!!8NG,@8P4R
MQ"'5I)=$FN6L@6]KH;P@V _RH8=\%IS(#6FQ02W5#0/JL$ 04U<_]YA'A0G!
M8 JD*)K[K4(]C%AC0+ X'!LR48[$^APVU*<D'Y[@ A90@5-*H@[$N0>)>+2A
M;)KX,"J. G+D<J,J8J?"NF7 =UI\3P;+U$4HE2>0[[' 5FHGF''XS2-J9*,_
MMMC(%PXD?_+IWR7?9T?S)+),.PP=N*0G2NGEABN_T]RK;*G*1]VQF)_9UW,,
MY;TING)\B]AD1RR)R15J$HW_KNCDDRQS1E]NI3V,$R8K+ZC)6S)'DJG(GSF%
M0$U:DA.1R'RD-G<)3VM\<Q)$1.4QE>B/(S*R.55S8"0=N8_@2+.#LR0.;V[C
MODE0106GK)L%;,-#1/S%.%E,1#0=88W:#$(%?P1/0]VC/-O\\ETEK<T:BX(-
M<"Y)'"@88"ECZLZ/=.,DW BA<48ZS-[P%!&PY*5'6=""':C@)"P I&T2,PGV
M]::BI<2 2&4J3.^<0(S.4*AYF%<<DU83:@351U E(DN9(@*##/UJ>ERP@H@J
MM39,M2@06##1WM3P$.KDY43#H@*E@.>D9O2I6M%JFY7Z[THPI6I,U8H]#"!N
M,'\U_^NKD'B;ZDV",2KH95'@2E2V.K:#=04+"VHZE>GU)BSN')U4C6-9[B6B
MKXW(ZEF9R%4F5E:R"6DF*R#Y+72B H[29.<%$CI;^-CFIWAUP5%#DM30QO40
M1 FM;3(*&3&^1Z=\]>M.?4?8VB WL+=9HPHNHLN7+O9]B25M4K('V>VZLZO>
M56OR0#G>O786HB&1Z%++*P2GWB:N)5RM8-%KRA/VU[0K, LWS3><[O9.O0;Q
M[2G&:M%V:K4W@(W$0\,"VOWBK2))Q6@=\;J#%(!RLV!905\%G%8"]K3%[S*N
M2GV05*@R:8B+M=[H8NIBZ"(P).W%L&0=;-ER1=.P]FT!6_\Y_#GG\C> IV7!
M_Z(:61VC#CC3"Z1L#W$)))X F X63X\1$M H\M-G8<V'0='C5/1@\'S1E0HB
M8E<;SF!0*I9!S(S>/&*#UCDPXPPLG*LAB#WW8*O C"YG^8@C$/^R(>K)B@K%
M>4U \X9Y?[%Q(JKRYSF2I39!! Y9+&B@/6ORKH$N9?9(RN"P[:X"">:S-ARM
MZ8)(V!04-L2K'?&40U?@RPW)M"[I?!P,AD4;=S8UHKN2OQD')=4+QO1<"]TA
M67=DVHN&$HBO >8C!V8C19SL/RNS2&FWH-!3UDQ);PF$:%I R^>@89]7<* I
M=_G7P#SDN%7-87U_&9P!U/(/F/C_[\K46,H*468M>.NM6Y<"N.CQ#FV.$A ^
M!]LBFB;?GU'(&Z8FNRMY;C6)L]+I"ZO0XM=FJ;)%_I>)UKI'U"C**#4JZ6\7
M&)6^/KFO!UV4C']ZD\TV2E;I&*!25_O4.ZAXSFVN#G"0&]&NSG*"!\X(GI.7
MT<9\IC]R_5K>L1OI%S]XNM=*\F)KTN-G7[D%-;[O>Z\3Y;16>Z+GJM2PC-U'
M%3GW^6*X3G#K$Y[/)OAPMNWS=<\PFG4>>C0+CN5Z<QGI(-]G),#]>"_GN[17
M%>2=YT[70=S]+6G^Q*GB"2R'DX+8E2W'WH!W II&8KZ($TGLMA(4V70#R.=M
MZ@I2H/K%_Y!%SB8/##=<#U1N8/4<Z8T$X?G+HQB.,>77J%S"*-W-H"1_SHLX
M?G*S<NS7;Q0I'=RC7RRL[[Z;4+8E)'["*%>XZR?7Q E.8^COT6P,G[(=N<<^
M(T+]?I$CPO8GX7[_MWLG 1Q5\7+W-FDYYGWPIPF)-6;+YU(]@EG:%W=CUUA.
M)V[FA&,\QH#PQF719'>O5V+[ID<(QPEEY6)N%QB-%7L)LV.XI4/D53@P.&;M
M=D9;5A"ZM0H,MRVF-PIL5UGW-WGY-Q;[MV5T!$X B'OJAPC>H128$SO=5RZ5
M1E8"N&F,X()7&%TM!275%7_7=G!X$S^JQW'51X1-F![B($82$?]#FD9)X&>"
M6&<(Y-=3L51&AR" X2<65RA!V@=66E=%B&=_Q9.'1:AN;"@2\J:$*W![K->!
MDK"$_8> Y61S:9@_S[>%T_9R/-)N^S=(%A@)^51^EAB#-QA;Q:=G>'.**!"'
M,^@)GW-)*BAY3GA^M0B)"9-+-!A3*3!FF(6*9#9_G: 7+D)ZO?*#H@"'D%!!
M(Q9=,W=6OD9Q(_>'8Y$56V%B72@)BC!!RL!UL\6-(N&,(Q98CK&'+K6'<Y@B
MP;-^'E2 TW=S@<5NT_:,CW>&!LB-03%?8&A3:5A ZI=JZ^A[#9@P='<4CT!7
M=_5TP;4:PE@/GG@<S ARTY91*^AI1[C_-_*662\70YR15XA2D=!%=_=47$FT
MAW?7/YR8(P$I@Q_D@AWQ8W_W3WG';> $DNJV;[_(?SZV@)U0@Y6W;T1$'-FG
M EF5=Q?@"#\ !'IW>:1X9O:@<&(C4+W5D-+PA=U(%O3H:/2HD!0432.D821X
MC=1V68UQ%9N1'0N&'G\QDO58%NCX._/4(R7D#1DX31<P7. @$AL1#^.TEN-H
MAX>'CQH63<_'CVJE?.X'D 7&@+!6E'2'E"+)E(#IE Y)E=$P>U<I' &BE9(Y
M3G!$C3<I&2;V<AZIAH))A?88AC2I4$C$&;D$/7(()90'73[$$39%#J73E"&Y
ME#5)BVL51X$Q_U^"M#<^V0D/^).M&!0MZ(%$:42/F0F\J5 LL&\,&8BC,'J4
M67J6:0QK1@^#P12#%',Z53Y 5V)8)0GRE@(7L)5MR1G;N)##!$H!<5'D:14'
M25[@= YQF2/+-W:[YIW=<$IFN$GT29Y7Y&WY:)Z%:8BXJ!'J4 $4(%BSF)H=
MH3?A.(_#L6%Y26CU"9^KM)W%P'60E6#.25?UV4L6R8;H.6I&)4I_28Y7"9P?
MZ9O;UJ%KE)2=5UXH>8)*TI\:!E+_%)2Z29!T)5W@<4OJL56 1IAF49R'H%I3
M-8M(E)Q$B)M;9I1<Y5E%I)1&"AY4"HC&6 H]^"\@2@R1MDF094C0U_^EO=&5
M%PF6UFB>[$F.2:F&62&-J$F@A&:D$7H;D&D-+[>?C;:)TJ=KIH4>E-::]%"C
M]4E!)*A"F&@65QAD:?5>AR:?5>HWRA>9D*9<)T$-S=6H85H,R!@*(MH-%4AW
MH=6G;4H/SI>#ILE@ZLF6LP5XOPF?-ND5JBJJ]ZEI^ID^-T9WGJ=AII5()=1T
M696K1FFC,Q26P:E<'WB+,4BI$(H;0T:C0B"D(8F0W38;(0&JXUD^ZU2=HWJ=
M4MEP93H,[^EF.S=XA#:GE1!I3 &KVWABH".!RDAV5I$Z:6DH(2ES+SH)E'..
M@GHC0=@;K I5)#&@:OFN 4L)^3IG:[B/X=3_>N-QK+;)H-S%1 K8=,&$ C+2
M?B K%MM&JT)CG?O =='FKG0%KY3PF0LJD"<VEBLJF!R)EE6XK2XJ@9(0E_U#
M.-%#@AV: 2LP9;/I%8MT2XZ6D)Q0FF<UE+!ZG.O%87K)DQK(@J:DIC85LJ64
M @BW;4SK$E!)+.?J@^DJ#&?J9F"7<NOYL [EE6:1MJ%$FM_W&'4;8YL4<RY*
M2LHW.'<CL,"Z)$'(JE&F&,<ZA.,$KBY+EJ?Y?J Y4[YCH>_XCSD+72N9%%P;
M(R1K$8N;22@K5@C:EH/&K7S+N(G(G+RTD<YJMS+Z+K9*I(_F%[H(N.(GN(-(
MGB(XM9BCK!A:ND;6_[K%EUG-:5%.>CDHX:2Y:@@PB1(XYK6[R+58*IDNL3IF
M=C%G&PS>B% 76[#:>):UUX@!>(B'(!N\%X6/BK,4*ERUNPGI5TUZ"WP^@H?X
MMVK\MKN5>PC.PWR7=;[YF'TZJ;'OLWQC:+4+UG?DP!%[HPA'Q0(_D%2_\98R
M4:J@$%3,&XMF];/Z6[/!]1XI<$I7B&6WUW_C.IF1P+T O*DY^GDX<CA"1'GG
ML)SD]KK;<%B?,%_K](M$B7\=.)/#*JU2"I0&9&1'M0(_4#?&:H(JO!([J IC
M>BT2_ FQ@Z?L2%Q"D%39Z G>>&#=8 [#IU:2*)"X>K]VN;[H(+["EHXF<O^Y
M[TB7X;28,$I6)BRQC7N/L#9(AFD] HR&&YN^:HQ98?$#18$><1R,GYL/P+5.
M=3C(=+Q.TN.(4AL)2^@1GXE-R;NCZ:B)8L@D/\8XDH"!'K&\5TM6KPD*0+"Z
M0FEBP^O#UW9N/?RD%OO#&WBT3SL;1.S ]#"[$7R]V,),NNPH3XS%9;DWKP:&
M!F5!EN&M(UAV=K:V9WI7S!@@ZYH=7*A+=*1T+*"I!B@<LV81G,6S*?(5&26Q
MVER_C)/'J<A@D7?->3D5_.N!,0NYM*2][O1J/&7.ANBQO]/ PY4"V2-[ZS%B
ME\ "&0NFV0E-<WQ@5T7,_QP@ >V.OD=R*-I3S"/_;P&2A"(LS82*-XOX> )M
M8/E3<([&64F,(M9&'M'$/"Z\RNC&F(SW*AV-$DY+8JB<.$YJP2X&96*VFZ]X
MF_VVJ5^4 MV@M;>*:C[0 HZ5<+W<Q,Y4K@75SO\'I,_WS%S6 R^-?<JL#"A7
MS'W&HA5]M[]#:#XWSN16U?HJ&9 072Z7P>VRMB_+U:5$EQYAS]GL?R[MT+=Z
MPX2Y>NY7ATY5S\*J2Y(K5TF5 7TUT&5]>0$]A 1=$S%MJ+SS?!;M'NK,F"6'
M<LU\><"U=EZ-PE?G?9K)T4.XT2$M6F@<(O<&;/%ZTL#D=T0J"'_[M%6'V#1&
MM21&3/V+@\3)D_V3TU@F_T NYJ,\'6YR94F%G9L@&!6R+= N&6%/Q"_5"S.%
MC ]9_!7 !U^X8=@WZ0CC=1L4N5"W@:GB[*&;5G8\163837.]D6#<8"1*,LS^
M$ET-9;SA'5_OI4E"6(BB=M!^^,Z/K&C[16] 35ILE]/R2X1218DRAAN*3<A,
M#;H';6PK=]^FRU%O1=?@U1LW;,H0RVF],Z&$F#CU5P&!U&XC6]H@ F6I3$)<
MFM,8>,I>]<.IA]]W_:P-N#?]37?_Q0+TUE<V.(B6=3J%I#U0FKNLB6%VO=CB
M4K9D&MWW$,V!9QY0163K0*_^>UW<_9<.5G+GC$VB1MX;FU+7;6! Q>$BWA3K
MK?_6)K([\ZH]JBF+Y%Q\7E[?">Y!=3ERP86)45N$HSU4.UY-9QI?UJ/&22%5
MST62$L[F'\KD]C#=:7=T<RZ@'KA2TL6T67[GF[VB<=Z6$MZ]*<6&FFOB%!)P
M%/O5=,7B5]9_@/Z3WYU O]MVYCF<HLB+O\VE3J;C/$[9'5Z_0C3DH^6ZO6$!
M1^VY#4[*K#/LK?++TH 5:[XV^(+LT:"/!<WLVJGH**CD3MS+-H'GTEXOSFX,
M^@BKV_XM2_PIUK[4T=X7RC[JX3Z5U,X6>([HZ[XLXXX*2DTRV,[8V;?<\8ZN
M[;X6,&O'^\[O8 -%LW;OB=+MQ1!#7QGP G_N=K'?X,[_\/*>U.5N[_VN%E\8
M\1+O.@8?$Y&Z\69[\>_RW%<C\B!_\K* \"@?[N%"*;QL\IFB\BLO[3(_\VM#
MO2]O[*Q2\S9_-CS?\UXS[T-1\7'3\4!_],BB\TB_]*;0\CN3\PXO*S_/]$\S
M]51?-&,2]<= ]&@&\U?_]0KE]6 _]CA_#D;/+6<_]CUO]6H_,TX?E20?/F+?
M]E3/]G2O,D+?]%S/\7-_]TAO]W[O,7DOIGL?+( ?^!IS^(@O,64_^+FB^(OO
M,) ?^0;C^(]4^-.N])1_]9._^0$3+5I/[''_0'WO^2#?^:;/[<WM\H=BO:6?
M^@R/^K!?\IJ_"=CI^K4_^S8O__NZ3RYCF_*8?XQIW_MJP_O$'_*Y3PGU7O2O
M?_PT/_S.WS66+PK+W_7)'_VQ#_W8/S5E7XRA?^S:O_U5'_[B7S1E!O6X__WE
MO_'&O_[ ,OVV$/R\TO[N/__D7_\V _^BC_[0??WX?_. X",()%1H>(B8J+C(
MV.CX"!DI.4E9:7F)F:FYR=GI^0D:*CI*6CH)).CS8WH8E!KD.L@Z2UMK*XHJ
M>[O+V^O["QPL/$Q<7)SK0VB\S-SL_ P=+3UM&IM<:PV;JDS=[>V)S/T]3EYN
M?HZ>?KRMWN[^#A\OCQY>BZRM.Z_?7+_O_P\PH,"!B_H1/(@PH<*%RY"MHI7-
MFCB&%/\W&:R(,:/&C1P17>P(,J3(D>\^ED(F1"+)E85,LGP),Z9,6RYGVKR)
M,V<D:P]GW5.I$V/-H$2+&B4Y]*C2I4P1)@45D5U3@D^G6KV*U5S5K%R[>C4&
M=%;4?%_C;2V+-JW:46?7NGT+5U);BZ^$2(U[;B[>O7S=ZNT+.'!6GMA>A15,
M[2_BQ8R#*FX,.?++QY9^WI7,[S+FS9QE4NX,.O3 SY0LDQ4=C#3JU:S;J6X-
M.[:WUSL-:Y9-\S;NW;SSZNX-/+@TPA!MGQ9.BC;RY<Q#*6\./?JEYXY,7Y/N
M_#?V[=S!:>\./CREP]6,7Q>?B3KZ]<O5LW_?VWU!\Q/A1Y+_;S\_:_SZ^X,F
M[A-]_MWWW8 &(L??@0HBEF K BXXWW$03KA;@Q1>N):%A8QU'H9":.AAB%R!
M*&*)4X%XCUT23DBBB>,!L<(%%<PX(P49L-"#(3^X@ *-/OJH0H<;MB#CCS.F
ML(,/+F:VXI*WH*+"C!:D(&00/[!@P0DL\*#C#BD8^2.5]07AP@5%UCCC"3OT
MY*0P ++"87T4MMCF(T' :($%/VJ98R$^\ @FD$(60J2>-%(P(PIKUKE.DXRR
M B6-8B)R)PL7\*FC"U\&>N2@0I1IZ(^**ODH,"BFDE*!!])9*B([]J@HFT+L
M@((*+"CY ZT5!"EG(J]6H"6IAD2*_X&BK?[":JD[;EI!L2Y0"H2E6G)9R+(5
M3/H($(#>V.>P/D3I[+&\D'?2@R$F*^ZOHR)"JZTY^N#EKIXF\F>/W'KT;;/&
MBLL+NHSFRFRQ.T"+):;5QHNM(];>2*VW45ZP+[_VJ.I)G"7Z^^B=,2(IZR*_
M\NJ(QA#?R@@J7\8J<6Z.INR)M1BHD,&UYU5ZZ0K= BQS$"%'FR6.)>>[+LOE
M"=(Q*1:+B#&C0.#),23P?@ER(QKWW&TBD:(L-*049XW)PBG$G/"=+?3<L+4)
M+T+SM"7WL *P27*=W-:<6-<KA$G7R<,*)UBP@LZ06!LU(WF?4$'??BNB,ZTG
M9-#"X7!GM__RXY?@C((/,680<:54#ZNIS'7[J;<%*L#BB.*,.R[YW')O<O2Y
MJZ<N"=N$&^YTYX$O(CO?GQ=B>@LIP?[)W4LN.Z4/EF+^[(;17KIEEU^>K8CE
MLP.!>B*FLP"\=Y%K[P,^\]K]>O92$XGYP)'DVN/MBBB.@>^/L)T!W]6+/UWX
M]/MJNP\]=$ZESF*3G2FH?:\0/$#!XK#W".D5CG3WN\2;3$&WB]FO@8@@7\02
M&"_U6<^ &7 ! QDANP7.CX($VAX)%6$V'_  8=?0G,&$D,+/!:%W(SR$Y5 @
MN@^>L(0#A(JY/"2\)06!2"CPV?D %:A[I<2"YG-$#U2P-]KML#3_$R0ASL1$
MI@N4+R4\4]O!F&4D)681>9#(W>BF. ER&>V'& KBDHAH1*?I*E &&Z(6+PA"
MO2T0C50T(1]AR+]K6/!98F/>S3J71!:8;XPH2)XCOA5%'?XQ0CT,7EVJR!XW
MEDAG<*R:PO(G0R:6,712G&1U,-G *U[C:6[K01>;]T7/.:),6TQ@Z$970U.F
MRH^L8^.%-+G)3DJ"E1ILA2C?!T41ZO*4O$2C*@FAK9/MP)72BF,,&:$S6C9R
ME-/+I2D=,C%!>&]WJT(E!8_Y-T 5\Q"T0@$><;<"%#!NF=DR)_VNF9(R8>!&
M5S*D(5@)O404T)V.; 3;Y-DX>E*2G-P;_Z<$FXE&.]92C@+<73O?J8B#GDZA
M/X/H#@%WG2QB  ,KN!( 6Y+!'EZTH(RPW-<0R%%\>=2!OIR3/>DW0P.V;YBZ
M"I(W+1>SODE-".B,J4PK:<IG.@Q8+,#A"_'9TEM*,A&#-.I1&=J)U@'QIO3K
MG21 NKO<E7(11;5J2[@*/+ .ZXE,=2HL8<C"W4&R<-23&BV19%9#J)$M-641
M6K-GL@H$[9$IW1T0V(HU%*H3J;H$9HB4RDZ=7F!SL0PHOMJ66%_%-:\;^JO4
M^@J^F>[P:HMZQ*M$UT/2%JU:@<3J-STK.<@:HH 9P("9O C7YZ46:*55K&Y=
MRT=PTB*"2(,M\/_@)]C>$G %*_ 9O-*'5.0.UD^Z"A9GKWI=M1XB4C-2(B!_
M.\J83?=#G6/8=3LKVDH0UW7IW6'>Q/NV0["-!22KE[P8^M[DRNI7+SRO8ST$
MU;.VK;MOQ=DZ$:' \?[*NYP%D5;;:%S YLM(3YTCIS+[H0D;27[>-.I_,61@
M3]$J9M[%&:?<)JRS1@E,'#ZOMXA6&''N-;2,52AW]V1-)%Y8N1E>\897 %QZ
M?OA" 38$K3!0 ?.RMD<G'B\J!KQA7+KXK.T]Q26K+)XA3WG+6MZRBV<<B@?_
M,L)>+C,FNFSFO HW0#(F<W/0G&:KPCG.,75%#VI,ES9C.3QSIK.-W>S_YT K
MPL&@75"?!?W:/2-ZT8U8,YP*K:!#,QJ-DI[T#L$,BO5N5=&6[G2&.>WI26/Z
M$V*V*:A#O>A*HYI^A-8SGO6CZE5+^-2R]O.H*P;I<M*ZUG&.-:\E]\!RN3K(
M^?'UK^%F[&-GK=7=N_6 DJULED$[VA([E3A5]&IJ:WO;W.9CJ;L-[G"+FX*:
M'K>YSXWNK'T[W>QNM[O9VVQ OWO>]*YW;-9M[WSK>]_,*3>__PWP@,,&WP(O
MN,$/#AA_(WSA#&\X6@CN\(A+?.(Y43C%+X[QC(\$XAKON,<_'I 4R1OD)"^Y
MR7_!\9.K?.4L;TBN6P[SF,L\QO'>]<QOCO.<_[^XYMG6N<]_#O1=\IS802^Z
MT5MN\:,K?>DP3SG3GPYUC"<]ZE2ONL2=;O6L:WW?4]^ZU[]>;ZR#?>QD[[;(
M;5[VM*L]SF)?N]O?SNBNPWWN=!=TV^N.][R;5>YZ[[O?Z_SROPM^\)0./.$/
MC_CLW3WQC&^\N/CN^,A+OE20G[SE+R^BQ6-^\YS7C^8[#_K0@^?L/1>]Z4\/
MG<^C?O6LETWE6P_[V,/F];*OO>TWH_K;ZW[W<<D][W\/?*_0/OC$+SY7?&_\
MY"L?)\-?/H!U/*,+M&^$F@MC\XATXA_I[AG5Q[$G;:A'@?W,Q];_OO.%T_SS
M4^BY/]*B^Q 'H\GZB/\"?+)CJ *%J JTN!DB.Q2!S5\(R"5^\T%^WJ=^S8%\
M!\@:.. !#>B #PB!$5@"C*!==N$"+1!'2W8M/-8N)+-=B!5?GD #&D"")6B"
M)XB",_!(@()A'=@P>D4D^S190#8_D9(PQ()1"B@;":B#HL& $0B$0&@"% A*
M_[0#+6 S",:"(<@[M9*!/:9?H#""*$B%5*B"C=8Y+8@"*?"$A")]M;5'@Y8O
M@7-8#Y.#/=@:*(%M1(>&L?&#00B'#3B$B%-5=K(\2))BD*!:H% #5>B')B@#
MV,0S>$A%*H!:*S E3+A4ZB,]^]>&]V9XCX@;.1"'E3B!='A'320U@\AC]13_
M)1BV"7WXAW]XA?"')4UC96T3)(B(BOABB- 30D FB:X7B;,(&V]8B4+("/JT
M4^]#2AUF-2"X6I@@BJ-8A:68"+$X5:7C3MMT49JXB$)29+88&NE'C:&!B[D(
M@9>8"':T3PGE1'HT5GKH ](TC)=0C,:(@H$(3U%$;,\X*\T(C2IV7ZY2A->(
M&CR(CXR1C=KH@'.842L0,P.(-F5%()_8B9J0CNIH@LAH3)GX(J>X*!5(CXPH
MCLNXCY*ACQDI&)3HCQ(H..%WAH6@3?.HA\+(APQ)A>S8C0:Y,Q*)*_>X5+ H
MCFS(D7%AC3<9&?WXD0 )3S$3?:?C.'941 !X2@AY_XZ6L) JJ0$LV0J?,C)&
MN0A/TV)I\U85>1[HPU12J9.+L9%=N1<\Z8_<B#O)%'V]J%=$-3(O*!>\E8>A
MR)0GZ)"'($R38"VRR$6(V%\9IHKG85]["9:0D9.!B1ABJ8T^R8QG4D=E ICD
MB)!OJ9!QV9 %&964X%5ZI4_SM%T:9B0'1I@,4HN?V1B&F8MD63HG@&3_9PAU
M61HH^0E+J9).^9"-V0@T=#@QB)8MP5:!XIFB"1A?Z9MJ09J5B)B08'_W)5$C
M.7Y1^)J268*RN2%0.5%V6#!/R /)1(;Y8EG!J9&AR9V!X9$?^8"F&0E$(B.\
MDIPFZ8G,Z0FPR9!SN9H0>?\?\;>7"G2#8UAZWPD7I&>3^HD7PQF'Q>F84>A5
MP+B92)F2SJD!\)D2[ ..V0)]_N<C2M9CJ-6?_JD6P(FA7!&>XMF Y#F@Z^*@
M!OJ!"-J<"LJ@\;@X[Y= $9I(W1(IO;FA?3&8,RJ<'OJ  MJBT 5-O)645N.C
M">J<T+E4X[4(#OH[&[2B?F.#^6FC95&C3UH6  J'((I!%06%H'B4R069F>">
MZIBB>_@(-'2D'/1^,>JD4MH5&JJF3$&E02B@4.*((D.0 2B07(H(;--<GE2&
M>'JB0QJ.\)6'>LH"+A"D'J,KZX*F%]JF6,&FC7H4;PJ$(!HI0J57>#*=0B!=
M/$;_J'QZJ.VIH L:J.QII\V5)(_94DNX"HL*J8(1I:W*&3<VH5VX5!1&JV*:
M&!.6?VG2/,I80YHC?JP*JWWQJ,.:<)Q)([0)A>4GAB::JP5(8$HB5KE$,\%J
M.?5HK'OQJMG*K=>XK=T*KH]8K.%*KL8WKN6*KK_'G^G*KH1I#4+'J.TJK\;W
MK?-JK[I7K_>JK[%WKOOJKYO7K_\JL)*7KP-KL #KG0>KL*=7L OKL(S7L \K
ML8,7L!-KL6]7L1>KL66WKAOKL:*7L1\KLE87L2-KLE]7LB>KLE87LBOKLD#7
MLB\KLSB7LC-KLS";L#>KLU17LSOKLS$7LS\KM!W7LT-K_[0D%[1'J[0.U[%+
MZ[105[1/*[4.E[13:[7[5K57J[7T%K5;Z[58F[-?*[81U[5C:[;M5K9GJ[;F
MEK5KZ[;'UK9O*[>KEK9S:[>_%K=WJ[>(UK1[Z[<!5[=_*[B(EK>#:[CG5;B'
MJ[ARABK.MKB/2VV!"[F3NW?FD0J7B[F9J[F;R[F=Z[F?"[JA*[JC2[JE:[JG
MB[JIJ[J@>V>KZ[JL^[JQ*[NS2[NU:[NWB[NY&[JMJ[NNR[N]"[S!*[S#2[S%
M:[S'B[S)J[S+"[O,^[F_Z[S1>[K>\[RW"[W2B[K7B[VDJ[W;Z[W?.[K=Z[O@
MF[WD6[KBF[KH:[[K*[OJF[[LRXB]\+N[M>N^IEN_IWN_\JL_^EN]M)N__ O
M >RZ.B/ XYL*_TN_Q(O SKO L8O #?RZ$%S YWNY$AS!"AS %JRZ#WR\&CS!
M\WO R>O!%/S!)=R\@C#"[SN\*8S!QLO!+HR[+(R\K<M%)FS#-XS#.:S#.\S#
7/>S#/PS$02S$0TS$16S$I?L#01 ( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>proxy001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy001.jpg
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M  (1 0,1 ?_$ 0<   (" P$! 0            @)  <$!08# @$!  (" P$
M               &! 4" P<!$   !0($! ,( P$        ! @,$!0 &$1(3
M!Q A%#0Q,P@P(C(D%34V-R C%A<1  $# @0"!0D$!P8' 0    ,! @01!0 A
M$A,4!A Q02(546%Q,D)2,W.T@;(C=3"18G)#)'2AL8(T%H8@DJ*#1&0U!Q(
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M"3=--(RFL4J=*4&9I3"';%5L]2&)3SXLL*4KM7#RNMYYZT=+IVP$;].3G?\
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MO#KS,.P=Q,TMN>5RP"11R',6.V+7;9^&F2IG7$&\V]Z/BS@-*W.JC<OQ O\
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MK;W[&"^2RZ*,/B9C&59+@C?^,2[ZORU-3E3 D3(<DK0Y$AF<QY62Y2B,#N7
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M8HMML$$82*(HS3Z#SQQLLO 0!6#IJOC2.",N!#O87D+^R<;=9J1,E*J5)!O
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3_O7J#Y\<UVQVB/BU?A&(^-/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>proxy002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ %P ( P$1  (1 0,1 ?_$ &   0
M      <! 0$                    !$  ! 00(!P$            ! A$2
M Q, (3$$% 45!D%182(6!P@7$0$                     _]H # ,!  (1
M Q$ /P!C4A"OH=)4D**-IE2"0UTG,6$CE464 E1N+V"?I#Q\WL3@O2S?1#$[
M2!&U&UCK\OL?99UKH4K#;^V_WY6>8^Z:J<E$ 9=/A8J=,KB27IC,/Q=LH1__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139653013382128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARTIVION, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000784199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139653007902368">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80F_eecd--PvpTableTextBlock_dU_zJebkmYsyoIk" style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"><span style="text-transform: none"><b>Pay Versus Performance Disclosure</b></span><span id="aort-def14a_051623a380"/></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">The following table sets forth a comparison of compensation reported in the summary compensation table to compensation actually paid to our Principal Executive Officer (PEO) and other Named Executive Officers (NEOs) as well as information on our </span><span style="text-transform: none">Company performance.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify">
					<table id="xdx_30F_zIQ7LRjGRw7i" style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 46.22pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 85.56pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 81.41pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 87.63pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 44.16pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 49.68pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Year</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Summary<br/>Compensation<br/>Table Total<br/>for PEO</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Compensation<br/>Actually Paid<br/>to PEO</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Average<br/>Summary<br/>Compensation<br/>Table Total for<br/>non-PEO NEOs</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Average<br/>Compensation<br/>Actually Paid<br/>to non-PEO NEOs</b></span></p>

							</td>
							<td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Value of initial fixed $100<br/>Investment based on:</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Net<br/>Loss<br/>($mm)</b></span></p>

							</td>
							<td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br/>Revenue<br/>Growth</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>AORT<br/>Shareholder<br/>Return</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Index Total<br/>Shareholder<br/>Return</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">&#160;</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(a)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(b)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(c)</sup></p>

							</td>
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt">(d)</sup></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2022</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--PeoTotalCompAmt_pp0p0_c20220101__20221231_fKGEp_zoEf4kskIFbe" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$7,548,808 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--PeoActuallyPaidCompAmt_pp0p0_c20220101__20221231_fKGEp_z1Qu7XcqCYK7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$4,718,496 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20220101__20221231_fKGIp_zWbcOm2Qgv33" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"><span style="text-transform: none">$1,848,198 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20220101__20221231_fKGIp_zGEWrtomBJeb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"><span style="text-transform: none">$1,352,869 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zeV9wWgxdR33" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"><span style="text-transform: none">$45 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 4pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zEulPXXfnq6d" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"><span style="text-transform: none">$97 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20220101__20221231_zwE0TSosjIAe" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"><span style="text-transform: none">($19)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20220101__20221231_z2GZLXsNRON5" title="Company Selected Measure Amount">9.8</span>%</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2021</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--PeoTotalCompAmt_pp0p0_c20210101__20211231_fKGEp_zogi3BWxgRc5" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$4,749,584 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20210101__20211231_fKGEp_zw41mpR1JMY9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$3,712,538 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20210101__20211231_fKGIp_zHDqLJh0MDl9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"><span style="text-transform: none">$1,304,288 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20210101__20211231_fKGIp_zQIPmXlQUGqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"><span style="text-transform: none">$1,108,935 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zs0vTC43Gq5f" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"><span style="text-transform: none">$75 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zSoyXi06F3w4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"><span style="text-transform: none">$144 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20210101__20211231_zM8zwXu2Q7ve" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"><span style="text-transform: none">($15)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_90A_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20210101__20211231_z2x0iOTB9I02" title="Company Selected Measure Amount">9.4</span>%</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none">2020</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--PeoTotalCompAmt_pp0p0_c20200101__20201231_fKGEp_zfaorajeEQfj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$3,415,458 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20200101__20201231_fKGEp_zxRIlHQvgEQ2" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"><span style="text-transform: none">$327,652 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20200101__20201231_fKGIp_zykulp7Uwsib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"><span style="text-transform: none">$977,089 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20200101__20201231_fKGIp_zEjATAkTc7Jl" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"><span style="text-transform: none">$454,525 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zoIbfM7FYZh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"><span style="text-transform: none">$87 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zqLvhC5aqkVg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"><span style="text-transform: none">$140 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20200101__20201231_zDVfMXJUcW8h" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"><span style="text-transform: none">($17)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20200101__20201231_znjCMgMagXTf" title="Company Selected Measure Amount">-8.1</span>%</span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0F_zXuwvGsg1JYb" style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup>(a)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_z8EHFZeEHNwc" style="text-transform: none"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--PeoName_c20220101__20221231_z8Zb0dfd6r86"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_901_eecd--PeoName_c20210101__20211231_zEA5j1JW9Cg1"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231_zlAEDYuREUAa">Mr. Mackin</span></span></span> served as our
only PEO for each year.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0A_zEGcUCL90B93">(b)</sup></span></td><td style="width: 5pt"/><td id="xdx_985_eecd--NamedExecutiveOfficersFnTextBlock_c20220101__20221231_zdIo2erIY1Q1" style="text-align: justify"><span id="xdx_F13_zIKeKCvIt5N" style="text-transform: none">Our Non-PEO NEOs in 2022
and 2021 were <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_z0L4uNyhE8j9"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zT6vzkGwhwP">Messrs. Lee</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zqrgItmHd5Z6"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zVADqc2qEF3e">Davis</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zedUaqxKrJb5"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zCNkddbB5pG2">Stanton</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zFbNFkeHXJw2"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zGlhLReROcUd">Ms. Holloway</span></span>. Our Non-PEO NEOs in 2020 were <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zPtaDtEIxdV4">Messrs. Lee</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zZCOthiqP5qi">Davis</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--SimpsonMember_z8JdtL9iGCM4">Simpson</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zhzx4i2n1YXb">Ms. Holloway</span>.
Mr. Stanton joined the company in March 2021.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zDeE3TEmiumj">(c)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zTQ5gViHTxil" style="text-transform: none">Shareholder returns reflect
$100 invested as of market close on December 31, 2019, the final trading day of fiscal 2019; Index Shareholder Return reflects NASDAQ
Medical Equipment Index.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0F_z9iyaN5pmf4g">(d)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F18_znPDQAJLT9c8" style="text-transform: none">Company selected measure
of revenue growth is used in incentive plans. Result is measured in constant currency and adjusted to appropriately reflect baseline.
For 2022, the incentive plan measure for constant currency revenue growth was adjusted to exclude PerClot sales in 2021 and 2022. For
2021, the incentive plan measure for revenue growth reflected the 2<span style="font-size: 7pt; line-height: 7pt"><sup>nd</sup></span>
half in 2021 as compared to the 2<span style="font-size: 7pt; line-height: 7pt"><sup>nd</sup></span> half in 2019. For 2020, revenue,
as opposed to revenue growth, was used as a metric in the Company&#8217;s annual cash bonus plan, but due to the impact of COVID-19 on
the Company&#8217;s business, the revenue result (along with adjusted net income which was also used that year as a metric) would have
resulted in no payout under the cash bonus program. Accordingly, the payout under the cash bonus program for 2020 was based on executive
officer performance to other goals as set forth in the Company&#8217;s 2021 Proxy Statement.</span></td>
</tr></table>
				<p id="xdx_84A_eecd--AdjToPeoCompFnTextBlock_dU_zz9HsyXm2gid" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">&#160;</span></p>

<p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">The following table sets forth a reconciliation from the Summary Compensation Table (&#8220;SCT&#8221;) to Compensation Actually Paid (&#8220;CAP&#8221;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, </span><span style="text-transform: none; font-size: 9pt">and 2022.</span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left">
					<table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>PEO</b></span></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>Average NEO</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SCT Total Compensation</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$7,548,808 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,749,584 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,415,458 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,848,198 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,304,288 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$977,089 </b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($5,919,725)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($3,098,512)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,323,534)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,176,295)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($658,199)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($499,129)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year End Fair Value of Equity Awards Made During Year (f)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$4,689,996 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$2,402,215 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$1,931,021 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$955,981 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$508,720 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$429,985 </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,385,504)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($495,663)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,326,940)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($239,756)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($72,575)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($371,199)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in </b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>the Ye</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ar (h)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($215,079)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$154,913 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($368,352)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($32,529)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$26,701 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($73,105)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Total Adjustments Related to Eq</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>uity Awards&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($2,830,312)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($1,037,046)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($3,087,806)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($495,329)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($195,353)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($522,447)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Compensation Actually Paid Total (i)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,718,496 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,712,538 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$327,652 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,352,869 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,108,935 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b><span style="-sec-ix-hidden: xdx2ixbrl0126">$454,642 </span></b></span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F06_zMiytBuyFtDi">(e)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zTDKLCPrF6n1">(f)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F02_zALNNCrU0SY9">(g)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zgUPQyOqT1Z6">(h)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zJbnKXFx12Pe">(i)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z57fmLv8s6if" style="text-transform: none">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</span></td>
</tr></table>

<p id="xdx_8A9_z9wUemXSmvDk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_853_zC2XhQ6om367" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span id="xdx_F13_zIKeKCvIt5N" style="text-transform: none">Our Non-PEO NEOs in 2022
and 2021 were <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_z0L4uNyhE8j9"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zT6vzkGwhwP">Messrs. Lee</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zqrgItmHd5Z6"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zVADqc2qEF3e">Davis</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zedUaqxKrJb5"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zCNkddbB5pG2">Stanton</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zFbNFkeHXJw2"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zGlhLReROcUd">Ms. Holloway</span></span>. Our Non-PEO NEOs in 2020 were <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zPtaDtEIxdV4">Messrs. Lee</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zZCOthiqP5qi">Davis</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--SimpsonMember_z8JdtL9iGCM4">Simpson</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zhzx4i2n1YXb">Ms. Holloway</span>.
Mr. Stanton joined the company in March 2021.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7,548,808<span></span>
</td>
<td class="nump">$ 4,749,584<span></span>
</td>
<td class="nump">$ 3,415,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 4,718,496<span></span>
</td>
<td class="nump">3,712,538<span></span>
</td>
<td class="nump">327,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84A_eecd--AdjToPeoCompFnTextBlock_dU_zz9HsyXm2gid" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">&#160;</span></p>

<p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">The following table sets forth a reconciliation from the Summary Compensation Table (&#8220;SCT&#8221;) to Compensation Actually Paid (&#8220;CAP&#8221;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, </span><span style="text-transform: none; font-size: 9pt">and 2022.</span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left">
					<table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>PEO</b></span></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>Average NEO</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SCT Total Compensation</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$7,548,808 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,749,584 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,415,458 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,848,198 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,304,288 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$977,089 </b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($5,919,725)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($3,098,512)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,323,534)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,176,295)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($658,199)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($499,129)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year End Fair Value of Equity Awards Made During Year (f)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$4,689,996 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$2,402,215 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$1,931,021 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$955,981 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$508,720 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$429,985 </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,385,504)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($495,663)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,326,940)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($239,756)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($72,575)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($371,199)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in </b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>the Ye</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ar (h)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($215,079)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$154,913 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($368,352)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($32,529)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$26,701 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($73,105)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Total Adjustments Related to Eq</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>uity Awards&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($2,830,312)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($1,037,046)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($3,087,806)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($495,329)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($195,353)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($522,447)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Compensation Actually Paid Total (i)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,718,496 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,712,538 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$327,652 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,352,869 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,108,935 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b><span style="-sec-ix-hidden: xdx2ixbrl0126">$454,642 </span></b></span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F06_zMiytBuyFtDi">(e)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zTDKLCPrF6n1">(f)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F02_zALNNCrU0SY9">(g)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zgUPQyOqT1Z6">(h)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zJbnKXFx12Pe">(i)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z57fmLv8s6if" style="text-transform: none">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</span></td>
</tr></table>

<p id="xdx_8A9_z9wUemXSmvDk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,848,198<span></span>
</td>
<td class="nump">1,304,288<span></span>
</td>
<td class="nump">977,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 1,352,869<span></span>
</td>
<td class="nump">1,108,935<span></span>
</td>
<td class="nump">454,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"><span style="text-transform: none; font-size: 9pt">The following table sets forth a reconciliation from the Summary Compensation Table (&#8220;SCT&#8221;) to Compensation Actually Paid (&#8220;CAP&#8221;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, </span><span style="text-transform: none; font-size: 9pt">and 2022.</span></p>
				<div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left">
					<table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
						<tr style="margin: 0; height: 0">
							<td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>
							<td style="border-width: 0; margin: 0; padding: 0; width: 69pt">


							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt">&#8203;</p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>PEO</b></span></p>

							</td>
							<td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>Average NEO</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2022</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2021</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse">
								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><b>2020</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SCT Total Compensation</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$7,548,808 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,749,584 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,415,458 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,848,198 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,304,288 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$977,089 </b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($5,919,725)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($3,098,512)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,323,534)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,176,295)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($658,199)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($499,129)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year End Fair Value of Equity Awards Made During Year (f)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$4,689,996 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$2,402,215 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$1,931,021 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$955,981 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$508,720 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$429,985 </span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($1,385,504)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($495,663)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($2,326,940)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($239,756)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($72,575)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($371,199)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in </b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>the Ye</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>ar (h)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($215,079)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$154,913 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($368,352)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($32,529)</span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">$26,701 </span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt">($73,105)</span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Total Adjustments Related to Eq</b></span><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>uity Awards&#160;</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($2,830,312)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($1,037,046)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($3,087,806)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($495,329)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($195,353)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>($522,447)</b></span></p>

							</td>

						</tr>
						<tr style="min-height: 3pt">
							<td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>Compensation Actually Paid Total (i)</b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$4,718,496 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$3,712,538 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$327,652 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,352,869 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b>$1,108,935 </b></span></p>

							</td>
							<td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse">
								<p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"><span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"><b><span style="-sec-ix-hidden: xdx2ixbrl0126">$454,642 </span></b></span></p>

							</td>

						</tr>

					</table>

				</div>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F06_zMiytBuyFtDi">(e)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zTDKLCPrF6n1">(f)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F02_zALNNCrU0SY9">(g)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F0E_zgUPQyOqT1Z6">(h)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 7pt; text-transform: none; line-height: 7pt"><sup id="xdx_F05_zJbnKXFx12Pe">(i)</sup></span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z57fmLv8s6if" style="text-transform: none">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</span></td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zbxBrHxhJyQg" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">Because a majority of total compensation provided to the PEO and the average paid to the Non-PEO NEOs is via equity-based grants that vest over multi-year periods, the primary driver of changes in &#8220;Compensation Actually Paid&#8221; totals for the PEO and the average for the Non-PEO NEOs is the change in the Company&#8217;s </span><span style="text-transform: none">stock price.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 416.48pt; height: 322.64pt; text-align: left">
						<img alt="" src="aort-def14a_051623img005.gif" style="vertical-align: top; margin-left: 0pt; width: 416.29pt; margin-top: 0pt; height: 322pt"/>

					</div>

				</div>
				<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_802_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zpULkLwNq9D4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As discussed in other sections of this proxy statement, in November 2022, the Compensation Committee decided to accelerate equity grants to officers that otherwise were expected to be made in the first quarter of 2023. The grant date and year-end 2022 fair values of these November 2022 grants have a significant impact on both the Summary Compensation Total and Compensation Actually Paid. The chart below shows 2022 Officer Compensation (SCT and CAP values) both as reported and excluding the impact of equity grants made in </span><span style="text-transform: none">November 2022.</span></p>
				<div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center">
					<div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 415.93pt; height: 307.46pt; text-align: left">
						<img alt="" src="aort-def14a_051623img006.gif" style="vertical-align: top; margin-left: 0pt; width: 415.15pt; margin-top: 0pt; height: 307.04pt"/>

					</div>

				</div>

			<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80D_eecd--TabularListTableTextBlock_dU_zIxA8D6CU2J9" style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"><span style="text-transform: none; font-style: italic"><b><i>Most Important Financial Measures Related To 2022 Officer Compensation</i></b></span></p>
				<p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"><span style="text-transform: none">As discussed in the CD&amp;A, the annual short-term incentive plan used revenue growth (constant currency) as the primary financial measure for 2022. Annual PSUs granted during 2022 were earned based on revenue growth (constant currency) and adjusted EBITDA. LTIP shares earned during 2022 were based on revenue growth (constant currency) and, with respect to the 2019 LTIP, </span><span style="text-transform: none">gross margin.</span></p>




								<p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><b>Key Financial Measures</b></span></p>


								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__1_fKDEp_zXE5NDaQp76a">Revenue Growth (constant currency)</span></span></p>


								<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none; font-size: 9pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__2_fKDEp_zZH5LmhgGgWg">Adjusted EBITDA</span></span></p>

							<p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"><span style="text-transform: none"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__3_fKDEp_zI4ZLYJ8kb9k">Gross Margin</span></span></p>
        <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (19,000,000)<span></span>
</td>
<td class="num">$ (15,000,000)<span></span>
</td>
<td class="num">$ (17,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.098<span></span>
</td>
<td class="nump">0.094<span></span>
</td>
<td class="num">(0.081)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. Mackin<span></span>
</td>
<td class="text">Mr. Mackin<span></span>
</td>
<td class="text">Mr. Mackin<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure [Axis]: 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Revenue Growth (constant currency)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure [Axis]: 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure [Axis]: 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Gross Margin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Subtract Grant Fair Value Of Equity Awards Made During Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">$ (1,176,295)<span></span>
</td>
<td class="num">$ (658,199)<span></span>
</td>
<td class="num">$ (499,129)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Add Year End Fair Value Of Equity Awards Made During Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">955,981<span></span>
</td>
<td class="nump">508,720<span></span>
</td>
<td class="nump">429,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Add Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">(239,756)<span></span>
</td>
<td class="num">(72,575)<span></span>
</td>
<td class="num">(371,199)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Add Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Year That Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">(32,529)<span></span>
</td>
<td class="nump">26,701<span></span>
</td>
<td class="num">(73,105)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Total Adjustments Related To Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (495,329)<span></span>
</td>
<td class="num">$ (195,353)<span></span>
</td>
<td class="num">$ (522,447)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Messr Lee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Messrs. Lee<span></span>
</td>
<td class="text">Messrs. Lee<span></span>
</td>
<td class="text">Messrs. Lee<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Messr Davis</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Davis<span></span>
</td>
<td class="text">Davis<span></span>
</td>
<td class="text">Davis<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Messr Stanton</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Stanton<span></span>
</td>
<td class="text">Stanton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Ms Holloway</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ms. Holloway<span></span>
</td>
<td class="text">Ms. Holloway<span></span>
</td>
<td class="text">Ms. Holloway<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Messr Simpson</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Simpson<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Average Subtract Grant Fair Value Of Equity Awards Made During Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">$ (5,919,725)<span></span>
</td>
<td class="num">$ (3,098,512)<span></span>
</td>
<td class="num">$ (2,323,534)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Average Add Year End Fair Value Of Equity Awards Made During Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">4,689,996<span></span>
</td>
<td class="nump">2,402,215<span></span>
</td>
<td class="nump">1,931,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Average Add Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">(1,385,504)<span></span>
</td>
<td class="num">(495,663)<span></span>
</td>
<td class="num">(2,326,940)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Average Add Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Year That Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">(215,079)<span></span>
</td>
<td class="nump">154,913<span></span>
</td>
<td class="num">(368,352)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Total Adjustments Related To Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,830,312)<span></span>
</td>
<td class="num">$ (1,037,046)<span></span>
</td>
<td class="num">$ (3,087,806)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--PeoName_c20220101__20221231_z8Zb0dfd6r86"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_901_eecd--PeoName_c20210101__20211231_zEA5j1JW9Cg1"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231_zlAEDYuREUAa">Mr. Mackin</span></span></span> served as our
only PEO for each year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=aort_TotalAdjustmentsRelatedToEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=aort_TotalAdjustmentsRelatedToEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aort_MessrsLeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aort_MessrsLeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aort_DavisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aort_DavisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aort_StantonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aort_StantonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aort_MsHollowayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aort_MsHollowayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aort_SimpsonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aort_SimpsonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>aort-def14a_051623_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aort="http://cryolife.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aort-20221231.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_StantonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:StantonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_StantonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:StantonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MessrsLeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_DavisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:DavisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_SimpsonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:SimpsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aort:MsHollowayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">aort:TotalAdjustmentsRelatedToEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31">0000784199</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="xdx2ixbrl0126"
      unitRef="USD">454525</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31">ARTIVION, INC.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80F_eecd--PvpTableTextBlock_dU_zJebkmYsyoIk" style="border-bottom: #7f7f7f 1pt solid; font: 12pt/normal Arial, sans-serif; margin: 0pt 0pt 15pt; text-transform: none; color: #024a76; text-indent: 0pt; text-align: left"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Pay Versus Performance Disclosure&lt;/b&gt;&lt;/span&gt;&lt;span id="aort-def14a_051623a380"/&gt;&lt;/p&gt;
				&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"&gt;&lt;span style="text-transform: none"&gt;The following table sets forth a comparison of compensation reported in the summary compensation table to compensation actually paid to our Principal Executive Officer (PEO) and other Named Executive Officers (NEOs) as well as information on our &lt;/span&gt;&lt;span style="text-transform: none"&gt;Company performance.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-align: justify"&gt;
					&lt;table id="xdx_30F_zIQ7LRjGRw7i" style="table-layout: fixed; width: 621pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
						&lt;tr style="margin: 0; height: 0"&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 46.22pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 85.56pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 81.41pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 87.63pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 88.32pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 44.16pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 49.68pt"&gt;


							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total&lt;br/&gt;for PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Average&lt;br/&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total for&lt;br/&gt;non-PEO NEOs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Average&lt;br/&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to non-PEO NEOs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Value of initial fixed $100&lt;br/&gt;Investment based on:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Net&lt;br/&gt;Loss&lt;br/&gt;($mm)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td rowspan="2" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;AORT&lt;br/&gt;Revenue&lt;br/&gt;Growth&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;AORT&lt;br/&gt;Shareholder&lt;br/&gt;Return&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Index Total&lt;br/&gt;Shareholder&lt;br/&gt;Return&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(a)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(a)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(b)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(b)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(c)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(c)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt"&gt;&#x200b;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;sup style="text-transform: none; font-weight: normal; font-size: 8pt; line-height: 8pt"&gt;(d)&lt;/sup&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"&gt;&lt;span style="text-transform: none"&gt;2022&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_981_eecd--PeoTotalCompAmt_pp0p0_c20220101__20221231_fKGEp_zoEf4kskIFbe" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$7,548,808 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--PeoActuallyPaidCompAmt_pp0p0_c20220101__20221231_fKGEp_z1Qu7XcqCYK7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$4,718,496 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20220101__20221231_fKGIp_zWbcOm2Qgv33" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$1,848,198 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20220101__20221231_fKGIp_zGEWrtomBJeb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;&lt;span style="text-transform: none"&gt;$1,352,869 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zeV9wWgxdR33" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$45 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 4pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_989_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKGMp_zEulPXXfnq6d" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$97 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20220101__20221231_zwE0TSosjIAe" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"&gt;&lt;span style="text-transform: none"&gt;($19)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20220101__20221231_z2GZLXsNRON5" title="Company Selected Measure Amount"&gt;9.8&lt;/span&gt;%&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"&gt;&lt;span style="text-transform: none"&gt;2021&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--PeoTotalCompAmt_pp0p0_c20210101__20211231_fKGEp_zogi3BWxgRc5" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$4,749,584 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20210101__20211231_fKGEp_zw41mpR1JMY9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$3,712,538 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20210101__20211231_fKGIp_zHDqLJh0MDl9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$1,304,288 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20210101__20211231_fKGIp_zQIPmXlQUGqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;&lt;span style="text-transform: none"&gt;$1,108,935 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zs0vTC43Gq5f" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$75 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKGMp_zSoyXi06F3w4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$144 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20210101__20211231_zM8zwXu2Q7ve" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"&gt;&lt;span style="text-transform: none"&gt;($15)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;span id="xdx_90A_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20210101__20211231_z2x0iOTB9I02" title="Company Selected Measure Amount"&gt;9.4&lt;/span&gt;%&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"&gt;&lt;span style="text-transform: none"&gt;2020&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_989_eecd--PeoTotalCompAmt_pp0p0_c20200101__20201231_fKGEp_zfaorajeEQfj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$3,415,458 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--PeoActuallyPaidCompAmt_pp0p0_c20200101__20201231_fKGEp_zxRIlHQvgEQ2" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$327,652 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20200101__20201231_fKGIp_zykulp7Uwsib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Total Compensation Amount"&gt;&lt;span style="text-transform: none"&gt;$977,089 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt 1.5pt 8pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20200101__20201231_fKGIp_zEjATAkTc7Jl" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;&lt;span style="text-transform: none"&gt;$454,525 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zoIbfM7FYZh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$87 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKGMp_zqLvhC5aqkVg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;&lt;span style="text-transform: none"&gt;$140 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eus-gaap--NetIncomeLoss_pn6n6_uUSD_c20200101__20201231_zDVfMXJUcW8h" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center" title="Net Income (Loss)"&gt;&lt;span style="text-transform: none"&gt;($17)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;span id="xdx_904_eecd--CoSelectedMeasureAmt_pid_dp_uRatio_c20200101__20201231_znjCMgMagXTf" title="Company Selected Measure Amount"&gt;-8.1&lt;/span&gt;%&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;

					&lt;/table&gt;

				&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0F_zXuwvGsg1JYb" style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_z8EHFZeEHNwc" style="text-transform: none"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--PeoName_c20220101__20221231_z8Zb0dfd6r86"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_901_eecd--PeoName_c20210101__20211231_zEA5j1JW9Cg1"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231_zlAEDYuREUAa"&gt;Mr. Mackin&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; served as our
only PEO for each year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0A_zEGcUCL90B93"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td id="xdx_985_eecd--NamedExecutiveOfficersFnTextBlock_c20220101__20221231_zdIo2erIY1Q1" style="text-align: justify"&gt;&lt;span id="xdx_F13_zIKeKCvIt5N" style="text-transform: none"&gt;Our Non-PEO NEOs in 2022
and 2021 were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_z0L4uNyhE8j9"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zT6vzkGwhwP"&gt;Messrs. Lee&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zqrgItmHd5Z6"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zVADqc2qEF3e"&gt;Davis&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zedUaqxKrJb5"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zCNkddbB5pG2"&gt;Stanton&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zFbNFkeHXJw2"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zGlhLReROcUd"&gt;Ms. Holloway&lt;/span&gt;&lt;/span&gt;. Our Non-PEO NEOs in 2020 were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zPtaDtEIxdV4"&gt;Messrs. Lee&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zZCOthiqP5qi"&gt;Davis&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--SimpsonMember_z8JdtL9iGCM4"&gt;Simpson&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zhzx4i2n1YXb"&gt;Ms. Holloway&lt;/span&gt;.
Mr. Stanton joined the company in March 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0E_zDeE3TEmiumj"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zTQ5gViHTxil" style="text-transform: none"&gt;Shareholder returns reflect
$100 invested as of market close on December 31, 2019, the final trading day of fiscal 2019; Index Shareholder Return reflects NASDAQ
Medical Equipment Index.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0F_z9iyaN5pmf4g"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_znPDQAJLT9c8" style="text-transform: none"&gt;Company selected measure
of revenue growth is used in incentive plans. Result is measured in constant currency and adjusted to appropriately reflect baseline.
For 2022, the incentive plan measure for constant currency revenue growth was adjusted to exclude PerClot sales in 2021 and 2022. For
2021, the incentive plan measure for revenue growth reflected the 2&lt;span style="font-size: 7pt; line-height: 7pt"&gt;&lt;sup&gt;nd&lt;/sup&gt;&lt;/span&gt;
half in 2021 as compared to the 2&lt;span style="font-size: 7pt; line-height: 7pt"&gt;&lt;sup&gt;nd&lt;/sup&gt;&lt;/span&gt; half in 2019. For 2020, revenue,
as opposed to revenue growth, was used as a metric in the Company&#x2019;s annual cash bonus plan, but due to the impact of COVID-19 on
the Company&#x2019;s business, the revenue result (along with adjusted net income which was also used that year as a metric) would have
resulted in no payout under the cash bonus program. Accordingly, the payout under the cash bonus program for 2020 was based on executive
officer performance to other goals as set forth in the Company&#x2019;s 2021 Proxy Statement.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
				&lt;p id="xdx_84A_eecd--AdjToPeoCompFnTextBlock_dU_zz9HsyXm2gid" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;The following table sets forth a reconciliation from the Summary Compensation Table (&#x201c;SCT&#x201d;) to Compensation Actually Paid (&#x201c;CAP&#x201d;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, &lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;and 2022.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left"&gt;
					&lt;table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
						&lt;tr style="margin: 0; height: 0"&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt"&gt;&#x200b;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;Average NEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SCT Total Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$7,548,808 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,749,584 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,415,458 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,848,198 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,304,288 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$977,089 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($5,919,725)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($3,098,512)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,323,534)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,176,295)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($658,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($499,129)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year End Fair Value of Equity Awards Made During Year (f)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$4,689,996 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$2,402,215 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$1,931,021 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$955,981 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$508,720 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$429,985 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,385,504)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($495,663)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,326,940)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($239,756)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($72,575)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($371,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in &lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;the Ye&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ar (h)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($215,079)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$154,913 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($368,352)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($32,529)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$26,701 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($73,105)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Total Adjustments Related to Eq&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;uity Awards&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($2,830,312)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($1,037,046)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($3,087,806)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($495,329)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($195,353)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($522,447)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Compensation Actually Paid Total (i)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,718,496 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,712,538 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$327,652 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,352,869 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,108,935 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;$454,642 &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;

					&lt;/table&gt;

				&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F06_zMiytBuyFtDi"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none"&gt;Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zTDKLCPrF6n1"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none"&gt;Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F02_zALNNCrU0SY9"&gt;(g)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0E_zgUPQyOqT1Z6"&gt;(h)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zJbnKXFx12Pe"&gt;(i)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z57fmLv8s6if" style="text-transform: none"&gt;Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_z9wUemXSmvDk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_853_zC2XhQ6om367" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      id="Fact000015"
      unitRef="USD">7548808</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">4718496</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1848198</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1352869</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="2"
      unitRef="USD">45</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="2"
      unitRef="USD">97</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-6"
      unitRef="USD">-19000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Ratio">0.098</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">4749584</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000033"
      unitRef="USD">3712538</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1304288</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1108935</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      unitRef="USD">75</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      unitRef="USD">144</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-6"
      unitRef="USD">-15000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Ratio">0.094</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">3415458</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000049"
      unitRef="USD">327652</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">977089</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">454525</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      unitRef="USD">87</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      unitRef="USD">140</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-6"
      unitRef="USD">-17000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Ratio">-0.081</ecd:CoSelectedMeasureAmt>
    <ecd:PeoName contextRef="From2022-01-01to2022-12-31">Mr. Mackin</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31">Mr. Mackin</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31">Mr. Mackin</ecd:PeoName>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2022-01-01to2022-12-31">&lt;span id="xdx_F13_zIKeKCvIt5N" style="text-transform: none"&gt;Our Non-PEO NEOs in 2022
and 2021 were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_z0L4uNyhE8j9"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zT6vzkGwhwP"&gt;Messrs. Lee&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zqrgItmHd5Z6"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zVADqc2qEF3e"&gt;Davis&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zedUaqxKrJb5"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--StantonMember_zCNkddbB5pG2"&gt;Stanton&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--PeoName_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zFbNFkeHXJw2"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--PeoName_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zGlhLReROcUd"&gt;Ms. Holloway&lt;/span&gt;&lt;/span&gt;. Our Non-PEO NEOs in 2020 were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MessrsLeeMember_zPtaDtEIxdV4"&gt;Messrs. Lee&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--DavisMember_zZCOthiqP5qi"&gt;Davis&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--SimpsonMember_z8JdtL9iGCM4"&gt;Simpson&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--PeoName_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--MsHollowayMember_zhzx4i2n1YXb"&gt;Ms. Holloway&lt;/span&gt;.
Mr. Stanton joined the company in March 2021.&lt;/span&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">Messrs. Lee</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">Messrs. Lee</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_DavisMember">Davis</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DavisMember">Davis</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_StantonMember">Stanton</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_StantonMember">Stanton</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">Ms. Holloway</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">Ms. Holloway</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MessrsLeeMember">Messrs. Lee</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_DavisMember">Davis</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_SimpsonMember">Simpson</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_MsHollowayMember">Ms. Holloway</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84A_eecd--AdjToPeoCompFnTextBlock_dU_zz9HsyXm2gid" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;The following table sets forth a reconciliation from the Summary Compensation Table (&#x201c;SCT&#x201d;) to Compensation Actually Paid (&#x201c;CAP&#x201d;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, &lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;and 2022.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left"&gt;
					&lt;table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
						&lt;tr style="margin: 0; height: 0"&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt"&gt;&#x200b;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;Average NEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SCT Total Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$7,548,808 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,749,584 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,415,458 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,848,198 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,304,288 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$977,089 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($5,919,725)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($3,098,512)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,323,534)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,176,295)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($658,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($499,129)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year End Fair Value of Equity Awards Made During Year (f)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$4,689,996 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$2,402,215 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$1,931,021 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$955,981 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$508,720 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$429,985 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,385,504)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($495,663)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,326,940)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($239,756)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($72,575)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($371,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in &lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;the Ye&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ar (h)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($215,079)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$154,913 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($368,352)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($32,529)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$26,701 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($73,105)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Total Adjustments Related to Eq&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;uity Awards&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($2,830,312)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($1,037,046)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($3,087,806)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($495,329)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($195,353)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($522,447)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Compensation Actually Paid Total (i)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,718,496 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,712,538 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$327,652 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,352,869 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,108,935 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;$454,642 &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;

					&lt;/table&gt;

				&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F06_zMiytBuyFtDi"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none"&gt;Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zTDKLCPrF6n1"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none"&gt;Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F02_zALNNCrU0SY9"&gt;(g)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0E_zgUPQyOqT1Z6"&gt;(h)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zJbnKXFx12Pe"&gt;(i)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z57fmLv8s6if" style="text-transform: none"&gt;Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_z9wUemXSmvDk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zpKMjhBcfiW4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: justify"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;The following table sets forth a reconciliation from the Summary Compensation Table (&#x201c;SCT&#x201d;) to Compensation Actually Paid (&#x201c;CAP&#x201d;) to our PEO and for the average paid to our Non-PEO NEOs for the years ended December 31, 2020, 2021, &lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;and 2022.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 12pt/normal Times New Roman, Times, serif; margin: 0pt 0pt 10pt 13.8pt; text-transform: none; color: #000000; text-align: left"&gt;
					&lt;table id="xdx_302_zeiDQBUh9fag" style="table-layout: fixed; width: 607.2pt; margin-top: 4pt; margin-bottom: 10pt; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
						&lt;tr style="margin: 0; height: 0"&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 193.2pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;
							&lt;td style="border-width: 0; margin: 0; padding: 0; width: 69pt"&gt;


							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="margin: 0pt 0pt 0; text-transform: none; font-size: 1pt; line-height: 1pt"&gt;&#x200b;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td colspan="3" style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;Average NEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 0pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SCT Total Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_z7BBg3UDj3Y" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$7,548,808 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--PeoTotalCompAmt_c20210101__20211231_zzGHxSzwcf12" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,749,584 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--PeoTotalCompAmt_c20200101__20201231_zXjmIPSA2X2c" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,415,458 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z387BpYlgqS9" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,848,198 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_ztu1QJu34Yob" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,304,288 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_zWjzSAH9pQc7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$977,089 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;SUBTRACT Grant Fair Value of Equity Awards Made During Year (e)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zYTJlqBb8xH7" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($5,919,725)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_z3LKLdE5rmt8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($3,098,512)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zfI5eMJxt12a" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,323,534)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zR2HQcZbv4Cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,176,295)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zpgYcEsvaRc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($658,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98C_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember_fKGUp_zS9m3ZMp5oM8" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($499,129)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year End Fair Value of Equity Awards Made During Year (f)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zvqpf1Wdcj8b" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$4,689,996 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_z91e0U7KsgNa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$2,402,215 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_988_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zf2FW2NGPRG" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$1,931,021 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zEaSKCFOaAKi" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$955,981 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zJxIfZPfpm77" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$508,720 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember_fKGYp_zo30PhJEo9G6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$429,985 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (g)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zuyjk2ykJWg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($1,385,504)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zJGMEIw4n2od" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($495,663)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98B_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zFMhZihYGgt3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($2,326,940)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zUeYNdCpGuTb" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($239,756)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_z7ySSjprCtnj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($72,575)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_fKGcp_zkaLq4dK0rUg" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($371,199)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in &lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;the Ye&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;ar (h)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_z0fAmjYhNODj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($215,079)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXSOLcZkUead" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$154,913 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zXvrdvM7ow39" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($368,352)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zCBAGqF0Wo86" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($32,529)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zgSFDQ8LzHec" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;$26,701 &lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember_fKGgp_zC2Iu4QDFeT3" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;($73,105)&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Total Adjustments Related to Eq&lt;/b&gt;&lt;/span&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;uity Awards&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zpXbYo8RcIx4" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($2,830,312)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zDNTe81JlK48" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($1,037,046)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zj3Hia5ueoT1" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($3,087,806)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zphCGXUtFQxa" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($495,329)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zlVSd7zv5Q6" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($195,353)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--AdjToCompAmt_c20200101__20201231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAdjustmentsRelatedToEquityAwardsMember_zt75Gc9wtED" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;($522,447)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;
						&lt;tr style="min-height: 3pt"&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt 0 20.7pt; text-transform: none; color: #000000; text-indent: -20.7pt; text-align: left"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;Compensation Actually Paid Total (i)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKGkp_z38NP7TCnYqc" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$4,718,496 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKGkp_zKl3xNauTc46" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$3,712,538 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKGkp_zNvXWjRWR4E" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$327,652 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKGkp_zjfvzF5V79cj" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,352,869 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKGkp_zEpuwWD4DCib" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;$1,108,935 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;
							&lt;td style="border-width: 0pt; padding: 1.5pt 6pt 1.5pt 3pt; background-color: #d9e3ea; vertical-align: bottom; border-collapse: collapse"&gt;
								&lt;p id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20200101__20201231_fKGkp_z9LyZ3YAyLRh" style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-align: right" title="::XDX::454525"&gt;&lt;span style="text-transform: none; font-size: 9pt; font-family: Arial, sans-serif"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;$454,642 &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;/td&gt;

						&lt;/tr&gt;

					&lt;/table&gt;

				&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F06_zMiytBuyFtDi"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zVhBtoesO9Xh" style="text-transform: none"&gt;Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zTDKLCPrF6n1"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_znrgrQFmMIDg" style="text-transform: none"&gt;Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F02_zALNNCrU0SY9"&gt;(g)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zm0gEpQ4qnx1" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F0E_zgUPQyOqT1Z6"&gt;(h)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zwn5bIW0nXoh" style="text-transform: none"&gt;Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/normal Arial, sans-serif; color: #000000; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 7pt; text-transform: none; line-height: 7pt"&gt;&lt;sup id="xdx_F05_zJbnKXFx12Pe"&gt;(i)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z57fmLv8s6if" style="text-transform: none"&gt;Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">7548808</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">4749584</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3415458</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1848198</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1304288</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">977089</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">-5919725</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">-3098512</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">-2323534</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-1176295</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">-658199</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">-499129</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">4689996</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000098"
      unitRef="USD">2402215</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000099"
      unitRef="USD">1931021</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">955981</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">508720</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember"
      decimals="0"
      id="Fact000102"
      unitRef="USD">429985</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000103"
      unitRef="USD">-1385504</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">-495663</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">-2326940</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000106"
      unitRef="USD">-239756</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">-72575</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">-371199</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">-215079</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">154913</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">-368352</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">-32529</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">26701</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">-73105</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-2830312</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-1037046</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_PeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-3087806</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-495329</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-195353</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2020-01-012020-12-31_ecd_NonPeoNeoMember_custom_TotalAdjustmentsRelatedToEquityAwardsMember"
      decimals="0"
      unitRef="USD">-522447</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">4718496</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000122"
      unitRef="USD">3712538</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000123"
      unitRef="USD">327652</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      id="Fact000124"
      unitRef="USD">1352869</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">1108935</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zbxBrHxhJyQg" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"&gt;&lt;span style="text-transform: none"&gt;Because a majority of total compensation provided to the PEO and the average paid to the Non-PEO NEOs is via equity-based grants that vest over multi-year periods, the primary driver of changes in &#x201c;Compensation Actually Paid&#x201d; totals for the PEO and the average for the Non-PEO NEOs is the change in the Company&#x2019;s &lt;/span&gt;&lt;span style="text-transform: none"&gt;stock price.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;
					&lt;div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 416.48pt; height: 322.64pt; text-align: left"&gt;
						&lt;img alt="" src="aort-def14a_051623img005.gif" style="vertical-align: top; margin-left: 0pt; width: 416.29pt; margin-top: 0pt; height: 322pt"/&gt;

					&lt;/div&gt;

				&lt;/div&gt;
				</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TabularListTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80D_eecd--TabularListTableTextBlock_dU_zIxA8D6CU2J9" style="font: italic 11pt/normal Arial, sans-serif; margin: 4pt 0pt 8pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: left"&gt;&lt;span style="text-transform: none; font-style: italic"&gt;&lt;b&gt;&lt;i&gt;Most Important Financial Measures Related To 2022 Officer Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
				&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"&gt;&lt;span style="text-transform: none"&gt;As discussed in the CD&amp;amp;A, the annual short-term incentive plan used revenue growth (constant currency) as the primary financial measure for 2022. Annual PSUs granted during 2022 were earned based on revenue growth (constant currency) and adjusted EBITDA. LTIP shares earned during 2022 were based on revenue growth (constant currency) and, with respect to the 2019 LTIP, &lt;/span&gt;&lt;span style="text-transform: none"&gt;gross margin.&lt;/span&gt;&lt;/p&gt;




								&lt;p style="border-bottom: #000000 1pt solid; font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;b&gt;Key Financial Measures&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__1_fKDEp_zXE5NDaQp76a"&gt;Revenue Growth (constant currency)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


								&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__2_fKDEp_zZH5LmhgGgWg"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

							&lt;p style="font: 10pt/normal Arial, sans-serif; margin: 0 0pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;&lt;span style="text-transform: none"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--MeasureName_c20220101__20221231__ecd--MeasureAxis__3_fKDEp_zI4ZLYJ8kb9k"&gt;Gross Margin&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        </ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="From2022-01-012022-12-31_1">Revenue Growth (constant currency)</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2022-01-012022-12-31_2">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2022-01-012022-12-31_3">Gross Margin</ecd:MeasureName>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_802_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zpULkLwNq9D4" style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 20.7pt; text-align: justify"&gt;&lt;span style="text-transform: none"&gt;As discussed in other sections of this proxy statement, in November 2022, the Compensation Committee decided to accelerate equity grants to officers that otherwise were expected to be made in the first quarter of 2023. The grant date and year-end 2022 fair values of these November 2022 grants have a significant impact on both the Summary Compensation Total and Compensation Actually Paid. The chart below shows 2022 Officer Compensation (SCT and CAP values) both as reported and excluding the impact of equity grants made in &lt;/span&gt;&lt;span style="text-transform: none"&gt;November 2022.&lt;/span&gt;&lt;/p&gt;
				&lt;div style="font: 10pt/normal Arial, sans-serif; margin: 0pt 0pt 10pt; text-transform: none; color: #000000; text-indent: 0pt; text-align: center"&gt;
					&lt;div style="border-width: 0pt; padding: 0pt; overflow: hidden; display: inline-block; width: 415.93pt; height: 307.46pt; text-align: left"&gt;
						&lt;img alt="" src="aort-def14a_051623img006.gif" style="vertical-align: top; margin-left: 0pt; width: 415.15pt; margin-top: 0pt; height: 307.04pt"/&gt;

					&lt;/div&gt;

				&lt;/div&gt;

			</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000062" xlink:label="Footnote000062" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"
  id="xdx_90B_eecd--PeoName_c20220101__20221231_z8Zb0dfd6r86"><xhtml:span
      class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"
      id="xdx_901_eecd--PeoName_c20210101__20211231_zEA5j1JW9Cg1"><xhtml:span
          class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__"
          id="xdx_90C_eecd--PeoName_c20200101__20201231_zlAEDYuREUAa">Mr. Mackin</xhtml:span></xhtml:span></xhtml:span> served as our
only PEO for each year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000047"
          xlink:label="Fact000047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000047"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000049"
          xlink:label="Fact000049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000091"
          xlink:label="Fact000091"
          xlink:type="locator"/>
        <link:footnote id="Footnote000127" xlink:label="Footnote000127" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the grant date
fair value of equity-based awards made during the fiscal year as reported in the Summary Compensation Table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000091"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000092"
          xlink:label="Fact000092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000092"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000093"
          xlink:label="Fact000093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000093"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000094"
          xlink:label="Fact000094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000094"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000095"
          xlink:label="Fact000095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000095"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000096"
          xlink:label="Fact000096"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000096"
          xlink:to="Footnote000127"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000097"
          xlink:label="Fact000097"
          xlink:type="locator"/>
        <link:footnote id="Footnote000128" xlink:label="Footnote000128" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the year-end
fair value of equity awards that were made during the fiscal year and remained unvested as of year-end.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000097"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000098"
          xlink:label="Fact000098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000098"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000099"
          xlink:label="Fact000099"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000099"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000100"
          xlink:label="Fact000100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000100"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000101"
          xlink:label="Fact000101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000101"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000102"
          xlink:label="Fact000102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000102"
          xlink:to="Footnote000128"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000103"
          xlink:label="Fact000103"
          xlink:type="locator"/>
        <link:footnote id="Footnote000129" xlink:label="Footnote000129" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of each fiscal year-end.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000103"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000104"
          xlink:label="Fact000104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000104"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000105"
          xlink:label="Fact000105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000105"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000106"
          xlink:label="Fact000106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000106"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000107"
          xlink:label="Fact000107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000107"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000108"
          xlink:label="Fact000108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000108"
          xlink:to="Footnote000129"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000109"
          xlink:label="Fact000109"
          xlink:type="locator"/>
        <link:footnote id="Footnote000130" xlink:label="Footnote000130" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the change in
fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000109"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000110"
          xlink:label="Fact000110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000110"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000111"
          xlink:label="Fact000111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000111"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000112"
          xlink:label="Fact000112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000112"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000113"
          xlink:label="Fact000113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000113"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000114"
          xlink:label="Fact000114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000114"
          xlink:to="Footnote000130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000121"
          xlink:label="Fact000121"
          xlink:type="locator"/>
        <link:footnote id="Footnote000131" xlink:label="Footnote000131" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Equal to Summary Compensation
Total plus/minus any adjustments related to equity award values as reflected in this table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000121"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000122"
          xlink:label="Fact000122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000122"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000123"
          xlink:label="Fact000123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000123"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000124"
          xlink:label="Fact000124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000124"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000125"
          xlink:label="Fact000125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000125"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0126"
          xlink:label="xdx2ixbrl0126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0126"
          xlink:to="Footnote000131"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&O.TEEU:T2)=:.*7;_"RRS] T]@ 9D_3F"_I\H($P/2[K2@20LMU0JL;'V2
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M3>_CJ%IC'B+VYEY(E>,4QA^T_ )02P,$%     @ L7R#5HWW+%JT    B0(
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\6230J#,!!&KQ)R@([:
MTD515]VX+5X@Z/B#T83,E.KM:W6A@2ZZD:["-R'O>S")'Z@5MV:@IK4DQEX/
ME,B&V=X J&BP5W0R%H?YIC*N5SQ'5X-51:=JA"@(KN#V#)G&>Z;()XN_$$U5
MM07>3?'L<> O8'@9UU&#R%+DRM7(B811;V."Y0A/,UF*K$RDR\I0PK^%(D\H
M.E"(>-)(F\V:O?KS@?4\O\6M?8GKT-_)Y>, WL]+WU!+ P04    " "Q?(-6
M;J<DO!X!  !7!   $P   %M#;VYT96YT7U1Y<&5S72YX;6S%E,].PS ,QE^E
MRG5J,G;@@-9=@"OLP N$UEVCYI]B;W1OC]MNDT"C8BH2ET:-[>_G^(NR?CM&
MP*QSUF,A&J+XH!26#3B-,D3P'*E#<IKX-^U4U&6K=Z!6R^6]*H,G\)13KR$V
MZR>H]=Y2]MSQ-IK@"Y' HL@>Q\2>50@=HS6E)HZK@Z^^4?(307+ED(.-B;C@
M!*&N$OK(SX!3W>L!4C(59%N=Z$4[SE*=54A'"RBG):[T&.K:E%"%<N^X1&),
MH"ML ,A9.8HNILG$$X;Q>S>;/\A, 3ESFT)$=BS![;BS)7UU'ED($IGI(UZ(
M+#W[?-"[74'U2S:/]R.D=O #U;#,G_%7CR_Z-_:Q^L<^WD-H__JJ]ZMTVO@S
M7PWOR>834$L! A0#%     @ L7R#5@=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "Q?(-6%B#JW^\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ L7R#5L# 9@($ P
M:P\   T              ( ![QP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" "Q?(-6EXJ[',     3 @  "P              @ $>(   7W)E;',O+G)E
M;'-02P$"% ,4    " "Q?(-6LDS[;U0!  #% @  #P              @ $'
M(0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ L7R#5HWW+%JT    B0(
M !H              ( !B"(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ L7R#5FZG)+P> 0  5P0  !,              ( !=",
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      H "@"$ @  PR0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>48</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>13</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="aort-def14a_051623.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cryolife.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aort-def14a_051623.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: ecd:NonPeoNeoAvgCompActuallyPaidAmt -  aort-def14a_051623.htm 26</Log>
  </Logs>
  <InputFiles>
    <File doctype="DEF 14A" original="aort-def14a_051623.htm">aort-def14a_051623.htm</File>
    <File>aort-20221231.xsd</File>
    <File>aort-20221231_def.xml</File>
    <File>aort-20221231_lab.xml</File>
    <File>aort-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aort-def14a_051623img001.gif</File>
    <File>aort-def14a_051623img002.gif</File>
    <File>aort-def14a_051623img003.gif</File>
    <File>aort-def14a_051623img004.gif</File>
    <File>aort-def14a_051623img005.gif</File>
    <File>aort-def14a_051623img006.gif</File>
    <File>proxy001.jpg</File>
    <File>proxy002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="88">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aort-def14a_051623.htm": {
   "axisCustom": 0,
   "axisStandard": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 3,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://xbrl.sec.gov/ecd/2023": 88
   },
   "contextCount": 48,
   "dts": {
    "definitionLink": {
     "local": [
      "aort-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "aort-def14a_051623.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aort-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aort-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aort-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    }
   },
   "elementCount": 107,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 3,
    "http://xbrl.sec.gov/ecd/2023": 1,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 10,
   "memberStandard": 3,
   "nsprefix": "aort",
   "nsuri": "http://cryolife.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-def14a_051623.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cryolife.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-def14a_051623.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-def14a_051623.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "2",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-def14a_051623.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 13,
   "tag": {
    "aort_AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Add Year End Fair Value Of Equity Awards Made During Year [Member]"
       }
      }
     },
     "localname": "AverageAddYearEndFairValueOfEquityAwardsMadeDuringYearMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Add Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Year That Vested In The Year [Member]"
       }
      }
     },
     "localname": "AverageAddYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Add Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]"
       }
      }
     },
     "localname": "AverageAddYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Subtract Grant Fair Value Of Equity Awards Made During Year [Member]"
       }
      }
     },
     "localname": "AverageSubtractGrantFairValueOfEquityAwardsMadeDuringYearMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_DavisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messr Davis"
       }
      }
     },
     "localname": "DavisMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_MessrsLeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messr Lee"
       }
      }
     },
     "localname": "MessrsLeeMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_MsHollowayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ms Holloway"
       }
      }
     },
     "localname": "MsHollowayMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_SimpsonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messr Simpson"
       }
      }
     },
     "localname": "SimpsonMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_StantonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messr Stanton"
       }
      }
     },
     "localname": "StantonMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_TotalAdjustmentsRelatedToEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Adjustments Related To Equity Awards [Member]"
       }
      }
     },
     "localname": "TotalAdjustmentsRelatedToEquityAwardsMember",
     "nsuri": "http://cryolife.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r72",
      "r83",
      "r93",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r103"
     ],
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r110"
     ],
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ],
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllTradingArrangementsMember": {
     "auth_ref": [
      "r128"
     ],
     "localname": "AllTradingArrangementsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AwardExrcPrice": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price"
       }
      }
     },
     "localname": "AwardExrcPrice",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "ecd_AwardGrantDateFairValue": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "localname": "AwardGrantDateFairValue",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AwardTmgDiscLineItems": {
     "auth_ref": [
      "r121"
     ],
     "localname": "AwardTmgDiscLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMethodTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "localname": "AwardTmgMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "localname": "AwardTmgMnpiDiscTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "localname": "AwardTmgPredtrmndFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "localname": "AwardUndrlygSecuritiesAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r128"
     ],
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "auth_ref": [
      "r65",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingPoliciesProcLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "auth_ref": [
      "r65",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "auth_ref": [
      "r65",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "localname": "MnpiDiscTimedForCompValFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r71",
      "r82",
      "r92",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r98"
     ],
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ],
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r67",
      "r78",
      "r88",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r68",
      "r79",
      "r89",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r75",
      "r86",
      "r96",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r70",
      "r81",
      "r91",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TradingArrAxis": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "localname": "TradingArrAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TradingArrByIndTable": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "localname": "TradingArrByIndTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrAdoptionDate": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "localname": "TrdArrAdoptionDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrDuration": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "localname": "TrdArrDuration",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "durationItemType"
    },
    "ecd_TrdArrIndName": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "localname": "TrdArrIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrIndTitle": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "localname": "TrdArrIndTitle",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_TrdArrTerminationDate": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "localname": "TrdArrTerminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "localname": "UndrlygSecurityMktPriceChngPct",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r101": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r102": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r104": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r105": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r106": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r107": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r109": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r111": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r112": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r113": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r114": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r116": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r117": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r118": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r119": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r121": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r122": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r123": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r124": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r125": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r126": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r127": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "F",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r128": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r129": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "A",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r131": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "B",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r132": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "C",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r133": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "D",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r134": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form 20-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "16",
   "Subsection": "J",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r88": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r98": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r99": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001387131-23-004393-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-23-004393-xbrl.zip
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M^!#@A>VGR?B6R(!R&0G(<D@J<D-1\ZJ;+X9@/2:7BU(2R3^)&C4Q)B:5B'8
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M7N$>/WAR. KA++-Y0@PV$_-K*C'7?DXK6F*7NGZT_SXM:LKJGB8U1])F#7=
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M A=J,C$A!\+^(('+@,%(7.BCN-#1/\2%OLL_O@CF,-X# LGUH:W7QYJOW.C
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M_5#*T[QPN_H1;T$?^,?%1_R?>4 A_^1_4$L#!!0    ( +%\@U8TY\Q8B@T
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MQDLE5'*P!:<=0H[*3,"P,V#C)'6,.D59V)+2SD&G:BYLS+'!;Q"'+2*])N*
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M#K336PY,"P_]FB"D3#Y-/G=L_&;@B(#15D2IRG'2_C./P,67T^G>E,ZG9IL
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M^18-ZGAA%,14[AGB*6/7,1D3@B\U<@4*DTY0+.'P()4$\'**#XVY V"G8>.
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MX:XR7-?A3+2M-KO0QW.6/3D:_U%E%\VKR_;)G^R\>?)GNR.-_Y,1=P(*_UP
MY5+-EQ1 )R-'#)8Q7W3#=M8=#$#2!2:]P*07F/0"DU[P(H+])KW I!>8] *3
M7K TP9KT I->8-(+3'J!22]XAND%13@=#/"?$C@U%H*3;DRYD/6O3GY%,"I/
M,%#Y /A)[ZI[\N>G[MEIZ[*W:-?.G=T5=NU</5N_=[5H.<9<==G5IU8.4*O/
MT,"ST=JF1%%4.8\W(B=C50$<A8;M'OO4NFR]_\8^MK^T.C+>LF $?A9$[!6^
MB@I;H_8V/P)]6'_[.@D^CX1K/U78_LSY(60 'N.^E;(-YY;)PV+X/8F@K"J\
M?F=\6W: 6J8GW]:[=+Y)'(!>*-:39/*@>KK;$?FN>KK<V\F8]<.'U=.5COJ
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M9P$H^%!N-Q#<+MU(A=V,' "[XUEN#-O.K3<:P6P(:C0&!H!C#,Y]$+L(%5N
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MH+/Q8+A4ZV,@J0#MI')"+*.HTM>WWA&8_A\>1@/'XQZ24=7RQX7.@8N$@.C
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M;Z.)8^=G"E'Q!^(BT8NCQJ$4FQ9HR')<'^PW!S-8\,4JWBA''7Z4G%$Y>+H
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M>TCG"#&/._PX=Q9N+UK*6[D3G99H-94@GFDWM9D:'K6;LGW0\LB%FU?\GWL
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ME'9%D425Y8%SV&3*&K/4FG4R*6U%]D A/E.BM% #E7*_R%U<,G_QM[RKJ7Y
M=S4!/^X#B<$3.23^@P,0 0W3IY(F&9*H,XV?Y 6:5/]+I%8.7-WV25VWJ9>J
M^\>G-*_K@N]H*J/J68?J<D#D>[?,+BN"@.RP+T+V%LH%4(9V)EM$>-%(.OS2
M%#M24 O<A8K!Z#)I&_51&YC15)Y*6DVU4\/$0;R#*Y!F4))I6#I-80;8L:S
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M1M@G27D\+D?3:#0&:T)&3:2/8DR%N-2)8R2\;1W93&LNLQ'6C&<%%?R):^F
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M34FR*4G;D2!D4Y+6/^/%IB2M^08]9TK2[IK3WZ8D;49*4EGYM[]HY"\-K0P
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MU*\!=Q:L:VGBAZ!DR%E:BCA6#HUQ'L\/$MG7+:@,J./ &L-'&V.N,URDE#)
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MPF9PX.-/?<ZXU,;?8M[D;DK[>UC:WT/<A#>]MS#:8OY,LF,SMJ>]@-CM/J.
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M(YW-BZ^7FY@2)@JV,+KK(EJ/%)/Y4F\M.2IS,F462>]H,*!@O\<*PD6/7_:
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MAT)CI&MDQ&+6RT1X*<$TE:(#=?$?PNL3.D=N1 C1Y:""1@FCX$I(+N/2K_+
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ME<%:U((:[$D!EI/L'.D@@7P?9F>C%"M/ANQ=75U Q>!Q)K!<2)T/0:/ DK
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M6?=HWQT</<XS8??LI?>L6^>'> 6[M)7->>]UZQEWO,".QF#K=^-J;*S^X'S
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MH1<LDWPK-'J^MIWV_A:UTS[&)M!QBM<</\4&S2,_ ;;8F7E?T!\^CZ.12$
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M>.F<:I!ML[58"QZ\(FY^AVX5RX.6!PT>O/3&\%D;F/Z,&9FKM@>>_UIY;0K
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MQU)ZI3V2O\9U+/R\+[B.0PL>Z:['=:QY'!_MY#1>'=91!7)\=JMTZ.'I4TT
M0^Y&AAG7R.KY3B1SX.&9$2D(F7\*8.9U!VZ"R3_Y65X]U<*1/O43NK:1A[GL
M1"!/['B.9A@[@>4^H> 4G+MGGCNCZT0V$0=0$>.@U%L>!4N#B0AAX=U0R[A>
M,!<.SRZR1IAJ,"!/ !BUAC\_?2.;Q0IB?D<DXK2<7N,&CZ$\OQO>ZLFVN 0X
M0*8C1PX/6KC\?L[OB5O&QH.WNU*G3U'+^ 3G1Z\0-%^G7<O*A:=XBL2HQ_<8
M[./R*9O"-[^%3C1!*;[S(N8F812+D!H\6S(.)5NMJ*:Y2F*-A_(U'BS-8V3!
MQ#2<*:@K/.0R[TX6>:S&7ES</%$=):U,%H<HB?LH%"E+S4 W\#O87V3T2Q+?
MT-=GF(%PF057OBSEP_&HD1"T3%.8ARDH;%SK=FM*K!@$&[OY6H)=VKT\"9_\
M 9X/NU)&(.W85"T^*+G<$04(A41_+G;D9,(_@M!P)CA(])SCQV^\'8_L3HUP
M%&9D?K[\T@"J;MT;H"7'5_I7A7.]2JO# TN/G?1[=K?5&50\Q&\%/Q>V@WYG
M6UBLO3YA#&\)^'70&@VVUEFOU:F',OL2L%Z[X/56Z*Q.9>P3D+8]#6G[_')F
M"6E['@2X,6<\5QEB^\F2@W'*43O/N8-ZAQX#]R&5FH9]AGS3T[\T_1H.=^=3
MH.%P=RI^;LNX^)]MQ?0TO'0:!#BNGH8=[P<\$D?30*$4=5YJ6Z?M;NX:S_6Q
MO+='\%SY[&I0UR,%NM)")IS1H4:^W)ZP-:CK]LP'7GML<T]^;NQE+[!&MYXA
M4@V,;%/P8ZL7"2\1V%/I!5L56! FXOK2X' #63TH_\Z6H-=VQ:57*^PO>WDT
M]M]I]49[%/NWVIU6U]I6T'K4:5GU@M8OZ*P_:G6WQC WZK6V)L7!J-7?'G6>
MW=+,>0<:5]C4-8-(%-K?((2>^:697\FDT"&]'0:XE?#>R4_ZKF&706X]%;N<
M"I''N'KAH$R.@8<,_HL7A<'U;&W@FIKJ.]=,UR=1XJGG9U>&C<JD]>71OH<5
M*X=@>)*O#MXVO7:&G9[9'NG[G\8%/>B.S'['UH+>L^L(+>;GB;G=TD9CWW1Y
M=Q[+@4])9;?D(V.'X-8?@&IWK)$YL'M:FIOA!1L.S':[KZ5Y("[$ZY%ETW["
MZY'DP3@#Q^NZ5?83_DDEJ,Z#=I$;W_ELR^Q8 RWHQLW/:&CV^R,MZ#VS\UK,
M^^F8:"$?DL]RX%-2V3%YY]QYL7;(-^-Z6);9Z^E#]X9,Q7!DCMK-.G*O2)HZ
MA'$PGL+KD>3!N /'Z[Q5]A2NL3(WU"D86W CNF:[/=2";CZ"89N6%O3>F7DM
MYOWT2[20-^.RB+^>K.Q<$@L'*38LJU9YYW#+CL(:8.4Q8BM3T=7',+@]NT$8
MS \YL8N$<!8569?$N<+QETM2= \4B_0W64CM!8LT,:91.(>Q!<XMYY/E'#4$
M@9OZ@M:8B'S^[?F^%QLWX3V2*_W;26($B2T2^4C@7 $:*^18(FM9XV;*_O#K
M@FRY & KOZ8 -W-J;\Y+E-$F<;(\_NVL!'SN?2=:*\Z=X]P[T21&K&40$?P.
M1@8".4MF7C0Q'-\/%0!=2MSF=%#.'(9O$$V4$2X($=A$F%:$846X9?X)LF_%
M_&U4M%;E0X01]OB8YLX#UKD[?D*B0JS7$OXJ&A!.59J@4*5<_FA=MSBW%<+U
MAA-D(,*O^G4HSIWOAA?'*8N/"V-7I1[+]472.<&<$>7PQ  M 54GT4T=3Q)_
M"0$+/<E!OY]6XPS(F]-FC:DO,*M>/(/>1/>"2V_BQ:X?QBQ3>UZR3HC'G&=K
M[L G@A:4Z-42#SLC/C+!PI4_38I_G:23!\2@SIYQ(@_69[P$H5[&6\;QQ!,%
M5SW&90^R<F/!OX8KAD0@(<=1S>4 G46!*(TD",)QO840-4$K%>ET5YZ0"WJ2
M@3_(]\.7\=EW7,!K*'DS(DL%89E(LF'9<U8"@H7_UY>;RPOC_'=L> IS *]C
MMZT!O<MY[#Y$:6Q\0J(UG.J/%X6OV6UNZ6#N. L<L7G=1HS;3+)"E\$D1"V5
MF/(<3-OE,P4]C4P5>[OP!I&S\"8*)KS@",->D+*.!,V)_9"ISW-3WQ&:&7N.
M<>40&#VU_A$>"HSS.4,61ZE$H'-IA&(A72$66BYN_%T=WED.36]OWF;LCF(Q
MS"T%231(YV-8]J O\<Q!GD#XUSIC+W$VRNT]GVZQ8^#"'C-N=Y#;K[AM3@A2
MGDW4?3A9/S)JOG1@I&"/CDIP ]+* BN$_Z87A;T3=IUU2TSL?GQ%YL;3K*X\
M?&@A1]Q?*W)UDU5&FAON56LMO^UDE-T$X8_#:QF_XU!CXY8%Q#OXP,WAW,'=
ME+_,U(MB$M8<]D,/#3$,'<\<T,+#DD59A<SG$/D.$31P4TE[1PMV"'B"\/T1
M2@ZY>[G4:.AQ#JT_?EA2!1H@+$\\R@CF3&7:'"&B;+)^LH:M;M<LS*?X,##>
MLW&4.M&#87=,6KC"B.&VETUD'?[?3'JK%H#^T,R#FGE0,P]JYL%#XP'4S(/[
M3VRGF0?W?(*:9!XL#77ND?PU\V#AY_UA'NRU>L.-,0_N[)3Z7I""\2,EG'2F
M:81,3Q@Q=2-OC$B9%*W*R @IFF2NL$NI!T$\],7I^"_B= ^-Y#Y<XIDBVHOX
M%^/$.C5>PF1GPJ$&YX-'PGKMG]_2:YS8IX4.<0S\Z,IIJ^#KE[]]N'EW+MLV
M^>%QJ;&6<0W'IO/% M7SNW'.B:Y !$L6G**LN=P2Q_,QFG8+YS5YOE.C6\MC
MJ'Y(*A-B"4W6@:IB"9,9AMWO/%#%/&RO1MPI AN%Z>VL:C!54)5]OOS"H_7*
M8;E&B%L]5I=%K#:!6&H\ [E^6>C2+%<^#O0ZW=:@5^4X8%4]#VR'Q&S4&FP-
M%=-J6UO$X-S[WEZ>L^9*S,^NQOQ\_KW]$N8GOV'F84KC(]X/[3,8E)Y*#>*Y
M7Q.P GEWC0XN_^<?Z.6J$Q*GB\K'TN'*X8R.$=#EB24!V]+%IMKD U:;K?+R
M)S]J0+\MZYNB7E_XO5,#"F:?UM4$ 26H]6';^O UNX!5S(_1E.7I'*SEV:Z?
MHDLFM@A::?<S@1]'>JX87(3:6$F^W8'9MQNK$-3RM>R^V>LV5M"J!5Q7@7=G
MS0]C O8:T&]9W0]#I/6-AF5V.ULSRD<JQ$[;[ P;P]9Y)4*LJXG:5SYBA#3M
M; S-05\[RXV)U^Z8]J@Q_%HMWYKJJUWE@X:.>B4NRA#.?QTMPY<97ML<6986
MXC854;O*QXO$HUV-H=EM#CM?BQ<,=J<\L5S+=P?J6V;+Q5]U(4I&E?,X^[U6
M3UKW3K?5>Z81/;-$36!Y5JV:6/_^R^>;Y?HU?+JM_F=G;>4]V*W"5]J4[YG5
M['D!7>^._=#]ME3X5I@JI<>5/MIKVONAWF7S8.6R>8#;+N7-T!6S4(E"N0&*
M9?VHRQ7L*X="B 6(PB-5SSP1F0,P( P'@@,0A_9*M3=SHB#+IG\L>_[>B7-8
M!?5+4V@ZC&(5@&*YR+=E" IOT9OH^X[%E-%>+$UV@L #"Q%C':\*4,'+>,-(
M_>J=X_F414R?.=-$O(0"T(*V9NJ)7.U%Y$$##S",K*(Y1X&8,TQMP!KSU,=J
M=D(U  E&AA<;OH-MGQ116<9LI>2X8U9]E=.WAMW+WCUF;HA9^(\]P<L(E(<$
MDLOJ,]6SQO/6GT[9UV9F'\V,?6H8QH8MS74!EX#6J?6F@\N>%@\H/DQU@ 41
M3RW=ZIJ8HRPTH8E#K8F-:V+GM').55Z>LK&]L0RRQ'!];SKE"OR4S53TS^ K
MZG$=K(<+9[\0+.JYQ]8UN'#>KUGEG,2 D\5([S@H&4>!.PZDK ^!J*F2A6]4
MDN!C119NYPC!)"JRBJ E-:NY?"P[]E08D@R"9"UB7'7[F!>A"8_KEP:F)ZLY
M?8Z-?'R:GK*1A:=SJSALM5]B!TM;?<P.UJGE)@M;J.5^M J=USK;_;>;-GY_
M+"8.1U-:AE CF# G*Y+E?CF* :M'L4BTNOY1JT',(0,E6F*0O-5:J+506%D.
M9 <[,(S+-&X9;B@+.$49L1LN&"_FSL#KUN+<*>6VB L';4B42HEH9R[CW>&'
M)9!V=3#L/B:3EJEBQ<%[L._P4>P1="@<]PA\;@5TSA0G1CY> S=/1*?#?20O
M%:]3QAO&6)E]BZ[WVR; *O7J.L35Q?%>P64EB$34PNHZ)1>6$K;19ELK5@F,
M; Z2FAE!!"F."*UBYMPQ@A(&OT)"#=> #'X4+)C0*FJ&KK@KSA$(M3YK?<[U
MN>"K+H-D<]1MB5K+YHN9@V\0&POGX0Q:.E-5E*!1</;B5<3J@BZ?X#=S3T =
MP2GW-:IK-JV+6>AC3)Z@<6$E:0W7&B[4XVI)/R.68 B"W-0,VM]Q9QZ[6XI>
MI#&!J K+*4!K:H9H8[J&T,JHE3$SMPL'L<X2Q/#'@U@$&@C:6 13YN;L+,,V
M$LJWH*"9B,FUC<N+#U<Y;+BXW_-\<4@4]X;\LK+.D<I)J*/C0J4JQ?['4#=A
M7+LS-DE]%E?GMA @]P5BC#'SI14!&1+BL^Q!@&")F<)I78# B)MA-:Y:-%/3
M4OX'H2_J^7N^\,,''$S+.$?L?&ZWRCHX24#9S^B"^E02&O"P/U[@.K6T)6+L
MC*ZY8'_WPLD1H;^_!\%?7?\1+P>E4XS:.)*/1%R$A]-]A\(S<6RNGV(>DLD5
M6^%X(<R_R9T78W9"4;=-KL]>0FD-JO(B"GUHQ'BW[SH@%E/2,JP>D01(NR=8
M86*!98Y?GH>@>6HD:!+1=1,:L9+#.(U.=?KXJ0K#:6);-S@-07'9NS!PBOI^
M]^;I'-U79$[)<CE@?0O7%\5E4:+%5,T=H66R B<X?1YL8/4%)F8V@PK4T.H:
M6EU#JVMH]>, .M?0ZON/W*VAU?=\@IJ$5B^M%=TC^6MH]<+/^P*M/ACU"_54
MAWD$K)$.YD-+5^1#9+]3<\*>W1.>/XU+2@1O(L=L9V=K3#*+X)A'M%4)G3XG
MS/5$^D A*:Q#E)Z4F<XS<D@F(CE^_$! X,M']"0,O_$T!)E!QL^&9>QE(ME?
M/6&*K/;L?"$QQYTQG#/.<EA]?O:/^5%S%?<<3KF!+$"8P4]X7I6\<*8X9(O3
MJ-*Y((*$-1RZ'F4J"1K31UO@J>GA8A%&"=X1>DPFY1M3QT<N4Z0'@^,6CW<Y
M/LLN$7DX@D>+0+:B*1Z^YJ_&7XB""@4T]Q+1T>BI:1&)B+.J@M52!WB5$-X$
M#\\95:ORWKRM/)1)88B:?&1<3TIBF9L >'_.6>3YR.Y@=ULCN\II9+^0W:U^
MJ]_;%OKYD*/?;Z>SP:#5M[>)ZVZ-MO9JO=:PNZW.^M!99U>(]7V-6/_< T6.
M6*_>LBHPM\N<Z>>XM7!465'D=D=;C-C:WMS0SO;FD]C4E%;_]J/5;[_=9UQ9
MK1A+BJ'JQ"<>O]8(U-N=@FQE\36G N+KF=CN3)!ET].PXVD0.XN>AQW/ ]_]
M]33L>HNF@R:?!KKP5LW4R<\:Q_\%^"GPYS/XWQ[-T:N,OO15)!W\SG-.OA(>
MPH5(3>&S>R'S4T[(@;]K40K*::.K;Q^G:>O+KMMJ_RR2@;2PFQ;V2 M[>\(&
MF][3TMZ>:@^UL+>FVI;5JH$&MSM/Z,"GI+*'\SY#HOK$$W"O0DJ8QCLLD=I)
M_NO^GR4.0/O[;2W(S9B1MI;DAB39TY+<C"3IBL9>+9C4TMR*-'709(=>!&?;
M+E;1:&>ZZ37R4V=H6O#_=L.[H18V"KO;-8=]+>SM"+MGF;W12 M[.V8$!#WL
M:F%OY0C8:[T0KEW'/W3\8Y]$K>,?.OYQP)+4\0\=_S@&:;[<57AN)O>^QT)V
MX%6<&9>..RL4] CD":3U6 (4:94!O[_DI9^JX6SLI04*WIA @7)8.F0[\052
M"&&?#(=XP8VX()0FM5I55$O+Q5]U^8L.I<1OUT@I1U,K>2-K]+ X3^+6> &6
MMOFB0I)*W3+"(:+(<>;L:3 B6>@8LP0G"'Y#)8Z\&@\^7# WD<6/-(0+)YX9
MOX5!&@L$_VS9Y 5\2Z!$JWT(D"#>%2G_$BRT(Q<=+#6^YJJKP2.K\Y 5X#'J
M*K#,GN]S!*^"$JS AI4@UL++WL%'OQ@*Y%&1[@K;Y6VN\#<9)TK5:SDT+B_^
M=#-8\H**Y--<0*M;IM;B=;:2 ZILC+D 2H;9?9N!Y$5L[GC$Q?.\IGI8T1JG
M<_G"JS"G4K*QX+SBL&R%XE="M*(I0O1R9"-8+6!VOD$+08@EME2X',(&1)7(
M,Z8@O<'[_"?U(@'3)>IY5\<T<]#6)AYBC>'R<EWP74BRV:J=,-CM,GCXK_1E
MZJ&P;%?0"M$DU64MRE#ECVN%+M=_Q[/POL@^QY4]PVM<7014V4Y"XJ!P#)VQ
MSY=?Q*I.%V)=DRFN+O;5I52V.^ZJ(%H>+J0[5*B'EIUTH0.$!Y.]/%(FW1GU
M6UU"-]F3 FC+'K6&6RO<A?URV->=K?6ZGWFV[.HJX1=5FO";=EX%K+! "<C%
MD_,<?@+]RM/5&F%N0T7!RAZ7I>B97YKYR\P=^<+=$5WDM<-:.Z7@Z^2:_-Z:
M15YZ/EXZ'X528#T?.Y\/702Y[_</E4.YGT $7M#4XK&[F<"/(S%$#"Y";:Q6
MNVB;5G>HY=N8? =FWQ[H;*:FK3X&E0_!I!_XC%2VVQ\9VY91.0R1UK8<5MNT
M;%L+\65"M,QNIUGS>QB2>TTV]G@WQ,KF]Y]T=>$\:,>N*<LR, >]&OG36KSU
MQ#LT!WWM-FN3_LK<YG?.G1=KG^^%EKG?:2R5^I7(<&CV[8YVFU^5C3W>#;&R
M^;W&W,I0AYL;M,W=[M9L\^L3[]#LMAL[E!R'3/?#HHN_ZE8*<!XAP[(J":<K
M;/QPRW9T#??1&.F/*&OH(S(8WR"#\8><L5T2"_!OW'RXXM0UP23+*7I'_+R<
M-:GD O=04TW/D:B6W7EA&OL/R([NIG',)N8R;9*]G%),]#U(LC3AR:6<YB=+
M%H[SS%(I3M-8I%&<8LZNJ $0V:.F$:3S,8ORQ.TE.B-1I."L5A94SUIUP$0/
MCR=%^'U.B83U+;%2#"/II'CR>T8N-F9^>&^N3@N5(L7I^"]1G.$8,=A=?SEE
MGLI@1#G>2UBI5SB/21=@?$M,C34J?)Z;NDROM*(2](=F0-8,R)H!63,@'QH?
ML69 WG^"7<V O.<3U"0#<ND!>8_DKQF0"S]K!N3F*QL+'+!T;! 5CJ*0EDZ6
M>("816%Z.RLYP8CC)%+WXI'#66"3)02QDGZ66E\^<RK%PJOG(QC\&9Q2D!-W
MJA9AKC0BBM&G7A3#:0I>WYTQ^8S=MD:\V1.BTH6SVZWC@46[%^<DGR4,3N$@
ML"GS"!DCQF??,9=1-]4/.AV+ZHNMT]8JIL;1E&;:HTZKMU>EF=:@-1QLC<%U
MT&L-ZO'%OOQ^)ZM@M'4%XXO*1(HVYG<J9?^(#-7[7!^B9U%7(^[7!*QA"E:G
M(4X7E9WXX8HK.\0% QV=6+)R*UULJDU>$Z8V6^653W[4-60[O[#;DQJR?N>U
MWSK;;1.VTD-8#(<Q 7M=?;.L[H<ATMHZW3$[=?*/M7T_XF(';>%MLS^JD0ZJ
M#?Q!YXF_$A-_,$I]\/9F[Q-SM87?P&+(KH0:0S\6R1CTB-'MMWK/YF*W>JV>
MO?X61;V]>O_E\\URD@@]WATI_V5MY5UT6I1=DZ7"> %%(,9^Z'Y;RB<I3)#:
MQTJS[34-_E O(-);"8B0N:(("X5!A"84KO%0$NN'_62?%)7_RJ8^<Y,"C.92
MQB=E,?H8A^6710['C%NYYQ'HKNONC$!& 5WK9 "Z3B&?;@KMAI37QJ(Y 1ZO
MWE4)N#K1D^C7];WI-,.3S:^:G"#PP#K$F*XI87'I71 /5D*YBJ_>.9Y/5R_T
MF3--Q"ODR9T"9E?<R2TB#QIX@(%D0*W3C"^&YW!*6&;3H)LMD%^$$.^^@VV?
M**_)46Q7D'_-JJ]RVBI!B3_,V] UF<K>KUG*ILQ*1@Q#@558DJG,<Y*KW0RN
M[9.P8B])U=3V#ES$/_SZ 59>%'EW>-WL)/#&,24MQXA,O)3BW$'EY)K_L+JD
MLR4/"Q4OFE<@EL/P&[2(381![(%9X!C5"DASMGJ$45$-@H0UEQF8\DZ;TIS/
M\J3>Y847&R<Q](YYH8;=/^5&:_6&G<4@36'W9O#3+/0GIC"!2\G6RJ#(#N*5
M>AQ"ETD.R_YH"WRQAHM%&"6(*NXQ:1; [/D^-X:Q[U$>;PS>#*-<WU4CRALB
M .-87MWCZU#J>2%KH$2@-'9J6*1)9^#A)<867B2$]\!4XQQX/G]KWE9N_),9
MJ%+URWB"T^?:LT= R=DJ*KV.?S*+4TW:7)O%:55-X]S&[;S='K7:VX,7[K:L
M>I?S+^AL,&CUM]:9U;9:UM8 J >]UK"[M<XZK?9P5QD5-?F&]%7PHQD5Y[AY
MK.(^RZWK#4?E?/-);%K*/?+??K3Z[;?[?,6JI_Z1+(!/O*Y')V)L&898KBR!
M1)S/B)Z)'0)"ZVG8U32(G47/PS[AU>MIV-D6K6'1&Z3V+,;):MY'E,78*E^.
M?15%V+_SRN^O#I:M7(@"<3Z[%[)*_(1<]+L6+TW04"&-0X4@UR$OR=?";EK8
MHU9;"WM;PK8L+>UMJO90"WMKJMUMMVJ@E.ETMZ;3?]YG5VZ?^%WW59@@;A02
MS ED(O)?]_\L<0C:WQA WZL3I);D9B1I:TEN2)("/DQ+<S?2W$W>Y$[3?Y:P
MYI[&E*N>U2'1Y];AR!VLS&Y6LQF%F^,%F,;BBVPI2FO)\QOY)6N>GU26W11.
M,\[WE4RG181Y3EFBX&WH^"MXCS*/B'UW&>.8(%DB)\ZMX#[/LS(Q#Q-O?3$7
M42;QK$$OK#[S.<XA?R\8AT<)GAGS.OCP%./D0SN>E,4RY: LK9A24KDFK"1W
M&B=*0IJ:=I4EQ(G,+)>GS,FDSU5&^Q6DEI>PUI\>UY)=3OJ+9^%](=-9B!%3
M]=:(=RGAD3+O>,YN=3DS!];GY\LOU8!GMH986 ][AG?R2 I<MSUL=>T]2FZS
M[%%KN+6DK)&]Q:2L/>]L@QE@79T!UGP&&#>&XCIRCR\=]>QJK)W]FH!")H5F
MFM_Y?!02O?1\['P^=(K+OD?7]@2UR>Z]^HKOH6D/F^.7UO*MB8JE+^N??5E_
M"!;]P"=D'Z#'EFW*88BTMN'HF@.K,>[-5R+#FO!M^I+S\ WL\6Z&>P.$IYVZ
MCCD8-,=?^NK%6Q.%2KO,1VW1#WQ"]@/,\=4X?%LTS$<JP^:M[V$([A69V./=
M#O<%6E0[==IG/G"K?? RW0N#+OYZ(LV;_M#4UYKZ6E-?:^KK0R.BUM37);O<
MGC$K:^KK/9^@)JFO2Z_$]DC^FOJZ\/.A4%]S$'/#LFJ5Z@QW9-+P&PKP^ABQ
MUREM_3P(,$5=I*??A/ -XYT7,3<A^' 6Q%0<Q<'92_((#[ET*4=1'S/?8W=4
MV.<D5*8$NA\0Z[;#!10[OA,]F(;KQ#-8XD&*]I"(/\,%"@A^C%B,]5U8NL0_
M013RF(.44V'3B1>X?IK5?!;*!DXY??@B0NAO_\%PW)D<$5-K&D6OB'C)(H->
M'/<8WDO$""$":]G&?\$4PKFB4/R8%[XI4XN0YK>PP#C4^8I,XEPF:4R<XO/4
M3[R%+^D1DH<%$I#'AH/-SJE!!_IVX0OPTZT!4P83$SW :[ H%H5@Q29)/"X<
M[!(D7@\,+(R$%XW@<?4M84S)/8./%LX#M:,(YM'AFU0I"3:"8^.'\"-N.3@3
M/O1QAN6?12F+:6?_2;WD018;LL -TP@Q[]T0GT[#-"X4G!8G88PEGD3]@1T)
M-'XC3EV7Q: -^&5WYL K9OSM7&] "5QV2LP7-2K@\/Q(SY25P!W%*DVQYM<Q
M[AP_96>\ I@6C8.<]I%#Y=4PV\$*;0KB[.>D)US2L(]FM8?%R>;(_P3=[R5+
MI@$F;X8**OLUYF&$/  NJ 6MV[F3N#.Q;#UP:@(L%Z81R_I2J5+!)/^"NAY;
MQOLR6H)EX@<2Q@H_S%0\"DLI!J.T7,B,7!2"LV%YO< ;^<A1@ 6UG"$!7B/U
ME39I.,4%03+)A11+>@11ZIE;-"GB?+6)%<@+L2,LB@_JE'MF13DA+\J)CZ>J
M]D.0Z:K<*J!I,. 3E""J"GPMX&7MI% KLA!VOJ#<!9-_XK58R\PV-5&I&\]
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MF<&L9@#M!$L\;OF_PPK!]P4E_\:2A>^X@M+)\='X.5AJ@,* N2,!>G.V#()
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M\CJ\6FX2+@2;>!X\H'I&.NUR8TGX .3EHIWG3=9(8\\Z5PL7?VE"B;*;X.<
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MK[?P@L)E9:PBQ^G0O0\C]*W//H;A-Y1O%K*JX<99%=RX@UG;V?O#F":,YVF
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M)LLCOYOO.8&K08R/-Y%>2[TLR#X:F)U&ZW^/0/ '$5/24N[W1V9WH"$!&[X
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MDY:,_Q9,PT48Q*'O36@ [[T NO80,S2!7\S))9AZ/GQ$HSD'=_[.4Y;H.;=
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MOGPR3=VHH)@0418H>]DC&$H+I86>U$()AA(,)5VCA=)"*8*J.%.GGR2HEQ%
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M-" :$ UVLL6G;(/WR:O0['ZI.\%= L&'[MBD]6UJ?T#VDT P@>!S$%RB =&
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M(8NMM3M4RI? \N$EKZ/;!JG[H<&R92)8KB!*(8TG&A -3I\&!)8)+#>9YOM
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M9FX2=?-%U#1:6IM"(O*F%!)12'06@DLT(!H0#7:RQ:=L@_?95=8Z=KFMJ*A
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M#8%:XL0G9!C67N!5-YW=I&Q,W-4 =S8T%O [&(+/Q$8HHGOU5WPGX,QY< (
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MHL2,O9@AF,#>B7,?XL0Q.?%-[<=](5[4AA>H%R$QX[C,>.M#,(&PO2 GBD
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M^G&Z'"FD.G3B46O]L(ZF'PTG>R$E:--65D/UPR;_<5S5Z5$L4F?]:)'_.$!
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M+_@/2HQJ?@OL97^V#$.#Z8+\WPI[(C^/7)I!,#]!L'D+DXG$,Y;=K$%_YP&
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M'4LW2?NJTCZ_;+V[PG0D$&V4^R2Q 21\,4-;'8G('HO7W('@#E5,G*MFZ@X
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MC05W@B4E"^ P27/9!/Z>$P1KGLGHE&TR?H-YRTT&=&I+O5O%,QIZOI2O7'K
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MA'!I;#SWO*5>; ^Q"PT%\Y.*-(IQ9*EX65OB6+&3\M@L9.@O#C\FSCV7^RR
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MG00<&3<'<ZY20+XY0YG!]MDY%%*N(T<:[3"(OD1?HB_1E^A+]"7Z$GUI]_D
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M52ZQ=4='&P=?(W_% ^(O8<9H"-I.1DLDZU6.CY\R8T!.RE@&TDF9 S"=!+
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M\!7P7:B$2B36(=JQ;I\V':UTSJN7\R90I!Z[0RHJ]^Z.H!% %$ 40!1 ?-%
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M\UBL+^B)'&%G.(];?JOL$ZZI7 W"MLM!<#_XWGDDA\*OAB7Y79@OKQP>-FS
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MBVBC8'+:MM[B33S3TRTF9I%\-?T7)#+VHH>>^.9T)&"\1S*P[*COGT7W_=B
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MT_EY<MRB>\357=P8A@<2[I'Q2N-[F\;L'*Z,/_PDTV-;XY7K(OFB<4#MI4Y
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MQ_9Z73OZU59_U8_S=/V$/Q<51I:](-'/Q6=/3<<^7Y;4*QL@]4M7,UW+# B
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M1K.(;)9%Y,#O+H:6?_\-FY0"C6)_4C^BT$6T_Z0N,+#E4 )4?43;C$E(7I&
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MS=NSAL[LB#YY=7G8Y(/6+OPMO.8+T1RP&C%A@';\-MUMP^L$?8&#57<GH!^
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M2Y>27QYUF+/S^839D*)9X--Q?(Z8CS*1R!A)!\&KUBA.[SJ_4&#06\TP1F'
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M!9['_2UQ ];^<L1=%;#9W1X<.:O:-TJ?XH=)/ U3?#@;._15")LW3$K#X7U
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M4:\_&N'KPX+5MW9LW!QW'U&0.&^#NT1H];F)5D">.IH0KRVJ0K0F00@5U5\
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M;=%]*[O*R%UG2+JK"+^8$7-J,V&-8F;%%E$JTZV2UAX^E^AB$201([B&N;"
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MUB+IIKYS>(@C_4]*)K-^)!ZQ.@@CWZ]X'-? 54DD/ZU$L_E76#>SM8IV;(K
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M9A)6-GD3C!]I+A'?ZR,N#,MG\F0P#HAR%Q[IP[O#RV=N^:/4!!NJ!Y,$6>"
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M\C#H[!%-"M"Q_*MR$  $AE+ *.%4U#2@_VD$ 6#(7T84 (*"(& HF((2!J>
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M1XNB3BGEYK0"WRE5LTZ1.62@VM\WCC[@B63IOM5&H^Y5I&&?UF&AG#0'8<:
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M;PF3(T4!1-:_[CKTA-1MY*NM$&5^]P:KR*NG;/G2?+[4J5&3 -K5^5,86.0
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MU%?N[FSEUSM3BQB2&6KO?1@A\'A45M5)HBVE9-,^ICRG-"_ND@^'-\_DS*/
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MVEA5,VMDO_R  \C+>>%O>U#EJM0M/*/:)"Q3\9V\"<EMV:H8@&B<57.W_3=
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M8[YS4AP-/W?0U]/S<?M^M<%$CIRK+?*YHI;L"*ZIF:$HWG15%P\Q6UJ;1 G
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M[HG"G-B [R1IY)7RGT;=J-8/2E_-*.+GR&6$TWM4:8V5&&XT4*R-+UOX1/'
M.C$'3A?H.@E\G-LZAKXDD*Z9"09O6*\V#GJIU:]3LRB':;>V\CYB2Y)'$U(K
M2?G?^.(.F!++"G)9P?AZY%$_F$B7-"3W]C&S<R"JU'\&M\1O:&4HO\DT5M'R
MNIT\6+_K*R-GU?M$8E4K.EO"PL>]$F<:ER%JL<.CHKOV220FL.H=HL&HT@S,
MGIFE3JSYL1=-RS:3]4BX]H5(UP!O<B$S7+7SVTV:R,J<6);;_M@B[:O]QA+-
MWP#T)B15?&V"D$5Z)?AB-AW9<4O3[F!)T7[BR(,U(C!LY!J/FM2+8U%+-AK:
MU,CZZ>:K^P.2;JTI_6BSDXX5#BKZ$Q".O,K98K[LV8<A<%."K<MOV4O9E1J/
ML>=&'7/3I37+?#(DH@K$/Q/9R@>OQW/SUW#J$3YJ.D12\L"&AV4[6W&9/>S(
M>'+ZQ77N/AW[LE%)4MB7+1'"^$DS:A7R/=P=O%V4R3L7L[O46$IX>.RS\=X'
M./GXN9B YS_=8=+W>#7B]5S< R91?#+SPF.:X2OX*BMF<?+:EQFT/N+SH1@Y
M>J)(G!%X?[GRCI!3GL/KE;B[W$J5*9+W[3.UA.3='6M<>=$52FS]I6;:\/*B
M:]]6RY_VJXZ]:<:/6:2Z.A,"[L-FK,5%JIR\X1*4.$P1&4MH<#+O@=OZQ#5\
M:G#PFLY7^0;2Y8*T52MBEWU=I]VHIT#7SGB"8>]^UY&OV!)4@F-A-\403SUW
M(DK'+HLJW@5X&BUNA+?O =:-MW-V)G)A^G7[)Z<HHD<].--K K&OXVL.9SM$
M0H]HOU%.SONFT*9/-0D&5S\33=WMVE<*)/; 71A4J)E!N>;K5TXC>0/_GK$P
MJIB&^' /JG&\59%6P*(!]K/4'=$@B&@6]_FABTSKO[#N+LDZK^?QSEBRW-5"
M$KN=:9^[O_IN]9=O(8GO>FFW!IR: I/$N#;NU*/JX'T+-^Q@R8(,GW*CA%F=
M(:4O65 IEIX,9"0M5 \VDM75QD5V[X?I\9D':CA<813"#UHW[FP8/;[R4?6E
M^%U[4;TV*T6S##M;>.I[4-.(KJ+#F_UA@)-EUR]',B/W^%Q'2#:1ZTAF J6S
MY^F6^&A>%6O4A-)$1D4 (,CXOM7Q(?.G7:RI+-0>".7HE+4/!ZP;[<B>&D6F
M5KOL@I09R.%EPOHQ;36BV.&OD9V'CACTQ*>\.HLRV/N'C,!/1K]UAWA%'[ C
M !=Y,5N3Z"$J;E,H_T;"8*8N'))PZC[-<2@^CGD'O<'6M;>)DJ><I&(0.XR]
M6QY2K]F07AO)>W62ST'!'[<#]0Z!+?2!H@+8A !URL!$'X_=X:'J-T%0'D .
M<+IEPD310+>L7K:Y IC,WJ.\9OB'+RX;)UD;F'B?8WS7/F&S&+T%2,E6<18Q
M.'78/C%F0O? 6DI#(%MN$'U>J'UB >+".-(7HWZQ7<2<8LL\%A&)">1]E3M8
M@874@1LQ 2OM(N>!1CD_D\@8*:].M $9V! O>7-A5T8")"T;#5Q@T/Y)966T
MHSLP^*!>+;])V:H@S%%ISCGU2-RBQLT%79DL8.1.+@8;F;.I \$J$+ :;^I3
M)E0.%QN(CFABS\/(#-O$5.+!X:X#GL9(6#30.)5%7="]-F,<;^K<;"I[P1!6
MPQ-;9J*V]=%?T]'E!N@O9-3;3=%D84"^B+ETAR8M-LLE&M-K<P8O +#:%$*3
MI)!UXHEFTC$X72$D4[?S6,DXX ,'T^6N<B+-\7K=8?/-E,YV]$>&JN\BV&43
MTFP&F0))<(QS V*MWC ]3KIENPK!_Y?O !_U+ 9]\6?2D=+#K9!X.83D#SXP
MIQAK')3BU*5%I^R"9 F +7V3*'O-#N:QX[<TC8N,01#.3+=T85^"2"P&VY9H
M,L)=8(+]P$KOLPA.0YD7)DS-"&B=WO+(^OS*-3"V4RUX$JSAH!EBH/0&</17
ML2*H7>W@$LZG#B)))1ML@8D8$(0,$-$'J?-!.@*0JCX(@@$I8T 6#/#:(0G(
M=YG"B7B?(EZ7O0Z7EZP^1/C#+OG=;G^IW=K'CK+#1J/::%V32FU;BOFOI?4#
MB]%U999N\F]Z#QY:@'PHXYE%0]V.1=Q+E/[!A-)6,@YF>NAM@=O(X2.]D31?
MC?@?.M(8O 5&"A,N]8X (-L1+];+5N."[U)H%C$V9[*E_5_O8B]5.KTWT2)O
M(D<_'/U#%DW]H5.]J@CN":<+ )&O3Z'- TQ94(<):1$#9[]V)]]Q]I=3P$BF
M>^>UR'^;I[)PNA&=Q0Y<< [9QLQ('(@![0=4V8&\9CNQGR9LVCB'<"!52!%>
M6\3]F&&@+-%SW2@2,NW]#@N4XB$8/B;Y\>*$N]6!PSK6!."VD+"1C,O_AGG:
M!D -@'MC,&>I>%A=]5LLPO\WYH<0V"FAX1B=]8#B8T(6V]M/9( <ATME;@!T
M#[FIDJ.S1( 4/T.0<I)Y)-F'MV/Q?%%><0+P_=6Q/SPD5I!>LZA!H4DJ.0"?
M_%\N7URS9Z[7I.F58(P5;Q<H:P1Y3B[/N O_3,0;;;G-&NEB9Z,T7M%1Q6*R
M?3*GPBRM 4:-);K">/%1NW+QF'H'=6D;%2O(1+U=FA&I![,#0%NKY/L:X5L[
MM*[+!AK4*_Y=T#8N\9C9NG$H""/Q71'7P3<AYFO% T>B%>[W7?F*57O#4&GA
M>,0.ZECQ&M_;)2@LDA($<C*=2D?#)6KJY?LE$7]#Y98) "M I?VD9/TK:<0X
MBA 7*W=;._Z]KN^X+/X]V+@',#^N0NA$YSQ1DHC-*OCM)1K,OQ)HD\L'\,$*
M_]PCJ9M@6Q%(8+3V5J=$N[I8RY9W?AWD#3'%@2#^WX]<?).>^6MIXQQ(Q*G=
M%O/;*.*FS+M%, , /;Q]H&!!AGH:M&_YV$@8RN*]#L2 -#53__5TAD0W'(,A
M<JIUGTVVQ$X<G+HK*SQ=TT!2-=V\9&,AO5P!Y.XGB"<"U3?%&3E)NQ$7UG$2
M\X%N=(\S)@#E*/E$Y"?,5QZ 0#QV]&Z+,*+9H2WTJ(1:4Y#,30S(BB=Y;$<.
M?QT?1KC-_ZA A$ONL$42$[WSDTEOJ!(H1NP5@U*%";_*QKWW/(%?-SLTP]$^
M?%EC(UVR!6FJ0]>4#92 1_YAB)W@J%RIIK9T(V_,GBEE$/4GI5I9&&EV'K8[
M\*$&'+I]@\'F401@<T8C^J.HT.S6U2*PX8==<#.=00DNU@FZ&P9,_\,4E\9H
MT SNM"[773I,C%77I6O+W/&V^XO;TS,B:T,&[8(MY#BB08%!CA>L"7V8-]'9
MAX/=()3'M@SPMK#SOW*IFC_\CW+NAD67^X (<V^Y3 ;P@P_DU56MZBZ^6302
MG,)FU2&K%V5!$%U/\N.%JV"NOOR.0,00+.$#C%%V@^ )Z)'<XO5-(%Z@-_=2
MH\(X<!98&CQ*OU0MT]6FNQ>AFS.)]=F".#+X=T2Y-7P'/SY4MZZRIAXB#4!U
M)7L1X6WC0'$\DR>S933Y5>/[;67=L:M#CKC5-H!<#L0+0SNQI=L#0J@/G.PX
M(_6-(2(5O0LD]^K=A4"J_5-3%F\Y,:"^Y%-G)\"]JJ-'MK#EBQK&=7*_55*,
MBTXKL9&3VM[B@;WZ5V1CFYUXUR%?.(_Q70H:;*#^!-A*_['2(?7=RZ>[X9!7
M/O<:#>!6Z[I./+ \TL J/,52<-9/ZXE2[,6&NGU/B6C MW/_<@T\>6TV/'"$
MP.-O8D?YY&,RP>#Z&LZ6#!J6/V :CYX7 -[N+R/4R7?_M*.,N)9\Q*"*T5UL
MB"L#0M\79;1MX;3Y,"F*^2\:7<8/O>]\[B_U& Z#LO._@.M&>V^"[9@0;^RY
M@TO@2C7U)]X3OR)1BU$8?XJ1<9 !I>V*1'/T"5[K6S#$3+ +?E2DZ\1E7:&1
MS_R1NU(*[5CL/NMF4=P.=>B1-6L3C;<9NSY-5]=1M>!!;464!KD0:2'J>8K]
M/(!5> 8H2X9")P[._I6W$MYI<9P,[>F;Q[TT,@BE\.4MV(BT/'<K($*6>W@_
M@2SK!CT<_:@PNM^N%'XURZ/W5&N]&$1> .(K[$6V-U9=SC@F9:E7=]IN!G]:
M+C/X GI *'6"C_<%.'NYL^CZ0.$FZ7.4SHJ!:%#JA>) <AL(XN K11)U;,2E
MWF$"]];=I&9!&#>R;-F .8+-)>U>$3LT!,"*<Q\]$*1\+A5<(<Q"[IE3B]DG
M9ZH':0.:M(%-"-(_>A25U7=?+MA'?7+3"J&>RR-*BZO+PE6/F9&!4;QNV43^
M7X$X4B!UMJFNLQ,LR@X^= N=-PYX&YJ"2<A^12'8\<!#I$.-1#&Q38@K'RQ7
MJ7B@&US  :\RK.]GW$5.=KX[B%N)!M8.OB)B1T\6@5O9Q?5DX+?.XS54!ID,
M+,/DZDZI'S!AX1=EWW+ HJMR<8 G 7_Q)W8P2P0OL:Z]-I?!3\:@7SO.S%2B
M1PD2B;F8(C<_JTWHEM_2C!DZ=$7./M6V$'A8U@U"FY[[)289I7\,Q7KW)U7%
MBX]D:V;%9$7O*4;O"%'E3'",VVG#7]X3[J_E8ZZPADR ^X13ZBW/M&&U:KOO
MN8HW_D2CQ<9-8]4QIS3RS=I BDMSVUS<3C3TU)K&F>,]^Z-3HIG_#TRL)$IN
ME0PP98.K'RA9"UOV\T1(L_/J@?P_9!&;/T8._!&'N#*1'<PZ!B"H.NY8)R^S
M ("1Q<6+T)T;KFHQ:$WVN2]TLC<9]$42=(?\ZJIXFS8?J+;F_-T73()-?2A(
MVF&"\ S0YJV$V@DPG@RP7;]9^A>I1 ;^*@!CXH@'VL X'A[' ^#/1C\_(3<1
M;9JR?B>J#E_# NQ=GL%[8M%UJ%P&",D&F_ *CIE*-%10:A9UWQA65*@0:WIB
MD]2!9FP@E@Q[UG8IX(EP=6/Y_4MTB7!7?SSHG>:RE ,#" (@93;.8IC@2"-I
MU7=>Y&BPMD"%D2']@X$PV3SP[4\DG:OKHY75L/4E5]5D,[HZIJ>2SC_]WAYQ
MY6F-Q7I6/=NT.)EP,A",X,-3'@_*?)+XPM8E]<IPKVMIM$4I[::2)E!BFP%5
M((G)RU9F3)"MYQ>)>^(0U]=/6EL0>W^-8W?,/8XV/4(D*\K::4 N[F6]%J[/
MA$WN)0.EH4;CL4!L&W*L2&8\Q?JIE^TF0>PD [S_R!6[[< 6(IE]>B?UU=<_
M$TH6!,(5,NIKPK>X@7WB%#2"K9N/5IC? N.9H,*UH[^8*!K#L#^0; C,(8\/
M3&K?'P7N@A'CSJ;U!E9"P!@ \Q<B.G;G).' V=\H/=;,^$(?!P&5PS?Q5#K$
M#YQ#(D"D+)0HF,E(6XN^U)^-^$J97&@?+%"P*@9<VUI4ZLU62]@PGKGYCAH.
MU/NKV8&%(7"R22VC[^/>3UW4E/S->@D8*E D9\ GBK@@8/R!7Y_W7\-\?-VI
M/>(]?6A<DB-JG9:"W'8;RDI"Z-:OY'I'V7+^O11=-Q:FXE3I&?X"("2[ #ZV
M4<>BW_T2<M'JUVN/(F#6G"(ET7.D!^#IFTTRN+E:=:((!I6/[YJ;,+%'M?AR
MUJ46MU1?*E!3  LY8/MT"/B9<=_0S4NO.;]\7#//?4FVWCV)CAT?G'6#0Q+$
M&EU?(10WR2DL/(2R[3.$471*69,!J"C:?C7[:J,6^1Q7\#IUK2YSOJ6]M6YK
MV&/\0<K&2.CUMV;-"ZE.&Z\U*/]A#)^KG$E\?3!3,1I3#R/XM5_5@29H9]6)
M?3%XCQK*X6?GX#[JOU=OUW=N)SYI^#14>^(>H,BL,%8&HI03.W=RZ"K._>#-
M,QOM@Z*DE#6]K@/"NPB+%Y7]8P0]MP=7Y<UYO),&"LN_+]=()%C2B9WWOA7O
M35\U3^N^V^;N*"UFLCSTU%S:#Z=?/!NA_R3:A].>03AQ664?AEMY?=]&&VXQ
M$QV3U(>+['KP@= N](\=5W13V6.R&SL?UG);>WZTH^72<DW)Z%>168VJ?<V0
M(%/%M*2\LIZ&P^XOM\<<KTH8NH<MY 6L!^YAA.G6OZ^P\@LCBKAN<$V54ZSK
M*"*R_L,OB>YUMTR4PZ1BZJ#2,MD9/G'**A]J W&^KZ#V?,Z^@.T?/;!*6688
M,"-E9Z5BY"P_AB;DR/]:%7+//X%=M N*IHC(G0M'!<6)][Z7=6W^)P2*:@H
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MNIN'"-V2,5N>'?KEHR,;562C2P9^7OT[ #< 8;Q@O <P&BY^5-?#6B8;\@<
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M8L>EV5T0YO)]X5K'%"XS]7XWT!MZ'$>Y/0B*G@/\V,KTLL6N<)H0R6ZJ:]S
M%U&07.!'6.9^>ADE@[[J44AH>P35B-(AI[Z)=;BP*X:7%Q8IZ3&GK::%;F4
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M%VGC4DG,X1[?>8>/@+4@S")%[?2)9VO2+DU,.,E=!VU(=-EXKD1VV+(#MH_
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M,ES(T%42X!]<8;'Z:Q"AB_*O%@!*[U\Q^L5K89 A9 "P7\@H%* "0*2#TD\
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MG5:D0XOZNO8F_E/;2Z=KU19L%*GC_G91;)V,6DBJ[+:DRV;CU!=.0B/M;E#
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MCI2MHK02!IB@.0/UANCUL%1Q@H:VDP ._ U[%-=T>:B.CN/$9\%H,HP&+!E
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M&P!C*9BW=%^*"/48T!VU:+Z<*?N231"394(H<#'Y^#K9Q) VV$H&ZAE/<0R
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M'IVS;MC+ G1>9C^5A+6,Y1-VVT*U.RPP5KUBXKMIK*,;)$>^FB]7WIVHWS.
MUNU@*GRENB,V\8O#)N\/?TDD''G76F@"L/ 5)QL?1UJJ&N:Q,>9$F-Y%M3QA
MD1\ 5<I@&E-S+>D I)H=5YUO2X3HQ<*C:8[NM?D.*BPU$L2D&FY%@J"F@3@:
M>.Z$MF'<*IN5/!J1)=MT=8T1^)Q/V/7AP-0#NVENV6XZ7)G)UBV4>;NN)!L%
M4OM96D2D8@N2RH1H4%D:HL[Q:K2861;'@^J1\RM&.#N!_)4/@.",PD-E!:+0
M?(-JEA9]Q6$O+J.:+94)9<IR(5<O%>6W%F71.;XDB!L1A!N#T:)<73'3O@E9
M,0H&5$.4>8@T(TX C:7(8\>*5S5UF+G_L"11<_VK<_1%B"Q&KA(E9P./D\WG
MA$PSB526SDA>U[3-EPQP8Q-,E\L.H7#V&.5"!.Q,E,5=UJIIUS--0MMD<IXA
M '6C(FU<E>,ZH')-[!U\[2\"T&:0:38"^'3 ]9A,&R _2@C#9, B;8E-PLH4
M6X0NCX48!+8-<AA-N2@5IHT@/YW)"0LO2UO'W4"&8I@L@LA^@'OQ!_>2WI!]
MU_W">Q2DIH29P"VT/41HYB,]46?J L!X$EQ9R)(3,J6!TQ[#W=RM8JB9+>)F
M1D=@?XX2'^I?S=O[$,RB(XUB69[58%,'MJN#D\&'R].9B%B63R@RC;*_KEEA
M#S$7',S-[&B(-F(K2IBA#$X7':5,8^D1P21AKGPHRX:O>-RN?U/ @?@,N(8M
MVU4,X,6(#%Z^HQ$$VLW)B,W3:<(1;',3*=3=_6#B8)X[#6I,S4L@R6[DYB@8
MY7E>K-?2NS[>7ZE^^UIE@5Q%$R>H ZH<FQ,AOGJ"I&&8A% G0;QB/?]4K]C,
MS9$S@FA*<NQN00.9" *WJ,M"+? RN)&:\XT++.^_F 8@Y%7*K+F(&)6+J1>/
MO-W+EA5!;$GYTN$G^OE>E[*9<)R@7Y0B]YQ15;,20>*SEK2<V<"MMDF"OY)<
MJ &ZTP&XEA@6*4+2IV%8:HX+HS"_N;%F!%Q;#271D&&02\OM$#_D *0(GB30
MK$']D8[*51+#=W+!<#X,1V6'4+U44_.(-$B $6=-!X Q@@^7]HAH=]_6P?2X
M.18BP#P6L<$MST240Z=RSHP#>&J>+PWJW\&]Q^0P!A%V&0",!-^HPLMF(DTH
M$#)#\!S5[S5ZNONAYHZN!G,5J)4 L<^O2.TII^D@$$QS?_T43!XT-)MFR:I
M2!D8]7X6BLZD#.8K[+)CT$6**)8. U%!)F8Q\Z36  L*,.%-2&B<V73_Y80,
MMHP*:=.;_1N/$1A)$*P1_[[+Y8I!,%B%+=>4LXENE-EQ#,=CVO'S1[?J[JZH
MW<U ZC"8^!$FM)^YRC;?X4?WZ;9<(S$DXP0V["*8:(M090*0#*8[7V]^@WL,
M+T=7D+>5EJ<C &P$R$ W5&837+&?%6L$Y\OG58Q>[TVQVL7C;"*R50;9E[K9
MX7R-+'ZN.A.V30+Z47)*#W%H7!9-F)\B ;>1$'9," G(#1?J,ZCZI% $7.9
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M_]FC>TI #DZ%B:2]G J(JF$6Q/#8AI1<FR:F;0<B4LVH(YZ+G08T:"R76%D
M3X<W#Y!LA7I /NR)\2X40H\.>>R,R+15>]S#)JFPEUDH%:W9?! %NC>Q9 ?S
MGHX>RIKN=?!<6WLQQ'#?JB]B).<%N^M'T;>3M1$"EG8_\O*#YIW](%:N(E&2
M%Z,240/LVV&+4*MF+>W(NTD,G!(L>[ ]X@3-6)K]7.D6L^31?!=E;SZ)R 2X
MZYAK-+=1  @#,/BDW23@)$[G"\_R><47#\D3O@@09D*(MP29.9)O)P$,^&PK
M+L2RO_?9QB=A'S@;&3E*S(6X("('!D+60C:=ANH*D(G#?EXU8#(=AB7F$ 3N
M.YF6N2/Y+OU,+!G.B%4432.C^":4\\NB^P'U06:<&$SC<1(HR,VDO/6H_.TJ
M' :*LPTXL T LT(Y%\5!:4J#LC_RW;G0E40C2R^9O>[W @6L923.<J<7GXUX
M)SLB#_L<".]@F_+@R2+/G/7JS3]UQY)NZ'6]X9PWW#W8JL0$#(37SJGB$  3
MJ(8QZ-'2FQFWJG:-B@?]9OH%NU.CLT.15BH0'5*N"ST';&)O%QFNEN3M '"4
MT8&$%Q#U099K/YB\Y7AS/V?+".3(10AE<(-*E_QF-,+3-@=* 0([!B=1.O!F
M<.&&4T[Z=-@57",W/&K)W=64A^5"UU=?W$Y#K,P8U.2SU(QZB$2(+141,UT6
M2T*N9\7WN ?7L9">PAPK(R?GM>\K$;;9_3!Y6WB\RO8'>/$RN$*_V_X=$E!4
M[H)]9;DK@Z-'$6VAK=5<C?J4"JAUX/@OFU]OV4AY OJ1F8^.06 TYH6ZC<J$
MXNM\^)(,IFX&_>V&(@8IQY0+M'B_KAGD;*S.41<QI;!0I!F!GEVD[O=-.\2]
M8-D;P)W$B8F%ZTRS3 "8.1>R)"-'B<S6I0!Q_9P=T^#UC.,8FS%TIDS@S1RR
M*%?(*\E?>BC=*$?&-B]S9$.ZMM'>\X^Y#>/$94NS0SDN=%B@!#P@.+^1!/<<
MU#!K2.J:R?>CP_1IT""^2>Y\D>:D4A&9XV8$U;*%)758GZY;N&+EZ--"$B'?
M=I/RH.=9RQFW7KU,Y2:844;!$"X$+8 Y<'.4^R$Z@]"%-1P8B@A6R8L@(B<I
M9\K6?@MY7%P1RMEP+L>-4;BW4+:E.A\]R.1_3=VT-2EMRZ?44N>W=1ASM.OM
MO9P,QH[Q:NVF)E":W 1*8.+ZVO4M9-"](X?,1YP^\K2:!R:,Y%OV#,<)8605
MM@8>[]9W;P;8F%@-T^J :$@@" ]F8-.!W2,)!W#>XK ,87OE/5NDU2"++'G%
MO(">>,VAJT",^\^^JWQRY,RXK1N84QBX?S2CB4 ]GG3CT-D0GZ.$K$&$%0_^
M<OFA$Q2BLN?3*B$G/#:/WN&[\?YC6 UG$PE0C^V6I8?R+Q;)S/R(>)-Y\D)A
M=G5F(B/74 CU$FTO"JCR1B+0$O8.JK.P:HZ_5BY@QGEBQ<R1,Z2[?C\DPO),
M(FBY-"LN\?5)E;H6[JZQ@MG,Z?R%;W:[O2P;*B**<09;_O!)P@YITV.=IE!.
M )=E3,]+Z^?.^E<U"CC6/*9_Q\N[JR[>>&7Y11BU(KD-E?XS4_^4U6R4R):'
M?1/C?;<Y]67:P8[-[[1DX<Y(.SI$HXFEU,%<PP<?VGQZDWQ_S9&YL LE0=7W
MW55 7>FFU"XP#D!IZQ=]>A,C.=*5BU:VC.\G''7FX@W]3\:.'UN]6T;_0SG7
M3W<53\6C+#"4$;Z*K>9H_[ Q46O-KN\2Q:@GY%?]68;CX[T994-K4C]\OA.)
M +G[-8,/A;D,$C9W<AP5<^;BOH;?.*GL[/)\1Y%WH=NSJ>,]W^5.!&=_==@N
MM,2_OMF>_/[^J5MG#+KS@@>>MG\,^?*B>+>A5$GAARBZNPFO?[\^XVSD^IY9
M^Y<?E4:]]J\\H#!/*_NTR:MGEXV!M=E,XGKNYTVLT:3&P=&R68/O$SUU-,<3
M69^NNW^:M9&(NSFWTNR>C?7LN"(W"92!U;94JP\=>[U2R$E7U98K-5SO\U#R
MGA0AES:WF53*UG](ZSTR[S@W_?7]@PM>9_;7:*W2>+NB07^O:>PG]\W!QN;U
M _:-H:P\O<BTA\^H2SZU^2@LJVXK=X;)=6ASEF1V:/LN'7556!9#'[BF^YS_
M#;_,W&T MU/KYB-?Y_+)-UXJOA5^15GZD]\>.AV/Y?>O])\TTBWS-+DX[.%W
ML7V?R?HYB9O!5+_"'27H20M5Z2K4POZX>O>G-R\(T4W^:ZG9E4$EFCAB14@^
M_::=X6&O*?D@IS](75V:YWJMUME5/Q3G&BY_I+KE@.&I-U2EB(<ZA+"M7^MN
M$I;LLGI06[.U<S31K* ]%@QH*MMPX)Z1,WM)YUA];</&+JM"Y4B!2XG3J,#D
MH-.8FP5,<S#PFK&@"WWBD9.XZ?4UA;J'/0&KEGW*$2(S#L$>"G9\>G!;FZ+1
M7<P=?O&AVOG!')FM-Q(?8MXYBK_U:/<F.HN[5/MKW3['1@5>KZE]N*)QXS+G
MX_<<R@#6=:-Q(2+<<Y0?<%-)5JSS],('+X?Q71N=%2I#=M M"BR_,M[[V^RN
MD'3U?$B?T)7:%CMTB3> TKSB)3"'L_ANA6>[VG99EU;>=7Q%?=VK>;T7UKCF
MWJXDF-Y'[Y/?S +HI2A+*VWER*VS$F@/]'YJ@=7CC?<NR-U[Y7UVM=:YARD$
M^^*A![ZF-F$#F$,C7KF8);[<@35.Q;77 S17#%L0'FW".-EN75+K>E??-Q%F
M'(EDR=\@EMQF[^MT*-[9+Q]>84F@/KNVL8PZLLLJ%W:"EJTWU'SBI7^<JE);
MG^HULX]1(9O\6A'/SWL=*C$)\.Y"-PL_/2@D^#&M'GVX8;K9S]<ZNIRKW,)+
M48F8FRB_9V(N<L8'RGV4]]&QH+K<=;*?K"]AI?B<)V@-OZP;_#I^ZYY(ZC35
M%'%=[U5[(]%-3//OU>\O:T@=Z%'P%;E:IRNI<$=\EB)*KQ/4A)B4.V=ROK[!
M6T[3P<AAMFE; <I:2$-LZL>$;LZYZ9@!X1@5O5[RN'5OK5%CB7\_@"]_4X5(
ML;6]R3R#J1*ZU]_-(Z2VX["OR J-:_WKLN@GT 5B]]ZSQTK:+\)E=:;AZQH:
M>LS];YLL:^:87 %DMH^<<) ==]?C!1.]DTRL-UJX+[&EY&V^W;#E[!#X=MJB
M6+N=KS9GA%&&C3JVG+RCM&4Z9]F^-F*!;23&AK):H2;76"::C77B=AF_2^J^
M&KI/BT^!:)[ENCF7)0?H6&!MB'YL-PV"79AT9[^]DP7<EEJ7=/!UE:-+:<5*
MO3<6K+HUK7.4G.#493K''=X)Z- 3A@]UM.K<AISR6Q%RTUV:OJK!ONU^H%GH
MD,(;YR4C]1$E_K':J&%AH%YI\UK5^:@EQ9(<@^MR9<B;49H-(RS4@;-+/XO8
M<D$9W>=Y(;;LV#<PXUBX=]'%NWE;;RI',@]4*G26,BC'D)2.O"MJU<95HGKE
MR$&(3D72OB;1R+*P48ZAII@=)JS/3(\R\I9I7^'-92D''\!&(?M+(ON'$+N)
M'O;$\K7XH"_:HQ(DB4$!H]P",XA/D!JA C +N[PA^,X^[UC_=D>2#LMB'=]Q
M_3@;&P;U7UWY0%H5^-5C9WT$:L-@7E?+!_EMAU\CK?@(VS,M(=.QR[4:23!S
MX/TIKCA2HY0*D<L>=[K_O$RK5^@J2W:^<GEKGL$PLP=^A;3OC^3]KEZYU.42
M!C)*KWV?_]!:RY=,Z*JB2*W16X'?)!:$_DIMU7B%NTZ[PO-,43#M99_,&//=
MU?PI*+8"U:>U"F7ASQ B*_@M@1]Z%6M2C17#^KOT;K)<7XGJ-<MC(:2QVDOB
MLBI;PYV%CN12Q*;V"D/-4;2MAA]@?ODU&QI]W\LLA!<I[$*E<Z_OS&\C1%?7
MPO\0' F[=8)NK,;&1S.1L9L.&G"IKGADK-M*N<S-9./64!ZI6S%8.N3R>H2M
M61W;I2S2&T*T=2R-&0)7DL;AWDS=M5NLJ:LVL> &P]"U%9.\K&_:A1N7&VU_
M\N.ZRA'QWIK+'=?6'ME+;0@'S11Z-%5S;OA:6Q)HMG3B(,HD6,[AZ.3X&]4,
M(4N3ITV@_%0)@_5R'$*'V)Z#[,+#>8/EF!UH+9*+AE:]EMN1(5 YK/MF<25U
M%;4USU02D2XK:Q5T/K@R4SP$]A'%B8AU*MG#=6S9&ZE'EOA7%VZ-R-R[$T7N
MYR-"VE4]4>/N2TY3"G2AEK57=A:$K*"# >P#%3/]G%5/G77U\]<O)=;V:<92
M,-3E<,OYZ3RE%=-VHVJYR<V#+JI+=U^1JBN#MU &H+ZM"/W Q9Y#O $Z3"7A
MUDWWZ/ZQ=(5/9SC2*/")XS2SSY@)%*B!'S4K;\!D#6K;Y<YW/LE]Z^%8"$'J
M 9\K=QSQ=NK6WKMC%^/:M?,HMUU#>;RU*[41M==UF629#=NVZD]5YQ*$%&+[
MY5D=YSOY>EP1LJKR68[*4P_;+0'W]U;!=8YG0,VOZWZX=-D%0Z%=VVZ5]S:B
M@H6LB3\2\,.9$,0-Q_1.^]'7GU[[^'7U,X?$%3Y&XWF5\OE+CDI8JH5=:6O_
MKPK-_RVI0X'#!PZ2"GY+133Y(J 2DJ&1D@)Q.&BH6+2<LT:F94L7I?9HNLWY
M'#CHJ-2LF;H>ZEJC<NI*[])K&S4XJ-EF986ES9PK9U:X7'.-NI:W^S=\WN=Y
MWQ\^O]E##\[@**>+TU=1+&%TW%7Z]TRW>[>3#WWPX.=5E]^6RKYC+RTK'Y#<
M:*O_3,3V^?_5?*&RM:EF\31)J#;L=]L6U'W*'J0P0OQFR^1E[=7NF6452;?]
MZA+GPD*W^I5&&8M E;I[&GMR;4<VRTLTV4+JGUNQ-W>?=XH+\5Y$E*G:PT-3
M7U]A;=)44R\4-UW)-]-VK<1X%J^(#T/RZ.>H<@].^\*!HEV, 2N>8AQ;(!=\
M;F/_U._#+:[[,!WTA2=1H7)]Y#_'&60%%7SXI*%(?,-;B!?U];\.G]0Y[=QA
M($KFV>[$*%/6.P6IFYVPA(N1M1!/L^F_[RO>^20V3T?3P@^6MWPY"T8,RV):
M[.,/LM:VXKVG9"^[':<T3($"1U'KX[7W"EW+XC1XGV;YJY86OX'%:U*EW(>#
M'O$BBI1RSYJMN14Y^_,-"7-PH@ C*>5Q1=>J/3Y8VP+&UN,"$?CVD3&_2EJ9
M$B/UI2E- Q)?D.I .):D$PK/JEJ(Y-*++:?>!GI+<^ ()[-L>$-()4TUCG(Z
MD6C.R7PF(VH&\&[%E[QY[ZC87=*)]U/9LE3773$$Z3"Z<@:B!L!+9HF!=!9<
M8&"=E5G,AY5..%$M]YBQ9>4,F@SNJ^=Q?@;\I, W<NQ>VC@:.P]1<^3V;T[[
M_8&RQP%_K+\HAA[:"_"47MU?]4O56( )BJ\8YA3?AH<&1"HYI=F6959<7<Z^
M^0!FFY$]*=2,T4681\!1 3BSX&1-OB*5@-)*$-Y"<-DGH;5,.#A/QU[H\VA[
ME%U\C:&0%5YF;A@'10LZ]X6,A-B4S0A(+]%1^'".;^UQS@1LM'.,NJR&9#G/
MG'U902,#/,&-SV9!@=+FGJ.W9=R,G A1&$?\E?CCH>ZB:H-D2!]DA!S,=>O;
M./ LR':7<8;!4K^[4H/<30V1$E)XWE\TB3%W!Q+#H4DS&R'74  S ]QYYCTL
M8-52@%YN9\W:Q0X=08V-&9)/,!7NMY"@>K2T/CGU.$':B4:5V^AB^]D5F5N\
MZ=)./#% MVI8:1ZW"XIPY'GL-3.\DM8G52S* ^>!\ 2/(F6?08P%.?0K/\_=
MGC!VC&,#%FS"^O$$A9XTK_/0IQ26H$$N)+3YMZ2[5877X#L*?.)4QL=Q#$V/
M#>\.L'/0)B<L0'1D-:O[D_'E#NL[%H[]_5%Q19[0::.%PL6\G.^<*#</ 0)D
M7(-=8D%CIG2>];JVBYYK1T'&),+B_WR7</5$ [H\"V(#V\I/TY5J.$0$@%J$
M/8-Q)W&>K;)/,<I9K3W(C&Q_LS-)G"0T0D&#\N#PG0C+7QF )S;+"&1@:2C.
MQXPPF$U5$_07#9B/%K=&<^J36C!"8PM7F[ZHY!HC#*LS,"(9(!BM[J.+@$^G
M/N?: :4U*;%!YV7"5*/A10 Y2JNC%\&'7G!5I772#) _I/.3R<!6W/+06Z=*
MJM*$MXD<WQVO!K1D.VW<QI]L:#R=G2X\).U N;YR?LG7+\>FDRU]D5FZ$$Y!
M5O* 5&EG9]E8S6CMR)/^V>2"E'Y&]#6M0R&9":-)VK;.J-;5@Q$E.E81FMH2
M;C[9]IJ*>I7K_I6>GOET"!Y%5YJ@X\$A;1-MJM*J%K[^6 L[,GB)U&#G&""N
M>B3#R3T?\8SE-A)7#_ETRJ$LTVO+*4D ^*WT[&I>>P]QR78S>J ;"0H],I%7
MH'2B<4K,7X5?WWNOIV=WT>0B'#<.D6I,^7CN5J/[FF%]L!,2JG[][%*4=>*9
ML0$C=0(>,<2LO8_%0UAP ^[BZ]W69*>&N4[BQ'E7V.8GLRM?5T7S]4'*NZ7<
MIKXZ?HJ5D) '^CJ P)IM.QSN&X;MO#R(R@<O'=7^<+Z6EP-YB9W;G 85&:5E
MZ")<7UVG[,EL024NB))OC0]M2RK1K!7G!M7@7U&_'<DF)#2"OI/6D(6IZ6\"
M%>/HR@J(I6U,RW\\0ID=NROWRM)Y7'FZ7TD0<C!:Q9G-+1_=W[('<H"L>1G+
M82QL>S]U".[=BO^F^>.)"9[E4]SPF4"!7Z-D#L\0#A9WI#_,CLXT+_I2+$BL
M67'HO.*F"KL52)1JPAYNWXN<W#.TSRJV3$P?<Y,:44X6%%Z"YCKX3RM;)3(Y
M91ZGRG?T/037=.JI3IN@**7R]S]&8NM%!MN[!4K^)-*OXT/G<-':D*[E%VZ]
M4'1?L7J7A/UU:129M5%$<"VS_24E4MJ'1ERT!L]M28VM/U %177L?F9^/KC^
M@W_",-(<OW HN3A=/O#"YVW(BC($#K98=[F8Y\?[XY1XAN;XY9X"7%J'5 W[
M:&7Q@Z3[6PAQ!M[1M]&"S+G!O1]*%7*/?-R7,8*D(<*)"532*0_.P[]B,CU^
MX3])!:D+",-%8>[L/W%_ \6X6'7CQ!]>[>;\.N4*,HY" *LMRU1F\'FY+MBE
M'Z9U3<@-$DZ=_]SQ3.I5R2!89\+M[VFPYW;]L&].4@^RQ+8 ];&[!Z9%3'G0
ME'S3J3]'SMI%S3;_&MVWJ>T[FMTD#7B*LM%A:?)[U,63]\>7V/R=$$.O6/(+
M55ISAURV/:?E HN1:VX%5R\ E/IZKTV&@KF^CE2]R'3US,3SB%^URGDX9@'P
MG3*%\P@W+ZX/7X;2 X(7+O[[_@0<(US2OU' ;>354T&Z"Q(Z-M-?[7M[,,_S
MC8PR#$8O):9.WZ6-6^\<.+GJD2#!@?F,XLZ]1SAYVR#BZ*E#(?+]W[G%+R:;
MO'2TCE5K?@Q;6XYR##9>QKO:C4Z,RA-WRKT1Z$58WQ$GF!"0QA']E#B.)HR&
MS[W\JX=B$/.[_#KLW(TD_2PJRM'3+V+R>[&*W<\V#QIB-#I/C3UD(TF^W;ZO
M 5I1Y*T$]BDCH\HFSY :9+R6]#!B=:GFXS6^%^@N;(WP+]4O'9E58."@==D@
MZ/;FJ[TF.*(!"NK QI39&T%MY1-[_*3-O]=*A-U>A!&SGJ/1!APGP"[8UCU"
M'!'S]<$**Z/&F-![V]ABETRE,,3RN%&T\/<,5OO??B$')0X\:Q1Q$\$;>L$7
MUQ^+6C'ZC"Z6&B4!>_H.3DL7?A*2!<@29E-:!1IIQ1)<>I9)%U%2\S,BW/FH
M[<H,84U^#L!!EO7J\ (;3F#CF'"L/+UH=/7Z+M;:<SU^3\D;&MQB]N,\ 1D0
M"NPC(40Q+H2/1G0)B@YW_#@"1AEL@, *$( R-L0>C5$-SI>D\54.-$:-L5VZ
M90$8=P8393PL?[QG'=E-<]0>;X"_#V<QWY161$YWG??\X679PY,CE^;^@YR;
MOI 7K*:7WY^N.D<5H5&_N\/5/R;U5FT35>_JK2XL/T$@ (G_ U!+ P04
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M8^(?43A!TFI!EK9!&/PA8T1PS+L^&81FHD_ R[ 0R?#0SV%PK&J(\DQ0$=U
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ME"3@$4!5UA>AXD8I_@- ?)(<0HT%ZA_S1/ZPUS?H9<"</K9(G;B8Y,2[SE,
M2>,32N,<BH9426$3C#*5B<S&NG\"86&TR6KO.<7Z%ZG"?O/+26A74VOL6M!&
MA(B)\=T)ROTUH6'0JP"=Q^D';RPK<NKQ4SG,.P%I-UM%B27\>%6"/PH8,K+6
M(Y![@D(XDC91KP@Z@FSM3#"\\EGTSA04M15_JO.$YVDFRN3!T<)+6V9 U-0B
M1(F+K"S;:0FQS+NVK6 HGGJ?M@F+GY,_N"=ZF0I/:*^JQ0V:]F6=-&V394.'
M+6M<>63B)P6.Y'\59W'%GB%8EISRR?](F:(&:EJ*;1S(RA*Z"4Y467PA$.0-
MLA?/P_J.18<AJ+Y<19V/-F3KQ+(V@: L10-/3 '/=*@>&_S7X*T"*(\ F)_S
MPQ6G^&O*S/I-(36.D_%H7XZ8MH@=M:\AA/.%N=M>H2:_ +^4=0G,4'.D$8M[
MFCJ'RF@7GHXO/>0H[V8Z99'2FZW !O7HX/F*/<BB327VAUT3F#/\@,T(@7[W
MH+*@-!UF9ETIX_'YUL5BEQ#QJV,9+]8%2*]#EZ[>7U"1CRW-Y@I24!^>KP^$
MA81<EF-FZHYSR!;$6-D74)+I3;]8%BHS8'>\)<?-1[@W%6<R<[":Z?OG/U#G
M?PJWM9#3^#ZWR("O!,"\(0B Z\(M$PVQ8M&)1"!9"D]![*MVY()*SA*>EL^0
M*CQE<2_1<)1P1WEI)@X3!4K+0:F]ZPH,/'2F6#*2V<R\CA&"G;D30ES1K=[3
MLB<U4M-Q+!$KU27P<*U7_FSQT*XQ]'(S'/&\G3]Z/P OJ3YRMDSSM0DC14A:
M,1AF#9FG%,2Y.8<^XV6A>+3QIS;7B?]IU,/P>&B<"HE ,5#$)CA!:V9RN.TT
M?-78IK2D@^\5#\55,T@?!F*MFX<#$D@7]89=C*4Q89*_@LD&#G /1YYQN2.Q
M_FX:2[?R?D7,J*)L9)I6&P< G:'BJZ;;K92UEK\,]K5_21&"%H<\#6X5]1IT
M(U+,4'YAC4Y0/FE&" 1?@_G_7 A>MUN5[BIH"/SA$8\E/.WD4+:)E3H5510&
M;^I.#>#5.(=C>)/(?UU?:&<>I:IQ/\,,TEV()3<O_6*TBJ>X-ERH)7?(T;I_
M,+T^Q!%X):[;J2%\DQ:ZJR$613![0:<3&]*[Q>[4'=?FQBL@T6<]6F>$07\@
M5DFM[H*14H[*93@GCO+, +KX*X_-35X[:2W#>DW;9_V9#@[%Q_.KWGD#LL=$
M<:0NBU1W]WZ0B$[_QB[F)W_8G V@V'1OPRT\"9)T=SV1%#_W3M!$-EG:^ZUV
M?5]$ .M=3GE-*7<]'MKM.>J?,!+CL[I(B5PD+<_F(M_BO?[QLQ$\=IU%ZJG8
M,:@7SM6'A#;[D1N=BI2[V1/3]41[0P?);"MY@UFJ WZ<6C=NVN*7*3:MU)_J
M0Z."]$.-"!%;MDQL,:A!&^7*\?<(:@C314XE)Y\@X+;7WR%R 44BC$'^7$W!
M5 @;\<<,VQ^1.B(KKPB,@ML$NI8#)AW.( 2JIS%"X_X/LF_DO)7G0WCS1U(C
MOL>\/5[3JFNG7=R@U.1B. PY'=ZLDC_M6B;6(.#>-#D=:]KL9!"UL.N,!HU?
M__E7&/Z6C0%"]XS*/]R>NW'7A]S8$T\W6J=9.:R6ITJDY;+X7-W1C_[^="5O
M?Z@\GZ<]=EYWD/T_EE=5VF4:^T&5M\^7>OYQ%Y(HM;;^D\JL?4<GLT1=4+W<
M.^CIB5S(G4>JAWNKK#K?Z&F3YSWY\P5Y_]>-12^26R\RO0 -G,A1)MUE)?#&
MO =]42R1N;8AH ?>K>B?8F\_E!/NDS JL$\ OAW'C3/H%!ZOB U>2;Q.O?W2
M0KQ33PRTV$=QV)=*]N4K5WC$1FX[. CCD\2]:T_C4R_)6R%!5U\(? I10%_8
M_!=&8"8BW:\/EZ6GF1*#">*L]J1EHQ+L21GDEWT\4@.?\--@5&P$+MP]0/,\
M!:96NJ*!+11X>A =EI0XYR856Y,XMR]UD%@1!WH9R^% 2?H7L4DF<7JI\)=^
MR2:">A))Z6!"'LT!Q<%!)24RE$]54,"O+U!ZVK(!=<T>AF"I>WDIA:Y"7'LI
M:>[!KTJ$.)K2\N9#VNAELL%#>A$#>I_(%!<'38 RE):2 !2)2(EN9MHARTV*
MKY-#K3B2P,,A&%S*WSII4>\AZR*"#]'#6O2@OV7#!O3X]M%DBQO#W&RQ<"C#
M;IJRO.0R,.+(86\9&;F/5D6RUO@C)6:%7]AD*^!ZG9J&1;IDK6XE;3=EG\RD
M_)7H#=%'G^.D_-CD% 1'OB>-1@3WPMPO?]HA< ;1MD%W$;S_RC74C81$2_?Z
MR)FRA!-)R2%TR,07_=1D&WM43TY2&G6V'"LI%X?ZRH?38[H5C>;\E9]N'$5F
M#7_MKVHG:?RI.1Q7-:97WYOUB8PC2?Y5;ZQX,-;&3>&1I*MLDRZD:/Q\MZ)R
MD<#D;:R>7K$;1>&."=1I5\6?)5E$+EU\J?#J+%\77 ,%B557Y99'*YZ/RF85
M*=K]-WQ@ GY_O'N2+^%-\0Y[HL%R<IA-4(4<-UJ85XX;OM57,>#3Y&O=^*!P
M1R+Y9-?@Y&06EMZA4F\54.A)J;](?@Y(,,^F/!0M-Y(TM?:W>(9NN%\I[QN>
M](2P1)OE%.R">'1E,UDM\=?B(&GWVY3!'%88_O0H&ZB?1Z6Z;^I0&'_(3F5U
M4SX-C7F>AH."FF^]J2CG%2=[(?Z[\,0-TY?!S"[I--EMPR\[12KGSE,77:,4
MD=.O*%-/1;%&1:IW:).OEIEG12KH%S. B"EP$&^('. 6J)J/!PJ\A2+S@I)0
MA__@YRW];8NA#Y>H4Z)R%L$(5GWWC3GZ.P$OK0H-YP1,D1[BJ\.G">,ELT&Q
M>0FTR."*IZ>"YW9TE0+EU4+X Y"6R(3E&-P#L6FNN&P09-#N8Z&]%4>- ?5]
M8C^# SPG>K$=U,LE)LF5": !*J1^!(0$<[N+\[!PL8]#I&3*TS $\J\Q@FHZ
M!N$(L_'$%BS4O'$DM/,(]0M!>;/TS5,O;_E/0KTMFC+MHR6/DS.LV;%$1@MX
MU< P[@5SN*\XV3/2W;/X?IH6X@N'BQ\4EF(H,-+R]7'PX(D%0^*$BPF_4B@R
MW&,PLHN-NP58"B<V(LQ)2FNNG"JJO,> NS3-(S1Q&-0-"7YR;RV9C2WNV(_B
M(FIGWRQ"X):@HX$B[.&Y!BT(SW'72OE"U4"PE1H0#L?.#\5!!!OLAZ+9S(5-
MHK-!BPV^7T[#7IG\JK7-"=J+$MXBEP8QP=<OT$H65^IW8ZHH:M,^SYB]:^@?
MK9B-S_M7QT#K- /]DLW?IY2E=?-TM6$0\+(W2D#<:*"E4 !ZAIIG'QQ>@AI9
M7R!G'@[<4TJTW]?8_U0R L&I 6XM]5S5UV;@(M*&N,C7Z9-0$?;NYC#&]):@
MVL(!?-&F#;'-1)E3 @4^.@%&'4^2W0^3O0(7:'K5&E!VW:6VI?!F#%,4N-#O
MR<8$ZM)+^EO8VK56!&%64Q84&SEIJU3EJPJ]1=\BXD@B^42.<*@SL0O?5T-F
MF<7S-D+*PE?O4A%,.7JF4GN;<8"KO-[/>K-K@7,%<</=NO1+@<0\1,<OX4/L
M#6 #?;7&]:\#!%#38,') @ELJ #KHL;;9F5SM/RB?E X?*,#0=W23)71QD:X
M_-IW@B8K95AX]U:6K<%_].,QO$&[:PB A@+EZA3E%A,#XU#BU /E;2A_!=QH
M-9"39K :>':%73@4WB.",J;%@F=>'D),=/N]A9Z,O7\H/I@8<!/2/EW]":HV
M 2^\S+0E1L4/[1';TMO26<[&W'C?R@;Q;ET5+G7K^U.8_B&F1G DV"90AONU
MM1L21WD$(C>/9YI83ABB"35M^&#7<H(!(+^!DL<U_U1@2>C>-13,MRV.IZHF
MPM#>2S[?_2F((KQ:/=\7! JAP1%@R=C835XU<[B-,X"G@*ZRHS 8S_?CP+7M
MD<?NB%)@!8W*86=E\E(/_:M>AR'NKO3.(?+10P%,R-98Z]5;L""*77C&@\<
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MH[2SHQ8FU-G:V=DCU#72V34CU+W2V;TC].ND\]>U4%?K:OT'H5[5^8;_ PY
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M;\,=;E;"LP[^=XN_]!ZB925LJ?[V&;8OGH*__%-C]MSL]E NY&ZB]BIA!Q*
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MIS5#)H(&D74M""G*6/8N'$";&HR;@&,A9[8CJE5 KC4[7W(?Q_1<@R\#<9(
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M(@(;H?.:(/:Z- W[;T$3F=OX;]'W_;Y:0DV&/93Q\H*@+ DK"+":+D#[+GB
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M,9D137Y04,19"6<A#)&26_Y)_Q9*H1*@H7 @T2BJ:O)>#>$ZYEN[1LE* Y1
MF^]PM<E>O>=]+4YV.GX<G3[(!_B;=DH$Z>5B(NJ"X.O[?09>?:9>L() ".+C
M?6#-W\\@\Z@,=1XBY$.=)1[R9K51V-.>32R:#O-M&"^[2>/>22*0O;IV;*OF
MT;R "]_:[_]^YFW>OW!>Y*U1=J0YU$R?;PIA#XX@Z.^%K#6#\N/"\NG"WZU?
M+AZ=&WD TCL_RN=B(HP% I#@?^N-U$8:6L?^\$4=$=@;69FKZ6/_V[_1G&WM
M[>'>W&-H]P$B0  %E0H6%"C0H,*%#!LZ? @Q8B6$ 13B22#0B\2-'#MZ_+B1
MAH>1)/\!F#R),J7*E2P!*-1 (*;,F31KVKR),Z?.G3Q[^OP)-*C0H42#:E#8
M,JG2I4R;.GT*-:K4J2<-QB&)E22,.@L+(7D -JS8L63+FCV+-NV#( 7S0 C+
MMM!;M0^05 HBMB!9NU_+0JA4*.R12GWYCE53*4\1'G0;.W[<N S#*A=R*C%(
M-;/FS9P[>W:J<$K6T:1+FSZ-.K7JU20?%=P#.;;LV;1KQ_Y1:"$=%#(C ,+\
M.;CPX<0SCY8",KGRY0PI'D" 8 !%A#H44F2./?EU@P@0:LP./GQVD5F+IS3H
MIJCZ]>S;NW\//[Y/+,#-V[^/W[Q"\J/A&(P4225CS&5;@;+__56)$(=54L0#
M/JRA1H1J]"6677B%I=>""IHEV89[5,)8782-Y4-NKR'A@X$J'M@&0TH88),!
MOQ647XTVWMB908B(P%J//OX()&HW&$3ABF(%02!9$*08&Y)&/IF6 T8PA 4&
M!#2!%(Y:;JGE<>)]"29%WQ4DB X"("2 (&"NJ5QW&;$)9YS[C9:?0BO(AV>>
M>N[)9Y\XI9 EEX(.6J-5HT7!R$)M, EEHV85=&%8AK&ED!I[W256;DD^@%BD
M9 E121D.5F(I6(:-!4$1DA'I:*MD_?"A0H"D4--E-!**:ZYU%K1%D+[^"NQI
M7!44XI,^K%K)'AN&)00?1&YJUK$&_RD[U@\-E>JJ;&L$J!"6]>D*;KA.>2EG
MN1R)R5 89PJ$ YMA>.&%FAO!VY @\'J!AT=N!C"FN?Z.1^>NE0 2@9\&'XQP
MP@K'Y-NWXCX,L5)SCC0#(@LIZT"V&C_PH:<B?@5!$"*+S*BDF(;5Z5@?%EN6
MIG8U:.J(9P4Q1D$E;_QDQD8D:I D;\#$L+R51$QTT4LI!$.P2B\=I$%Y9/QD
M$+F-@43-"8951"6,(('$AWFH);6 51>T[ -3,H0MSHY!T&)#1K\M+KG_SKT0
MN@SA@-  !FVG $+M+H0WNPKE(!U"!^S0'+OJ"B1 =041/IT "@A]$$(%!3[=
M0'XSA)% CO_333=_)0E<21,+GXXG!D"CSKI[MMX*=^SB&OK"L 9M#:W:3]9\
MQ%AY5'+S6196*#-8/"2;ULM[R&5RD3Q0K:'NKI+!4!,67!FH[-H_;%"O3'\/
MOFE9&-3[DQ#D!O,#@\'V  ^%%,(D!+^G[Q?Z@B%O<MG2RT:$B=EO#\#\R UT
M=+/;0KQ $7EM!X$"T=M""A> ?%5"$/N:#D&LPZYU"20,!>E;Y@1R ,IM!W/3
MV4'>%B*(!!(P= $CW>I:!T.@1,!;!:E2#&\(E*,X+( \M)%"Y, 0,N1N?RN*
M"Z.RQCZZ#"\LQV,>6"13I++X(%D"(EZ1$%2R#P6/B"KB 1L6 HC_UPVMAV04
ME$)D$+XTJO$.!AEB;;(V!I45@C%3*M(4OW86.*J,$<5"#,NX&!NKP:Z,A/S,
M %?H+P/6S3N52TA!(,A!@YA0( DP2.= > "*Y "#F7.@#O*6 !PD0(,7;&1%
M*D'"ZT!2(9\42"D1:2[1C>1&Z,&A+7?B!H8 PDJW[*5-<CG(0@IS. Y9@\<
M^22[>$4(5CNF\$YFLD(<H0B(<8M:?@?-CXU%F5Q# F+6@$Q'A<UMPRSG?0QB
M!S6JDVDP,(BHH"29+8(E96)9V5GBF1:MA7,V=MFA.?_)E$/"4DZ*Y"2_3&F0
M'"#DE1X,@.,8&  !1')Q$17:='#@A1S\_^V20J/H 0Q:$#QX(9,"R0&],/>W
M#B($<0.-90M)IP1?RC0F@!I8"E  S"K,=*8K^!] ?QH5AA2B"%#;9Z.*$*MD
M.?.9QT2"_]3@1K&L;YO%DY3_"!-5H]+F; L!JE<Y$YIUBO577# (_5:4&[ $
M 0F+R50E-D7/EE5"K6S]XQ31X ,DK $)^M.JDGSZU<":1* M95-!]\;(B5B.
M3&@R2 H99Y"&?JX2K70H8@6WD'U--@R1!"EW$EL)/)S0(.L20&%=6AY:%@00
ME=GI+:M0$%H1( (&<6TO&Q9,P>J6)0I!0E;]:AL?!$&>M!'9']&2M2BF1;A+
M!:Z!S@#8W4J7M_\&0>-8K]NC0Q0D,(U*C ^26KP,B04Q?<50'K[;6[& "KRD
M^BTR'="V,4Y7L(0][9<.:\KO;$>E F%I95,*0<J)UI67C2!#&AK1!.2@LXMT
M9$'VU:]]17*2 4BI?=DD2P_@2"$ZM2T.O;6ZU7K8EC24[WQ/K) X.G?%1D(#
MB%ALU'[F]L0T-@DZL8OCU,S ("HV7[(*L8<CK#4W?1%O\\SRE^4%><C%XR8/
M4O6AM*V8JR:N,4#K>V'PX%>Q;^+R*0L"T4I6@J0&-B5TSKPO!!2X(6'X8$05
M(,$U?[;+!?DO?P/ X"Q_*<-:>LF(8UC3#M?4='^&H0YG;&7!*N0',&[_M&R$
M:Y<>.YJ(/.!9E1--X[#F>-/],4AS:T,I:ZH5,&^I1"0NI=Q1)X9 <9E+$9#@
M*?<!#\:5]B>FA8EE/3,'OVU&2"3W^TB$"&+  5!S@=U<;#DSQ$S(GBRP(:P0
M0:S+@>OZJ*[7Q.<^%X0.A8:AMP!!AX*XH6#=9EVX$7WKKSIMTNRF"V*T=MQV
M;\S%Z$[W;I'&Z7R/A&=)]/'5QLN@!Q2DJ/.\F@\D%"'?DFU!9QU+S5)MU'?7
MV]X\S/6UM0-:5C86H8.C#N:<C1 TBSREHZV7#BXYG3$].^.5:*@7*+S)B^_Y
MI3XT2$S+?;H+ -,@O,'YZ<1(<>FF5]Y$'XL0_]0PAG@7O56#L770=6LH?6]Z
M2 5)0JL@1=6O) JNF**402R%=2NBY53.;?K$G[X]B\O<(_C=5RF!/<%U)8"D
MIE6(!BGGD)#/"P<5)/EB'\SR7@^DH7%>.\!2J^V"O-#G?KK C+#0A!G)EO$'
MPT!TT0[012]]\YQ7&P0LC?E,&T0*4L^Q[91NH(YEG5/9Y-B+0S:RX;K>8Z<2
M&:I7+.NSASYV:C?\1@Y+0I7_/;*9LW E+CG9'># I!85B+&CK7P%&%^AE%1V
M):#]0,;)W??AR?:6#$(PRAO,6W<B  9FU%KQ\RD"Y[[T[G\Z+?=V?O[T?TQ\
MW?]^=1<$$4DK_777W?\JO.,[LT9V[8,_9B& 8O$[3)(;-],BY15.:W!Y^<=[
M68$<W+=K"X4#&X@#"@!! 2!F'*<0@H<0A4=9:!))@D!FGZ-W"T%L!V40*&5]
M^X(XA4=]%#%9&*@<WI=XE8 %ZM<G!D%NV%,)Y0>$>@);3D>!PC1T]>>$3P@9
M9H=_2PA_4>=_ZS0^!6$$KF)$6(,_340@4(0670@62!06-9,V@Z$'*R:%5-A#
MO:>#>8=LSB%"PV<09)9L#$%F A!*$#0 S9>'@$,1H<1W:!)GP(9@#A9:D8-W
M<?@1/-B#-W>$>%);,F$KDCB)\=%32NB&A*00GP:%H0B%N3>%G?A/"D%Z5ZC_
M3FQ4$/)'&]S$3&$G(M)$3:N6/(#!5\T4%N=#*M,D&8S@ P2W3U/$B:88,7#H
MB TVAPF =W!79SC8$'B AQ0A49ST?-%609D#<HI86<*F$"CW2LGXB#37@XN7
MB>UA$*MS;I-WCNYA><5HC#UD$$XDBO58CQ)7BO$X3&>DBFGT NZT,4@U+;3W
M5.XED*_A,1" +*1"7%S$B_"HC^""C.)H2IF#  J09R(8;:7U$(*@ !KD2B;8
M@@V! Q_H?/WB98)($0Q&83!(D>.(>&:T6D/8CNSA+;NA =]&DS6I'NPW@1')
M0PKQ3O;H*C[0D$2I(FT(E%ZE$#O2C^!35@71<*TB_US$95R0495G 7NHATSX
MN)05B!47^)+<=R_QPAPB=2^-&!%H:98*06$.-)8> 8G?9Q _R)/L@5L+P8YW
M611)J'M?J3T* 8%(61L0, 8F4@@#0IA04B(0"9A!>6-/R33:!1C"N)@K)F/Y
M^)BY,I%QZ9EQLB_&]YD0,9=T61"8R)=#,4,*L1NIN1Z;^)>;&3OSR)67^1C8
MI!"B9INV 0'@)9M5R"N2J30[5A"2MIO !2J.^9M;TIFCZ9S,P4%A@& F^)P-
M49JF60GFZ)HRI $:P$O;213O&)O+:30* 4['21M-YQ5.51#E@YZS(8'*29ZR
MHQ!/()S XA^R^)Y&]9":.?^?7-*<U2F@'9&- S&@I$F.,CDP.PF>#6HP/BF?
M_PDQ"N&>^^D8V'0A64,J%AH;F2FAIUA=]^DKKG& '!I.N.F?'WHC 7J@+>H0
MV1A"+FJ="<HE"F&7#HJC?N*7*:JB1#./1VFB3+16S%(04A:D>?23/;H]3<DC
M(NHC5%=51[H_U!.A2FH>+"JC65H)-S@ .*"6,GJ=-6H0A):C98HG)6:E\OBC
M4KHV[S:5;!H6C3F>:5J>D>FDK&$[K@BG*Z*A<TJGQ8&E6BJH@\H082JF!4&F
M9JJH[ %T?QI N:FG)EH&)F*<>[J+ONFHGM@]=\H: &BI.".G/)JI@&J!A&JJ
MIPK_$H9ZJ)6PEXOJJD!14WXZJKD"J9]:%@-IJV,1G[(ZJ[-C$/;)J:B1A96P
MA;F:+:$JJKT:'(&*JLUZH*JZJJWZJM.:$[&:K,I*JSQFK$S$-28"<6SJH=A*
M1OP8K*;!BF^UK:U"BM<JKIS!K,X*K\X)K=A9"3U'K?=Z$X?&J^VZJI6:JP]9
MFQS:I^S*K[K2E-95KEGQCP4QE/+& Z X:?*3I 6[K*4:KQ?KK/.*G;N$KQT[
M$^<WL11KL&:5KBA3$-]JHJ$JLI"Y?PB;L",1E0'7;A @!I:6!X/9:!);I2L[
M%>^*L3^;C!J[L=_IL=0*LCO+LSV(LQ8J!%P#<%$JI;T9_[))&RX'^[(D09G<
MQ6XZNQ!OVF@H2K7XX;- 2[;<)[0;RZ!%:Z80NJ]A6W/;!:3H:1#Q8R)>:Z%<
M2[!NJZ"5@ @N&ZS$647MUD_K^6[TR&Z"E+=ZVQ1C6[:->W%GBYWCIK:N&@$[
ME[B*2SI\M*=6LP=%( 389+A'BK>8&Y@ZXK=W:CL0JU6QLB%2VWJ-AKBD2ZIA
MZ;BU*Z"0&[EI.[G;6;E3*[O8J9NB>U6>MJ>C^[NS:;H)2Z+]-FEEH 9X5'"O
MRV+A>KP52[NVB[V?B;NYN[LXVKM(6[WXD9O%NY!J$+>[:;SA^S96RZE0BK+L
M%BNJ&TY*J;Z>P;C9B[\KM+W82?\'1-N]?*ESOEN_JE6<EKJ5!@RV [R^R7NG
MYQJPC::>ARO "IP4]YN_%_PO^SNT_YN:1]NV%*P?K%*R09J^(.RC#"RBGKIY
M?5JA+(:XEVO" &#!&$S#<:+!&ZN=' R$'@S#,4Q,VCK"=YO /GS"+2NBP]K"
M1->G#;MB"ME51$P5,US#4SQS,0DW>JG#YY@",_+!4/S#Q1FI04Q_)>S%W*,C
M-G"?@=!&G->GP>M<9%S&3R'%5$S'V''#J\JJ67R$UMK#<>P9"^'&8HR4"^G'
M15P0P-J/"QLJ;,QC8>QY0US(<FRQ=4S)A77'>(R:>EQNL-G%D?P9N7F^@LQY
MACG!GES_* KA/:H8LW8+8WWJKWZ%K*8,%7-<R;7,$9>,QXFJR8568GTLRV"U
MIJ)<CW#\R]EJ%4WJ?XJP79N7>TSL7+%<S(L[R;9,S7.#R[FLN[OL2ZM9RM'\
MQ5(IS*$(S=Y<M0IA!Z>[:8#[RHZ&+'F <.;K5^/4R65,R]5LSPMQS7OK!OZK
MS;Z$ 99+SB-+/N'LA$5P50$]H2B<;ZF[=,?S$/*K,9GIRUY<S_=LT?F\M[/2
MSS.UQ=V,T-\<N 3->1+]T0G]JU*WO"L,$1#=*D[LT:9<T19MSQB]MZ63S1N]
M,-P,OB4=' M1!HXLTH!$RB_-TR%L$*+!:5!J=4$=+>Q5U!4\_\TR+=7=1Z,
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M  Q+LI1&>*O*J\Q*B=O*0.O*KU1+!?1'JE1+K*1 "X3%9OP*M"1+NV1+=H1
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MP0MB\($$S" '.^C!^S4PA"(D5D   #M02P,$%     @ L7R#5NB=Y4(K?@$
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M)UTE<[='"2%SIT>=?]HT=GBK;VVL+*JN_/?+_BC(.]C:FB@9.SG;R1E8&#[
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MPI$='N? _P$_C2O:/WJ/&<U_"OR#8S]5'SL1ZHE^E ">#?\K1ID/UX>'ZBH
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M+ZYWD"=:_>RCS6]F[J.O._PYP-QCQ3C ,F-U-L2Q8T4_Q'5U>#8B *]#4T"
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MH$,%]H+68T:@>[$ T"X=+&N;#,H4=C*VA,];X3!E*-+5?,'X@J!UOQ"PS"H
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MZ1UPROAN^NDT7VQ_1,S!9=&/AV:8Q:RY1*<A59;,:UAS?-U0CT*#M[7WM9*
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MI/R2'F3%(@C%!2T-FS0"@ 4?3 Q?HO2@#QZ8,N@=, ##+^R"%N" "!(A"<I
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MF9JGF<[FFJ8I:K8IFL8GG,+FG 9GG;KFG<+GAGXHB%9"*DP!%:2H$VCGC-Z
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M$B@I!+5$,@=JL2SUS.!HB$$ER$$?E&@BE&#NXZAZ*;U6HJG80JAF(AF(Y0(
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M)&!LR58".)9Y4((!*X!L%6!LR_1>DQ41*F "VK9L_^MV;-N"$5B" 3=  LK
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M-4YX.Y> $E0X\E5CJ<G"\Z7Z0G:1"&1"IPNX;2G@ ]U7V2.8>O.@B"DWGB5
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MH.8E@GO>$1C!U%8A#51 A2K,FD64P:<,K%"%FZN%2S(",1G*L/^%K -&*;*
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M*Q@%Z]YP[.YJ#R?/Q#1C(B#K"C?K'E0#%O<*\QY/XJ@OI*:4C=95[L$LYKF
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M&F"PN/J)7X#!(H'C;LD.,\0.K T[3&')*<A CKO__P-03*E3W;-*%\ #;F2
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MK5@B?+,)?[4,:BC"ZT" E:S @ 8YB (3<E #&M! !C7( 1,D0I%S6A@IU]R
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M-YJB/\7M"#M,$+M3&/NQ<\YV\@C<S.O#A/9X^.U22S+G&.SZ7"7<K@]'Y:4
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M042#"LY'/_WT*3@? ZJ_CTLWE#-N$2%;&+$1CQSCJA$/#:I6B#+Z]S_XU<Z
M!T1@ A7X%]C%#E"S6V"]C(64.)'K/<;CD-5$UT 'FLEI$01A:6HA$/7=:'_
M(L:02JB_^D7H8A>H /O.1[(]20Z&&[C !M1W@1SV$(8\!*+[+%/ 9H7O83%+
M'A]V5T(FIN\"&%@$$1$BO$6,9E6V*/\<D3B$D&04 W^'LY#S@&:T830H>7G
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M4-!<='J/\EBG.,S1\Z@]^6!1KT8^-"*"JJ%,GH@2DHP)Y4$(B8/?9OB  3Z
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M$S%E9KF%1$ C'/VH?:O!5G;F1;;@- 94D^D%D"U@&8M>7;3D'D:AX:HD#*
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M1CXJ'LP,X.E$<,2TT(T]F( ,0(0JVFA8F6V_^%X-F  "OPS3V.C?+L&_-N'
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MD6)%BQ<Q9M2XD2/&5V9 AA0YDF1)DR=1IC0#J^,R2!U@QI0YDV9-FS=QYNP
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M:2L3/1KDUKH'3Q #EG*EY=/\&V,9SSA6 %Y6_Q<@X( &['@#9=CICX&<TJ(
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M*AE!NS32;K77>=.$55>55J+7,Z>W-(V3*%/4)?:T>M>7(_#V5NZO.N-JJBZ
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MI3FC53E8'-BC^RN.<28JBL)-!L)>XJ8J%X)>$E%I!N*K6XH]U'=W5(8"#K6
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M/[^"^[V $5TZ;"3_728@S!?3*D3*S*^2& ;?=N)K( 3B9%*&"/)FZM0X.C
MH2RB]$N;XY_/XW<)[NM>[D<_<*!^^?N8[RWBRV_GIB%;LBDBLR7@:<7WCGK:
MITFZ^\M +30"P;_[C]Q>2Y!?RNV>G9;^OX/1^8VV^>'?>Z[#FG#*)W7R_IWL
M)672I)!L_P$"CP:!> H2+#CP8$*#"Q,Z-$BP(4*&"/DLLK4LH\:-&C4 ^*B!
MH\B1RY(10T0A0YY9)9,ENI !CZN1LOADH,"'6#*2)8G%X@,T*%!!1"I4V*!!
M$"-;Q'AJ3+8(@]1%//%\!!#2J=:M7+MZY?G*C-BQ9,N:/8LVK=JU9EY]_UT&
MJ8/<N73KVKV+-Z_>O1T@O?T+.+#@P83!LCV,./%AMU_C\GT,.3)?OX4K6[Z,
M.;/FS9P[<R5F*[3.T$P]FSZ-.K7JU:Q;N\;<2(."J[1KV[Z-.[?NW;Q[^[Z-
MX$(BKE8_X@%LDL^$#(58+E/&* ,&X<F4;4P6.P/UG8"5-<J@(0.CMX@J8- P
MGF1Q ,=?KPZK.+[\Q(R].I:,/S]DRN[[^S<\7X "F@7+6_?IAV""=/'W7X,.
M/@AA?Z"%EDPRI#45888:;LAAAQX&)H@"!/Q&8HDFGH@B;00DP =Q5[7'D3+)
MS)+(+#IQ9$LB&DR0ARS#:%0+(F50L,<L/V8$&O\?%VC AW/+@,8('TMQYY1W
MX*''T3",S&(+E1G5T@@>%.!Q$4\>&?=A9? -R&: ]75UH()RYL=@FG8.MF:;
M>M)GX)Q^TGEGH((.RMJ$75HH&J&*+LIHHXH*D6*DDDXJ:59:G8G52,D,H]P>
MM12SD3*+:+"!!#E12<PL1$B 01].VC*J!'F4EA&L&DB QU)<,:)!>.EE9*64
M&&D$':FF8JC>BXYRE>>>SJKU)E=Q_DEM7G4NVVBSSVY;5K1;35MMN MB2VZY
MV!I:X87FKLMNN^[^M1ZN _4JT$/SUAO1O/KB&U&^_O:Z1J\"XTMOP00/7/"]
M"?>[;\,2*+O5>C!>!U7_!F40L0<B?""B<1X:Y('(+!4^-4PC>FB 01X;(^(Q
M'GDP<F.ML>&JZU:+7/GKEXCL\;'&/N.!@1Z"B&Q=LFB^FY&VW"[MK5;@BBON
MM4A_J/32VQ;8&-1:CSMUUUZ[-@QIZ2;Z==EFG]WA>I:BK97:+H+$4TT82$ W
MW0I(4 &6)!%32QYUWTWWK,C6.JH"Z!U9):_@Y?QDWW7_30$&B7AI=*935VVU
MLTT[]?36?TK-MH.89Z[GYCQU[OF<H(?.>NL\H8LHK:[/3GOM@I4!L>T=Y>X4
MIFMG*4LC? "-@4I\),((XB*95)//&_,A2\P:08F(++([94LCC+@R+,DU!>5S
M_R*+U%)T[[R[.SKI;)I.$NJI*[BZ[JJEK[Z 6-OW/M3QR\__U+"KV[\ "G!V
M&A  W/HGL;>QARNSV -0G#2U!%ZN?DSK4_["M;\!;H9^%)0/^T;BO@L"2H,D
M=-?_R%;"%*IP71+D7PO-=S2MR$(/#JS%UUZ(O@YNZX,B":$()9/!%1:&@SI,
MS/W@]$-J!5&(3.30":_7Q"A*L4.^"Z#;(G:5WXW$.Q]KT@VSV#4B%G$Q%DRB
MZJ:H&3&.<2T\Y(@/S3@9-,JQ0T\<W!SOB,?58&IBNMNC OFX15NX0A:U4![2
M_#C!-;:IC1MY(QSULL0\.D6-BD0+(S7BR$?B)9+R,_\)C;HD20?5,92D+&5F
M<&@[5([DBBX\7[LH64FS7#(CF=2D73AI2HW ,I9D.:*T;)D@7-HN21= Q,AR
MZ9I1(G.9S/RC%<&XE2HB$)I(VR4OQ3)+N  30<+,I36OF<U:;E,NW:0=WQ A
M.<HU\S3*7*<[W\E*^2&R;:ZLW3S?]4U>AG.<(WPG@*XI'U]^BY_X*>?L^):(
M##2B.OX\3=@H%#L[-G2BH50E[2S*$8RZ3J/DRF<L]TG0R!B4E!ZMI$"=%E*1
MKC 9Q:#1SE &,E=\:B2V"%XB;GK31OB()[!:!$YO*HM>2+24[:2H4?-XSSY2
MTRGQ5.H!JPG0^8 TI7$\ZD;_2JK(J5(5DBODVQZ, E:C""$1-A2)+/*0@;!6
M0"6RT-0R$C$=M?;(D*8LJE7O*D6.9H1Y(3LFTO2Z#,"R3;#9BJH'R[A5:^$U
M:8:-CU83>Y>1FFU3C-B#98]W4X[MH4=^'48M$J$RG&I,#QF 'N)D]%D^A/:F
MJLW#'A8QC*%*TJZ+K6T*I:D5S^9A H+PZ[N:2A+<R@^X[,+J&A\+V;I(5I+&
M'>-).9=<Q9;0%HS( Y%VNE=BP'5R&PF2:MN:D6+8XJML?<I)+I"'1'2O%Z[(
M0P7FNDS:VG:^ DSJWAI8 6-ZS;ZKK"?M^+NNYA81N=$E9VT%K,/GGJ[ D4UA
MD/* _P%$Q/8I%KJ(7U,U"^SV9%3A66A&AB&WH2&.&+= A$J&%E^Q192^+-8@
M8/FFI,F5[[?^Y8AP=4=81B&X@P0N\'+SN&,*]CBZ/_;:6?&0@46H\R^UX,,:
M-C"YG3Q8 PN=\3*.+!Z&UE7% &RQEX=;8T_R80]ZP,!:%=&(68"*)#GBV,JD
ME O9\J1DB7"S(%8F,C8S8A&* (K/^FKER@&ROQ_!U406,A&%'!HB#U$THN]%
MD49+>M&,3K2]*JWH?N'A83'$9V,5,^3D%OF.0:Z?@MO'X%NFL+T"8826!5.+
M1>@!RB.;H6O!RY$'2TYZI)3OEW\=.N(B:19^^QO=,(!B3?^A9 */PU4CZ)JX
MM#9; A,XE4B*50' U:W:OC734KU-J7"+>]RVT6)Q/\VGK*6::W@MM?I"#=E1
M(TT9GLB#0)1<&"WMH9@5@DK*R$K3RE: #U"<[864T65@*SQT_ 6-K 7B0#X4
MPK*M?K6,9,&R+@(%K1HH@WKEO!$0@S;B&K/)<IKT:F+(8N1N!DH&EC.T)6>T
MQAO) P$"0.Z<Z_Q$ 0A 'L*(;L3 .['REJ.[23?TK1;]7;1 !-!,2YA8NS<1
M.M%NRAK1O9#CMTC0QJ.O%P[V"'Z;<+?2@/6>4@P^Y%=ZFU(.<UXU,SR<?2L-
MY(,@R@JL1%2  M66GBPB#L&W\MW_5-T6"6#Y(**=*W[QN@G  7Z>R*"S$;'K
M7OH4CYZYI%/5\NW2DGO+.YA9.'T#QB2&=C>P!PUO!#1?37W7[_CUL,N>73?.
M2$UNL@?9R8A&>=9(3=U;)&0E*6\]XLHP9H%\Y2DC%D"3P!Z&0:7C)Y\CKFC^
M\T&^C-J/9!:JU5?##*8PAHD__ K[?K[,[_V#D7_\[%]_K_)0_,A+/BV:3RGG
MHXAYJ]4_I/=?%S&&H2,9D %$@%,V(G.:D@R,4!"<]7^%@'JJ-SVU\%7PM640
ME7"SAX'M@DK%@@%0]AP,Q#/4,6.B$AXB*!BT$"MY4 O8EQ&W$!L\4G SUVD9
MZ!KY5T'J_[9N!K98-L@MIP9".3@7_<<NHE<&1K$!1B$(,4@2)O$2> !PQ2"!
M[P6!2&(+:N=ZN11[-*B%BH)*"1@>M,85V $>N;)]>Y!6?% ,![@5MB(K2H@C
ML>(IV"=L6W@:/+A#E)=J0BA$=O@L^T=0>F@NGL4(B:!::55:B8!U7$%=>7 !
MP?<D55@!5R@2K!>)4YA'AC(:*$2'F[@HVA<=4C$<:J@1*)$4@2<SMR(X@I$]
MFZ:"++@,;)@'MX!] ,:)G<&'FH.'# :(*G2+>^*#/02$.LA$O5!=8'4>5*&&
MRG!6&E !4=8X$VB)E$B!1,5EFIA"+$4CM2"*M>AB]=1 -Y$KK_^W5\G !V.B
M7C0E"YN&!T:"',4P*M*Q"&FH%4P8'AE =:(XA]R81O,W>3B8@[N80KVH)[_H
M1L'8%U'T?RO7?1C !RO($U!H8D)#-$\R#()0B= FC9;H==7HA@)$3,ZHCTQ$
M7&R8-XT0:-?!*1.0*UDW/<1&,RS9%7SC-QB@"*8X$E#H-Z6%=TQ%<R%Y&0*Y
M2+GH8P?&C] BE$0F1YY7 4ZXDQPA>G@P<++#4N@DB1P!8U(HCG*4A?T#&N@$
MDCZI0MK7E=.Q 670!QPC"_*X>N/UDB,ADPH0CHHXB"4'?RC3)$-%78F@"'>V
M6>'1)%F9$3D&EH !E.MSE*)&E$6)%@3_V4@&"9#O0DQ,8I/_IR/P!S-48A*(
M@%Z)*!+'!WR%A(4<Z8KRTY7HL8V#B6,UUD!S\SBM:)6.(W<8"9LUHQ6Q42J/
M@VPV^1R\4@'-QI!-"4.6@YH;I)B6=)CQEIC%V2W'271W%!4?@VLA5UT;,(W9
MA4Y,.1+$F <;0'"C&44/=2@7*$">E B"L =E< $$R @.21*QYE,_Y2.GN2DT
M\E,W]9[C<YK#V1^T>'R+T'V]B5Z*4"8?-ILP^20N&9=K.(AWUF?=ES$&^(9U
M)A0> S+1@X\]J9^!49@#XH?\])@DM*'VPYQ*)T<5 E=XX$6K-PR+8&]D,F$4
M<S,TQ!)6%B1 _W./H6F!UNB1D*A62PEP6Q051QA65>D4P]>C8?65&1HA^>A[
M,T,W%&""?+-IA^.6M3"EM/D6R5 >S.::6[&E;2B'8Z>DA!&B;C*BFY><RCD6
M'3I.']HNIJ>9V"F=[B6G-&%O248YRFAO&H!O.!J>.LH_Q$",8[9:=39Q>1 +
MR! JR9!:H84(A A_>?!LV#=\&I Q]2D^VGB28^H?+T9=W7<!%+ 2/\)Z-(.1
M")H\L(8(.Z(!/ZH5HO=R&H (!KH1M,BI?U&F4G6F]I>F:MH6N\I_)(1:BR R
ME+.(%]"0R&(2C="B'[=%K\BBOSEB)98!>T!6F[J1.=J1M3,,[75=O?^@$<=0
M#-O%=MIU 4[8/;<0"^Y5G6X)B=UYJW;"I")Q"[&2 2B6'!.@!UC:DNK(KUE:
M'DO".#SA$N:A-U6!H?'*++Y*%FRZ36XZ0+EZ6/Y8>224F1%V/7J: :1W84U6
M 6O@JGOCL75J"['P5?"*3%LY.S6*L<K*J%CG)2#&![\I?#EB/+HY/9"8A-ZI
ML.YAJVYY"[N5,FV5KZUZ"R,!8JRHD5WA$E*! 501AG E%8U 3S/8L[C*L&L*
MK'_8JVKJL, $L8-2(0IH68_Z4ZI5"-?:78L E1B !]:*J3KU(\RS66^+4V/F
M0!::8J*Q8@.4#%CF:ETA>A[C:B.(951[@,/_A[)7NR'SNCQZ=Q[CL2E[ ',V
MF3T[TJ6"X0HER%U<D1W"41+@)IR,B[59^ZL4FX==JYR,B4F.F4*BQXQ@10%&
M 7K7<59I=:1@5;N4V*.+F[*B24)'QJ?Y:6M%LGTLLVN)Z[&^2[H0\K/+0XXI
MD7HMH7>+4X8W86V#L0@74#Q0NQ5-.Q5J*)C-RUBF^[6V%+8!)+&.M;4>FD)\
M,X@\<S''LPB6"&*-@*GU*;?F19_U":',I+*MHZ<"0;78^A11D5[ N0S#4&\5
ML+,DH0R*^Z+D"R&":1*46UI.$AOA.V/8@3+I9,!:(2-]$#E4YA6)4,(SP9-6
M2\%:L;Z@UKYMJKK%_\FZM.2Z0B1ZCZK G!C K?.4#+FTXPA7DFJ@Q]=Z-O(Z
MR[NM+<P:.+1[U<-KKZ@C*LF.&0&[[U7%C\@'9=DD10,:GF!:R/)9UF-'JS@!
MLHIWG\4E@X-P"C@!98 (M' I8LK$)/'"Z88_P9B^_7/'B%'#VJ3'3,1]Q[/#
MFXB)?3M 2EF[2VBN1!J!K;>T5\F\=>RSW[8I@D D&6N;A(<JM: '"I#!OA<K
M1" [L)(!$H >PZ*E[Y6J&Q$;%\ C#KD3*/$RAA0=&S !1,">",O"E"P2?4Q&
MJ*N+,ZR8YZM)>ZPHR5!OA#R8/<PZH)$(92" <%LC4?Q_6^S(2.*QV9RS:O]7
M6F9KG__KRZF15!5R,T+@6H6@,87@H(!&,LP:'GC@,SSC,HV@EM!:=I[P(];1
M0!3Z/'8'82BJMU;<ER C<1V# 4( /5%L>'0\SKIDNJ>;QT"(S/(#S&SQQ^(D
MPT($8K,@B\T,O"5$"WT0NV#%O!DIF]#X>E>9NY.\3B'\12S\=W.C;7>3-P/;
MDL6F;<ZWRV2'RMR3T\UV-U#:IQO14GKP.'>C % J8USQO*P#TZQST?TXT?](
MS$69T3?\T,\<TB24*H,X9FEEJ8B($=9!8FK7KMJ,UDM+GIBZ!RXC)=!G&B9A
M>G5MUW>-UWFMUWO-UW8=6WW=UW\-V(--V(5MV(?_C=A^G=?:=WS"(P1.&UK_
M:E[?4W)H:<V?FCS*JG)^]L_B8PN!9A*NT ?_K#'B<[11C2D9D-BKS=K_U]JN
M_=JQG=>"O=JTG=BVC=BL$-&K<-B/8)"/(-O!+=R%C=N'7=R&7=RKL-N]_=O#
MO=?'3=R#G9];;95=K4*+:(RFB22WH-+NNM: .1)!PHQIG1F&0AKGC=[IK=[K
MS=[M[=[O#=_Q+=_S3=_U;=_PC0$]67<I&M, @ 'W#> !+N #3N %;N $K@H1
MK0KT[0@&Z0@'#N$1+N$2GN"FN^#SW>#!^. 3SN'LS;/43844@G" JD$)":D:
M@*P.^7\6R<U7R<U;<7Q*_Z('(;L9YMWA-S[AM2#A.H[C!Y[?O:P1[?6@9K,>
M_XW>M]#C2:[D2\[D[EWA67OA\IWA0+CA!,[C38[E'?[D#!OE\3WE.5CE67[@
M'P[BSLP_2BG/-G2Q+3Y>6!D8HG(>\=<9-A[A5R[F=X[G!?[CHWMMGG"S1'X5
M&=#C=I[GA6[H [[EOMKE\/WEZQ;FAP[I39[H:KKH[]WHJ?;HD4[?9$[=9DZ:
MMB (%U &#=D3FID' YHE6P>:R!$=98 ')ND9=.W<LT[KM6[KMP[8&="3U"4+
M2%PVZZ':Q% ,N$[LQ6[LQR[;NFVZO&W8OAV,P(WLT2[MLJW<ILL*S/WLT3WM
MA?\]W2 >XG^ZQ!H$YQI !$1[7NE5Q,7HTERQ?'I !.*A#%'M&?+.$_2N*/;N
M%?C.&8X[6 D++(2A[VD2\-@RU48IS$-9)9LQ\,]:+@5/?Q^(1('L[6CCZ;IC
MHF[K1>8\$-,K$H.;O(+!*P7A"@L_\;S,Y[93!@:T0"4/T>8;PP][U?QHS(]4
MT2Q?*-;-1$QXKJYZN*]F>W?J88'A;]!)\C9O8_Z.-NLA!/]>\K 0T3,/1Y$0
M\_.7U1)O]%USR.*I.\-J(U:6/8S8)&NV#)\%80TY8K9@8M9J0R9N),@"8H5D
MK#71B*U\]86A?1=U%1< "9$ "7WO]W[/]W\O^(-/^('_3_B'C_B0@ M3+WE0
M;T92OX,17?447?=8?R&(W#\7.ZML?+NTABIMCJX:P5XG^]&_Y^;/<5;5HWR=
MGZ25'QCCV]\,4+&1[_('CY2TG[6.GT0U[_J>4?%E,[9PG;9G&UK:>!W$$"7V
M1LUXN] [H933V*B8A5-O3<C=WON$MO+\@RD+,/OM]O0O#[:,'W23;]77_Z8X
MWS_BW:,IL1*OPZ-JM;C8794LK5;%4[CF/QC\GO17P?VIB_L,"Q"OE@TD6-#@
M0$@=%"YDV-#A0X@1)4[L .G@18P9-6[DV-'C1Y A-[XR4]+D290I5:YDV=*E
M&8$@$U*D6=,F18LB=>[DV=/G_T^@084.)0J2F"VDR9(AM46LZ%.H1F<Q2L1'
M0YDA>Q(QDC4L8S)BLQ*-)9MH%K%D!(D-DY6H:]J!8,66';N(D2VX4?7NY=O7
MKU \  3C^5LXJ ;! !C<9-P8IV'(D7V2?%G9\N67,3_.=-S9<\.<DD6/YD@9
M\VG4EF&%Y/S9M>/0I&7/IEV[]M&D2Y$ZM=W[XBQ$?1#5\EW<^''D'Q$+UI!\
M=&#!"UY/KQG;^?6?IE-OYWY2L\?6U,5+M([=O$[MW=6C_MXQ_'CXH,_/IU^_
M+VZ\NIO:%SUK#Z)$B.-O0 (+Y @Z "30  \&%]3 00;Q6+#!"">L\$(*,Z30
M0@@WO/^00PDA!%'##B<T,<(0)4A,NOA:K,A & =*;ST:*VN/H_=<A*^\&.V;
ML48@5[IQHQQU%(_''I-4\CK\E&**MR6?4D:6//@(,$HLL[1MN<2Z]/)+,,,4
M<TPRRS3S3#%9-/)(+>G[,4@X31I2HR+7? W)-H][,TXX5Y/)SA;QS'-00J%J
M4C\H"^W)%EEFV4]12"/]*0\" D#S4DPSU733+@408#% IQ-44M+VY!/(.3.J
M,]3.1B55-%-/I3%5C%9EM3%77]5UUX'P0^M)7H,5=EB=^%"  $Z3579933WE
MX%;7<B5VKUAE58_6BVR%UB9IIXVJ6FNYP_8@;;>EJ5MOTTW_\E!@U77WW5=G
MX2,/$4L444)\[]4W7WY#Q#?$>O]],& 3]S68X 8?E/ "!AC@X%ES88/7,'##
M36U<@\J-F+R)"ZO8XM,P+DCCC2%"MV.4L6-WMY1;=OEE_D@NV:&380;I8Y O
M$YD@F6=FJ&:;/<(YY\K\W,QGB8-6FDFFG&1Y::BCEIJOGI%^<>KLB YR9X2L
M9@QHK T:6NN6C ;/ZYO #GOMH%9^E&VXXY:;9[2YG3NDL<D6DK6ZJ[O[9KUG
MY;OOQ_XVG"BW$SU\<<;AK1IIM=G..W"4N%[F<9\C7WMRRDTRVSW""V]\=)%\
M191TU%/G%?.9-0^;\\YA&CSTB%S'_QKVSBUGO63;58\[<=^#%S[/W3?N76K<
M*=>==HZ'3S[PY9DW>7CJ>VWZ].JSUSYFZ:=W/G9Q9^_^9^J?U_MS',>G>?O@
MFU2F7?;CE]^XXB,^/FKSR8Y>_87NASI_K>V/?U>;W^B 5T $)E T]3.7_Y8&
M0*()D'\.5!H$<X8^(@VP?PIDW $Y^$%X">,5(R1A"4UX0A2F4(4K9.$KA*$3
M!FZ+@D&S(,@DJ+X9VJR&%KOA^'((PFF9#GY )"*Q=A@NRW5-@P0,WA&MU</N
M_?!E3I05%*4GQ2+RRH-9Y**NJ'BJ)%YNB4STW1?Y9$7F8;%E9HP3&FFGQBY*
M:HMQI&.AV/\(IS#&$%IP1-D=MR:^"98/?-MQ8^CX6$="S1&1B\22'U$%PS$>
M<F*.K%$A"2=)>%&21ABD4R09*35%?E*4,-+D>O+HR>\-$C6<5!4JA5=*];"R
M5JX<I<U"64M<U@>6W3GE$C'YKEV&[T^^%*0J3R/+;-$RERV[Y3*=Z9Q@$A*2
MQ$RE,74&2!P6TYJ6L63??OE, C43G./L330O-DT-?E-=YF0/-GVHS6UFQIU1
M)"?*A/BT>N;3-^P,&3H'J,YT\1,SW:P;0+TET,L@DUS*U*>WQ-E0B'HLGMST
M9R"K.=&6$!1M!IT60BDZS'1&5%T/%6E)OX51>8I$C[?BJ!%1ZA+_C7JMI</R
M:-'F>463!O%Z0\QI3_52TY3>-(WP?&E*8FJUF0H+J# 5ZAM]*JQ[ONVI4R7*
M4C-:T6Q>M*B5:ZHAB;I5SW7UDE3=%4G)>E:A@54EO0RI5M4J.Y#^\ZMJ/2KD
MT$HJL]Y5KQ>Q*DO8*E>WTE6LWIPK6.N:N;U"*J^)96Q?]Z92AJ;.L6L=;$$+
MNU6%9BRRC,728CFKU\D:%:OO#*QA*[O1RQ;UL*W[[*"BJKC6QG89H>4J9*DI
M/%B\M;9'NVT3=7N2S(YLL[*-D6>).U7:>F>T]!Q>;G];DM7R+K4OC:[QCMO9
MG>+SNI]-KIR6B]/2;K6Z]ILN2H-+D$@,_W>[ WKM>EO;7>A^=ZCA5>UI95I>
MC(ZW@>Y=5]/>IUW^@O:Y\;5M6U\Y8+CRUL"^'?!YE;C@ (<SNU*-,%KAF^"X
M6O3  ]:O#/$[T0[OL<(&,NZ(]7GAOVJ8P<\-,4L_',\6LRJI)MY)>VE\5A3+
MUZGTI:Y]D?KB;3I8C+V]\7Q*7&1PYKC @-TPBWUL5QZC-,:AFC&2/W)D*R]3
MR4]&;)3SRV76>GFB0EZIC+-LY G#]LP1W7*&L]KDWTX94%7>59M!1^0U(V<8
M:<YS3NU\-CQ+%L%RMA.=O8A@,JNWS[?A\Z)%^N<[0UAUD.YDH%%'Z59:VM&,
MS@U/-UU/3%=:TO^"YC"8I2MF&)O:NI\V#I993<=09WK4EQZTJLF+ZB#;>K^O
M]HVK><W%6,]2TZ,+MF:'W;AB"_?8OX:,KTDEET3@A=FZK/6255S&:BN8R<%S
M[G,3O6QUR641M4B&,A;I;#G:@@\70(12ICV?9!M[UJ2+]X.WC>U2NYFT+SL*
M'RJ0"'<C$MV1ZC<&%A'P=V.GWG0#]^&Z'>>0I+?AAKOPM^<-+V+4 A$8 #@C
M!ZY86R1" XW(2\*OLW![7WO2V0;TQ9&-:%U[&&893T0&2&YN1.ZYTP!V%[3Y
ML(<U7" /6Z%P06RQB$70Y2TA.7K2R[)TDX^$Y=I6.:F=K&_FPEFW%K__-[R2
M40RQ(&(/&L! 'A#ABEH4(R--5_HP2DZ]C^<IX_ZN0-TK0($*X"':&$G&(C!P
M ;O7/0]= 4DR$O'WP%=@\%Z)ND90/F27,V[A9:8RD*W)]:J[*^-[2'S=A7"E
MB_0= QM(_.*W%_<LK841\]J#E<:""+$/ON1*J455JD26>>5A#XT8AIH+HHQD
MU'Y>KK>][GGO^\8_GO)SMKPQ";TF0[^JXC$7<<>2,0Q&[$'[Q(?]'F2?%^#7
M8A&"J!* BK_[WF</]5C"?AX43_BX$./PB4 +0<"2"*'O?2"]<(7[3:^1^\L_
M6R"(]GL_QFN\@U ^19.\J4N?B?N;Z<,Z\)H8_UM@A#R@@#V OV6X/XZ;/6)
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M+*X EZUC"\E4 +4KMK)V:I1ESU% "!<CZ0;4C+$]#+?*1,V8_W_9W!]IO?E
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MA>0?G:2?L <9^:.]G:6(OH6^S4<[?;TG^I^L_AP$"+^-'Y%'C9BY(?'_A0!
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M)T]:?1A*$L%D&J,D5LXV T.@IQS>B6W(M7X^X6V1N-W%:0/S<(IJ9EV>.^5
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M%@&7D2E[3=JKSD#L7^:R=4-<K?]&\<5I-ATU'@P./_6RYCI\[^6Z.W?!9A#
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M048M>%#!2J%T ,23<GT&N_2PYM]9Y]\SGR,*4(U295]_^Z^&QI_>)SVR1H*
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MSYHB F8BE&\B_NH;O3.*M'*(]D:'FU)1<83\Q]K2JT79HE^K2CQ]=4K5<7$
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M=T][::%27LIIU<:2&C9( ;F$R4Z,.I#*/>*J%MY'18P8<IVB<KX!R=VK"OQ
M]V4%89P@-@W9+#L:^7P@:<@3@&L*2'90.9$"9,?(7S-&/C(;-@)+V*<PV4M
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M<9S5C+\%[XL"<E@_C E#"WRLK^>Y,%][70[91928<Y_:Y?M$ZFR%'[*">!4
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MZ#=Z),'DT#TRHI1X<75K5I26."K<WT"AZQ'!-"B'C01._V'>2-^,GS,32-8
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M(8;.AGP2:0M$CA5^KA"/(&VAVHWG+H.&8+%9MNPDM184]<<0E%"98XM C?L
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M.K&(Y7,)GE7L6#_38,YE+NOM&K09P"Y^TT3W $6&RKGDKBWF:"^!0N66Q@:
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MO?T ;\P ?_6 P.2 T.F "/J@&,N@A.*@E/U@Z<M;,6S4-P+_!U!+ P04
M" "Q?(-6L(G)GP@Z  #).@  #    '!R;WAY,# Q+FIP9XVZ951<3=,N/+B[
M:V!P=P_!?7 8W-W=@TMP@KL-[L$MN'MP=W<('D(XN>_G>Y_S?O].[1][K:ZN
MJ[IV5]6N7EWO*^\[ $QY:3EI !0T &#^]P&\7P"P)#W,['P 4 !8 .#?H2L
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MV05GJB$X) ?GR71@6+DAVBVHPV%>*/-G)0T%4 D/+PT*.Z8 (9;^'6 K958
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MTG[HVDNM.NJ&+V2Z[) ?D<EHI2_V?7TK(88?C<FM,F[B%OH=0 G[.YU @-*
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MX)+2 TJ(H?E"*+;3QX;7(2Z$N):O-^D^1=G=6Z$[])9@)O9QP0%U,(/9/.E
MLC_'<.DX%GS0U!>[=<3[:R@K*--WP,J#AF>*EVDXGO$Z61P^M@G"<PXN!%.
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M.D4\T(C0(P(TO]:%.GP*/#3,G1*4W=ZW ,8Z6_H(9"F&629D.2P'A,-,Q _
M&5\;5@U!MQ!;-B7_<%K+9W@HMKM"GWWUL.#K6A=FD MK=B.)*]A6EB@2/D=V
M/GMP=Y!C2^=NF$X((5ZM0NJ?9\--V6UG6_8WQD @3;7=L]H6'?@@\/'/^1G;
MI:'U>3=O67D="[YE^O/@\[YL+@-I_JEB,]?GF4<%%/Y,C)9$E8,_5- GPALV
ME+@*T2[+C>465&SB.=0F.#YG+DNI&IKX[2HP3#KJD'!1X\&'.=IW0-V3S$%1
MO^!B5.18[!U?LFV#*#[2*ETT%#4\RA<:O,FPM:O3J#W;#PQ8+?J*.2S.4*-
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MD"SO_&*+%UCM\FT<>9"(JE/\A/&G;/&LM^Z[YO,[X'7W)$:)S3#9UBC]UV$
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M 7<_>(K263J9QJ2!U$E4#C%(SR+4+<NGH-C^2NJL#VB6HF[E2:10%0HS\T@
M8>GA,5D#*<>]5?'A$/S-6M#,ZQ\^'!) !-SF;)\\O".?FYVET@:?ZUKKN_:
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M;6<P,#(N9VEF4$L! A0#%     @ L7R#5JJZE_7S2@  _U   !P
M     ( !56,# &%O<G0M9&5F,31A7S U,38R,VEM9S P,RYG:6902P$"% ,4
M    " "Q?(-6^'<7<5"%  !:A@  '               @ &"K@, 86]R="UD
M968Q-&%?,#4Q-C(S:6UG,# T+F=I9E!+ 0(4 Q0    ( +%\@U;HG>5"*WX!
M %.$ 0 <              "  0PT! !A;W)T+61E9C$T85\P-3$V,C-I;6<P
M,#4N9VEF4$L! A0#%     @ L7R#5F8(N Y.ZP  ?O(  !P
M ( !<;(% &%O<G0M9&5F,31A7S U,38R,VEM9S P-BYG:6902P$"% ,4
M" "Q?(-6L(G)GP@Z  #).@  #               @ 'YG08 <')O>'DP,#$N
M:G!G4$L! A0#%     @ L7R#5B$>A_\N 0  E@$   P              ( !
F*]@& '!R;WAY,# R+FIP9U!+!08     #0 - 'P#  "#V08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
